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Abstract 
The cross-sectional Biomarkers Study was undertaken in Canberra, Australia (2000-
2002) to examine the role of psychosocial factors in the socioeconomic health 
gradient, via physiological changes consequent upon activation of the neuroendocrine 
stress response.  
 
The study population was derived from healthy 40-44 year old men and women 
already participating in a longitudinal cohort study. Using data from the cohort study, 
four groups with similar occupational status were formed. The study sample was 
randomly selected within these groups, thus representing the socioeconomic 
spectrum. 
 
A pilot study involved 60 participants with blood and saliva samples measured on 
two occasions. A further 302 people had blood and saliva samples taken on one 
occasion. Socioeconomic status was measured by occupational code and status, 
personal and household income, education and perceived position in the community 
and in Australia. Psychosocial and behavioural factors, including job strain, job 
security, coping style, anxiety, depression, optimism, self-esteem, sense of belonging 
and trust, social support, smoking, exercise and alcohol intake were assessed by self-
report. Five biological parameters: plasma fibrinogen, glycated haemoglobin, waist-
hip ratio, serum neopterin and salivary IgA were measured as outcome variables. 
Three hypotheses were tested: 
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1. There is a socioeconomic gradient in measures of psychosocial stress, and of 
psychological resilience. 
2. There is a socioeconomic gradient in biological measures that have a plausible 
association with future disease. 
3. Psychosocial factors mediate the demonstrated association between 
socioeconomic status and the biological measures.  
Data analysis confirmed a socioeconomic gradient in some psychosocial and 
behavioural variables: economic strain (r=-0.44, p<0.001), job demands (r=0.45, 
p<0.001), job control (r=0.26, p<0.001), active coping style (r=0.28, p <0.001), sense 
of optimism (r=0.24, p<0.001), social capital (r=0.26, p<0.001), job security (r=0.17, 
p=0.002), job marketability (r=-0.16, p=0.005), sense of belonging (r=0.22, p<0.001), 
number of adverse life events (r=-0.13, p=0.01) and positive interaction with family 
and friends (r=0.20, p<0.001 ), vigorous physical activity (r=-0.16, p=0.002), alcohol 
consumption (r=0.30, p<0.001) and smoking status (r=-0.25, p<0.001). There was no 
socioeconomic gradient in anxiety, depression, neuroticism, hostility, locus of 
control, self-esteem, perceived stress or mental health (SF-12). Four of the five 
biological markers varied with socioeconomic status: plasma fibrinogen (female (F): 
r=-0.26, p=0.002, male (M) r=-0.08, p=0.30), glycated haemoglobin (F: r=-0.23, 
p=0.01, M: r=-0.11, p=0.17), waist-hip ratio (F: r=-0.19, p=0.03, M: r=-0.27, 
p<0.001), serum neopterin (F: r=-0.21, p=0.009, M: r=-0.04, p=0.56), salivary IgA 
(F: r=-0.07, p=0.38, M: r=0.004, p=0.97). A more adverse biological profile was 
associated with lower socioeconomic status. Work characteristics, coping style, 
smoking and exercise were particularly important mediators of the association 
between the biological markers and socioeconomic status. Particular psychosocial 
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factors were consistent mediators of the association between specific biomarkers and 
socioeconomic status (with little variation for different measures of socioeconomic 
status). However, the particular psychosocial factors providing significant mediation 
varied for the different markers.  
 
In this sample of healthy 40-44 year olds, four out of five biological markers showed 
moderate socioeconomic variation with a more favourable profile associated with 
higher SES. The data provide limited support for the importance of psychosocial 
factors in the socioeconomic health gradient. 
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Glossary 
Acrophase: The time of the day when an individual is typically at his/her highest 
level of the characteristic of interest. 
 
Acute phase response: a physiological response to injury (and probably stressor 
exposure), mediated by cytokines and glucocorticoids, which results in the hepatic 
release of acute phase proteins (including fibrinogen, haptoglobin and C-reactive 
protein), as well as mediators of pain, leukocyte trafficking and vessel permeability.  
 
Adrenocorticotrophin hormone (ACTH): a hormone released from the anterior 
pituitary gland under control of CRH and negative feedback control from cortisol 
levels. ACTH stimulates the adrenal cortex to produce glucocorticoids, of which 
cortisol is of primary importance in human physiology. 
 
Autonomic nervous system (ANS): A subdivision of the motor nervous system of 
vertebrates that regulates the internal environment. It consists of parasympathetic and 
sympathetic divisions. 
 
Corticotrophin releasing hormone (CRH): produced primarily by the parvocellular 
neurons in the paraventricular nuclei of the hypothalamus and stimulating the anterior 
pituitary release of ACTH. There are also CRH-producing neurons in the 
paragigantocellular and parabranchial nuclei of the medulla and the locus coerulus 
allowing communication between the fast and slow stress responses. 
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Cortisol: a steroid hormone released from the adrenal cortex. Cortisol has multiple 
effects on the metabolic system resulting in increased blood glucose and may 
suppress the immune system. 
 
Cytokines: protein factors secreted by macrophages and helper T cells as regulators 
of neighbouring cells, e.g. tumour necrosis factor alpha (TNF-α), interleukin 6 (IL-6). 
 
Gini coefficient: A quantitative measure of inequality, based on the Lorenz curve. 
The higher the Gini coefficient, the greater the level of inequality. 
 
Glucocorticoid receptor (GCR): the cytoplasmic receptor to which glucocorticoids 
attach to exert their intranuclear action on target genes. 
 
Hypothalamic pituitary axis (HPA): Incorporates the hypothalamus, hormone 
releasing factors, the anterior and posterior pituitary and the hormones released from 
these regions. 
 
Interleukins: specific cytokines released by different T cells of the immune system. 
Currently interleukins are labelled 1-15, i.e. IL-1, IL-2 etc. 
 
Lymphocytes: A family of white blood cells. Lymphocytes that complete their 
development in the bone marrow are called B cells, and those that mature in the 
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thymus are called T cells. T cells are further differentiated based on a cluster of 
differentiation (CD) number, e.g. CD 4. 
 
Parasympathetic nervous system (PNS): A division of the autonomic nervous 
system, that enhances body activities that gain and conserve energy, such as digestion 
and reduced heart rate. 
 
Sympathetic adrenal medullary (SAM) system: The combination of the pathways 
of the sympathetic nervous system and the adrenal medulla, activation of which 
results in the release of adrenaline. 
 
Sympathetic nervous system (SNS): A division of the autonomic nervous system 
that generally increases energy expenditure and prepares the body for action. 
 20
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Chapter 1.  
Introduction 
Health is a state of complete physical, mental and social well-being and not merely 
the absence of disease or infirmity.  Preamble to the Constitution, WHO, 1946 [1] 
 
Everyone has the right to the enjoyment of the highest attainable standard of physical 
and mental health. International Conference on Population and Development, Cairo 1994 [2] 
1.1 Health and hierarchy 
This thesis investigates aspects of health and socioeconomic inequality and how these 
interrelate. Beginning from a basis of socioeconomic difference, it examines variation 
in a number of psychosocial factors and how these might mediate socioeconomic 
variation in physiological measures that are plausible precursors of ill health. The 
research is nested within the broader framework of the socioeconomic determinants 
of health, which have been widely documented in most developed countries, 
including Australia. Briefly, research indicates that in most developed countries and 
for most health outcomes, there is a positive gradient in health in relation to 
socioeconomic status (SES), regardless of the health and SES measures used [3]. This 
is a consistent finding and notably, is not just a difference between the most deprived 
groups and all others. Rather, it is a finely grained association, present throughout the 
whole range of socioeconomic status [3]. This characteristic of the association is 
extremely important – at any point on the socioeconomic health gradient, people have 
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better health than those below them and worse health than those above. That is, 
poorer health outcomes are not only a result of absolute deprivation or poverty, but 
also of relative deprivation.  
 
Difference is a basic attribute of nature. Genetic diversity, tempered or enhanced by 
the environment, has been responsible for the evolution of all life. Natural selection 
and “survival of the fittest” are inequality-based processes. Why did individuals of 
some species survive adversities such as ice ages, to ensure continuation of their 
species, when others died? Whether due to differences in physical features, survival 
following injury, or intelligence in choices, inequality has framed evolution. But 
humankind is special – for the first time a species is not primarily at the mercy of 
nature’s selective pressures, but rather, through the development of culture, has been 
able to subvert the process, mould nature to its own purposes and to flourish, even in 
apparently hostile environments, almost without restraint [4]. 
 
The physical evolution of animals has been accompanied by the evolution of 
societies, in which each individual has a place and a role. Bee societies contain 
workers, drones and a queen, each with different roles. In ant colonies there are 
workers, males and a queen, with some colonies having subdivisions of the worker 
caste, with different roles. Many higher animal species display social dominance 
hierarchies, in which the strongest assume leadership roles. Weaker or less able 
individuals adopt, or are forced to adopt, subordinate roles. Animal research indicates 
that such social hierarchies are also associated with hierarchies of health [5]. In a 
somewhat circular manner, the fittest are dominant and the leaders have the best 
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health. Those who are subordinate suffer poorer health and those with poorer health 
are subordinate [5, 6].  
 
Modern human societies also tend to be characterized by dominance hierarchies, 
based on those attributes typically used to denote socioeconomic status – education, 
occupation, wealth and income. As in animal hierarchies, there is a health cost to 
being in a lower socioeconomic position. As Evans writes, “Top people live longer” 
[3]. Such socioeconomic variations in health have been observed over many centuries 
[7]. 
 
With the recognition, late in the nineteenth century, of the importance of infectious 
agents in disease causation, the biomedical model, including the belief that a specific 
agent caused each particular disease, was prominent in health research [4]. Humans 
were considered as being composed of interacting but separate “systems”, each 
available for study by different specialists. Physiologists studied biological processes, 
psychologists the mind, neurologists the nervous system, endocrinologists the 
endocrine system, immunologists the immune system and sociologists the social 
environment in which humans lived. In the last thirty years the threads from these and 
other disciplines have been brought together in hypotheses that emphasise the 
importance of the social environment as well as individual psychological attributes, 
drawing on new knowledge of the pathways through which social and psychological 
experiences are embodied and thus may affect health [3, 7]. 
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While the biomedical model is a useful framework, it fails to span the breadth of 
influences on health. The social environment somehow affects individual psychology, 
physiology and even the immune system. In fact, each component sphere of influence 
has a bi-directional relationship with each other component and research has actively 
attempted to delineate the nature of these relationships. While much work remains to 
be done, it is clear that over the billions of years of evolution, complex systems have 
developed to deal with the complex challenges of a changing internal and external 
environment.  
 
The current study aims to further inform the search for the routes by which health is 
associated with socioeconomic status. The literature distinguishes between 
fundamental, distal and proximal causes of health inequalities. Proximal causes are 
those immediately preceding diseases – smoking causes lung cancer. They typically 
act on individuals. Distal causes act via proximal causes to produce disease. One 
might question why people continue to smoke despite clear evidence that it causes 
lung cancer. The answer may be found in societal processes that induce teenagers to 
start smoking and produce a disparity in the ability to cease smoking later in life [8]. 
Fundamental causes are the root causes that are not themselves caused by something 
higher up the causal chain. Some would say that socioeconomic status is a 
fundamental cause of disease [9]. Certainly a hierarchical social structure is common 
in primate species (including Homo sapiens), and is associated with health disparities 
[6]. As a fundamental cause, socioeconomic status underlies the societal processes 
that are distal causes and these in turn determine the proximal causes of disease.  
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1.2 The social structure of disease 
Several models have been constructed to depict the hierarchy of disease causation. 
Two are presented in Figures 1.1 and 1.2. 
 
Each model emphasises the many layers involved in disease causation, in particular 
the importance of factors upstream of, or distal to, the individual. Social structure is 
depicted as a fundamental cause of health, while the social, community and work 
environments act through individual factors to affect the health of individuals, and 
thus cumulatively the health of populations. 
 
Figure 1.1. The Dahlgren and Whitehead model of the source of health inequalities 
1991(cited in [10]) 
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Figure 1.2. An approach to sketching in the environmental, psychosocial, and biological 
pathways linking socioeconomic status to diabetes mellitus (DM), coronary heart 
disease (CHD), and well-being. Adapted from [11] 
 
 
 
 
 
 
 
 
 
 
 
Marmot’s model (Figure 1.2) more explicitly addresses the routes by which distal 
factors are embodied in individual pathophysiological processes, with modulation by 
health behaviours and genetic heritage. But, perhaps necessarily, each model is 
greatly simplified with a lack of feedback arrows from the final health effects on the 
individual, back to the more distal determinants. In reality, there is a dynamic 
interaction between the social, community, and work situations and individual health 
and well-being.  
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1.3 The Biomarkers Study 
This thesis examines the most proximal pathways – the end-point where proximal, 
distal and fundamental causes are translated by biological processes into biological 
aberrations and subsequent ill health. It is based on a psychosocial hypothesis of the 
causation of socioeconomic health inequalities – that psychosocial factors, working 
both distally and proximally, are somehow embodied and alter disease susceptibility. 
This is a study of healthy middle-aged individuals, the age at which, in many studies, 
health inequalities are most marked. In some studies it is difficult to be sure that the 
measured psychosocial factors preceded the disease, and are not a result of the disease 
process. The current study does not examine disease outcomes; rather it examines 
biological measures that are plausible associates of an early disease process. 
Measured on blood and saliva, there can be no question of reverse causation. Thus, 
although this is a cross-sectional study with temporal limitations in regard to causal 
inference, the use of biological markers overcomes the possibility of reverse 
causation and justifies the use of mediation analysis, which uses a causal framework.  
 
Specifically, the thesis aims to investigate the following hypotheses: 
1. There is a socioeconomic gradient in measures of psychosocial stress, and of 
psychological resilience. 
2. There is a socioeconomic gradient in biological measures that have a plausible 
association with future disease. 
3. Psychosocial factors mediate the demonstrated association between 
socioeconomic status and the biological measures. 
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The psychosocial hypothesis suggests that there is a differential distribution of 
personality characteristics and of psychosocial stress, such that those of lower 
socioeconomic status suffer more stress and have a lesser ability to manage this 
stress, through poorer coping styles, lower self-esteem etc. The bodily stress 
response, mediated by the neuroendocrine system, results in alterations to body 
physiology that may ultimately cause disease. 
1.4 The study setting 
The research is set in Canberra, the capital of Australia and its immediate 
surroundings, including Queanbeyan, a satellite town in neighbouring New South 
Wales. Canberra is a small city, with a population of 312,000 people, while 
Queanbeyan has a population of 31,000 [12]. The Australian Federal Government is a 
major employer in the region.  
 
Australia has a system of universal medical insurance, Medicare, which provides 
subsidized medical care to all residents, regardless of age or circumstances [13]. 
Medicare pays a fixed rebate for service, but there is no legislation restricting the 
amount a doctor can charge for a service. Patients pay the gap between the fee set by 
Medicare and that charged by the doctor. Most general medical visits in the region 
entail an out-of-pocket cost of at least $10-$20. Heavy users, or those on government 
welfare programmes, have access to a health care card that allows them free medical 
care. Young and colleagues studied use of medical services in Australia and found 
that lower SES was associated with lower out-of-pocket costs, suggesting that there is 
 29
some adjustment by the health care system for income inequity [13]. Australia-wide, 
30.5% of the population has private health insurance in addition to Medicare. 
 
Compared to the rest of Australia, Canberra has an affluent population – indeed, in 
the 2001 census, the Australian Capital Territory (ACT) had the highest median 
weekly individual income (for people aged 15 years and over) of any state or territory 
in Australia ($500-599, compared to $300-$399 for Australia). It is a young city, 
having just celebrated its 90th birthday, and carefully planned – the result of an 
architectural competition. The plan includes designated open space, delineated 
suburbs each with a local shopping centre, arterial bus routes for public transport and 
a mix of housing types in most suburbs. The Canberra climate is hot in summer, with 
an average temperature of 27ºC, but with frequent days over 30ºC and occasional 
days over 40ºC. In winter, the average temperature is 11ºC, but with overnight 
temperatures commonly below freezing. Houses use a range of heating methods, 
including wood fires, freestanding electric and gas heaters and central heating. 
Smoking is banned in most indoor workplaces, in most restaurants and in public 
transport. Such community characteristics are important in determining access to 
health care, exposure to noxious environmental factors (such as smoke from wood 
fires and temperature extremes) and favourability of the environment for positive 
behavioural activities (such as exercise and not smoking). In addition, the forced mix 
of housing within suburbs may have implications for social cohesion within 
neighbourhoods.  
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1.5 Thesis outline 
I begin the thesis with a review of the health inequalities literature (Chapter 2). 
Following an examination of the wider literature on the types of inequalities in health 
in the modern world, the chapter moves on to describe the nature and the causes of 
the socioeconomic variation in health. Several competing (and overlapping or 
complementary) hypotheses have been developed to explain the socioeconomic 
determinants of health, and the supporting evidence for these is explored. The review 
then focuses on the hypothesis that psychosocial factors are important in the causation 
of socioeconomic health inequalities, as this hypothesis forms the basis of the thesis. 
From there, I review the rationale for the study and identify the contribution that this 
project can make to furthering our understanding of this important area. 
 
The study investigates the routes by which socioeconomic status “gets under the skin” 
to affect health. As such it has a strong biological emphasis. In order to understand 
how this biological embedding may operate, in Chapter 3, I outline the physiology 
that underpins the psychosocial hypothesis wherein wide-ranging effects on multiple 
body systems cause physiological alterations, mediated by the neuroendocrine 
system. This leads to an examination of the rationale for using biological outcome 
variables and the requirements of an ideal marker. Finally, I outline the measures 
chosen and review each of these in some detail to show how they plausibly link to 
both the psychosocial hypothesis and to disease outcomes.  
 
Chapter 4 outlines the methodology used in the Biomarkers Study. Several measured 
and derived aspects of SES were examined and their measurement is outlined. I detail 
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the mechanics of data collection and the analysis of the biological samples. This 
investigation was undertaken as a sub-study of the Personality and Total Health 
(PATH) Study, which is briefly described. The origin and derivation of the 
psychosocial measures is outlined. Procedures for data collection, recording, 
manipulation and analysis are presented as well as information on the response rates 
and the likely representativeness of the study sample. The study limitations are 
discussed, as are sources of error and bias. 
 
The results of the statistical analysis are presented in Chapter 5. This includes an 
examination of the correlation between different measures of SES (including 
childhood SES), as well as the variation of biological and psychosocial factors by 
different measures of SES. The chapter presents the results of the mediation analysis 
for each biological marker in which psychosocial, behavioural and biological factors 
are tested as mediators of the association between each marker and each measure of 
SES. 
 
Chapter 6 presents the discussion of these results, within the context of the wider 
research knowledge. The value of each biological marker as an outcome variable for 
this type of research is examined. In particular the results are discussed within the 
framework of the psychosocial hypothesis with an assessment of the level of support 
that this research provides, for the hypothesis. The Biomarkers Study presents an 
assessment of the socioeconomic variation of a wider variety of psychosocial factors 
than has previously been undertaken. Such variation is a critical part of the 
psychosocial hypothesis, and the study explicitly examines the variation of not just 
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psychosocial stressor exposure, but of elements of psychosocial resilience. By using 
healthy individuals, and biological measures as the outcome variables, the study 
avoids the problem of reverse causation, while using middle-aged individuals aims to 
measure the age group for which socioeconomic health inequalities have been 
greatest in previous research.  
 
Chapter 7 concludes the dissertation with a brief summary of the findings and 
suggestions for future research directions. While this thesis is based on the 
examination of associations in individuals, the biological translation of external 
experiences is recognised as a final pathway by which wider political, social and 
economic forces influence the health of individuals and populations. The population-
level implications of the current research and of the psychosocial hypothesis are 
discussed. 
 
In the last thirty years there has been an increase in interest, and significant progress 
made, in describing and understanding the socioeconomic determinants of health. 
Distinct groups of researchers have proposed and championed particular hypotheses 
of causation and often presented these as competing and exclusive theories. They are, 
I believe, not competitive but complementary, and different aspects of the same 
complex story, with a final common pathway via psychosocial effects, indirectly on 
proximal behavioural risk factors and directly via the neuroendocrine stress response 
and subsequent physiological change. This thesis examines this final common 
pathway, to provide supporting evidence for its existence and importance. 
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Chapter 2. 
Literature Review 
2.1 Introduction 
Health is central to the continuity of human life. To some extent it is determined by 
genetic heritage. But environmental influences moderate the expression of that 
heritage and the net effect is an unequal distribution of health and disease. 
 
Research and thought from many disciplines permeates the health inequality literature 
– from physiology and medicine, to sociology, psychology, and economics. This 
chapter briefly spans the breadth of this research with a gradually narrowing focus, 
culminating in the identification of my specific research questions. 
 
I begin with some general comments about inequalities in health and then focus on 
socioeconomic inequalities in health. After considering the global picture, I review 
the international literature and the situation in Australia. I explore the various theories 
of causation for this phenomenon and then focus on the psychosocial hypothesis in 
some depth. The following sections narrow the focus further to explore the rationale 
for looking for markers of health disparities due to socioeconomic status, the qualities 
that would be desirable in such markers and then the logical possibilities from current 
knowledge of physiology. I finish the chapter by identifying three research questions, 
aimed at clarifying aspects of the psychosocial explanation for socioeconomic health 
inequalities. 
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2.2 Health inequalities 
Health is not a resource that is equally shared among different groups in society, in 
any society. Women live longer than men. Minority groups, and particularly 
indigenous populations who are minority groups, fare badly compared to dominant 
groups. And the wealthy live longer and suffer less ill health than those who are less 
wealthy. 
2.2.1 Gender 
There are gender inequalities in health. On average, women live longer, make more 
use of health services but may experience greater morbidity, than men. “For every 
age group, male mortality is higher than that of females, life expectancy is lower for 
men, men tend to use primary health services less than women, are more likely to 
delay help-seeking when ill and are more likely to adopt health damaging or ‘risky’ 
behaviours” [14]. Research indicates that the determinants of health may be different 
for men and women. Denton suggests that for women, social structural factors, such 
as being in the highest income category, working full-time and caring for a family 
and having adequate social support are more important predictors of good health than 
for men. The relative importance of various behavioural determinants of health may 
also vary by gender, with smoking and alcohol consumption more important for 
men’s health, but body weight and physical inactivity more important for women’s 
health [15].  
 
Some research suggests that ‘gender identity’ has a role in health differences between 
men and women. Health is seen as women’s business and responsibility, rather than 
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men’s; men tend to keep quiet about their health problems and know little about 
men’s health; health and health promotion is ‘female’ and so being a man means 
being denied a self-monitoring role; men delay seeking help and tend to see the body 
as a machine, so that there is an allowance that they don’t deal well with emotions 
and feelings [14]. 
 
In addition, socioeconomic gradients in health may vary by gender. This may, in part, 
depend on the unit of measurement used for socioeconomic status [16] and at least for 
occupational measures may be associated with the differential employment rates and 
types of employment available to men and women [17]. There is likely to be a 
complex interaction between SES, marital status, work and home responsibilities, and 
gender, which affects health. Indeed, over the last forty years there have been such 
marked changes in the employment of women (at least in developed countries) that 
older studies examining gender differences in SES gradients may no longer be 
pertinent. 
 
Gender differences in health probably result, not just from biological differences, but 
also from social and psychological influences, at least for morbidity. Gender may 
modify the effect of SES on health, with some studies showing that for diseases such 
as myocardial infarction, there is a steeper SES gradient for women than men [18], 
while for other diseases, the gradient is less steep, e.g. limiting long standing illness 
[19]. A recent review notes that the gender differential in the SES gradient for 
mortality is apparent only for absolute risk and disappears when the comparison is 
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made using relative risk of mortality [20], suggesting that pathways producing SES 
mortality gradients are similar for men and women. 
2.2.2 Ethnicity 
Minority groups and particularly indigenous populations who are minority groups, 
tend to have poor health compared to the rest of the population. In addition, in many 
countries indigenous people disproportionately occupy lower socioeconomic groups. 
For example, in New Zealand only 13% of Maori earn $30,000 or more, compared to 
the New Zealand average of 21.6%, and only 2.6% of Maori achieved a tertiary 
degree in 1996/7, compared to the NZ average of 8%. However, even when SES is 
taken into account, Maori still have worse health than non-Maori [21]. 
 
In the 2001 Census, 2.4% of the Australian population identified themselves as 
Indigenous Australians. On average, Indigenous Australians are much poorer than 
non-Indigenous Australians and experience worse health status on every indicator 
[22]. Life expectancy at birth in 1997-99 in Australia was 82.1 years for Australian 
women and 76.6 years for Australian men. We can compare this to the life 
expectancy at birth for Indigenous Australians: 63 years for women and 56 years for 
men [23]. And, while mortality rates are decreasing in Indigenous Australian 
populations, the gap in health between Indigenous and non-Indigenous populations is 
not declining [24]. Indeed this gap remains greater in Australia than in other similar 
countries such as New Zealand and Canada [25]. 
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In addition to poorer education, lower levels of home ownership, lower incomes and 
higher rates of unemployment, Indigenous Australians are more likely to be classified 
as obese and are about twice as likely to smoke as non-Indigenous Australians [24]. 
But these factors do not fully explain the difference in health between population 
groups. Recent research in Indigenous Australian populations highlights the 
importance of the social environment, including the immediate local environment, 
friends, family and community and the perception of mastery or control, both in the 
workplace and the wider society, to health (Trudgen, 2000, cited in [24]). 
 
In Canada, the average life expectancy of Registered Indians is approximately six 
years less than the overall Canadian population (Canada 1998, cited in [26]). This 
represents an improvement since 1990, when the life expectancy of male and female 
Registered Indians was 66.9 and 74.0 years respectively, compared to the total male 
and female Canadian population of 73.9 and 80.5 years respectively (Canada, 1996a 
cited in [26]).  
 
What causes the poorer health of indigenous populations, over and above that related 
to SES and to the higher prevalence of health damaging behaviours, and can these 
causes inform research on disparities that are related to SES? 
 
Indigenous populations vary significantly in culture and traditions, but most view 
health much more holistically than in western culture [21]. “Aboriginal people from 
almost every culture believe that health is a matter of balance and harmony within the 
self and with others, sustained and ordered by spiritual law and the bounty of Mother 
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Earth” (Royal Commission on Aboriginal Peoples Volume 3, cited in [26]). Health 
includes not only physical health but also social and emotional well-being, spirituality 
and the well-being of family and community groups [27]. The apparently all-
encompassing definition of health adopted by the World Health Organization (see 
Introduction), appears narrow and individualistic in comparison.  
 
The origins of ethnic disparities in health may include genetic, cultural or 
socioeconomic causes. But, in addition to questions of access to services, and 
material explanations, experiences of racism may be important determinants of ethnic 
health inequalities [28].  
2.3 Health and Socioeconomic status 
2.3.1 Introduction 
For countries with a gross national product (GNP) per capita of less than about 
$5000, there is a clear relationship between GNP and life expectancy. The 
relationship is quite steep, with small increases in per capita income related to large 
increases in life expectancy [29]. See Figure 2.1. 
 
This is hardly surprising. At low levels of GNP per capita the driving forces of 
maternal, infant and childhood deaths are malnutrition and infectious diseases. As 
GNP increases, living conditions improve with resultant improvements in life 
expectancy. 
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So it has been over history. As developed countries have grown economically, and 
have undergone social modernization, public health initiatives have dealt with the 
hazards related to the physical environment – clean water, sanitation, nutrition and 
immunization, and this has been reflected in increases in life expectancy. But beyond 
about $5000 per capita, the relationship between GNP and life expectancy weakens; 
countries with the highest GNP are not necessarily those with the greatest life 
expectancy.  
 
Figure 2.1. Life expectancy and income for selected countries and periods (World Bank, 
1993, cited in [29]) 
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Within countries, the shape of the curve linking socioeconomic status to health is 
remarkably similar to that between countries, i.e. the greatest gains in health are made 
from the lowest levels to the middle levels of SES, while the curve flattens with 
higher SES [30]. This relationship holds for most measures of socioeconomic status 
and for many health outcomes. 
2.3.2 Historical Background 
Observations of the presence of socioeconomic inequalities in health are not new. 
Antonovsky notes that lower life expectancy and higher death rates in the lower 
classes have been observed since the 12th century, when data on this question were 
first organized [31]. In 1848 Virchow, recognized that socioeconomic position was an 
important determinant of the factors driving infectious epidemics of typhus and other 
illnesses [32]. William Farr, in 1885, wrote, “the lifetime of sovereigns and peers is 
prolonged” [33]. At that time “the mean lifetime in the healthiest districts of England 
– and in the healthiest ranks – is 49 years; and we have no evidence that under the 
most favourable conditions it exceeds 50 years.” 
 
During the late 19th century and the first half of the 20th century, the study of health 
became focused on the individual, with research centred on individual risk factors for 
disease. But in the 1960s there was a resurgence of interest in the issues of 
socioeconomic and racial inequalities in health, although it was thought that this was 
mainly caused by disparities in access to health care [32].  
 
 41
Meanwhile, in the early part of the 20th century, interest increased in the social 
production of health, beginning perhaps with Donnison’s book “Civilisation and 
Disease” in 1938, which theorised that the interaction of an individual with his/her 
social environment was a principle cause of disease. In 1949, Halliday’s book, 
“Psychosocial Medicine: A Study of the Sick Society” built on Donnison’s theory, 
with extension to a wider range of disease outcomes and causative factors, including 
urbanization, increasing instability of society and occupational exposures (cited in 
[5]). In 1974, Lalonde advanced the health field concept which “linked the macro 
structures of the social and physical environment……with the micro factors of 
lifestyle and biology” [34]. For the first time, it was proposed that access to health 
care, particularly physician and hospital care, was not a principle determinant of 
health disparities. 
 
Psychologists postulated that emotion was a driving force in the evolutionary 
development of human biology [5]. The intrinsic rewards, via the limbic system, of 
species-preservative and self-preservative activities acted to reinforce these activities 
to ensure survival. The neuroendocrine components of emotion were beginning to be 
researched and understood. 
 
Physiologists such as Cannon and Selye began to elucidate the neuroendocrine 
pathways involved in stress and distress in the early to mid 20th century. And in 1953, 
Wolff’s book “Stress and Disease” showed that laboratory induced stress could cause 
adverse changes in almost any human body system [5]. Holmes and Rahe extended 
this work to show that disease could also be associated with stressful life events [35]. 
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In the mid-1970s Cassel proposed that not only psychological stress, but also the 
social environment, including dominance hierarchies, marginal social status and lack 
of social support, worked via neuroendocrine mechanisms to alter host susceptibility 
to a wide range of diseases [36]. Susser et al (1985) suggested that individuals of 
lower social status experienced more stress-related alterations of physiology in 
response to any particular stressor, as a result of poorer coping abilities (cited in [34]). 
Berkman and Syme found a link between having fewer social ties and an increased 
risk of mortality over nine years of follow-up [37]. There was both theoretical and 
empirical support for the importance of psychological and social factors in 
determining health. 
 
The release of the findings of the first Whitehall study of British civil servants, in 
1978 was a watershed in the development of research into health inequalities [38]. 
Previous explanations of the socioeconomic gradient in health had focused on poor 
health in those in the lower classes, with explanations including poor housing, 
crowding, poor education and unemployment, resulting in poor nutrition, poor 
medical care and increased exposure to noxious agents [7]. But in the Whitehall 
studies, Marmot described not a difference in health outcomes between the highest 
and lowest SES groups, but a gradient of health such that at any point on the SES-
health curve, those just above have better health and those just below have worse 
health, in an employed population with good access to medical care. 
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In the last twenty years, there has been an explosion of interest, research and writing 
on the socioeconomic health gradient. Advances in different disciplines, as outlined 
above, have been drawn together to create theories of causation. Many of these have 
been extensively researched and vigorously debated in the literature. The following 
sections briefly review some of the recent research, the theories generated from it and 
the evidence supporting them. 
2.3.3 Cross-national studies 
In 1979, Rodgers published the first study that suggested a link, not only between 
income and health at the individual level, but between income inequality and health at 
the aggregated level of states and countries [39]. Examining cross-sectional data from 
56 countries relating income and income distribution to health outcomes (including 
life expectancy at birth and at five years and infant mortality), Rodgers found that the 
most consistently significant association was not between absolute income and health 
outcomes, but between income distribution and health outcomes. Those countries 
with greater income inequality had higher infant mortality and lower life expectancy 
than more egalitarian countries.   
 
Wilkinson has continued and extended this line of research. In 1992, he examined the 
association between income distribution and health in 23 OECD countries [40]. There 
was a low correlation between life expectancy and GNP per capita. In addition, the 
correlation between increases in GNP per capita and increases in life expectancy 
(over the sixteen years of 1970/71 to 1986/87) was very low (r = 0.07). Although data 
on income distribution were available for only nine countries, the results were 
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striking: three quarters of the variance in life expectancy was explained by GNP per 
capita and the proportion of income going to those below the seventh decile of 
income for each country. But of the variance explained, less than 10% was 
attributable to GNP per capita. Wilkinson also examined longitudinal data, which 
showed a high correlation between changes in income distribution and changes in life 
expectancy (r = 0.80, p<0.05). Although these findings were based on a small and 
select group of countries, Wilkinson concluded that, “Overall, there is clear evidence 
of a strong relation between a society’s income distribution and the average life 
expectancy of its population.”  
 
Similar results were found in a cross-sectional comparison of US states with respect 
to income distribution and mortality (strong association between increased income 
inequality and mortality (r = 0.54, p<0.05) even after adjustment for poverty) [41]. 
Greater income inequality was also associated with higher rates of homicide and 
violent crime, higher rates of unemployment, poor social cohesion and a smaller 
proportion of total spending on education [42]. Kawachi et al went on to investigate 
and theorise the causes of these associations, concluding “ A large gap between rich 
people and poor people leads to higher mortality through the breakdown of social 
cohesion” [43]. 
 
A number of studies internationally have supported the income inequality finding. For 
example, a longitudinal study of 21 regions in Taiwan reported that income inequality 
replaced absolute median income as the best predictor of mortality, during the course 
of economic growth [44]. Hales et al (1999) showed that income distribution had a 
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stronger association with infant mortality than GNP per capita, except in poorer 
countries [45].  
 
These studies have led to the elaboration of the hypothesis that relative, rather than 
absolute, income is important to the health of individuals. More egalitarian countries 
have greater life expectancy and lower mortality and morbidity – the theory suggests 
that psychosocial pathways may be important, with individuals in less egalitarian 
countries perceiving themselves as relatively deprived and developing poorer health 
through the direct effects of chronic mental and emotional stress and the indirect 
effects of health-damaging behaviours [46].  
 
However, while both the relative income hypothesis, and the role of social cohesion 
or social capital in explaining the importance of relative income to health have gained 
a considerable following, not all studies support the importance of income inequality 
to health. Studies with similar methodologies have produced conflicting results and 
there has been criticism of the interpretation of the results of Wilkinson’s original 
study. 
 
Comparison of provinces within Canada indicated that income inequality was not 
significantly associated with mortality after adjustment for median household income 
[47], while within Denmark, parish income inequality was not associated with 
mortality, but individual household income was [48]. In their study of small areas in 
the United States, Fiscella and Franks found that community level income inequality 
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showed a significant association with subsequent community mortality, but that this 
effect was lost when adjustment was made for individual household income [49].  
 
More recently, Lynch et al have re-examined the association between income 
inequality and health, using data from the Luxembourg Income Study. When data 
from the nine countries of the 1992 Wilkinson paper were examined, there was a 
statistically significant association between income inequality and life expectancy in 
1989-92 (r = -0.45) (compared to r = 0.86 between more equal income distribution 
and life expectancy in the 1992 paper [40]. However, when a further seven countries 
were added to the analysis, the association disappeared (r = -0.09) [50]. Indeed, the 
graphs presented in this paper suggest that the negative correlation between the Gini 
coefficient and life expectancy at birth is driven largely by data from the United 
States (USA) and the United Kingdom (UK).  
 
Studies examining the links between income inequality and health in the US states 
(which have provided the strongest evidence for the relative income hypothesis and 
the role of social capital) have also been repeated. Statistical adjustment for ethnicity 
[51] or for education [52] has been separately shown to account for all of the 
association between income inequality and health. However, other studies continue to 
confirm the differences in health outcomes for US states by their level of income 
inequality [53] even after such statistical adjustment. Even after controlling for 
personal characteristics and household income, individuals living in states with the 
highest levels of income inequality were 30% more likely to report their health as fair 
or poor than individuals living in more egalitarian states. Such effects were more 
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marked among those on low incomes (<$20,000 per year) than those on middle 
incomes (20% higher than more equal states) or high incomes (no effect). 
 
Ecological studies compare populations and taking account of individual level 
variables adequately is difficult. Gravelle postulated that the relationship of income 
inequality to health is a statistical artefact resulting from the shape of the curve 
relating individual income to health [54]. Studies suggest that health is approximately 
linearly related to the logarithm of income in all except very high and low incomes 
(thus increasing income is associated with better health, but the returns diminish at 
higher levels of income) [55]. Thus in more unequal societies, transferring income 
from the poor to the rich will result in greater losses of health in the poor than gains in 
health by the rich. When income inequality increases, overall population mortality 
will rise, purely because there are more people who are poor – their own mortality 
risk depends on their own income without a need to postulate any direct effect of 
income inequality itself [54]. However, recent simulation studies have failed to 
support Gravelle’s artefact hypothesis and confirm the importance of income 
inequality, independent of personal income [30]. 
 
It is difficult to reconcile such conflicting findings. Statistical artefact probably does 
not explain the association between income inequality within countries, and their 
health outcomes. Wilkinson suggests that an effect of income distribution is not seen 
when small areas are examined, since small areas tend to be relatively homogeneous 
with respect to income [56]. But cross-national studies have also delivered conflicting 
results.  
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Pearce suggests that there may be an association between income inequality and 
health, but that this is not automatic [51]. Rather it depends on the social, political and 
cultural environment in which income differences are experienced and is enhanced in 
those countries that also systematically under-invest in safety nets for people in 
unfavorable circumstances [47, 51, 57, 58]. The association may be diminished by 
policies that ensure access to primary medical care [59] and education [52]. Coburn 
proposes that the decline of the welfare state is central; it is not so much income 
inequality that creates poor social cohesion and ill health, but neo-liberalism that 
creates all three [60]. 
2.3.4 Country-level studies 
One of the first epidemiological studies to examine the socioeconomic health 
differential was published in 1973, by Kitigawa and Hauser. Using data from the 
1960 Matched Records Study and the Chicago Area Study, they found a strong 
inverse relationship between education (years of schooling) and mortality for four 
race and sex classes, in individuals aged 25-64, but not in those over the age of 65. A 
similar relationship was found when income was used as the socioeconomic measure, 
but multivariate analysis suggested that the education and income were independently 
associated with mortality, rather than alternative measures of a single construct [61].  
 
The Black Report, released in 1980, was commissioned by the British Labour 
Government, to assess the evidence on health inequalities in the United Kingdom and 
provide policy recommendations. Using an occupational class measure of 
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socioeconomic status, the report showed that in 1971, members of the lowest class 
experienced a mortality rate more than twice as high as members of the highest class, 
even after controlling for age and sex. In addition the report found that health 
inequalities had increased over the preceding 30 years, despite the introduction of the 
National Health Service, which was intended to provide equal access to health care 
for all [62]. 
 
As well as describing the presence of health inequalities, the report outlined four 
possible explanations for the socioeconomic health disparity: 
• Artefact. 
• Natural/social selection.  
• Materialist/structural explanation 
• Cultural/behavioural explanation 
I return to these in more detail in a subsequent section (section 2.4), but by outlining 
these possible explanations for socioeconomic health inequalities, the Black Report 
supplied a framework for subsequent research. 
 
More recently the Acheson report has reviewed the progress made since the Black 
Report in the reduction of health inequalities in the UK [63]. Health inequalities 
persist - the life expectancy of a baby boy with parents in the professional or 
managerial groups is estimated to be about 5 years more than one born to parents in 
partly skilled or unskilled occupations; life expectancy at age 65 is 2.6 years greater 
for men and 2 years greater for women, from the professional and managerial groups 
than for those who are partly skilled or unskilled. The report emphasises the breadth 
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of reform that is needed to reduce socioeconomic health inequalities, with a focus not 
only on proximal, but also on the fundamental and distal determinants of health [63]. 
 
Inequalities in health associated with socioeconomic status have been found in most 
countries that have been studied, for a variety of different health outcomes. In the 
Netherlands, Boshuizen demonstrated that Dutch men with higher education have 12 
years longer healthy life expectancy than men with lower education [64]. In Japan, 
lower individual income was strongly associated with poorer self-rated health [65]. In 
New Zealand socioeconomic differentials exist for most health outcomes with lower 
life expectancy at birth, more cancer deaths from smoking, poorer self-rated health 
and higher disability rates in those of lower SES as defined by the NZ Deprivation 
Index [21].  
 
SES gradients are seen for a wide range of diseases, including various cancers [66], 
cardiovascular disease [38], diabetes [67] and respiratory diseases [68] with lower 
SES associated with higher rates of disease. For a few diseases, there is a positive 
SES gradient, e.g. breast, pancreatic, kidney, thyroid and colon cancer [69], while for 
others there is no apparent SES gradient, e.g. cancer of the rectum, prostate, and 
bladder and cancers of the haemopoietic system [69]. 
 
Socioeconomic inequalities in health are not just an issue in affluent countries. In Sao 
Paulo, Brazil during the late 1980s, adults in non-professional jobs had death rates 
two to three times higher than those of professionals; and in Venezuela, poorer 
municipalities have had infant mortality rates three times higher than those in other 
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municipalities [70]. Indeed, health disparities appear to be widening in low and 
middle-income countries, as well as in high-income countries [70].  
 
Population health status is very malleable, over short time spans that rule out effects 
of changes in genetic endowment as the explanation [3]. Rather, health differentials 
appear to alter rapidly with changing social and political circumstances, even for 
diseases whose etiology is based on chronic physiological change e.g., coronary heart 
disease. In Russia, between 1990 and 1994, life expectancy fell from 63.8 to 57.6 
years among men and from 74.4 to 71.0 years among women. This was a time of 
political upheaval and rising income inequality. Heightened violence and increased 
levels of alcoholism may have driven this change, but it is difficult to separate these 
factors from the direct or indirect effects of income inequality, decreased safety nets 
and/or decreased social cohesion as a result of the social and political instability [70, 
71].  
 
Similarly rapid change is evident in the comparison of life expectancy between 
Australia and New Zealand. Prior to 1970, Australia and New Zealand had similar 
trends in life expectancy with a fairly flat curve over time. In the early 1970s life 
expectancy in Australia began to increase faster than in New Zealand and this trend 
persisted for about ten years. Since the early 1980s the two countries have had 
virtually parallel increases in life expectancy, with Australia ahead by one to one and 
a half years. While many causes could be postulated for this difference, the timing 
parallels reductions in welfare funding in NZ in the mid-1970s [72]. 
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In the last fifty years in Japan, there have been dramatic improvements in mortality 
rates, which have gone from being markedly worse than most European countries to 
markedly superior. This improvement does not appear to be due to increased health 
expenditure or beneficial lifestyle changes, although there have been changes in diet 
(more meat protein) and class structure, with a substantial reduction in the proportion 
of self-employed farmers and an increase in the working and middle classes [73]. 
Evans postulates that the improvement in health status may be driven by a change in 
the hierarchical position of Japanese society as a whole, relative to the rest of the 
world [3]. 
2.3.5 Individual-level studies 
In 1978, Marmot published the first results of the Whitehall study looking at 
employed British civil servants. This was a longitudinal study in which mortality over 
several years was related to occupational grade. Marmot et al found that mortality 
from coronary heart disease differed more than three to one from the lowest to the 
highest grades of the civil service [38]. Much of this difference remained unexplained 
after adjustment for traditional risk factors for heart disease – smoking, serum 
cholesterol, blood pressure, glucose tolerance and obesity. Importantly, Marmot 
showed that the difference in health was not simply due to poor health in those in 
poverty – all participants were employed civil servants. Rather this was a gradient in 
health, in which at any point, those higher up the socioeconomic scale experienced 
better health than those below them and worse health than those above them. 
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The second Whitehall study sought explanations for the gradient, in particular that 
seen in coronary heart disease incidence and mortality [74]. In more than 11,000 civil 
servants, adjustment for the traditional cardiovascular disease risk factors (smoking, 
blood pressure, serum cholesterol, age and glucose intolerance) explained less than 
half of the socioeconomic gradient in the incidence of coronary heart disease. A 
measure of workplace job control explained most of the remaining variance [75]. 
 
Other studies examining the causes of SES health differentials have shown mixed 
results. Some have confirmed the findings from the Whitehall II study that traditional 
risk factors for disease fail to fully explain the SES gradient in health [76]. However, 
a recent study found that fourteen measured risk factors almost fully accounted for 
the SES health differential [77]. Social status was measured only by housing tenure 
(renter or owner-occupier), which is a relatively coarse measure of SES. In addition, 
one of the risk factors was plasma fibrinogen, which itself has been shown to be 
elevated with psychosocial job stress [78]. One difficulty lies in determining how 
factors should be entered into explanatory models of the effects of SES on health. 
Adjusting for proximal risk factors such as smoking, physical activity, fibrinogen, job 
stress etc may leave no residual SES effect, but these risk factors may be on the 
causal pathway between SES and health. Such proximal risk factors may mediate, 
rather than confound the SES/health association, i.e. they represent a route from 
fundamental and distal risk factors, to disease.  
 
It is not just physical health that varies with socioeconomic status. In a cross-sectional 
study of adults in the US, there was a strong gradient between lower income and 
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symptoms of depression [67]. Lower income women living in a state with high 
income inequality, were particularly likely to report depressive symptoms [79]. 
 
Subclinical disease also shows a socioeconomic gradient, with asymptomatic men 
and women in their 30’s in lower social classes (as assessed by occupation and 
education) having significantly higher prevalence of coronary artery calcification on 
computed tomography [80]. In Whitehall II, heat shock protein (HSP60) was 
measured as a marker of CHD susceptibility in 229 adults, 45-58 years old. There was 
a significant inverse association between HSP and socioeconomic status [81]. 
 
Although SES inequalities in health are seen at all ages, the greatest disparities occur 
in middle adulthood [82].  
2.3.6 Australian Studies 
In a recent review of Australian research into the association of health and 
socioeconomic status, Turrell and Oldenburg state,  
“Taken as a whole, the evidence on SES and health in Australia is unequivocal: 
those who occupy positions at lower levels of the socioeconomic hierarchy fare 
significantly worse in terms of their health.  Specifically, persons variously 
classified as ‘low’ SES have higher mortality rates for most major causes of 
death, their morbidity profile indicates that they experience more ill-health 
(both physiological and psychological), and their use of health care services 
suggests that they are less likely to act to prevent disease or detect it at an 
asymptomatic stage. Moreover, socioeconomic differences in health are evident 
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for both females and males at every stage of the life-course (birth, infancy, 
childhood and adolescence, and adulthood) and the relationship exists 
irrespective of how SES and health are measured” [83]. 
More than three decades of research has confirmed the presence of significant 
inequalities in health in Australia, with those in lower SES groups having poorer 
health and higher mortality than those economically better off. Early research in the 
1970s and 1980s reported increased all-cause mortality rates in lower SES groups as 
defined by occupational status [84] or occupational group [85]. Middle-aged men and 
women suffered an increased probability of chronic illness (both physical and mental) 
associated with lower income, education [86] and occupation [87]. Although 
mortality rates from ischaemic heart disease decreased by 25% from 1969 to 1978, 
the greatest decline was in upper SES groups [88].  
 
While these early studies largely described the association of health with 
socioeconomic status, some researchers were already beginning to challenge the 
causes of this health gradient. McMichael (1981) stressed “the co-existent influences 
of work environment, socio-cultural environment, and personal behaviour and 
psychological characteristics” in the determination of health [85, 89]. Others tackled 
methodological issues - Najman critically reviewed methods of measurement of 
socioeconomic status for use in health related research [90] as well as noting the 
relative lack of participation in this research of those most severely disadvantaged 
[91]. 
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Family composition and marital status were recognized to be important determinants 
of health, particularly in association with socioeconomic disadvantage. Never 
married, divorced or widowed males of lower occupational status were found to have 
higher mortality rates than other groups [92], while men who had never been married 
had a standardised death rate 124% higher than married men. In a study of social 
participation, Baum found that people with lower incomes were more likely to visit 
their neighbours, but were less likely to visit or be visited by family than those with 
higher incomes. However, there was no correlation between physical health and 
informal social contact, though those with poorer mental health and high social 
isolation reported less informal social interaction [93]. 
 
In 1992, the National Health Strategy published “Enough to make you sick. How 
income and environment affect health”. In this comprehensive summary of the state 
of Australia’s health with respect to SES, the authors noted that those of lower SES 
were more likely to suffer disability, have serious chronic illnesses, suffer recent 
illnesses and to report being in only fair or poor health (as opposed to good or 
excellent health). Similarly the most economically disadvantaged made the most use 
of primary and secondary health services, but were the lowest users of preventive 
services. A number of behavioural risks were more common in those of lower SES, 
including smoking, poor diet and physical inactivity. In addition the importance of 
social support was noted [94]. 
 
More recently there has been considerable research using ecological measures of 
socioeconomic disadvantage to characterize areas. The Australian Bureau of Statistics 
 57
has developed the Socioeconomic Indexes for Areas (SEIFA indexes) in which the 
socioeconomic aspects of areas are summarized using principal component analysis 
of census data [95]. There are five indices, of which the most used in health research 
has been Index of Relative Disadvantage. Using the SEIFA index it is apparent that 
while mortality rates declined between 1985-7 and 1995-7, SES differentials persisted 
and in some instances increased. For example, among males aged 25-64 years there 
has been an increase in mortality inequality for diseases of the circulatory system 
(including coronary heart disease), cancer (including lung cancer) and 
asthma/emphysema. For females, mortality inequality has increased for coronary 
heart disease, diabetes mellitus, cancer and respiratory disease. These patterns have 
tended to be in the form of a differential decrease in mortality for those in more 
advantaged areas rather than an increase in less advantaged areas [68]. 
 
Area effects on health (as opposed to the effects of personal SES on health) have been 
investigated, with research examining the health of individuals in similar occupations, 
in different areas within the same state. Dobson et al found that mortality rates from 
ischaemic heart disease in different areas of NSW did indeed show the usual SES 
gradient, but that rates were higher, for most occupational groups, in the Hunter 
Valley compared with the rest of New South Wales. Particular features of this region 
such as social capital, income inequality etc were not examined [96]. 
 
Health behaviours associated with socioeconomic status have been well studied, such 
as smoking [83, 97] and food consumption patterns [98]. While the expected trends in 
smoking prevalence were demonstrated, with increasing prevalence in lower SES 
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groups as defined by education and occupation, there has been a lack of consistent 
evidence that food consumption patterns vary by SES. 
 
Is income inequality increasing in Australia? 
During the 1990s, income inequality nationally increased significantly, as evidenced 
by an increase in the Gini coefficient (see Glossary) from 0.311 in 1990 to 0.328 in 
1999-2000, with an upward trend throughout the decade. Similarly, those in the top 
ten percent of the income distribution increased their share of total income from 
22.7% in 1990 to 23.9% in 1997-8. While those in the bottom ten percent maintained 
their share of the total income at around 2.5%, the middle 20 percent experienced a 
decline from 17.8% to 17.3% over the same period. Through the 1990s there was 
increasing spatial income inequality, with affluent areas tending to become richer and 
middle and lower order areas becoming less affluent. Overall, while there was little 
change in the relative socioeconomic positions of middle and lower SES groups, 
higher SES groups tended to become more distant from the other groups [99]. 
2.4 Theories of causation 
The Black report outlined four possible causes of socioeconomic health inequalities. 
As listed above, these are: 
• Artefact 
• Natural/social selection 
• Materialist/structural factors 
• Cultural/behavioural factors 
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In addition to these four major divisions of cause, others have proposed subdivisions 
of some of these, combinations and new theories. MacIntyre also notes that there are 
literal and more liberal interpretations of the Black Report’s four causal paths and 
these are briefly outlined [100]. 
2.4.1 Artefact  
The literal interpretation of the artefact explanation is that there is no real 
relationship between health and SES, it is simply an artefact of the measurement of 
health and of SES. The more liberal interpretation is that the magnitude of the 
association may be an artefact of the measurement of both health and class and may 
relate to the relative shrinkage of the poorest occupational classes. However, Fox et 
al found little support for the artefact explanation [101]. 
2.4.2 Natural/Social selection 
The literal version of this explanation suggests that health determines class and less 
healthy people drift to the lower social classes, which thus have the highest mortality. 
The more liberal version suggests social class affects health, but that selection may 
explain some of the observed gradient. The Black Report concluded that there was 
little evidence for drift and its contribution to health inequalities was likely to be 
small [62]. Selection on the basis of health may be one cause of social mobility, 
which is itself separated into intergenerational social mobility (change of SES 
between parents and children) and intragenerational social mobility (change of socio-
economic position after entry into the labour market). Social mobility may in turn be 
mediated not just by health outcomes but health behaviours (smoking, nutrition), 
structural/environmental factors (occupational exposures) and psychosocial stress-
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related factors (life events, lack of social support) [64]. While Dohrenwend concluded 
that in general social causation was more important that social selection in generating 
a socioeconomic health gradient, schizophrenia in young adults was an exception, 
with selection being relatively more important [102]. 
2.4.3 Cultural/Behavioural explanation  
The literal version of this explanation is that the association between SES and health 
is completely explained by health damaging behaviours, such as smoking, poor diet, 
lack of physical activity and inappropriate use of health services. The more liberal 
version suggests that these behaviours contribute to the social class gradient in health, 
but provides no explanation for why there should be a social class variation in these 
behaviours. Notably, the Whitehall studies found a residual SES effect on health, 
after adjustment for health damaging behaviours [74, 78]. Lantz suggests that the 
major health-damaging behaviours explain only a modest portion (10-20%) of the 
SES health gradient [103]. More than twenty years ago Berkman and Syme suggested 
these negative health behaviours may be a form of coping with stressors hypothesized 
to be associated with lower SES [37]. 
2.4.4 Materialist/structural explanation 
This explanation emphasises the role of economic and associated structural factors in 
the distribution of health and well-being. Thus poverty or economic deprivation 
directly influences health through lack of access to health care or health information 
as well as higher exposure to disease-causing processes. The Black Report includes 
the notion of relative poverty in those who have sufficient for their most basic needs 
but lack the means for participation in a wealthy society. 
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 Access to health services 
The Black Report noted that the richer occupational classes made more use of the 
National Health Service than did poorer occupational groups, particularly preventive 
services. Poorer occupational groups consulted their primary health care providers 
less than their counterparts in richer groups when indicators of their greater needs 
were taken into consideration [62]. Thirty years ago, Tudor Hart described this 
“inverse care law” and has recently noted that it “is not a law of nature but of 
dehumanized market economics. It could be unmade by a rehumanized society” 
[104]. 
 
Research in Australia indicates that men and women in low-income families report 
more hospital episodes, outpatient visits and doctor visits than higher income 
families. However there is less use of preventive services [105]. Superficially, 
countries with national health systems provide adequate access to health care for all. 
In reality, increasing evidence indicates differences in the quality and appropriateness 
of medical care, and differential uptake and access to preventive services, may 
account for some of the socioeconomic health gradient [32].  
 
Medical care has been likened to “the ambulance waiting at the bottom of the cliff” 
[106]. It does not determine who falls, though it may alter the outcomes for those who 
do [3]. As Sparks notes, “the fact that we get an equal chance of being cured once 
we’re ill is no compensation for the fact that our chances of becoming ill in the first 
place are unequal anyway” [107]. 
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Research evidence suggests that while access to health care may be decisive in 
individual cases, the availability of such services – or their lack – cannot begin to 
explain the observed SES gradients in the health of populations [108], [109, 110]. 
Furthermore, despite universal access to medical care, there is differential uptake of 
the benefits of medical services and health education [111], [109], [106], so that the 
determinants of access become important. 
 
While the Black Report makes no specific mention of a psychosocial theory of 
causation, MacIntyre suggests that the liberal version of the materialistic/structural 
explanation is that it is not only physical conditions that vary with SES and determine 
health, but psychosocial factors and social as well as economic capital. Implied 
psychosocial influences are indeed scattered throughout this section of the Report, 
e.g. social circumstances may determine access to dietary information; levels of job 
satisfaction and security as well as mental strain are noted as aspects of occupational 
class that may affect health; and the notion that unemployment may increase 
mortality through the “ill-defined concept of ‘stress’” is noted. I have included the 
psychosocial hypothesis under the materialistic/structural explanation, recognizing 
that some researchers would regard these as competing, rather than nested 
explanations. 
 Psychosocial factors 
By the time the Black Report was published, the theory that both physical and 
psychological stress could increase vulnerability to disease, was already well-
developed [36]. Cassel postulated that the social environment, including dominance 
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hierarchies, social disorganization, social isolation and rapid social change, could 
alter host susceptibility to disease via the neuroendocrine system. Positive social 
support and various psychological assets could buffer such effects. 
 
The hypothesis that psychosocial factors may cause the socioeconomic health 
gradient proposes that although the basic material requirements of health (such as 
food and clean water) may be met, lower SES people suffer higher levels of stressor 
exposure through financial strain, monotonous work, greater number of stressful life 
events etc [112], [113]. In addition, individuals of lower social status may suffer 
greater distress for a given level of stressor exposure, as a result of poorer coping 
skills, lower self esteem or feelings of mastery that may be differentially distributed 
by SES [114], [113]. Greater levels of social support may be able to moderate both 
the level of stressor exposure and the health effects of greater stress experienced by 
lower SES individuals (Pearlin and Aneshensel, 1989 cited in [34]), but lower SES 
may be associated with lower levels of social support [113]. Thus the physiological 
impact of a stressor is subjective, depending on the objective features of the stressor, 
as well as the availability of buffering resources [113]. 
 
An interesting, indeed important, characteristic of the socioeconomic health gradient 
is that it has been persistent over several centuries, even though the causes of death 
have changed radically. Even over the last one hundred years this is so – at the 
beginning of the 20th century infectious diseases were important causes of mortality 
and age-standardised mortality rates were higher in lower socioeconomic groups. By 
the end of the century, heart disease and cancer are major causes of mortality, and 
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apart from a few exceptions they are also more common in lower socioeconomic 
groups [3]. Evans writes, “While death is ultimately quite democratic, deferral 
appears to be a privilege correlated with rank. The diseases change, the gradient 
persists.” Being in a lower SES group appears to be associated with some kind of 
increased susceptibility for disease, perhaps in addition to increased exposure to risk 
factors for specific diseases. 
 
The finding from the Whitehall studies that measures of job stress could account for a 
large part of the socioeconomic gradient in the incidence of coronary heart disease 
suggested that not only could psychosocial factors alter susceptibility to other risk 
factors, they may be directly pathogenic [78], [75], [115]. Bosma also found that 
participants who had changed from a work environment of low job control to one of 
higher job control had lower risk of coronary heart disease than those who had 
remained in low control work. This suggests that policy responses targeting 
psychosocial factors such as job control may be successful, at least for cardiovascular 
disease, in improving health [75]. 
 
Psychosocial factors may have direct and indirect effects on health. Direct effects are 
caused by increased psychosocial stress and moderated by psychological assets and 
social support (covered in detail in Chapter 3). Indirectly, psychosocial factors may 
act through health damaging behaviours and decreased “access” to medical services – 
through decreased recognition of the need for health care, failure to use preventive 
services and lack of uptake of health promotion [116], [117]. 
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Both ecological and individual studies provide support for the importance of 
psychosocial factors to health. In particular, the relative income hypothesis has as its 
basis a psychosocial causation of disease (see section 1.3.3) – above some absolute 
level of income, it is less how much you have, but how much you have compared to 
others that is important for health. While there is considerable debate around the 
relative income hypothesis, there is also considerable support for the importance of 
psychosocial factors in explaining the socioeconomic health gradient, from individual 
studies. 
 
Bosma found that self-rated health in adulthood was associated with childhood SES, 
i.e. lower childhood SES was related to poor self-rated adult health, independent of 
adult social class (OR 1.67, 1.02-2.75) in 2174 men and women aged 25-74 years. 
Lower childhood SES was related to personality variables, with external locus of 
control (42% vs 15%), parochialism (35% v 12%) neuroticism (34% vs 23%) and 
lack of future orientation (41% vs 27%) more prevalent in the lowest compared with 
the highest social classes in childhood. External locus of control, neuroticism and the 
absence of active problem focused coping explained about half of the association 
between self-reported health and childhood SES [118]. 
 
All-cause mortality in Lithuanian men is much greater than that amongst men in 
Rotterdam. In the Kaunas-Rotterdam study, Bosma showed that Lithuanian men were 
substantially less optimistic with respect to their health and this factor (statistically) 
accounted for 30% of the excess in all cause mortality in Kaunas (cited in [119]). In a 
longitudinal study, Power et al found that two of the most important factors 
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explaining the poorer self-rated health of men and women in lower social classes 
compared to those in higher social classes were adolescent socioemotional adjustment 
and current level of job strain [120]. 
 
The psychosocial hypothesis of causation requires differential distribution of 
psychosocial factors by SES. Ruberman demonstrated that social isolation and a high 
degree of life stress were inversely related to SES (as assessed by education) and 
were positively associated with increased mortality following a myocardial infarct 
[121]. In the 1958 British birth cohort, there was a significant social class gradient in 
psychological distress in women by the age of 23 [122]. Job insecurity, higher job 
strain and low social support were more common in women in lower SES groups. In 
one hundred healthy middle-aged men and women, those in lower occupational 
prestige positions experienced more interpersonal conflict but there was no 
association between occupational prestige and measures of work strain [123]. The 
Whitehall studies found a socioeconomic patterning of job control, social support and 
social networks, with less favourable patterns in lower SES groups [124].  
 
Studies of non-human primates provide support for the importance of psychosocial 
factors to health and their differential distribution by social hierarchy. Sustained 
social subordinance in stable dominance hierarchies in captive primates was 
associated with depression of the HDL:LDL ratio and increased stenosis of the 
coronary artery. Higher-ranking olive baboons had more efficient cortisol and 
sympathetic nervous system (SNS) responses to stress, while lower ranking 
individuals had a higher basal level of cortisol, consequent upon frequent activation 
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of the stress response [125]. A recent meta-analysis of studies examining primate 
dominance hierarchies and stress physiology demonstrated that the association of 
cortisol levels with rank varied for different primate species, depending on the social 
environment experienced. Subordinates in aggressive societies suffering high rates of 
physical and psychological stress exhibited much higher basal cortisol levels than 
dominants, whereas in non-aggressive societies subordinates had lower basal cortisol 
levels than dominant individuals [126]. Despite interspecies variation, consistent 
predictors of high cortisol levels in subordinate animals (compared to dominants) 
were higher rates of stressor exposure, decreased social support and lower interaction 
with close kin. 
 
The psychosocial hypothesis suggests an increased susceptibility to disease that 
would explain the persistence of the health gradient, despite changes in the particular 
diseases experienced over time. It provides an explanation of why those who are not 
impoverished, not apparently lacking access to health care or the basic necessities of 
life, but occupy a lower social group, might have poorer health than those occupying 
higher social groups. Considerable epidemiological evidence exists of the importance 
of psychosocial factors in human disease – social isolation rivals smoking as a health 
risk [32]; acute stress may precipitate myocardial infarction and sudden cardiac death 
[127]; chronic stress (particularly occupational stress) is associated with an increased 
incidence of coronary heart disease [75] and psychological dispositions such as 
hostility and pessimism are predictive of all cause mortality [128],[129]. 
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Although there is biological plausibility for the association of health with 
psychosocial factors, biological plausibility is only one of Hill’s criteria for causality 
[130]. Furthermore, most of the studies linking psychosocial factors to health are 
cross-sectional and self-reported chronic stress is liable to confounding by poor health 
[32] (although even studies using objective measures of job strain found associated 
health effects) [75, 131, 132]. Longitudinal studies are needed to confirm that chronic 
stress, lack of social support and adverse personality styles do indeed precede 
physiological changes that lead to disease. 
 
Since the Black Report, a number of other hypotheses have been generated to explain 
the socioeconomic health gradient. The “programming” hypothesis and the life-
course explanations focus on the timing of the insults that result in disparities in 
health in adulthood. The “programming” hypothesis ascribes health disparities purely 
to biological effects on intrauterine and postnatal development. The life-course 
theories incorporate both biological and psychosocial effects over the whole of the 
lifetime. 
2.4.5 The “programming” hypothesis  
Geographical variations in mortality in the United Kingdom have been recorded since 
the first national statistics were collected. Farr ascribed these geographical patterns to 
variations in provision of sanitation and clean water [33]. In the 1980s, Barker et al 
investigated regional differences in mortality from ischaemic heart disease in England 
and Wales and found that such variations appeared to be related not to current 
conditions, but to differences in infant mortality seventy years previously [133]. 
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Using detailed birth records from as far back as 1911, researchers were able to trace 
74% of males born between 1911 and 1930. Subsequent analysis revealed that men 
weighing less than 5.5 pounds at birth had the highest death rates for ischaemic heart 
disease and chronic obstructive airways disease. The weight at one year was also 
significant, with standardised mortality ratios (SMRs) of 111 in men who weighed 
≤8.2 kg at one year, compared to 42 in those who weighed ≥ 12.3 kg at one year 
[134].  
 
Studies in a number of countries have confirmed the importance of the intrauterine 
and early childhood environment [135], with different diseases having associations 
with differing periods of life. Thus cerebrovascular disease appears more closely 
related to intrauterine life [136], while chronic obstructive lung disease may be more 
related to the environment in the first year of life [137]. Cardiovascular disease is 
associated with both intrauterine and early postnatal life, possibly through effects on 
systolic blood pressure [137]. Lower birth weight and lower weight at one year are 
associated with increased risk of impaired glucose tolerance in adult life [133]. 
 
Birth weight itself appears to be of some importance. Key determinants of birth 
weight are the mother’s weight before she becomes pregnant and her own birth 
weight [138]. This means that the effects of low birth weight could be perpetuating 
and it may take several generations of improved circumstances to overcome the 
handicaps associated with intrauterine malnutrition. Such perpetuating risks have 
been noted in studies of women suffering famine in the first or second trimester of 
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pregnancy during the Dutch Hunger Winter of 1944-45. Not only were the offspring 
of these women of low birth weight and subsequently suffered a relatively high 
incidence of diabetes [135], but they in turn gave birth to babies of lower birth weight 
than those whose mothers had not been exposed to famine [139].  
 
The proponents of the importance of intrauterine and early neonatal development to 
health in later life argue that health is programmed at this early stage, and there are 
critical periods in development during which adverse circumstances can have lasting 
effects on health [133]. The risk of hypertension, diabetes and heart disease in 
adulthood is linked to the combination of thinness at birth, and rapid postnatal growth 
[135]. Fetal growth, and growth and nutrition in infancy may have lasting influences 
on plasma concentrations of cholesterol, apolipoprotein B and fibrinogen, blood 
pressure, body fat distribution and liability to impaired glucose tolerance and diabetes 
[136].  
 
There are plausible biological mechanisms by which the intrauterine environment 
could set the scene for later health, with some support from animal experiments 
[135]: 
• Maternal malnutrition may trigger an increase in stress hormones in the mother, 
with disruption of placental growth, breakdown of the placental barrier and transfer of 
maternal stress hormones to the fetal circulation. This in turn may affect organ 
development in the fetus with later development of hypertension and vascular disease.  
• Fetal malnutrition consequent upon maternal malnutrition may result in diversion 
of nutrients from other organs to the growing brain, resulting in abnormal 
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development of the liver, kidney and pancreas and increased risk of disorder in later 
life. In addition, fetal malnutrition may result in a decrease in the number of 
telomeres present in DNA. Telomeres, at the end of chromosomes, dictate the number 
of possible cell divisions, so that a decreased number implies cells may stop dividing 
prematurely, with subsequent loss of function in affected organs. 
 
Criticisms of the programming hypothesis focus on the possible confounding effect of 
early-life social class and continuing social disadvantage in research studies [136]. 
Low birth weight is associated not only with higher morbidity and earlier death but 
with lower social class [138]. Low birth weight may simply be a marker of lower 
social class and the higher mortality in adulthood of low birth weight babies may be a 
reflection of social class, rather than birth weight per se. A recent report indicated that 
babies born to parents from social class I (highest SES) weigh on average 130 g more 
than those born to class V and 200g more than babies registered by their mothers 
alone [138]. In addition, there is a steep social class gradient associated with breast-
feeding [138] and early infant feeding may have effects on lipid metabolism 
throughout life [133, 134]. 
 
Some research suggests that the associations between early weight and later risk 
factors are independent of SES, either currently or at birth [136]. The lack of an 
association between birth weight and social class at death argues against the 
persistence of an adverse environment from intrauterine life to death [134]. In 
addition, the specificity of different diseases for effects operating at different stages 
of infancy argues against this being simply an effect of continuing adversity. 
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It is clear that there are long-term sequelae of intrauterine malnutrition [140]. It also 
seems likely that these long-term consequences are independent of social class. What 
is less clear is whether it is possible to modify the risk of long-term consequences of 
intrauterine malnutrition, by influencing the postnatal environment.  
 
The gradient in health associated with SES is finely graded – this is not a difference 
in health between the poor and the rich, but a difference in health along the whole 
socioeconomic range. While Barker’s work indicates a greater health risk for those 
under 5.5 pounds at birth the average birth weight was 7.9 pounds. Can this 
explanation of the origins of adult disease create the fine-grained differences that are 
observed, or are there other influences over the intervening time between babyhood 
and adulthood?  
2.4.6 Life-course theories 
Life-course theories emphasise the importance of influences operating throughout 
life. Two alternative models suggest different routes by which life circumstances may 
affect health, either by determining the range of possible subsequent life trajectories 
(pathway models) or by an accumulation of adverse effects (accumulation models).  
 Pathways models 
In contrast to the programming, critical periods or latency hypothesis, the pathways 
model of health focuses on not only the early environment, but the moderating effects 
of subsequent life trajectories. Thus early life advantage or disadvantage sets the 
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trajectory into and through adult life [141]. Life is a series of pathways choices and 
each prior choice determines possible later choices [142]. 
 
Increasing research evidence suggests that health outcomes in adulthood are the end 
result of ‘chains of risk’ or ‘unhealthy life careers’ [143]. Of particular interest are 
studies that examine “resilient” individuals: people who experienced economic 
disadvantage in early life, but do not develop patterns of ill health in adulthood. 
Singer et al found a trend to increasingly adverse physiological profile with 
increasing economic disadvantage both currently and in childhood. But more 
importantly, some defied this trend - people with strong positive relationships with 
parents and partners. These resilient individuals did not follow a path of disadvantage, 
but started on a path of economic disadvantage, which could then be altered by other 
intervening advantages [144]. The researchers stress the importance of considering 
not only cumulative disadvantage, but also cumulative advantage, from starting 
resources (e.g. growing up in an intact family), biological endowment and positive 
movement through life transitions. Pathways to health outcomes are postulated to 
depend on the interplay between adversity and advantage, and this is what gives the 
fine grain of health inequalities.  
 Accumulation models 
In accumulation models, exposure to disadvantage at different life stages has a 
cumulative effect on health [143]. Early disadvantage can be modified by later life 
experiences and the accumulation of adverse circumstances has a dose-response 
effect on health [145]. From origins in lower social classes, individuals may begin 
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with biological disadvantages such as low birth weight; perhaps have an increased 
risk of childhood psychological adversity and exposure to adverse environmental 
influences (e.g. tobacco smoke). There are likely to be fewer educational investments, 
poorer working environments, lower expectations and perhaps acceptance and 
encouragement of adverse health behaviours such as smoking, lack of exercise and 
poor diet. 
 
Using the 1958 British birth cohort, researchers showed that birth weight was related 
to subsequent social circumstances from childhood to adulthood, suggesting that the 
effects of birth weight on subsequent well-being cannot be isolated from the 
childhood and adulthood environment; rather they tend to be intimately entwined 
[146]. Low birth weight should instead be seen as a marker of a disadvantaged life 
trajectory with later health being affected by the accumulation of risk, both social and 
biological [147]. A Finnish study incorporating measures of childhood and adult 
socioeconomic status found that poor adult health was associated with the 
combination of low childhood and low adult SES, but that those men who went from 
low childhood SES to high adult SES had the same mortality risks as those who were 
in high SES groups at both time points [148]. Similarly, Davey Smith reported strong 
positive trends to elevated blood pressure, angina, bronchitis and body mass index in 
men who were in manual occupational classes at three life points, compared to men 
who were in non-manual classes at all time points [149]. This effect appeared to be 
more apparent for cardiovascular disease than for cancer. Socioeconomic position in 
early and later life contributed independently to disease risk, but the association with 
cumulative social class was independent of the order in which the social class 
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position came, suggesting that social mobility or selection was not contributing in a 
significant manner. The postulated dose-response relationship in physical, 
psychological and cognitive functioning in association with the number of periods of 
economic hardship experienced during 1964-1983 has been demonstrated [145]. 
 
The timing of adverse influence such as low SES may be important, with Blane et al 
finding that childhood SES was associated with physiological risk factors, e.g. BMI, 
serum cholesterol, blood pressure and FEV1, while adult SES was more closely 
associated with behavioural risk factors (exercise and smoking) [150]. 
 
The life-course approach includes aspects from each of the individual-based theories 
presented above. Childhood disadvantage may be genetic, congenital (due to 
intrauterine influences), psychosocial and material. Exposure to adverse early 
childhood conditions may then influence educational opportunities, psychosocial 
development [113] and subsequent employment. But the effects in childhood are not 
irreversible as the programming hypothesis suggests, and there is evidence that initial 
disadvantage can be buffered by a supportive early environment [3]. Even genetic 
predispositions may depend on the environment for their expression and this is 
apparently true also of intrauterine insults. In the Kauai Longitudinal study, children 
who had suffered moderate or severe perinatal stress, but were subsequently reared in 
“good” environments (stable family of high socioeconomic status) suffered little or 
no disadvantage in development at twenty months (cited in [3]). Children with no 
perinatal stress likewise showed little disadvantage despite poor, unstable households. 
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But two negative factors together had quite severe consequences for child 
development.  
 
The hypotheses presented above are largely focused on the individual – individual 
health behaviours, levels of stress and social support, exposures in utero and over the 
life-course. But individuals are members of a society and subject to the social 
influences of which they are a part. Exposure to physical and psychosocial risk 
factors is shaped by the social, political and economic environment. To focus only on 
the individual in theorizing the causes of socioeconomic health inequalities is “a bit 
like studying why some people swim well and others drown when tossed into a river 
and this displaces study of who is tossing whom into the current” [151]. 
 
While the current study is based on individuals, each individual reflects the 
experiences of the hierarchy of social, economic and political influences. These more 
upstream theories are briefly outlined below. 
2.4.7 Neomaterial explanation 
Lynch et al favour an explanation for socioeconomic health inequalities in which, 
“health inequalities result from the differential accumulation of exposures and 
experiences that have their sources in the material world” [152]. Policies that favour 
dismantling of the welfare state and systematic under-investment in human, physical, 
health and social infrastructure expose individuals to physical, psychological and 
social stressors.  
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Proponents of the neomaterial explanation have been critical of Wilkinson’s relative 
income hypothesis and the importance of income inequality to the health of whole 
populations. They have found little support for the importance of population level 
psychosocial attributes, e.g. social capital and sense of control over life, to differences 
in health between countries [50]. Rather they emphasise the importance of the 
economic environment and the historical and cultural context that has generated it. 
 
At an individual level, neomaterialists suggest that the economic environment works 
through physical, behavioural and psychosocial pathways to affect health. The 
neomaterial explanation represents an attempt to look at the more upstream causes of 
health inequalities, but one final pathway of effect is similar to that postulated under 
the psychosocial hypothesis outlined above. This allows explanation for multiple 
disease outcomes through multiple mechanisms and the maintenance of a 
socioeconomic health gradient, even when the intervening, disease-producing 
mechanisms, change [9]. 
2.4.8 Social production of disease and/or “the political economy 
of health”  
These theories focus on the social and political production of disease with an 
emphasis on the social, political and economic environment, rather than individual 
characteristics and behaviours. Socioeconomic status is a fundamental, or root cause 
of inequalities in health – and SES itself is seated in the economic and political 
institutions and decisions that create and enforce it [151]. Hand in hand with the 
creation of widening SES disparities is the dismantling of the welfare state and safety 
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nets that shield the disadvantaged from the effects of major life events such as 
employment or ill health.  
 
Examples supporting the central nature of social, political and economic 
circumstances include observations of stalled health improvement in countries which 
have had large increases in GNP (but no change in social policies), and in countries 
and states that are relatively poor, but have high levels of social investment and little 
SES health gradient (e.g. Kerala in India and Costa Rica) [51], [73]. 
 
Social capital and social cohesion are hypothesized to be eroded by political and 
economic processes and affect health through psychosocial effects such as increased 
negative emotions of shame and distrust, directly via the neuroendocrine system or 
indirectly through health damaging behaviours, such as smoking [51]. These theories 
suggest that moves to increase social capital without altering the underlying 
determinants may be ineffective and the equivalent of a community level version of 
“blame the victim” [51]. 
2.4.9 Ecosocial theory and related multi-level dynamic 
perspectives 
Multi-level theories, such as the ecosocial theory, eco-epidemiology and social-
ecologic systems perspective embrace the economic, social and political determinants 
of health as macro-level factors, as well as individual determinants of health as micro-
level factors. As their names suggest, these theories propose health is the result of 
multiple levels of influence over the life-course, finally being embodied in the 
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individual through biological pathways that have been shaped by evolutionary history 
[151]. 
 
Influences on individual biology come from all levels (individual, neighbourhood, 
regional or political jurisdiction, national or international) and in multiple domains 
(home, work, school and other public settings). Although public health is concerned 
primarily with the health of populations, population health is itself an aggregate of the 
health of individuals. One facet of our understanding of population health must come 
through the investigation of influences on individual biology.  
2.5 Biological Pathways 
The final pathway for all theories that invoke (at least partly) a psychosocial 
hypothesis of causation is through the embodiment of physical, social and 
psychological factors via biological pathways. This is outlined in Figure 2.2. It is this 
final step that the thesis seeks to investigate more fully. 
 
The neuroendocrine response to stress is well characterized and it is clear that this is a 
response to physical as well as perceived psychological stress. (An overview of the 
stress response is presented in Chapter 3, with a more detailed coverage in Appendix 
A). However, there is little research on the socioeconomic distribution of 
psychological and social assets that are thought to modulate the stress response as 
well as the socioeconomic distribution of stress itself.  
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Figure 2.2 Causal pathways linking the social and biological causes of disease 
(adapted from [153]) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It may seem logical to assume that those in lower SES groups are more stressed, but it 
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elements of the neuroendocrine stress response) and the immune, haemostatic and 
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Laboratory stress is well studied, but in general researchers examine acute effects on 
the immune and metabolic systems in association with acute stress. In contrast, 
socioeconomic disparities in stress (as postulated by the psychosocial hypothesis) are 
likely to be evident particularly for chronic stress e.g. perceptions of financial 
hardship, lack of control in the workplace. 
 
In a review of the “biology of inequality”, Brunner notes the biological outcomes of 
early life stress and their importance for physiological change over the life-course. 
Using results of animal and physiological experiments he makes a plausible case for 
the role of continuing psychosocial adversity and personality assets in the causation 
of the socioeconomic variation in health [6]. 
 
In 1997, Kelly et al called for “population-based, person-specific health surveys, with 
concomitant biological measures” providing information on socioeconomic and 
psychosocial factors to investigate whether these are in fact embedded in physiology 
in a way that could be associated with future disease. The paper detailed the 
requirements for such biological measures and is reviewed here in detail [154]. 
 
Two primary conditions are required of such biological measures: 
1. they should be sensitive to systematic, long term differences in socioeconomic   
status and living conditions 
2. they must be feasible to measure in large scale population surveys 
 
To these requirements, I add two further primary requirements: 
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1. they should be plausibly associated with psychosocial factors 
2. they should be plausible antecedents of disease 
 
To confirm the embodiment of psychosocial factors that vary by SES, biological 
measures should be proven to be altered by these psychosocial factors. Secondly, if 
the measures that are chosen are logical forerunners to disease, then the pathway from 
SES, via psychosocial factors, to disease will be clearer. 
 
Steptoe has outlined a schema for the embodiment of stress, giving examples of the 
types of physiological variables that may be altered, and thus could be measured for 
this purpose. This is presented in Figure 2.3. 
 
Kelly et al further describe the criteria required for markers of the chronic stress 
response: 
The criteria proposed for the ideal marker are: 
1. It must be affected/caused/created by stress; 
2. It should have a long half-life (months to years). It should not require repeat 
measurements; 
3. It should be independent of demographic factors (e.g. sex or age) or else have 
a well-defined demographic distribution; 
4. It must be relatively easy and cheap to measure (preferably with an easily 
reproducible, automated method); 
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Figure 2.3. Schema for the biological pathways by which stress is embodied. (adapted 
from Steptoe (1998) The psychobiological basis of disease .[155] 
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5. It should require no special sample preparation; and 
6. It should have readily available reference standards. 
 
Kelly’s review went on to consider the qualities of possible markers. Using this 
review as a basis, and the criteria outlined above, I chose five biological markers to 
examine the possible biological pathways from socioeconomic status, via 
psychosocial factors, to ill-health. 
2.6 Conclusion 
Recent research provides considerable support for the role of psychosocial factors in 
the causation of health inequalities. The evidence is strongest for socioeconomic 
health inequalities, but psychosocial factors may also play a role in gender and ethnic 
health inequalities. 
 
Several of the competing theories of causation are only superficially competing – 
disparities in access may work partly through psychosocial avenues; health damaging 
behaviours may have their origin in psychosocial influences; effects of the social, 
economic and political environments, at their individual levels work through 
psychosocial channels as the final common pathway to ill health. 
 
For psychosocial factors to be on the causal route from socioeconomic status to 
health, they themselves (or the body response to them) must vary by SES and there 
should be physiological evidence of their effects on body physiology in multiple 
systems. Plausible biological markers of systems postulated to be affected by 
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psychosocial factors should thus also show a socioeconomic gradient. Evidence of a 
link between these biological markers and subsequent disease would provide support 
for pathways between SES, psychosocial factors and disease. 
 
This thesis thus tests the following three hypotheses: 
1. Measured psychosocial factors vary by SES 
2. For each of five biological markers there is a gradient associated with SES 
3.  SES variation in the biological markers is mediated by psychosocial factors. 
 
In the following chapter I begin by reviewing the physiological stress response and 
the intercommunication between elements of the stress response and other body 
systems. I introduce the markers and describe how they fit into the stress response 
and their plausible association with subsequent disease susceptibility. 
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Chapter 3. 
Part One: Background physiology 
3.1 Introduction 
A psychosocial explanation for the socioeconomic gradient in health invokes the 
notion of a differential distribution of stress across socioeconomic groups. In order to 
select appropriate biological markers to investigate the psychosocial explanation, we 
need to understand something of the physiology of the stress response. The following 
chapter reviews the current literature on the neuroendocrine response to stress and the 
physiological consequences of this response for body systems. A more detailed 
description of the stress response and its effect on body systems is contained in 
Appendix A. 
3.2 Stress – a definition 
As originally used in a biomedical sense by Selye and Wolff, the term stress referred 
to “that state within a living creature which results from the interaction of the 
organism with noxious stimuli or circumstances, i.e. it is a dynamic state within the 
organism” (cited in Cassel, 1976 [36]). Combining this with Cannon’s postulate of 
homeostasis [156], in this thesis, stress is “a threat, real or implied, to homeostasis” 
[157]. Something that poses a threat is a stressor; the body’s response is the stress 
response. Stressors may be physical or emotional and include both stressors causing 
“distress” (stress in the negative sense) as well as the exhilaration of “good” stress. 
Activation of the stress response leads to behavioural and physiological changes that 
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improve the ability to maintain homeostasis and provide defense against perceived 
dangers. 
3.3 Stress, stressors and the stress response 
The cycle of the physiological response to a stressor contains several elements, 
illustrated in Figure 3.1. 
 
Stressor exposure: The stress response may be activated by any type of stressor 
exposure, whether physical, e.g. a marathon, psychological, e.g. academic 
examination, or biological, e.g. injury with blood loss. Each type of stressor 
precipitates a similar response, referred to by Selye as “the general adaptation 
syndrome”(cited in [158]). 
 
Perception of threat: Some stressors will be universally perceived as threatening, such 
as physical attack. However, other stressors will be experienced as threatening to 
some, but not to others, e.g. public speaking. The perception of threat by 
psychological stressors is particularly varied: what is stressful to one individual is 
exciting and empowering for another. Social support, coping skills, self esteem and 
previous life experiences probably all play a part in altering the perception of a threat. 
 
Neuroendocrine response: The general neuroendocrine response to stressor exposure 
is modulated by inputs from adjacent brain areas encoding memory, reason and 
personality, ensuring a response that is specific to an individual.  
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Figure 3.1  The response to stressor exposure 
 
 
 
 
 
 
 
 
 
 
 
 
The extent of the stress response is proportional to the intensity of the stimulus [158] 
and is usually somewhat specific to the stressor, e.g. the coagulation cascade is not 
activated during psychological stress. However, the response can become non-
specific if the stressor exceeds a threshold in magnitude or duration [159]. 
 
Maintenance of homeostasis: Cannon first postulated the concept of homeostasis in 
1929, to describe the recurrent minute physiological adjustments required to maintain 
a constant internal milieu, essential for metabolic processes [156]. He further 
suggested that the body responds to a threat to homeostasis by activating a series of 
interconnected neurohumoral pathways, which he termed the fight or flight response. 
Fight/flight has been the classical stress response, understandable in evolutionary 
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terms as a response to a physical threat. We now know that fight/flight represents 
only one part of the stress response, the immediate reaction to stressor exposure that 
is mediated by the sympathetic nervous system and the adrenal medulla (the 
sympathetic adrenal medullary system, SAM). This response mobilizes the immune 
system, the haemostatic system, the metabolic system and the nervous system to react 
optimally to restore homeostasis. 
 
More recently researchers have identified a slower stress response, occurring over 
minutes to hours, which is intimately connected to the immediate stress response, but 
is activated particularly in circumstances where a stressor is perceived as 
overwhelming [5]. A number of authors describe a “defeat response” resulting in 
activation of the hypothalamic pituitary axis (HPA), with a secondary role for the 
sympathetic nervous system [160, 5]. In most situations both the HPA and the SAM 
system are activated and are equally important to survival – indeed they are 
intimately interconnected and activation of one triggers activation of the other. 
 
Recently, Taylor et al hypothesised that a more effective response to a physical threat 
throughout evolution, particularly for females, would have been a “tend and befriend” 
response, rather than a fight or flight response. Females who were pregnant or caring 
for offspring might be less able to fight or flee. It would be more practical to remain 
calm, soothe offspring and develop strong social ties ensuring a supportive and 
protective group. There is some physiological evidence to support this hypothesis, via 
activation of oxytocin secretion [161]. However, this research is in its infancy, and 
although consideration of this type of response may explain some gender differences 
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in responses to stressor exposure, the remainder of this chapter concentrates on the 
fight/flight response and the response of the HPA. 
 
Turning off the stress response: An efficient stress response is appropriately triggered, 
reaches an amplitude commensurate with the intensity of the threat and is turned off 
shortly after exposure to the stressor ceases. The entire response is tightly controlled 
by positive and negative feedback loops. Hence, the widespread effects of the stress 
response on the body are ordinarily transient and tolerable [158]. 
3.3.1 The neuroendocrine stress response 
The neuroendocrine response to stress is complex and the understanding of its 
components and their interactions is continually being refined. An overview of the 
neuroendocrine stress response is presented below, with a brief outline of its 
widespread effect on multiple body systems, in order to position the chosen biological 
markers within the stress response framework. A more detailed account of the 
response (including a description of the functioning of the body systems involved) is 
presented in Appendix A. 
 
The early stress response occurs via activation of various elements of the central 
nervous system. The autonomic nervous system (ANS) receives inputs from higher 
centres involved with memory, emotion, anticipatory phenomena, and cognitive 
functions and in turn exerts its effects peripherally via circulating catecholamines.   
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Box 3.1  
Effects of activation of the sympathetic adrenal medullary (SAM) system during 
acute stress 
 
2) Direct effects 
a. Cardiovascular – vasoconstriction with diminished 
blood flow to the gut, kidney and mucous 
membranes, but with maintenance of blood flow to 
the heart and improved blood flow to skeletal 
muscles; increased heart rate and cardiac output 
b. Metabolism – increased metabolic rate; accelerated 
fuel mobilization by lipolysis and gluconeogenesis. 
c. Fluids and electrolytes – maintenance of 
extracellular fluid volume by action on the renal 
tubules; promotion of cellular uptake of potassium. 
d. Viscera – bronchodilation; stimulation of bladder 
and gut sphincters. 
e. Immune– induces secretion of IL-6 
 
3) Indirect 
a. Endocrine system – influence the secretion of 
renin, erythropoietin, thyroxine and a number of 
other hormones, thus assisting in the homeostatic 
and allostatic feedback loops for these hormones. 
b. Insulin – suppression of insulin secretion and 
stimulation of glucagon release, supporting 
mobilization and availability of blood glucose.  
 
4) Corticotrophin releasing hormone (CRH) is released from the paraventricular 
nucleus of the hypothalamus 
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Activation of the sympathetic branch of the ANS results in the release of adrenaline 
from the adrenal medulla; adrenaline in turn has multiple target organ effects, as 
outlined in Box 3.1. These effects cause the typical signs of the acute stress 
(fight/flight) response: accelerated heart rate, dilated pupils and improved blood flow 
to skeletal muscle. The central nucleus of the sympathetic nervous system also 
produces corticotrophin releasing hormone (CRH), providing one route of 
communication between the neural and endocrine arms of the stress response.  
 
The primary site of activation for the slower endocrine stress response is the 
hypothalamus, which also receives inputs from brain centres for memory, emotion, 
cognitive function and anticipatory phenomena. CRH is released from nuclei in the 
hypothalamus and stimulates production of adrenocorticotrophin (ACTH) from the 
anterior pituitary gland. ACTH in turn stimulates the adrenal cortex to produce 
glucocorticoids, of which cortisol is the most important. Cortisol is released over 
minutes to hours and exerts its effects through widely distributed intracellular 
glucocorticoid receptors (GCRs). The effects of activation of the HPA are 
summarized in Box 3.2. 
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Box 3.2 
Effects of activation of the HPA during acute stress 
 
1)  Direct effects 
a. Metabolism– increased blood glucose via 
gluconeogenesis; increased protein breakdown 
and lipolysis in muscles;  
b. Immune – elevation of circulating 
polymorphonuclear leukocytes, depletion of 
eosinophils and T cells; inhibit the production of 
IL-6;  
c. Reproduction – increased CRH (hypothalamus) 
and cortisol inhibits release of gonadotrophin 
releasing hormone and increases resistance of 
target tissues to sex steroids; 
d. Growth – suppression of growth hormone 
releasing hormone by CRH; cortisol inhibits the 
effects of insulin-like growth factor 1. 
 
2) Indirect 
e. SAM – permissive effect on secretion of 
adrenaline; 
f. Insulin – cortisol has an antagonistic action in 
skeletal muscle, potentiates insulin effects on 
adipose tissue; 
g. Acute phase response– cortisol enhances the 
effect of IL-1 and IL-6 on acute phase protein 
production. 
 
3) Cortisol inhibits secretion of ACTH and CRH. 
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The stress response is closely linked to the immune system: cortisol affects immune 
cell distribution and function; catecholamines activate release of cytokines (in 
particular IL-6); and the hypothalamus is stimulated by IL-6 to release further CRH. 
These connections are outlined in Figure 3.2. 
Figure 3.2  Communications between the brain, HPA and the immune system. (adapted 
from [29]) 
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Interconnections between the central neural and endocrine arms of the stress 
response, and between different parts of the central endocrine arm, result in a 
positive, reverberatory, feedback loop so that activation of one part of the system 
activates the other [162]. This permits fine matching of the intensity of the stress 
response to the intensity of the perceived stressor. The response is damped down by 
negative feedback loops involving cortisol, causing inhibition of both the central 
nuclei of the SNS and the secretion of ACTH and CRH. 
 
The immediate stress response is modulated by prior experiences and contributes to 
building memory and memory contexts for future reference, via reciprocal 
connections between the central nuclei of the SNS, the hypothalamus and higher 
centres. Such connections also promote enhanced arousal, alertness, vigilance, 
cognition, focused attention and appropriate aggression during the stress response 
itself [171]. Recent evidence shows that not only perceived stress, but also the 
memory or anticipation of stressful events incurs physiological changes such as 
increased cortisol levels [163]. 
3.3.2 Behavioural responses 
In addition to the neuroendocrine response to stressor exposure, behavioural 
responses occur. These may be focused and appropriate, to diminish the threat posed 
by the stressor, e.g. flight. Other behavioural responses to stressors, such as eating, 
alcohol consumption, smoking and other substance abuse may occur when the threat 
is ill defined or imaginary and when there is no clear alternative behavioural response 
that would end the threat [164]. Such responses can exacerbate and potentiate the 
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production of the physiological mediators of health outcomes, e.g. smoking elevates 
blood pressure and accelerates atherogenesis, exacerbating the hypertensive effects of 
repeated activation of the stress response [165]. In addition, depression, anxiety, 
excessive alcohol consumption and smoking may directly sensitize the HPA axis 
resulting in an abnormal stress response [166]. 
3.3.3 Individual difference  
Marked individual variability in neuroendocrine reactions to various stressors 
depends on the individual perception and interpretation of a situation [167]. This in 
turn is influenced by past experience, memory, coping strategies and the context of 
memories contained in the mesocorticolimbic system, the amygdala and the 
hippocampus. Prolonged stressor exposure may overwhelm coping resources with 
resulting psychological distress and depression [167]. 
 
A number of studies have identified high responders (HRs) and low responders (LRs) 
based on measures of SNS activity, such as heart rate or cardiac pre-ejection fraction. 
While the two groups show no differences in baseline measures of, for example, 
serum cortisol, HRs may show exaggerated SAM or HPA axis responses to stressor 
exposure and fail to habituate to a stressor compared to LRs [168]. Genetic factors 
may underlie at least part of this difference, but influences from very early life may 
also shape the neuroendocrine response [169]. 
 
The young brain undergoes rapid growth and a high turnover of neuronal connections 
during the prenatal and early postnatal period. Exposure to hormones of the stress 
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system in early life may have lasting effects on the developing brain and influence 
behaviour and physiological functioning throughout life [158]. This brain plasticity 
lessens during childhood and adolescence and plateaus in young adulthood. Early 
exposure to stress hormones may underlie the important influences of prenatal 
conditions for later health, outlined by Barker [133]. 
 
Individuals also differ in their physiological ability to respond to stressors, which is 
determined by genetic factors, as well as behavioural and lifestyle choices [165]. For 
example, atherosclerotic blood vessels consequent on a rich diet, smoking and lack of 
exercise would be likely to respond poorly to typical stress-induced changes in blood 
flow to muscle, thereby restricting the efficacy of the stress response. 
 
Box 3.3 summarizes the behavioural and physical adaptations seen in acute stress. 
3.3.4 Animal studies 
In animal societies, rank correlates well with the efficiency of the stress response. 
During times of social stability, dominant male olive baboons have a faster, larger 
stress response than subordinate males, with faster recovery. They are more resistant 
to the suppressive effects of the stress response on testosterone. Subordinates have 
centrally induced hypercortisolism and show resistance to cortisol feedback inhibition 
[170]. However, under conditions of instability of the dominance hierarchy, 
previously dominant males no longer show the more favourable stress response, i.e. it 
appears to be related to rank rather than inherent individual characteristics.  
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Box 3.3   Summary of behavioural and physical adaptations during acute stress 
Behavioural Adaptation 
Adaptive redirection of behaviour 
 Increased arousal and alertness 
 Increased cognition, vigilance and focused attention 
 Euphoria or dysphoria 
 Heightened analgesia 
 Increased temperature 
 Suppression of appetite and feeding behaviour 
 Suppression of reproductive behaviour 
 Containment of the stress response 
Physical Adaptation 
Adaptive redirection of energy 
 Oxygen and nutrients directed to the CNS and stressed body site 
 Altered cardiovascular tone, increased blood pressure and heart rate 
 Increased respiratory rate 
 Increased gluconeogenesis and lipolysis 
 Detoxification from toxic products 
 Inhibition of growth and reproductive systems 
 Inhibition of digestion-increased colonic motility 
 Containment of the inflammatory/immune response 
 Containment of the stress response 
 
Adapted from [171]  
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Studies in rats indicate that early stress and neonatal handling may set the level of 
responsiveness of the HPA axis and the ANS. Those exposed prenatally to 
unpredictable laboratory stress showed overreaction of these systems, while animals 
exposed postnatally to handling (involving the mild stress of brief daily separation 
from the mother) showed an under reaction of these systems, in response to a stressor 
[172]. There is a slower rate of cognitive aging and a reduced loss of hippocampal 
function in rats experiencing this recurrent mild stress as neonates [173]. 
3.3.5 An evolutionary perspective 
Humans have evolved from relative simplicity to complexity - in their social 
behaviours, cognition, emotions, diet and physical wants/needs. It seems however that 
human physiology has evolved more slowly and the stress response that was a driving 
force to human survival when dangers to life were largely physical is not particularly 
suited to stressors that are chronic, psychological and do not require a physical 
response. 
 
The body is primed for defense against traditional dangers – fierce animals, 
aggressive humans, and other environmental dangers. Indeed, bodily systems are 
more adapted to recurrent, episodic, acute physical stress with brief activation of the 
ANS and the HPA to enable fight or flight, followed by activity to replenish supplies 
of energy – increasing appetite and food-seeking behaviour. But the same stress 
pathways may be persistently activated by chronic or repeated psychological stress, 
with adverse consequences to health and well-being. 
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3.4 Allostasis and allostatic load 
Cannon proposed the notion of homeostasis as the maintenance of internal conditions 
via a series of metabolic feedback loops involving nervous and endocrine systems 
[156]. More recently, Sterling and Eyer have advanced the theory of allostasis: the 
ability to achieve stability through change [174]. McEwen has subsequently refined 
and distinguished the theories of homeostasis and allostasis so that homeostasis 
concerns critical variables such as body temperature, blood oxygen and blood pH that 
must be maintained within a narrow range, through a series of metabolic feedback 
loops, to ensure cellular survival. In contrast, allostasis concerns other physiological 
systems that respond over a broader range, e.g. changes in blood pressure, to internal 
and external perceived or anticipated demands as well as circadian rhythms, as an 
adaptation to the environment [172].  
 
Like homeostasis, allostasis operates through a series of metabolic feedback loops, 
but body systems providing defense, adaptation and recovery can be rapidly 
mobilized, operating set points and the balance between systems changed within a 
wide range, and then turned down when they are no longer required. Large changes in 
pulse and blood pressure within the fight/flight paradigm are simple examples of 
allostasis. McEwen suggests that the core of the body’s response to a challenge is 
twofold: turning on an allostatic response that initiates a complex adaptive pathway, 
and then shutting off this response when the threat has passed [172]. He has further 
developed the concept of allostatic load, which is “the wear and tear on the body and 
brain resulting from chronic over activity or inactivity of physiological systems that 
are normally involved in adaptation to environmental challenge” [172]. Such 
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challenges may be psychosocial or physical and allostatic load may occur as a result 
of chronic psychosocial stress where repeated inefficiencies in the allostatic 
mechanism lead to damage to body systems. 
 
There are four types of physiological responses that might result in allostatic load: 
 
Type 1: Frequent stress causes repeated mobilization of the allostatic system with the 
level of allostatic load dependent on the frequency and intensity of “hits”(i.e. repeated 
excess secretion of various mediators). Example: Frequent repeated elevations of 
blood pressure in response to stressor exposure cause damage to the cardiovascular 
system.  
 
                                         
Type 2: Lack of habituation or adaptation to repetition from the same stressors. 
Example: many people in whom serum cortisol is raised with public speaking will 
adapt to this stress, so that continued experience with public speaking leads to a loss 
of this cortisol elevation. However, other people do not become habituated and 
repeated exposure leads to repeated elevations of serum cortisol. 
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Type 3: Failed shut down following chronic activity. Example: women with a history 
of depressive illness experience decreased bone mineral density due to chronic 
moderate elevation of serum cortisol and subsequent inhibition of bone formation 
[165]. 
 
 
 
 
Type 4: Inadequate production of mediators in response to a challenge. This may 
trigger compensatory increases in other systems. Example: the blunted HPA response 
to stress seen in chronic fatigue syndrome may reflect this type of allostatic load. 
 
                                              
Cortisol 
Stressor 
habituation 
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The concept of allostatic load has been investigated in humans in the MacArthur 
Studies of Successful Aging. Using a theoretically derived panel of markers of 
allostatic load, Seeman et al [175] demonstrated that higher levels of allostatic load 
were associated with poorer cognitive performance (r = -0.13; p<0.001) and increased 
risk for decline in memory, as well as poorer physical performance (r = -0.09, p = 
0.01) and increased incident cardiovascular disease (χ2 = 5.2; p = 0.07). In addition, in 
this longitudinal study, higher allostatic load at baseline predicted increased risks for 
decline in cognitive and physical functioning. 
3.5 The acute stress response vs chronic response to 
stressors 
The chronic stress response is the summation of many large and small acute stress 
responses, perhaps with no opportunity for a return to the basal resting state between 
successive activations of the involved systems. However, acute and chronic stress 
may have quite different effects on body systems, e.g. although the acute stress 
response activates the immune response, in situations of chronic activation of the 
stress response, immunosuppression occurs; in acute stress there is mobilisation of 
energy stores to provide substrate to muscles, but with chronic elevation of stress 
mediators there is deposition of fat, insulin resistance and hypertension [176]. 
 
In the brain, glucocorticoids and catecholamines released in the acute stress response 
act in concert to promote the formation of memories of events of potentially 
dangerous situations or strong emotional overtones, as input to future responses to 
similar events. Chronically, however, stress hormones and glucocorticoids in 
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particular, contribute to impairment of cognitive function and promote damage to 
brain structures such as the hippocampus [164, 173]. 
 
McEwen refers to this as the protection-damage paradox, whereby in acute stress 
adrenaline and cortisol mediate a protective response from the immune system, the 
metabolic system and the haemostatic system. Yet chronic activation of the same 
response is associated with allostatic load and impairment of these systems [176]. 
 
Feelings of anticipation and worry can also contribute to allostatic load. Anticipation 
primes the reflex that prevents us from blacking out when we get out of bed in the 
morning and is also part of worry, anxiety and the cognitive preparation to cope with 
a threat. Anticipatory anxiety can drive the secretion of mediators like corticotropin, 
cortisol and adrenaline and for this reason prolonged anxiety and anticipation are 
likely to result in allostatic load [172]. Behaviours such as excessive alcohol intake 
contribute to allostatic load, in this case by impairing hepatic function, thus altering 
the ability of the liver to respond to normal physiological cues.  
3.6 Conclusion 
The acute stress response represents a finely honed physiological reaction to an acute 
stressor, refined over thousands of years of natural selection – those with the most 
efficient response survived stressors while others perished. Over the last few hundred 
years (at least in developed countries), psychological stressors may have overtaken 
physical stressors in frequency. But the acute stress response reacts in a similar way 
to stressors, no matter what their nature. In addition, humans now face more chronic 
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stressors – poverty, malnutrition, racism, long work hours, a materialistic society 
where more is better and communication systems allow each individual to be aware 
of all the “mores” that are available. 
 
The nature and wide-ranging effects of the stress response indicate the biological 
plausibility of the psychosocial explanation of socioeconomic health inequalities. It 
also guides the choice of markers to examine the effects of chronic stress, as 
postulated under the psychosocial explanation of socioeconomic health inequalities. 
The following sections introduce the markers selected: their physiology and known 
associations with health, SES and stress. 
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Part Two: Biological Markers 
3.7 Introduction 
In the laboratory, the stress response is measured by changes in the levels of those 
hormones that are intimately involved in the neuroendocrine system, i.e. adrenaline 
and cortisol. Adrenaline is very reactive to acute stress, rising in seconds to minutes 
(including during taking blood), with a short half-life in blood and is thus not suitable 
for examining chronic stress or for population based studies. Cortisol can be 
measured in blood, urine or saliva but shows large diurnal fluctuations that vary from 
individual to individual. If urine is collected it should be at least a 12-hour collection, 
thus creating problems for participant compliance. Cortisol levels are also very 
responsive to acute stress, so that they are of less use in the measurement of chronic 
stress, while the individuality of the diurnal variation poses problems for population-
based collection. 
 
Kelly et al’s review concluded that likely candidates for markers of the stress 
response would be glycated haemoglobin (as a marker of the neuroendocrine system), 
possibly serum immunoglobulin concentrations or functional lymphocyte assays (as 
markers of the immune system), fibrinogen (as a marker of the haemostatic system) 
and waist-hip ratio (as a marker of the metabolic system) [154]. 
 
I chose to measure three of the biological markers suggested in this review – glycated 
haemoglobin, fibrinogen and waist-hip ratio. Functional lymphocyte assays were not 
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financially or logistically viable. In a review of immune markers of the stress 
response, Vedhara et al emphasise the importance of measuring multiple immune 
parameters, reflecting the complexity of the immune system [177]. One immune 
effect that has received a modest amount of research is the effect of stressor exposure 
on the susceptibility to the common cold [178]. Saliva is the first line of defense 
against pathogens invading the oral mucosa, with the principal antibody being 
salivary IgA. Canberra has a centre for research on mucosal immunology with 
expertise in the collection and measurement of salivary antibodies. Immunoglobulins 
reflect the activity of one branch of the immune system, so that a marker of the other 
branch (cell-mediated immunity) was sought. Neopterin is a small, biologically stable 
molecule, reflecting the degree of activation of T cells. It is measurable with 
commercial assays and a single study has shown that acute stress elevated, but while 
sub-acute stress depressed, serum neopterin. 
 
Because the neuroendocrine stress response has wide ranging effects on body systems 
(see Chapter 3, Part One), in this study, five biological markers were finally chosen 
(three from Kelly’s review, as well as neopterin and salivary IgA) as representatives 
of the haemostatic system, the metabolic system and the immune system. The 
remainder of this chapter reviews the current knowledge of each of these markers: 
their physiology, association with disease, population distribution and issues in their 
measurement that are important in their use as markers of the stress response. 
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3.8 Fibrinogen 
3.8.1 Physiology 
Fibrinogen was first recognized and named in the middle of the nineteenth century as 
contributing to the formation of a blood clot. Malpighi had earlier recognized that the 
central structural component of a clot was a white fibrous substance, later named 
fibrin. Its circulating precursor was named fibrinogen [179]. 
 
Fibrinogen is synthesised by hepatocytes under the influence of proinflammatory 
agents such as IL-6 in the acute phase response (see Appendix A), with feedback 
inhibition by extracellular sterols (mixtures of cholesterol and 25-hydroxycholesterol) 
[180]. IL-6 and catecholeamines upregulate the synthesis of fibrinogen while 
glucocorticoids enhance the effect of IL-6 [181-183]. Smoking increases fibrinogen 
synthesis, possibly via a prolonged acute phase reaction and IL-6, or via stimulation 
of catecholamine release [183]. Activation of the acute phase response can result in a 
two to ten fold increase in plasma fibrinogen [180]. 
 
Fibrinogen is a dimer, composed of two identical sets of three polypeptide chains 
termed Aα, Bβ and γ, joined by disulphide bonds [184]. There are three genes coding 
for fibrinogen (FGA, FGB and FGG), corresponding to the three polypeptide chains, 
situated in a cluster on the long arm of chromosome 4 [185]. Synthesis of the Bβ 
chain is the rate-limiting step and is responsive to IL-6. There is some evidence that 
individuals with particular fibrinogen genotypes may be more likely to have elevated 
levels of fibrinogen [185]. 
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Conversion of fibrinogen to form fibrin is the final step of the coagulation cascade, 
leading to formation of a blood clot, or thrombus. Following the thrombin-mediated 
cleavage of, firstly, the A peptide and then the B peptide, fibrin is formed and forms 
the basis of the network structure of the clot which also includes platelets, red blood 
cells, monocytes and a variety of growth and chemotactic factors released by these 
cells. 
 
Fibrinogen has a number of roles besides being the precursor for fibrin. 
 Platelet aggregation 
While the adhesion of platelets to vascular subendothelium is the initial event in 
primary haemostasis, continued platelet aggregation to form the haemostatic plug is 
mediated by circulating fibrinogen which links adjacent platelets via glycoprotein 
receptors [186]. 
 Leukocyte trafficking 
Fibrinogen may play a part in leukocyte movement from the blood into extracellular 
spaces in the acute inflammatory process. Leukocyte adhesion to fibrinogen may be 
crucial for the localization of leukocytes to sites of inflammation and the activation of 
a specific leukocyte response [187]. 
 Tumour progression 
Recent research has revealed abundant fibrin within the stroma of a variety of 
tumours. This fibrin may protect the developing tumour from infiltration by 
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inflammatory cells that would attack the tumour. Fibrin deposition is seen in small 
cell carcinoma of the lung, renal carcinoma and malignant melanoma. Within some 
tumours, fibrinogen (rather than fibrin) is present in the stroma. Mesothelioma, breast 
cancer, colon cancer and lymphoma have abundant fibrinogen and recent studies 
suggest that it may promote the formation of new blood vessels (angiogenesis) 
allowing the tumour to grow and metastasise [188]. 
 Association with lipid metabolism 
Hepatic cells secreting more fibrinogen also secrete more apoB, a large protein that is 
the principal structural protein in low-density lipoprotein (LDL) and very low-density 
lipoprotein (VLDL) cholesterol [180]. Elevated plasma fibrinogen is associated with 
abnormalities termed “the metabolic syndrome”: raised fasting insulin concentrations, 
low high-density lipoprotein (HDL), high levels of low density lipoprotein (LDL) and 
high levels of triglycerides [189]. 
3.8.2 Association with disease 
 Cardiovascular disease. 
Many studies have now shown that elevated levels of fibrinogen are independent risk 
predictors for cardiovascular disease [190-193]. Some studies indicate a steady rise in 
cardiovascular risk with increasing levels of plasma fibrinogen; an increase of 1g/L 
has been associated with a 45% increased risk of myocardial infarction [192]. Other 
research indicates that there is a threshold effect, with increased risk (relative risk = 
2.09, 95% CI 1.15-3.78) only at the highest levels of fibrinogen (>90 percentile of the 
distribution among control subjects) [193]. In a recent meta-analysis of the 
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relationship between fibrinogen and coronary heart disease (4018 CHD cases in 18 
studies), comparison of individuals in the top third with those in the bottom third of 
baseline measurements yielded a combined risk ratio of 1.8 (95% CI 1.6-2.0), 
associated with a difference in long-term usual mean fibrinogen levels of 2.9 μmol/L 
(0.1g/dl) [194]. Adjustment for other risk factors (serum lipids, alcohol consumption, 
body mass index, history of diabetes etc) had little effect on this relationship. In 
Kannel’s analysis of data from the Framingham Study, the independent contribution 
of fibrinogen to cardiovascular disease risk was greater than that of cigarette smoking 
[195]. 
 
Epidemiological studies show a strong predictive association of individual fibrinogen 
measurements and risk of cardiovascular disease. Longitudinal studies have indicated 
that a single fibrinogen measurement predicted fatal and non-fatal cardiovascular 
events as much as 16 years later [196]. In men in the Northwick Park Heart Study 
[185] an elevation of one standard deviation (about 0.6g/L) was associated with an 
84% increase in the risk of cardiovascular disease within the next five years.  
 Other diseases involving atherosclerosis 
Elevated fibrinogen has also been associated with an increased risk of other vascular 
diseases including cerebrovascular accidents, peripheral vascular disease, venous 
thrombosis and progressive arterial narrowing [191, 195]. Elevated levels of plasma 
fibrinogen due to chronic inflammation and activation of the acute phase response 
have been postulated as a vital link in the association of chronic dental disease with 
increased risk of cardiovascular disease [197].  
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Fibrinogen may be causally involved in the production of atherosclerotic lesions. 
Atherosclerotic lesions are rich in fibrinogen and it is thought that fibrinogen may 
directly enhance the progression of atherosclerosis, by its conversion to fibrin [193, 
198]. However, further research is required to confirm a causal role for fibrinogen in 
the production of atherosclerotic lesions. 
 
Even if not directly involved in atherogenesis, fibrinogen may contribute to vascular 
disease by exacerbating the effects of prevalent atherosclerosis. Fibrinogen may 
promote platelet aggregability [199] and in response to rupture of an atheromatous 
plaque, fibrinogen is part of the ensuing coagulation response. The thrombus formed 
may be large enough, in a coronary vessel, to cause myocardial ischaemia. Fibrinogen 
and plasma lipoproteins are key determinants of plasma viscosity [193, 200], so that 
elevated levels of fibrinogen may decrease blood flow, resulting in ischaemia if blood 
vessels are already stenotic. 
 
But elevated fibrinogen levels may also be a consequence of atherosclerosis, which 
may be viewed as a chronic inflammatory response to endothelial damage. In support 
of the non-causal hypothesis of the association of elevated fibrinogen and 
cardiovascular disease, van der Bom showed that while increased fibrinogen was 
associated with obesity, adverse lipoprotein profile and an increased risk of 
myocardial ischemia, increased fibrinogen due to genetic causes was not associated 
with a similar increase in risk [192]. Increased fibrinogen may be a marker of 
something else that is causing the increased vascular disease. Mirshahi suggests that 
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secretion of cytokines may simultaneously increase fibrinogen synthesis and induce 
vascular modifications leading to atherothrombosis [201]. 
 Interleukin-6 (IL-6) – a link between stress and fibrinogen? 
IL-6 is secreted from activated macrophages, lymphocytes and fibroblasts after 
activation by IL-1 and TNF-α in the acute phase response [202]. Among other 
actions, it stimulates hepatic release of fibrinogen.  
 
Il-6 may also be elevated during the stress response via catecholamine-mediated 
release from adipose tissue. In healthy adults systemic concentrations of IL-6 are 
increased in the obese and as much as one third of total circulating IL-6 may originate 
from adipose tissue [202]. IL-6 in turn has stimulatory effects on the HPA, increasing 
hypothalamic secretion of CRH and responsiveness of both the anterior pituitary 
release of ACTH and adrenal cortical secretion of cortisol. Yudkin believes that 
psychosocial stress may increase circulating levels of IL-6, which through stimulation 
of the HPA axis, results in a tendency to central obesity, insulin resistance and 
dyslipidemia with increased visceral adipose tissue mass further increasing levels of 
IL-6 and fibrinogen [202]. 
 
Obesity and smoking may resemble a low-grade persistent inflammatory state. 
Consequent elevation of IL-6 levels and chronic activation of the acute phase 
response may explain the association of obesity and smoking with elevated levels of 
fibrinogen [202].  
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3.8.3 Measurement issues 
Fibrinogen has a half-life of 3-6 days, and levels are very responsive to activation of 
the acute phase response, resulting in considerable intraindividual variation. Several 
studies have quantified this with repeat measurements. The results range from 
intraindividual variation accounting for between 12% and 67% of the total variation 
[190, 203-206]. Values for the correlation between two measurements range from an 
intraclass correlation of 0.49 (on the basis of 127 individuals who had samples drawn 
one year apart; Pearson correlation = 0.39 (p<0.0001)) [198] to Pearson correlations 
of 0.45 (for fibrinogen levels over 1 year among angina pectoris patients) [207] and 
0.54 (over 6-7 years among employed men) [208]. Results of a meta analysis return a 
correlation coefficient between two measurements taken some years apart of 0.6 
(range 0.5-0.7) [194]. 
 Circadian rhythm 
There are conflicting reports in the literature regarding the presence of a circadian 
rhythm in levels of plasma fibrinogen. Bremner et al report a significant daily pattern 
with maximum levels in early to mid morning, based on a study of 11 men ranging in 
age from 46 to 72 years [209], although there is considerable variability in individual 
acrophases. However, in a large study in which different groups of individuals were 
sampled at hourly intervals during the day, no circadian pattern was evident [210]. 
 Seasonal variation 
Seasonal variation in cardiovascular mortality has been linked to seasonal changes in 
fibrinogen level. Seasonal variation in plasma fibrinogen may only be apparent with 
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some methods of measurement. Two studies have shown significant seasonal 
variation in fibrinogen levels using immunonephelometry [211, 212]. Maximal levels 
of fibrinogen occurred in spring (maximum variation of 0.32 g/L). However, 
measurement of the same samples from one of these studies [211], by the clotting 
method of Clauss, showed a small but non-significant seasonal variation, with 
maximum fibrinogen levels in summer. The discrepancy between these two methods 
was explained by interindividual and intraindividual qualitative differences in 
fibrinogen and the different sensitivities of different assays to various fibrinogen 
forms. Using the prothrombin time method, van der Bom found that fibrinogen levels 
were considerably higher in late winter/early spring, particularly in the elderly. The 
level of seasonal difference was age dependent with 0.34 g/L (95% CI 0.29-0.39) in 
the over 75s and 0.29 (0.24, 0.35) in the 55-75 year old group. This variation did not 
appear to be temperature dependent [213]. 
3.8.4 Population distribution 
 Age and Gender 
Plasma levels of fibrinogen increase with increasing age in men and in 
postmenopausal women, but not in premenopausal women [189, 193, 194, 196, 203, 
214, 215]. Postmenopausal women had significantly higher levels of fibrinogen than 
premenopausal women [200, 216]. Over six years of follow-up in 549 women and 
440 men, mean fibrinogen increased by 26 mg/dl (0.26 g/L) with the greatest increase 
in older subjects [217]. Age–adjusted fibrinogen levels are higher in women than men 
at all ages [216, 219].  
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Table 3.1  Seasonal variation of fibrinogen using different methods of analysis. 
Reference . No. 
subjects 
Age of 
subjects
Method of 
analysis 
Seasonal variation 
Van der Bom 
(1997) [213] 
2325 >55 Prothrombin 
time derived 
Higher in Mar/April >75yo 
0.43g/L; 55-75yo 0.29 g/L 
(Rotterdam) Significant 
Frohlich 
(1997) [211] 
16 20-41 Immuno-
nephelometry 
Highest in April (Germany): 0.32 
p<0.001 
Frohlich 
(1997) [211] 
16 20-41 Clotting 
method of 
Clauss 
Highest in July (Germany): 0.09; 
non-significant 
Ma (1999) 
[193] 
400 40-84 Method of 
Clauss 
No significant seasonal variation 
Pitsavos 
(1998) [212] 
2009 18-34 Nephelometry Seasonal variation – no specific 
information supplied 
Wilson (1993) 
[218] 
2011 42-60  Thrombin 
method of 
Clauss 
No evidence of a seasonal effect 
 Genetics 
Genetic effects may determine 30-50% of interindividual variability in plasma 
fibrinogen levels and may affect the response of fibrinogen levels to environmental 
factors [190]. Genetic studies indicate that carriers of the A allele, (approximately 
20% of the population), have, on average, 7% to 10% higher fibrinogen levels than 
those with other genotypes [185]. Smokers with the A-allele experience a greater rise 
in fibrinogen than those with a different allele. 
3.8.5 Behavioural variation 
 Diet and Drugs 
High levels of fish oil and dietary fibre in the diet, and the use of several drugs 
(platelet aggregation inhibiting drugs such as ticlopidine and lipid lowering fibrates) 
may lower levels of plasma fibrinogen [190]. Oral contraceptive use is associated 
with increased plasma fibrinogen levels [220], while hormone replacement therapy 
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can impede the elevation of fibrinogen that is observed in post-menopausal women 
[200].  
 Smoking and alcohol 
Plasma fibrinogen levels are positively associated with smoking [189, 190, 193, 203, 
216], in smokers consuming more than 10 cigarettes per day [221], and negatively 
associated with moderate alcohol intake [199, 203, 212]. Cessation of chronic 
smoking is associated with a marked fall in plasma fibrinogen with levels that remain 
intermediate between smokers and non-smokers for several years [183, 222].  
 Physical activity  
Plasma fibrinogen level is inversely associated with reported leisure-time exercise in 
some studies, [190, 216] while others find that this relationship is no longer 
significant after adjustment for possible confounding factors [215]. However, 
physiological assessment of fitness (maximal oxygen uptake) indicated that those 
who were most fit had a lower level of fibrinogen, and this relationship persisted even 
after adjustment for possible confounding factors [215].  
 
Ernst reviewed the relationship between physical activity and fibrinogen levels in 
longitudinal studies and found evidence of a reduction of about 0.4 g/L with physical 
activity [223]. Lee suggested that the relationship between activity and fibrinogen 
could be largely explained by smoking [224], while Connelly found that those who 
were vigorously active had lower fibrinogen levels, even after adjustment for age, 
smoking, alcohol, BMI and occupation [225]. 
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3.8.6 Psychosocial and SES variation 
A summary of the literature examining the association of psychosocial factors and 
SES with plasma fibrinogen is presented in Table 3.2. This literature is covered in 
greater detail, in the context of my own findings, in the Discussion, chapter 6. 
 
Table 3.2 Summary of SES and psychosocial variation in plasma fibrinogen 
 Direction of 
effect 
Consistency of findings References 
Childhood SES Inverse 
association 
Few studies, but generally consistent [196] 
Adult SES Inverse 
association 
Some consistency; few studies indicate 
association disappears after adjustment for 
lifestyle factors, eg smoking. 
[182, 196, 
200, 218, 
226- 228] 
Acute stress Positive 
association 
Five out of seven studies show a positive 
association. 
[182, 229, 
230] 
Chronic stress Positive 
association 
Consistent finding for job stress. [78, 182, 
196, 199, 
231, 228, 
232] 
Social network 
/participation 
Inverse 
association 
Few studies [227] 
Social support Positive 
association 
Few studies [227] 
 
3.8.7 Association with other cardiovascular risk factors 
Plasma fibrinogen levels are positively associated with body mass index [189, 190, 
203, 212, 215, 216], LDL cholesterol [189, 190, 216], waist-hip ratio [189, 222, 233], 
blood leukocyte count [222], history of hypertension [189, 193], and triglyceride level 
[189] and negatively associated with HDL cholesterol [189, 190, 193, 216, 234] in 
men and women. In women, obesity, total cholesterol, and systolic blood pressure are 
positively associated with plasma fibrinogen, while in men, height is negatively 
correlated with plasma fibrinogen [234]. 
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Plasma fibrinogen concentration is positively correlated with the number of cardiac 
symptoms experienced in the previous fortnight [196], and with a positive family 
history of coronary artery disease [216, 221]. In longitudinal studies, fibrinogen 
increased more in those with, or who developed, diabetes and those whose plasma 
HDL cholesterol or triglycerides decreased [217]. 
 
Margaglione suggests that age and lifestyle factors may account for about 30% of the 
interindividual variation of plasma fibrinogen levels (with intraindividual variation 
accounting for up to 25% of the total variability in plasma fibrinogen in the same 
study) [221]. 
3.8.8 Conclusion 
There are plausible biological links between activation of the stress response, and 
elevation of plasma levels of fibrinogen, via IL-6 and activation of the acute phase 
response. There is strong empirical evidence that plasma fibrinogen levels predict 
later coronary heart disease. Fibrinogen is commonly measured, requires no special 
sample preparation and has a well-defined population distribution. It thus fulfils all of 
Kelly’s criteria for a marker of the chronic stress response, except that it does not 
have a long half-life and there is thus considerable intraindividual variability. A 
single measurement on an individual may provide little indication of the level of 
chronic stress, although measures averaged over a group may be useful in delineating 
group associations between stress and SES. 
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3.9 Glycated haemoglobin (HbA1c) 
3.9.1 Physiology 
Human haemoglobin is primarily responsible for oxygen transport by erythrocytes in 
blood. Haemoglobin is a tetramer consisting of two pairs of entwined and folded 
polypeptides chains. Several different types of polypeptides, including α, β, γ, and δ 
chains are found in human red cells, covalently linked to a heme group [235]. In 
normal adults about 97% of red cell haemoglobin is HbA (α2β2), which can be 
separated on cation exchange resin to give haemoglobin fractions designated as 
HbA0, HbA1, HbA2 and HbA3 [236]. HbA1 can be further charge separated into 
HbA1a1, HbA1a2, HbA1b and HbA1c [237]. 
 
HbA1c is created when glucose condenses with a free amino group of valine or lysine 
on a β chain of haemoglobin to form a Schiff base (pre-A1c), which then undergoes 
rearrangement to form HbA1c. The formation of pre-A1c is reversible, while the 
formation of HbA1c is irreversible [235]. Since the formation of HbA1c is non-
enzymatic, the process is termed glycation and HbA1c is commonly called glycated 
haemoglobin, although strictly speaking there are a number of different glycated 
haemoglobins [237]. 
 
Formation of HbA1c occurs over the life-course of the red blood cell (~120 days), but 
recent glycaemia probably has the largest influence on measured HbA1c. It is likely 
that 50% of glycated haemoglobin is formed in the month before sampling, 25% in 
the month before that, and the remaining 25% in months two to four prior to sampling 
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[237]. Thus the amount of HbA1c in blood reflects a time-averaged blood glucose 
concentration over the previous four months [238]. 
 
As has been noted earlier, following perception of a stressor the HPA and the SAM 
are activated, with subsequent rapid elevation of blood glucose level. Repeated 
elevations of blood glucose, following chronic or repeated acute stress responses 
could be expected to cause an increase in the level of HbA1c. 
3.9.2 Association with disease 
HbA1c measurement was developed for use in the monitoring of blood glucose levels 
in diabetics, but has been little studied in non-diabetic populations. In a cross-
sectional examination of postmortem atherosclerosis and glycated haemoglobin in 
young non-diabetic persons dying of external causes, McGill found that there was 
evidence of extensive early atherosclerosis in those with glycated haemoglobin levels 
greater than 8%. There was no association with atherosclerosis at lower levels of 
HbA1c [239]. 
 
In a case-control study as part of the Atherosclerosis Risk in Communities Study 
(ARIC) study, after adjustment for other risk factors, a 1% increment in glycated 
haemoglobin level was associated with 1.77 greater odds of having carotid intimal-
medial thickening, a measure of asymptomatic atherosclerosis. However, it was 
uncertain whether the association was linear, or whether there was a threshold, 
possibly within the normoglycemic range [240]. Other studies have also reported an 
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association between the level of glycated haemoglobin and symptomatic 
cardiovascular disease in non-diabetic individuals (cited in [240]). 
 
Glycated haemoglobin may not be only a marker of diabetes or atherosclerosis, but 
part of the disease process itself. HbA1 is not the only protein to undergo glycation in 
the presence of glucose and other sugars. Over time non-enzymatic glycation of 
proteins leads to the formation of irreversible terminal products, the advanced 
glycation end-products (AGEs). These accumulate in long-lived proteins such as 
collagen. There is now extensive evidence that AGEs play an important role in the 
pathogenesis of diabetic complications, including nephropathy and retinopathy by a 
variety of mechanisms including DNA mutation, generation of oxygen free radicals 
and alteration of tissue immunogenicity [241]. 
3.9.3 Measurement issues 
In general HbA1c is expressed as a percentage of total haemoglobin, but there are a 
number of issues in its measurement. 
 Haemoglobin variants 
As well as the HbA group of haemoglobin fractions, there are more than 700 other 
haemoglobin variants, which may be present in human red cells. At least half of these 
are clinically silent; others including HbS, HbC, HbD, and HbE may cause various 
levels of sickle cell anaemia, while variants such as HbF (α2γ2) or fetal haemoglobin 
are commonly present but in small amounts in adult humans. A number of these 
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abnormal haemoglobins can interfere with the measurement of HbA1c, either by 
giving falsely high or low results, or by making the measurement impossible. 
 Measurement methods 
There are currently about twenty different methods of measuring glycated 
haemoglobin, using four different principles – affinity chromatography, 
immunoagglutination, electrophoresis and high performance liquid chromatography 
[238, 242]. Unfortunately, different techniques may measure slightly different 
glycated products, use different units for reporting results, and can produce different 
values for the same blood sample. Indeed, different laboratories using the same assay 
may not produce similar results. Efforts are underway to standardise the analysis and 
reporting terminology [242]. 
 Individual variability 
There is strong intraindividual stability of the measure but wide inter-individual 
variability [243].  
 Seasonal variation 
Research suggests a seasonal peak in early spring and a nadir in early autumn [244, 
245]. 
3.9.4 Population distribution 
In a random sample of Victorians aged 40 years and older, (as part of the Melbourne 
Visual Impairment Project) 3% of the non-diabetic study population had an elevated 
level of HbA1c [246]. 
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 Age and Sex 
Individual concentrations increase with age at approximately 1% per year [154, 247]. 
While some studies suggest that men tend to have higher levels of glycated 
haemoglobin than women, at all ages with no effect of menopausal status [248], 
others indicate no gender difference in non-diabetic populations [247, 249]. 
3.9.5 Behavioural variation 
 Physical activity 
Poorer diabetic control is associated with low levels of physical activity [250] as well 
as lower socioeconomic status and lower educational level. While this is reflected in a 
higher HbA1c, it is not possible to understand the effect of physical activity on HbA1c 
without taking account of the confounding effect of socioeconomic status and 
diabetic status. 
 Smoking 
Current smokers have higher HbA1c levels than ex-smokers or non-smokers [248]. 
3.9.6 Psychosocial and SES variation 
A summary of the literature outlining the psychosocial and SES variation in glycated 
haemoglobin is presented in Table 3.3. These findings are covered in greater detail, in 
the context of my own findings, in the Discussion, Chapter 6. 
 126
Table 3.3 Summary of SES and psychosocial variation in glycated haemoglobin. 
SES measure Direction 
of effect 
 References 
Adult SES null Few studies in general population; no 
convincing association 
[250-252] 
Acute stress Positive 
associati
on 
Examination stress. No association with other 
psychological factors. 
[244] 
Chronic stress  Inferred stress in Indigenous populations [251]  
Anxiety Positive 
associati
on 
Single study looking at anxiety levels in 
relatives of cancer patients 
[247] 
Social support null Few studies in non-diabetic population [244] 
 
3.9.7 Association with other risk factors for disease 
Few researchers have examined the association between glycated haemoglobin and 
risk factors for disease in non-diabetic populations. In a Japanese study, levels of 
glycated haemoglobin were significantly correlated with levels of fibrinogen and 
factor VII in men and with BMI and total cholesterol in women in multivariate 
analysis [248]. 
3.9.8 Conclusion 
Glycated haemoglobin is plausibly increased as a result of repeated or prolonged 
activation of the stress response, via elevation of blood glucose under control of the 
SAM and the HPA. There is little evidence that elevation of HbA1c within the normal 
range is predictive of later disease, although mild elevations may be associated with 
subclinical atherosclerosis. Glycated haemoglobin has a long half-life, a well-defined 
demographic distribution, is commonly measured and requires no particular sample 
preparation. It has readily available reference standards, but there are problems with 
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the interlaboratory correlation of measurements. There is a good fit with Kelly’s 
criteria for use of HbA1c as a marker of the chronic stress response. 
3.10 Waist–hip ratio 
3.10.1 Physiology 
Waist – hip ratio (WHR) is simply the waist circumference divided by the hip 
circumference. It is measure of fat distribution and visceral fat mass, unlike body 
mass index (BMI = weight/height2), which is a measure of generalised obesity, 
measuring the sum of fat mass and fat free mass, regardless of the distribution. It 
seems likely that BMI is dependent on the regulation of energy balance via the HPA 
and leptin resistance, whereas localisation of body fat is probably regulated by other 
factors, such as endocrine perturbations [253]. 
 
There is high (but not perfect) correlation between BMI and WHR [254, 255] and 
increased health risks are associated with abnormalities of each, independently.  
 
Figure 3.3 indicates the health risk associated with different body profiles. In general, 
low BMI (leanness) is associated with better health than high BMI, but being lean and 
having greater central fat is a particularly unhealthy profile, which predicts premature 
mortality [254]. 
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Figure 3.3  Body fat distribution and health risk [256] 
 
 
In the general population, around 65-70% of body fat is subcutaneous, 20% intra-
abdominal and 12% intra-muscular [257]. Premenopausal women preferentially 
deposit fat in the gluteofemoral region and carry on average only 8% of their total 
body fat mass in the abdominal region [258]. Increased abdominal adiposity may be 
due to increased intra-abdominal fat or increased subcutaneous fat (lying between the 
abdominal muscles and the skin). Approximately 80% of intra-abdominal fat is 
visceral fat, while 20% is retroperitoneal [257] and it appears to be increased visceral 
fat that is particularly associated with poorer health outcomes [259]. 
 129
 Pathogenesis of central fat deposition 
Fat deposition is a complex process controlled by brain neuropeptides, leptin, the 
SNS and the HPA. Obesity in turn affects the SNS and the HPA axis through 
secretion of IL-6 from adipose tissue.  
 
During puberty, under the control of androgens and estrogens, characteristic male and 
female fat distribution is established. Males develop a more central fat distribution, 
whereas females tend to store more fat peripherally, [260, 261] although the 
preferential site of fat deposition is determined by genetic and environmental factors 
[254, 260]. Estimates of the contribution of genetic factors to the variation in fat 
distribution vary from around 25% [260] to 50% [262] and these genetic factors 
probably work through alterations in the HPA and ANS. 
 
Perhaps the most striking example of central body fat deposition is that seen in 
Cushing’s syndrome, the result of diseases that cause elevated levels of cortisol. This 
typical pattern of fat deposition associated with cortisol excess has led to considerable 
research investigating the role of cortisol and the HPA axis in the development of 
central adiposity in non-Cushingoid individuals. Such people display increased 
excretion of (urinary) free cortisol that is proportional to WHR, and blunting of 
dexamethasone suppression (a test of an intact cortisol negative feedback on ACTH), 
with depressed levels of circulating sex steroids and growth hormone [263]. The HPA 
appears to be hyper-responsive and it is hypothesized that increased levels of cortisol 
stimulate the increased deposition of body fat. Sex steroids and growth hormone 
(GH), which have opposite effects on fat deposition, are depressed, further favoring 
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net fat deposition [263]. Indeed, GH and female sex hormones not only mobilize fat, 
but they cause it to be stored peripherally (at the hips) rather than centrally [254]. 
 
Bjorntorp theorizes that stress-induced abnormalities in the HPA are causative of 
central fat deposition. The defeat response to stress is characterized by elevated 
secretion of cortisol in response to ACTH stimulation [264] and decreased secretion 
of growth hormone and sex steroid hormones [263]. In humans with central adiposity, 
there is physiological evidence of both the fight/flight and defeat responses to stress, 
with hypertension, high haemoglobin concentration and increased plasma free fatty 
acids (FFAs) [265].  
 
Similar outcomes have been observed in rats and in non-human primates under 
chronically stressful conditions. Studies in cynomolgus monkeys indicate that socially 
subordinate animals who are the recipients of constant aggression by dominant 
monkeys experience a defeat reaction associated with this chronic stressor exposure, 
with activation of the HPA and accumulation of excess visceral adipose tissue in a 
dose-dependent manner [163, 254, 261, 266-268]. There is concomitant development 
of insulin resistance, dyslipidemia, hypertension, impaired glucose tolerance and 
early signs of coronary atherosclerosis [162]. 
 
In humans, chronic over-activity of the SNS may manifest as essential hypertension 
[263], while chronic activation of the HPA axis results in the loss of the normal 
diurnal rhythm of cortisol excretion, with lower morning values and blunted 
responses to stressor exposure [163, 269]. In association with blunting of the HPA 
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axis, the central glucocorticoid receptors (GCRs) may become atrophied and less 
dense, with diminished cortisol feedback inhibition of CRH and ACTH and an 
abnormal dexamethasone suppression test. The SNS may become overactive in 
compensation [163]. Consequently, adults with central fat distribution may have 
greater cardiovascular reactivity to stress (such as blood pressure reactivity) than 
those with peripherally distributed fat [254].  
 
In adipocytes, glucocorticoids (in the presence of insulin) inhibit the fat-releasing 
effects of insulin (by inhibiting hormone sensitive lipase) [163], and promote fat 
storage by enhancing the activity of lipoprotein lipase [270]. The net result is an ever-
increasing accumulation of fat and enlargement of adipocytes. Visceral fat is 
morphologically different from peripheral fat with higher levels of GCRs (fourfold 
higher in intraabdominal fat than in subcutaneous fat [270]), greater blood flow and 
denser innervation. Thus cortisol acts via the GCRs preferentially at visceral sites to 
increase fat deposition [166, 263, 271-273]. This is summarized in Box 3.4. 
 
 
 
 
 
 
 
 
 
 
 
Box 3.4.  Cortisol effects on visceral fat  
Binding to glucocorticoid receptors 
(High density of receptors) 
Lipoprotein lipase activated →Triglycerides accumulated 
(Gene transcription & enzyme stabilization) 
Lipid mobilisation inhibited → Triglycerides retained 
(Insulin required)     [163] 
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The reproductive system is inhibited at all levels by components of the HPA axis: 
CRH suppresses hypothalamic LHRH, while cortisol inhibits the actions of pituitary 
and gonadal sex hormones on target tissues [273]. Consequently, women with central 
obesity may have a higher incidence of oligomenorrhea, elevated free testosterone 
levels [163], and low levels of sex hormone binding globulin [261]. Men with 
elevated WHR are prone to relative hypogonadism and abnormally low levels of 
testosterone [273]. 
 
Growth hormone (GH) and the sex hormones have opposite effects to cortisol on lipid 
accumulation, inhibiting lipoprotein lipase and stimulating lipolysis [163]. Thus the 
prolonged combination of elevated cortisol levels and low secretions of sex steroids 
and GH (as in the defeat response to stress) will tend to favour the accumulation of 
body fat, with preferential accumulation in intraabdominal visceral depots [163], 
insulin resistance and ultimately the metabolic syndrome [274]. Figure 3.4 
summarizes the pathophysiology of central obesity. 
 
Other hypotheses regarding the pathogenesis of central fat distribution include a 
primary adrenal [261], hypothalamic or pituitary [166] abnormality with hyper-
responsiveness of the HPA and excessive secretion of CRH and cortisol. Depression 
of the normal negative feedback mechanism could be the result of downregulation of 
GCR due to HPA hyperactivity or a genetic polymorphism at the level of the coding 
sequence of the GCR gene [166].  
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Figure 3.4  Pathophysiology of central obesity  (adapted from [261]) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SNS: sympathetic nervous system 
FFA: free fatty acids 
VLDL: very low density lipoproteins 
CVD: cardiovascular disease 
ACTH: adrenocorticotrophin hormone 
FSH/LH: follicle stimulating hormone/luteinizing hormone 
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3.10.2 Association with disease or risk factors for disease 
 Why is the distribution of body fat important? 
Vague (1956) was the first to propose that the level of body fat was less important to 
health than the distribution of this fat, following studies of health outcomes in obese 
mice (cited in [259]). Subsequent studies have confirmed that centrally deposited fat 
is a greater risk factor for a number of diseases, including cardiovascular disease and 
diabetes, than peripherally deposited fat [162].  
 WHR and the metabolic syndrome 
The metabolic syndrome is a cluster of signs including insulin resistance, 
dyslipidemia (elevated cholesterol and triglycerides, elevated LDL and depressed 
HDL cholesterol), glucose intolerance, hypertension and a hypercoagulable state. 
Individuals with elements of the metabolic syndrome are at increased risk of 
cardiovascular disease. Elevated WHR is an important feature of the metabolic 
syndrome and may be the driving force behind the associated abnormalities [257, 
275]. 
 WHR and cardiovascular disease 
In cross-sectional studies, elevated WHR and excessive visceral fat or central body 
fat distribution are associated with hypertension [276, 277], peripheral arterial 
disease, cardiovascular disease [239, 259, 278, 279] and cerebrovascular disease 
[261, 280] in men and women [259, 263, 281, 282]. In many studies this association 
is stronger than the association between these diseases and BMI and persists after 
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adjustment for total cholesterol level, blood pressure, diabetes, BMI, smoking, 
alcohol consumption, education and race [282-285]. 
 
Increased central fat deposition is also associated with other measures of 
cardiovascular risk, such as increased levels of fibrinogen, total cholesterol, decreased 
HDL cholesterol and elevated triglycerides [257, 278, 279, 286-288]. The association 
between central adiposity and disease appears to be dose-related such that higher 
WHR predicts higher disease risk and this is independent of sex, age and race [256, 
285, 289]. 
 
McGill noted that visceral adiposity at postmortem, in young persons dying of 
external causes, was associated with increased vascular fatty streaks and 
atherosclerosis in the coronary artery [239].  
 Association with diabetes mellitus 
There is a strong association between central fat deposition and (non-insulin 
dependent) diabetes mellitus Type 2, in adults [261, 290, 291]. In the Iowa Women’s 
Health Study, women simultaneously in the highest quintiles of BMI and WHR had a 
relative risk (RR) of (self-reported) incidence of diabetes of 29 (95% CI 18-46) 
compared to women in the lowest combined quintiles. Even women in the lowest 
quintile for BMI had increased risk of developing diabetes if they had elevated WHR 
(RR = 5.1, 95% CI 3.9 - 6.8) [289]. 
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 Association with malignancy 
There is a positive association of central fat tendency with breast and endometrial 
cancers in women [259, 261] with a relative risk (RR) for developing breast cancer of 
1.3 (95% CI 1.1 - 1.5) and for endometrial cancer RR = 2.0 (95% CI 1.4 - 2.8) in 
women in the highest quintile of WHR compared to the lowest [289]. Among women 
with a family history of breast cancer, the relative risk for developing breast cancer 
for those in the highest quintile of WHR was 3.24 [292]. Hyperinsulinemia is 
commonly seen in association with central adiposity [293] and insulin is a known 
growth-promoting hormone for normal breast epithelium and human breast cancer 
cells. In addition, visceral adipose tissue synthesizes significant amounts of insulin-
like growth factors, which may facilitate the response of breast cancer cells to 
estradiol [292]. 
 Association with other diseases 
Increased central adiposity is associated with sleep apnoea (in men) [294] and renal 
impairment [295] even in those with normal BMI. WHR predicts total mortality, as 
well as mortality from the specific diseases already outlined [289]. The relative risk 
for stroke in a large study of male health professionals was 2.33 (95% CI 1.25-4.37) 
in the highest quintile of WHR compared to the lowest [280]. 
 
WHR and BMI are also associated with psychiatric ill-health, including use of 
psychopharmacological drugs, personality disorders, depression, anxiety and 
psychosomatic disease, but this relationship appears to be stronger for WHR in 
women than men [261, 296, 297]. Non-obese depressed women had higher cortisol 
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levels and a twofold increase in intra-abdominal fat compared to controls (non-
depressed) [270]. 
 
Obesity is increasing in the populations of developed countries over time, but the 
increase in central obesity appears to be more marked than the increase in generalized 
obesity [298]. 
3.10.3 Measurement issues 
A number of different measurements have been used to evaluate central fat 
deposition, including waist - hip ratio, waist circumference and waist to height ratio 
[276, 279]. Waist circumference is often more highly correlated with BMI than with 
WHR and may reflect both general and abdominal obesity, thus adding little further 
information beyond that contributed by BMI [276, 289]. WHR appears to predict 
disease in adults better than other simple measurements [259].  
 
Waist and hip measurements may each provide different health information [261] and 
it seems likely that it is the combination of increased waist circumference with 
relatively decreased hip circumference that is predictive of disease, rather than just 
increased waist circumference [299]. Hip circumference includes the measurement of 
the large muscles in the gluteal region, and muscle tissue is a major regulator of 
systemic insulin sensitivity [160]. A small hip circumference, indicating a small 
muscle mass may mean less quantity of this important tissue [160]. The combination 
of high waist circumference (with excessive visceral adipose tissue and release of 
FFAs into the circulation) and low hip circumference (with lower gluteal muscle 
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mass), may be particularly important in relation to insulin resistance. Thus, while 
waist circumference may be an important indicator of increased cardiovascular 
disease (CVD) risk, both hip and waist circumference may carry information for 
insulin resistance. 
 
WHR is highly correlated with more advanced methods of determining visceral fat 
mass, e.g. magnetic resonance imaging, dual energy X-ray absorptiometry and CT 
scan [259, 289, 300]. 
 
There is considerable variability in the position of the measurements taken. Waist 
measurements have been taken at the level of the umbilicus [267], midway between 
the costal margin and the iliac crest [282], 2.5 cm above the umbilicus [289], at the 
mid-level between the processus xiphoideus and the umbilicus [233] and at the 
smallest diameter between the rib cage and the iliac crest [274]. Hip measurements 
have been taken at the level of greater trochanters [267], the largest girth between the 
waist and thigh [274], the widest point between the hip and the buttock [282] or at the 
level of maximal protrusion of the gluteal muscles [276, 289].  
 
For consistency all subjects must be similarly clothed although there is a high 
correlation (r = 0.994) between measurements taken over clothing and those taken 
over skin [298]. Some researchers have measured the tension of the measuring tape to 
ensure consistency in technique [287]. Despite the variation in measurement 
technique, the associations with disease are robust and were apparent even when 
participants self-measured using a paper tape [262, 296]. Comparisons of different 
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versions of the WHR measurement suggest that they measure disease risk similarly 
[301].  
 
Upper limits of WHR vary by gender and in different populations. A survey of 
Australian populations in 1993 returned a mean of 0.89 for men and 0.76 for women 
aged 40-44 years [301]. Increased CVD risk may be present when WHR exceeds 0.85 
[259]. 
3.10.4 Population distribution 
 Age and Gender  
Central fat distribution increases with age and is correlated with the level of decline 
of the sex hormones. Higher WHR is more common in males and post-menopausal 
women and is correlated with parity [302]. 
 Genetics and intrauterine effects 
The greatest risk for developing abdominal obesity and insulin resistance occurs in 
children who are born small but gain weight rapidly between ages 4 to 7 [257, 303]. 
Higher birth weight is associated with higher adult BMI, while maternal and paternal 
obesity predict childhood obesity in their children [303].  
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3.10.5 Behavioural variation 
 Smoking 
Most studies indicate that central body fat tendency is more prevalent among smokers 
[259, 265, 286, 289, 297, 304], possibly associated with hypothalamic arousal, 
hypercortisolemia and depressed levels of sex hormones similar to that seen in the 
defeat response to stress. Male smokers tend to have increased WHR but decreased 
BMI, that is, they are leaner than non-smokers but tend to deposit fat centrally [259, 
301]. 
 Alcohol 
Alcohol intake has an inconsistent association with WHR [259, 301, 302].  
 Physical activity 
Physical activity is negatively associated with both abdominal adiposity and BMI in a 
dose-response manner [301, 305], although Visser found that this association was 
restricted to intensive exercise training (but not low or moderate intensity exercise) 
[305]. 
3.10.6 Psychosocial and SES variation  
The literature examining associations between psychosocial factors and WHR and the 
SES variation in WHR is summarized in Table 3.4. These findings are covered in 
greater detail, in the context of my own findings, in the Discussion, Chapter 6. 
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Table 3.4 Summary of SES and psychosocial variation in waist-hip ratio. 
 Direction of 
effect 
Findings Reference
s 
Childhood 
SES 
Inverse 
association 
Highly consistent [281, 286, 
306-310]  
Adult SES Inverse 
association 
Consistent. May be strongest with 
education. 30% of studies report direct 
relationship in men. Inconsistent results 
with employment status and for housing. 
Subjective SES may be more strongly 
associated than objective indicators, for 
women. 
[150, 226, 
256, 265, 
287, 290, 
297, 301, 
304, 308, 
311-314] 
Acute stress Direct 
association 
May be an interaction with BMI in men [254, 315, 
316] 
Chronic 
stress 
Direct 
association 
Strain in social relationships, perceived 
inequality and constraint, work stress 
[254, 263, 
310] 
Affiliation 
and 
extroversion 
Direct 
association 
 [297] 
Self-esteem Inverse 
association 
 [254] 
Social 
support 
Inverse 
association 
Lack of social support associated with 
increased risk of the metabolic syndrome. 
[317]  
 
3.10.7 An evolutionary perspective 
Vague referred to central fat tendency as an android fat distribution, more commonly 
seen in males. Gynoid fat distribution, more common in women is characterised by 
localisation of fat in the thighs and buttocks. Abdominal adipose tissue is 
metabolically active and relatively easily mobilized to provide energy in time of need, 
such as in response to stressor exposure, and may therefore have survival value [160]. 
Fat stores in the gluteofemoral area, more common in premenopausal females, may 
have evolved primarily as an energy store (during pregnancy and lactation), insulator 
or to have a reproductive function [256]  
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3.10.8 Conclusion 
WHR is a stable, easily measured, biological marker with strong associations with 
cardiovascular disease and insulin resistance. There is considerable evidence that 
central fat deposition may be a consequence of activation of the neuroendocrine stress 
response, particularly to stressors perceived as being overwhelming. 
 
In addition to an association with the metabolic syndrome and a number of endocrine 
aberrations, central fat deposition is also associated with adverse behaviours such as 
smoking, excessive alcohol ingestion, sedentary lifestyle, high daily caloric intake 
and weight gain during adulthood as well as psychiatric disorders, such as depression 
and anxiety, peptic ulcers and increased use of stimulants [263, 273]. Bjorntorp 
suggests that this constellation of behavioural and metabolic abnormalities is the 
human equivalent of the defeat reaction seen in cynomolgus monkeys [160]. 
3.11 Neopterin 
3.11.1 Introduction 
In its simplest conceptualisation, the immune system can be divided into cell 
mediated immunity (activated T cells stimulate the body’s own germicidal cells to 
engulf and destroy pathogens) and humoral immunity (plasma cells produce 
antibodies that bind with pathogens, which can then be destroyed by various means). 
Activated T cells of the cell-mediated (TH1) and the humoral (TH2) immune systems 
release a number of mediators called cytokines, with diverse actions throughout the 
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body. (A more detailed description of the immune system is provided in Appendix 
A). 
 
While measurement of cytokines may provide a window on the immune system, most 
have been difficult to measure as they are often labile, bind to target cells and may 
disappear from the circulation soon after release [318]. Neopterin is a sensitive and 
stable marker of the cell mediated immune system reflecting the outcome of 
activation of the system and the net biological effect of release of a mixture of 
cytokines on the macrophage population in vivo [319, 320]. 
 
Neopterin belongs chemically to the family of pteridines. First isolated as pigment 
from the wings of butterflies (Lepidoptera) by Hopkins in 1889, the name pteridines 
was coined in 1936 by Wieland and Schopf, from the Greek pteron, meaning wing 
[321, 322]. 
 
In 1963 neopterin was isolated from the larvae of bees and in royal jelly [321, 322] 
and was first detected in human urine in 1967 [318]. It was subsequently isolated 
from the urine of patients with malignant tumours and viral diseases in 1979 [318, 
323] and observed to accumulate in blood following antigenic stimulation in 1982-3 
[318].  
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3.11.2  Physiology 
 Biosynthesis 
Activation of TH1 type T cells results in the release of interleukin 2 (IL-2) and 
subsequently interferon gamma (IFN-γ). IFN-γ acts on monocytes/macrophages to 
stimulate conversion of guanosine triphosphate (GTP) to 7,8 dihydroneopterin 
(DHN), which may then be oxidized to neopterin [324]. 
 
In most human cells, including fibroblasts, endothelial cells and cells of the central 
nervous system, GTP metabolism results in the formation of tetrahydrobiopterin 
(BH4) and only small amounts of neopterin. BH4 is an essential electron donor in the 
hydroxylation of phenylalanine to tyrosine in the liver, and of tyrosine to L-dopa and 
tryptophan to 5-hydroxy-tryptophan in neuroendocrine tissue synthesizing 
catecholamines or serotonin [321, 324]. Monocytes/macrophages however, lack the 
enzyme 6-pyruvoyl-tetrahydropterin synthetase, which converts GTP to BH4, and 
consequently preferentially form DHN and neopterin [321]. Atypical phenylketonuria 
is caused by defective biosynthesis of tetrahydrobiopterin with accumulation of 
phenylalanine and neopterin, and deficient production of the neurotransmitters 
dopamine, noradrenaline and serotonin [318]. 
 
 145
Figure 3.5  Biosynthesis of neopterin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biosynthesis of neopterin from guanosine triphosphate (GTP). PTPS is the enzyme 6-
pyruvoyl-tetrahydropterinsynthase. 7,8-dihydroneopterin triphosphate is converted via a 
magnesium-dependent 6-pyruvoyl-tetrahydropterin synthetase to unstable 6-pyruvoyl-
tetrahydropterin, which in turn is converted to 5,6,7,8-tetrahydrobiopterin an inhibitor of 
GTP-cyclohydrolase I. 5,6,7,8-tetrahydrobiopterin is an electron donor in the hydroxylation 
of phenylalanine to tyrosine in the liver, tyrosine to L-DOPA and tryptophan to 5-hydroxy-
tryptophan in neuroendocrine tissues synthesizing neurotransmitters such as catecholamines 
and serotonin. 5,6,7,8-tetrahydrobiopterin is also a cofactor of nitric oxide synthetase [325]. 
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 Stimulants of neopterin release 
The main stimulant of neopterin production is IFN-γ, while IL-2 also provokes 
neopterin production via induction of IFN-γ and tumour necrosis factor alpha (TNF-
α) [324]. Interferon-alpha (IFN-α) can stimulate neopterin production in vitro, but 
only at a dose 1000-fold higher than the required dose of IFN-γ [321, 323, 324]. 
While such levels are unlikely in vivo, high local levels of IFN-α may occur in some 
autoimmune diseases and in AIDS, so that in these situations IFN-α may be 
responsible for induction of neopterin production [326]. TH1 immunity is inhibited by 
activation of the TH2 (humoral) immune response, so that neopterin production is 
suppressed by TH2 cytokines, IL-4 and IL-10 [327]. 
 
The interaction between macrophages and activated T lymphocytes is a dynamic one, 
with each influencing the behaviour of the other. Interleukin-1 (IL-1) acts on T cells 
to induce IL-2 receptors and to stimulate IL-2 production. IL-2 in turn stimulates T 
cells to secrete IFN-γ, which activates macrophages to produce large amounts of 
neopterin [321]. 
 
The physiological response to acute stress results in the elevation of IL-1β and TNF-
α, and downregulation of IFN-γ [328-330]. The response to acute stress should 
therefore be associated with a decrease in neopterin levels. The TH1 (cell-mediated) 
and TH2 (humoral) branches of the immune system are generally counterregulatory, 
so depression of neopterin levels (as a sign of cell-mediated immunity) fits well with 
the enhancement of humoral immunity seen with acute stress [331]. 
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Figure 3.6  Neopterin secretion [332] 
 
 
 
 
 
 
 
 
 
 
On the contrary, chronic stressor exposure may be associated with diminished 
production of IL-1 β [333], and increased serum neopterin. There are however, 
contradictory findings of the effects of acute and chronic stress on cell-mediated 
immunity, depending on the parameters measured for both stress and immunity [334]. 
 Biological Role 
Neopterin is found only in primates so that it has been hypothesized to be the primate 
homologue of nitric oxide [335, 336], a substance important as a neurotransmitter 
(when secreted by neurons), as a vasodilator (when secreted by endothelial cells) and 
as a cytotoxin to certain cancer cells and bacteria when secreted by white blood cells 
[337]. 
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Redox reactions 
Neopterin and 7,8-dihydroneopterin (DHN) coexist in a ratio of approximately 1:2 
[318]. At a slightly alkaline pH (pH 7.5), neopterin enhances the activity of powerful 
oxidising agents such as hydrogen peroxide and chloramine –T [321, 338]. DHN on 
the other hand is an antioxidant, which scavenges free radicals. Thus neopterin/DHN 
can both enhance and reduce cytotoxicity by powerful oxidants, depending on the pH 
and the oxidation state of neopterin. The cytotoxic potential of activated macrophages 
may be enhanced by neopterin, while intracellular accumulation of DHN may protect 
the cells from damage by reactive oxygen species (ROS) [321, 325, 332, 339]. 
 
Modulation of macrophage mediated effector mechanism 
Interferon gamma and neopterin are produced in the course of a cellular response to 
an antigen. Neopterin may act as an endogenous inhibitor of folate synthesis by 
pathogenic micro-organisms within the macrophage, aiding that cell to destroy such 
pathogens [321]. 
 
Neurodegeneration 
Neopterin is elevated in the cerebrospinal fluid (CSF) of patients with inflammatory 
neurological disorders, including AIDS dementia, Lyme disease and multiple 
sclerosis [340]. Neopterin, DHN and ROS are secreted by infiltrating 
monocytes/macrophages rather than from neuronal cells [340]. Prolonged production 
of ROS and their enhancement, e.g. by neopterin, can result in oxidative stress and 
cellular apoptosis which may play a part in the pathogenesis of neurodegenerative 
diseases [340, 341]. Increased concentrations of neopterin derivatives are also seen in 
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some patients with neurodegenerative disorders such as Alzheimer’s disease and 
Huntingdon’s disease [341]. 
 
Tumour angiogenesis 
By disturbing the cellular redox state in the tumour microenvironment neopterin may 
promote tumour growth and, via promotion of angiogenesis, promote metastatic 
spread [325, 342].  
 
Inhibition of erythropoiesis 
Neopterin inhibits production of erythropoietin and may play a role in the generation 
of anaemia commonly seen in diseases involving chronic inflammation or malignancy 
[325, 336]. 
 
Atherosclerosis generation 
Neopterin has effects on lipid metabolism in the liver [343] and has multiple roles in 
atherogenesis by promoting cholesterol precipitation [344], vascular smooth muscle 
cell proliferation [321, 345] and upregulation of IL-6 and TNF-α [346]. There is an 
overall increase in inflammatory tone in the vascular wall [346], and activated 
macrophages produce proteases that can weaken the structure of the plaque, causing 
rupture [325, 346]. Serum neopterin levels are correlated with the extent of carotid 
atherosclerosis and neopterin levels may be elevated in unstable coronary artery 
disease [325]. 
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 Interaction with UVA 
Neopterin appears to enhance UVA induced cytotoxicity in mouse melanoma cells 
[321, 336]. 
3.11.3 Neopterin and disease 
Neopterin levels are a direct measure of activation of cell mediated immunity and 
reflect the level of oxidative stress during an immune response [324]. Neopterin 
concentration increases rapidly during an immune response, correlates with the 
intensity of the underlying stimulus and decreases rapidly on cessation of the stimulus 
[332]. 
 
Neopterin concentration is elevated in atypical phenylketonuria and serial 
measurements allow monitoring of the progress of diseases in which there is 
activation of cellular immunity – organ and bone marrow transplantation, some 
malignancies, autoimmune diseases, some infections (particularly viral) and diseases 
of chronic inflammation [324, 339]. Patients undergoing immunostimulatory 
treatment show increased levels of neopterin, and neopterin levels decrease when 
graft rejection is successfully treated by cyclosporin A or corticosteroids [321]. In a 
number of diseases, higher levels of neopterin are predictive of more extensive 
disease, worse prognosis and more rapid disease progression and death [324]. Table 
3.2 summarizes disease associations with serum neopterin levels. 
 
Concentrations of neopterin are significantly higher in patients with viral infections 
compared to those with bacterial infections [320], reflecting the greater involvement 
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of the TH1 immune system in viral infections [336]. In common acute viral infections 
such as measles, mumps, chickenpox, rubella and influenza, elevated neopterin levels 
are seen at the end of the incubation period prior to the onset of clinical symptoms 
and reach maximum levels just before specific viral antibodies become detectable 
[336]. Vaccination with live measles/mumps vaccine causes a similar pattern of 
neopterin secretion, with declining levels as specific antibodies are produced [321].  
 
Diagnostically neopterin levels may help to distinguish autoimmune disease from 
non-immune disorders, e.g. rheumatoid arthritis from osteoarthritis, autoimmune 
thyroiditis and non-autoimmune thyroid disease and infectious and non-infectious 
hepatitis [318]. Neopterin levels are significantly correlated with diastolic blood 
pressure (r = 0.13, p<0.0001) and (weakly) with body mass index (r = 0.084, p<0.01) 
[347].  
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Table 3.5 Diseases accompanied by changes in neopterin levels  
 
Disorder Variation in neopterin Higher levels predict 
worse disease 
Organ 
transplantation 
Higher levels indicative of immunological 
complications 
Yes 
Rheumatoid 
arthritis 
Higher levels reflect more active disease. Helpful in 
diagnosis to distinguish from osteoarthritis 
Yes 
Ulcerative 
colitis 
Higher neopterin levels reflect more active disease Yes 
Crohn’s colitis In adult and juvenile forms, high neopterin 
associated with more active disease 
Yes 
Celiac disease Linear correlation with anti-gliadin antibodies. 
Decline with gluten-free diet 
Yes 
IDDM Juvenile (autoimmune) diabetes associated with 
increased neopterin levels 
? 
Thyroiditis Autoimmune type associated with increased 
neopterin. Useful diagnostically. 
? 
 
SLE Decrease in those where steroids cause clinical 
improvement. Higher levels with active disease 
Yes 
Multiple 
sclerosis 
Slightly elevated CSF (but not urine or serum) 
levels in active disease, exacerbations and relapse.  
No 
Sarcoidosis High levels in active disease and slightly raised 
even in inactive disease 
Yes 
 
Congestive 
heart failure 
Good correlation between neopterin and disease 
stage and left ventricular function tests 
Yes 
Acute 
rheumatic fever 
Neopterin levels at presentation may be a predictor 
of valve lesions 
? 
Atherosclerosis Conflicting results for unstable angina, stable 
angina. Those with acute myocardial ischaemia or 
exacerbations of unstable angina have rising 
neopterin leves 
? 
Hematological 
neoplams (90%) 
Non-Hodgkins lymphoma, chronic lymphocytic 
leukemia. May be elevated in Hodgkins lymphoma 
and multiple myeloma 
Yes 
Gynaecological 
malignancies 
High incidence of increased neopterin in ovarian 
cancer (80%). Also seen in carcinoma of the uterine 
cervix (55%), uterine sarcomas 
Yes 
Genito-urinary 
malignancies 
High incidence of increased neopterin in bladder 
tumours and prostatic carcinoma. Also seen in renal 
cell carcinoma, testicular cancer 
Yes 
Lung cancer 
(58%) 
Increased neopterin often present at diagnosis; no 
difference in neopterin by histological type 
Yes 
Gastrointestinal 
malignancies 
Elevations may be seen with gastric carcinoma, 
colorectal carcinoma, pancreatic carcinoma, biliary 
tract carcinoma, hepatocellular carcinoma 
In some cancers, not in 
others 
Breast cancer Occasionally associated with elevated neopterin Slight 
Malignant 
melanoma 
May be useful for detection of visceral metastases. 
Neopterin increases precede clinical deterioration 
? 
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Viral infections Elevated neopterin in cytomegalovirus and Ebstein 
Barr virus infections, chickenpox, measles, acute 
viral hepatitis, chronic viral hepatitis 
High levels during 
acute infection 
Malaria Almost all patients with acute malaria have elevated 
neopterin. In P.falciparum infection positively 
correlated with the degree of parasitemia. Neopterin 
levels normalize with treatment 
Yes 
Schistosomiasis Worse disease with hepatosplenic involvement is 
associated with higher neopterin levels 
Yes 
Pulmonary 
tuberculosis  
Extent and activity of infection correlates with 
neopterin levels 
Yes 
Leprosy Most patients have increased neopterin. No 
Melioidosis Elevated levels in patients compared to controls Yes  
Lyme disease Normal serum and urine levels of neopterin but 
may have raised CSF levels 
Yes 
Multiple organ 
failure, sepsis 
Neopterin levels correlate with multiple organ 
failure scores: strong indicator of overwhelming 
sepsis 
Yes 
Vaccination Similar changes in neopterin as infection with wild 
virus; neopterin changes precede antibody response 
and fall as antibodies increase 
 
HIV  Neopterin concentrations increased in most HIV 
infected individuals before effects on T cell 
populations are detectable and long before clinical 
symptoms; dramatic increase in neopterin in AIDS. 
Inverse correlation with absolute number of CD4+ 
T cells  
Yes 
Psychiatric 
disorders 
Patients with schizophrenia and endogenous 
depression present with normal or decreased 
neopterin levels. Successful treatment associated 
with normalization of levels  
Yes 
Anxiety, stress Decreasing neopterin levels with increasing anxiety 
and also during acute stress 
 
Kawasaki 
disease 
Increased neopterin levels in the acute phase of the 
disease  
 
Periodontitis Increased salivary neopterin Yes 
Acute 
pancreatitis 
Higher neopterin levels in patients with poor 
prognosis; more specific for disease progression 
than C-reactive protein 
Yes 
Pancreatic 
cancer 
Elevated neopterin in 70%, but no correlation to 
tumour stage or specific tumour markers 
No 
Alzheimer’s 
disease 
Inverse correlation between neopterin levels and 
mini-mental scores (MMS) 
Yes 
Idiopathic 
cardiomyopathy 
No difference in neopterin between cases and 
controls, but cases with higher neopterin have 
worse prognosis 
Yes 
[318, 321, 324, 325, 339, 348-351] 
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In the Austrian Tyrol, neopterin has been used for screening blood donors since 1986, 
to detect those with subclinical infectious diseases. In this setting, abnormal is defined 
as >10nmol/l. Serum concentrations may reach more than 200nmol/l in some diseases 
[319], with the highest levels being found in endotoxic shock [325]. Elevated 
neopterin levels in individuals without established diagnosis indicate the presence of 
(i) acute disease associated with or caused by cellular immune activation or (ii) 
chronic inflammatory disease [319]. 
3.11.4 Measurement issues 
Neopterin is a small molecule, with no known catabolism in the body and its 
biological half-life thus depends solely on renal excretion [318, 324]. Renal disease 
can alter the serum neopterin concentration and if there is a suspicion of renal 
impairment, neopterin levels should be adjusted for serum creatinine [319, 339]. 
Neopterin and DHN are both clearly important in physiology, but DHN is typically 
short-lived and unstable, so that usually only neopterin is measured [318, 324]. 
 
Neopterin can be detected in a range of body fluids, including serum, CSF, synovial 
fluid, pancreatic juice, urine, saliva and ascites fluid [325]. There are three common 
methods of assaying neopterin: high performance liquid chromatography (HPLC), 
radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA). HPLC 
is the method used most commonly to measure urinary neopterin, and can be used 
with serum samples, but high levels of protein in the serum interfere with the assay 
and samples must be deproteinised prior to assay [318, 321]. For this reason, for 
serum samples, RIA or ELISA is preferred. 
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RIA relies on competitive binding of unlabelled neopterin (in the sample) and 
radiolabelled neopterin for the binding sites of a polyclonal anti-neopterin antibody. 
An antigen-antibody complex is formed and the radioactivity of the sample is 
inversely proportional to the concentration of unlabelled neopterin in the sample [318, 
352].  
 
ELISA is a competitive enzyme immunoassay in which sample neopterin competes 
with a neopterin/enzyme conjugate for binding sites on anti-neopterin antibodies 
coating the wells of a microtitre plate. The subsequent addition of an enzyme 
substrate results in a colour change, with the intensity of the colour (measured by the 
optical density) inversely proportional to the neopterin concentration in the sample 
[353]. 
 
The normal range for serum is 5.3±2.7nmol/L in healthy adults [336] with RIA, 
HPLC and ELISA giving comparable results [345] although ELISA may be slightly 
superior to RIA in reproducibility of elevated neopterin levels [354]. Commercial kits 
are available for RIA and ELISA assays of neopterin. 
 
Samples must be protected from direct sunlight, (by enveloping them in tin foil 
covers), although normal indoor light generally has no effect [319, 355]. Neopterin is 
otherwise stable [318]. Urine samples can be stored for 2 weeks at 4˚C and for at least 
2 days at room temperature. Serum samples are stable for at least six months at -20˚C 
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[318, 355] and can be stored at 2-8˚C for up to 24 hours [321, 355]. Frequent thawing 
and refreezing affects the neopterin levels in samples [318, 355]. 
 Individual variability 
In a study of healthy blood donors, 8.1% had neopterin concentrations above the 
accepted 95th percentile figures for their age range (8.7nmol/l), while 2.1% had 
neopterin concentrations >11.0nmol/l [347]. Among a population of voluntary blood 
donors, 1.62% had neopterin levels >10nmol/l [356] while 10% of a population of 
normal volunteers had levels higher than 10nmol/l [357]. 
 
A single study has examined variation in neopterin levels over time, showing that 
while mean population values remained remarkably stable over three months, 
individual subjects exhibited significant variability, possibly related to subclinical 
disease [358]. The mean difference in neopterin over three months was 0.15 mmol/l 
with a range of –3.70 to 4.50.  
 Diurnal variation 
Individual neopterin concentration varies diurnally by 10-15% [319] with higher 
levels at night [318]. 
3.11.5 Population distribution 
 Age 
There is significant age variation, with children under 18 years and adults over 75 
years having higher neopterin concentrations than adults between these age limits. 
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There appears to be little age variation in those between 19 and 75 years [318, 321, 
325], although Diamondstone reports increasing neopterin with increasing age in 
adults 20-69 years (20% increase) in a random community sample [359]. Increased 
neopterin production with age may be due to a higher incidence of diseases such as 
atherosclerosis or dementia, associated with immune activation, where the 
pathological process has started but is not yet clinically detectable [336]. Indeed, 
higher neopterin levels in nonagenarians are associated with reduced life span [347]. 
 Gender 
There is no apparent gender variation in serum neopterin levels [318, 321, 325, 357].  
 Drugs 
Current use of antihistamines is associated with increased levels of neopterin [359]. 
3.11.6 Behavioural variation 
 Smoking  
There are contradictory findings on an association between neopterin levels and 
cigarette smoking, with some researchers reporting no difference [360] while others 
report lower neopterin levels in smokers compared to non-smokers or ex-smokers 
[325, 359]. A suppressive effect of tobacco smoke on the human immune system has 
been hypothesized [347]. 
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 Physical activity 
Several studies have examined the effect of exercise on neopterin levels, both in elite 
athletes and in untrained subjects [361-364], showing mildly increased levels with 
exercise [363, 364], or no change [361, 362]. Smith demonstrated a trend towards 
depression of neopterin concentration in the very fit [362].  
3.11.7 Psychosocial and SES variation 
The literature examining the SES variation in serum neopterin and the association 
with psychosocial factors is summarized in Table 3.6. These findings are covered in 
greater detail, in the context of my own findings, in the Discussion, Chapter 6. 
Table 3.6 Summary of SES and psychosocial variation in serum neopterin. 
 Direction of 
effect 
Findings References 
Adult SES  No studies   
Acute stress Inverse 
association 
Perception of stressfulness of the situation 
alters serum neopterin 
[318, 365-
367] 
Chronic stress ?direct 
association 
Decreased in post-traumatic stress disorder, 
but much interindividual variability 
[368-373] 
 
Psychiatric 
illness 
Direct 
association 
Increased levels in anorexia nervosa, 
depression, seasonal affective disorder. 
Conflicting results for schizophrenia 
[304, 357, 
360, 374-
378] 
Social support null Few studies [329] 
 
3.11.8 Conclusion 
Neopterin is a relatively stable, measurable, and sensitive marker of early immune 
activation. Urine and serum neopterin levels correlate with the level of immune 
activation but are not disease specific. While its physiological role and use in disease 
monitoring are increasingly well understood, little work has been done to determine 
variation in levels with demographic factors. 
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3.12 Salivary IgA 
3.12.1 Physiology 
 Saliva 
Human saliva is produced from hundreds of minor salivary glands in the tongue, lip 
and palate in addition to the major salivary glands: the parotid, submandibular and 
sub lingual glands [379]. Approximately 600-1000ml of saliva is produced daily 
consisting of water, minerals, electrolytes, buffers, immunoglobulins, growth factors, 
cytokines, mucins and other glycoproteins, as well as enzymes and enzyme inhibitors 
[380]. The composition of secretions from different salivary glands differs, as does 
their response to stimulation by nervous and hormonal mediators. 
 
As well as being involved in maintenance of the oral cavity, digestion of food and 
lubrication to assist speech and swallowing, saliva is part of the mucosal immune 
system. This forms a first line of defense against pathogens by providing an acidic 
environment, mucous to trap, and antibodies (immunoglobulins) to react with, 
pathogens, allergens and other antigens [379, 380]. 
 
Salivary secretion is normally controlled by reflexes, such as chewing and taste, via 
the autonomic nervous system [381]. The amount and composition of saliva depends 
on whether the parasympathetic (PNS) or sympathetic nervous system (SNS) is 
predominantly stimulating secretion. This in turn depends on the nature of the 
stimulus. Stimulation of the sympathetic nervous system, such as in an acute stress 
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response, causes a thick, viscous secretion to be formed, whereas stimulation of the 
parasympathetic nervous system results in a copious watery secretion [382]. 
 Salivary IgA 
The predominant antibody class found in saliva is of the Immunoglobulin A (IgA) 
form. While serum IgA exists mainly as a monomer, the form found in saliva is 
primarily polymeric (pIgA), consisting of two IgA monomers linked by disulphide 
bonds, with an extra J-chain attached to the end of the heavy chains. In addition, this 
salivary form of IgA has an attached large carbohydrate-rich glycoprotein derived 
from the epithelial cell, called secretory component (SC). Thus the salivary form of 
IgA is termed secretory IgA (sIgA). 
Figure 3.7  Structure of sIgA (adapted from [383]) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Secretory IgA has a relatively short half-life (3-6 days) and a high synthesis rate 
(66mg/kg/day) [384]. It is secreted by both major and minor salivary glands under the 
control of the autonomic nervous system [385]. Most salivary IgA is synthesized and 
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secreted locally by plasma cells located in the interstitial matrix of salivary glands, 
then bound to polymeric immunoglobulin receptor (pIgR) on the basolateral 
membrane of the glandular epithelial cells. The pIgR-IgA complex is internalized and 
trancytosed across the epithelial cell to the apical surface. Here the pIgR is cleaved 
from the sIgA and sIgA is released into the saliva [386]. SC represents the cleaved 
product of pIgR. Figure 3.8 outlines the synthesis and secretion of sIgA.  
 
There are important differences in the concentration of sIgA released from different 
salivary glands; in particular, saliva from the parotid may have a lower concentration, 
and minor salivary glands a higher concentration, than saliva from other glands [379, 
387]. Preferential collection from a particular salivary gland, or stimulation of 
salivary flow (which results in greater parotid contribution) will result in spurious 
variations in the measured concentration of sIgA [379].  
 
Influences on the secretion of saliva are not necessarily synonymous with influences 
on the secretion of sIgA – differential secretion of saliva and sIgA will have marked 
effects on the concentration of sIgA bathing mucous membranes and thus resistance 
to infection. Both the PNS and the SNS are involved in the secretion of sIgA into 
saliva and the resulting sIgA concentration.  
 
The secretory process is also influenced by hormones including glucocorticoid and 
thyroid hormones, aldosterone [388] and adrenergic, cholinergic and peptidergic 
neurotransmitters [389, 390] as well as a number of cytokines including IFN-γ, TNF-
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α, IL-5 and IL-6 [391]. Nervous and hormonal mediators could affect salivary sIgA 
levels in saliva at a number of different points: (see Figure 3.8) 
 
1. Stimulation of the plasma cell to increase production, (possibly under 
parasympathetic and cytokine control); 
2. Production of pIgR and uptake of pIgA by the epithelial cell; 
3. Transcytosis across the epithelial cell (probably under control of both the 
SNS and PNS); 
4. Release into the duct from the apical/luminal portion of the epithelial cell 
5. Salivary flow (under SNS and PNS control) 
 
Both the PNS and the SNS are involved in the secretion of sIgA into saliva and the 
resulting concentration of sIgA. Evidence from animal and human studies indicates 
that stimulation of the SNS (as in the acute stress response) results in a markedly 
increased concentration of sIgA (the net result of a modest increase in sIgA secretion, 
but decreased salivary flow rate) [385, 392-396]. Stronger effects on concentration 
than secretory rate have been observed in studies of acute laboratory stress in humans, 
although increases in secretory rate do occur. The effects of chronic stress on sIgA 
secretion and the pathways by which these effects are mediated, are less clear.
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Figure 3.8  Synthesis and secretion of Salivary IgA (adapted from [391]) 
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Monomeric IgA is synthesised in the plasma cell and assembled into polymeric IgA – two IgA
monomers connected by a J chain. Secretory components (SCs) are produced in the rough
endoplasmic reticulum of the epithelial cell. SC–containing vesicles fuse with the basolateral
membrane and this membrane-bound SC interacts with pIgA. This complex is internalized in
endoplasmic vesicles, which are transported through the cytoplasm of the epithelial cell, to the
apical membrane (trancytosis). The vesicles fuse with the apical membrane of the epithelial
cell and sIgA is released into the lumen of the salivary gland, and is available for external
secretion. 
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3.12.2 Diseases associated with salivary IgA  
Secretory IgA is part of a mucosal protection system. Individuals with poor salivary 
flow show an increased incidence of dental caries and other oral infections, and 
higher levels of sIgA appear to protect against dental caries [397]. 
 
A meta analysis of studies examining the association between sIgA concentration and 
upper respiratory tract illness indicates that reduced levels of sIgA are associated with 
an increased incidence of upper respiratory tract infections [398]. While a direct 
cause and effect relationship between low levels of sIgA and clinical illness has not 
been shown, sIgA levels should be viewed as a risk factor for developing infection. 
Determinants of the occurrence of infection and subsequent illness are more complex 
than a simple deficiency of a particular immunoglobulin [399]. 
3.12.3 Measurement issues 
 Sample collection  
There are many different saliva collection methods. This lack of a standardised 
method means that results are not necessarily comparable from one study to the next. 
Variations in methods include: 
• Fasting vs non-fasting. Salivary IgA levels from fasting and non-fasting 
samples are not comparable, with fasting samples having a much wider normal range 
than non-fasting samples. However, some studies fail to control for fasting status and 
may compare fasting and non-fasting samples [396, 400]. Most studies collect saliva 
from non-fasting subjects, or fail to specify fasting status. 
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• Stimulated vs unstimulated. Chewing stimulates saliva flow and decreases 
sIgA concentration [401, 402]. However, sIgA secretory rate is higher during 
chewing than at rest [401, 402], i.e. both output of sIgA and saliva flow are increased 
by chewing, but the latter undergoes a larger increase than the former, resulting in a 
net decrease in sIgA concentration, with chewing. While some authors report higher 
correlations [401], others report greater intra-individual variability, using stimulated 
samples [379]. Most studies collect and measure saliva without stimulation. 
• Timed collection. Recent studies collect saliva for a timed period in order 
to calculate the saliva flow rate and thus sIgA secretory rate (see below for detail). 
Collection time varies from 2 minutes to 5 minutes, depending on the method of 
collection, e.g. two minutes for absorption onto a Salivette [403], 4-5 minutes for 
dribbling and spitting collections [381, 400].  
• Collection method. Variations include spitting [381, 404], dribbling into a 
cup [400], suction using a suction pump [405], absorption of saliva using a Salivette 
[403], or the use of other cotton absorbent material [406]. Collection methods using 
Salivettes or other cotton absorbent material may be associated with unsystematic 
error in the sIgA measurement, with significantly lower levels of IgA recorded [406, 
407]. Comparison of saliva collection by spitting or suction indicates that IgA 
concentrations collected by these methods are similar [407].  
 
Anything that causes oral trauma (e.g. teeth cleaning) may spuriously increase the 
levels of salivary IgA due to contamination of the samples with blood [406]. 
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 Sample storage 
After collection, samples should be placed immediately on ice to prevent degradation 
of sIgA by salivary proteolytic enzymes [379] and stored at -20°C [381, 403, 408]. 
Long term storage does not cause degradation of sIgA [379].  
 Method of analysis 
Salivary IgA can be analysed using either an enzyme linked immunosorbent assay 
(ELISA) or radial immunodiffusion (RID) assay. The RID assay was developed to 
measure serum IgA, and uses a correction factor to adjust results to saliva levels. 
There is some dispute as to the size of this correction factor and thus some authors 
recommend ELISA rather than RID [409]. Comparison of the two tests suggests that 
ELISA methods may be more sensitive, less variable and cheaper than RID [410].  
 
(Note that salivary IgA assays measure total salivary IgA, i.e. secretory IgA as well as 
IgA without the secretory component, for example due to blood contamination of the 
sample). 
 Concentration or secretory rate? 
Researchers continue to debate the relative merits of measuring IgA concentration, 
calculating IgA secretory rate (from timed saliva flow rate and concentration of IgA) 
or measuring the ratio of salivary IgA to salivary protein. While there are good 
theoretical reasons to measure secretory rate, changes in concentration appear to be 
more sensitive to psychological stressors [395, 396, 411, 412], and to relaxation 
techniques [411]. 
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The concentration of IgA in saliva (mg/ml) is a function of both secretory rate (the 
rate at which IgA is transferred from the basal to the apical membrane, released into 
the lumen of the salivary duct and thence into the saliva) and the salivary flow rate. 
Secretory rate is expressed as mg/min and salivary flow rate as ml/min. Thus, 
 
Concentration (mg/ml) = Secretory rate (mg/min) /Salivary flow rate (ml/min) 
 
Which parameter(s) to measure depends on the research question. If we are interested 
in the mechanism by which stressors (exercise etc) affect salivary IgA, then secretory 
rate (a measure of how fast IgA is secreted into saliva) is of interest. The research 
question might be: does stress work via increases in secretory rate or simply via 
changes in salivary flow rate, or a combination of these? If, on the other hand, we are 
interested in salivary IgA as a marker of stress, then the correlation in experimental 
studies appears to be higher and more consistent with IgA concentration (reflecting 
stress-related alterations in both salivary flow rate and secretory rate). If we are 
interested in the way in which stressors may affect health and the incidence of upper 
respiratory infections then we are probably most interested in the absolute amount of 
salivary IgA bathing the mucous membranes [384, 413]. This is a combination of 
sIgA concentration and salivary volume (as distinct from flow rate). 
 
The ratio of sIgA to salivary total protein concentration has been used to control for 
salivary flow rate (commensurate increases in sIgA and total protein should be due to 
increases in salivary flow rate rather than sIgA secretion rate). However, under some 
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circumstances, e.g. exercise, there is an increase in secretion rate of salivary proteins 
and so a decrease in the ratio of sIgA to protein, without any change in sIgA output or 
salivary flow rate [414]. 
 
In summary, the choice of measure should be tailored to the question being 
investigated and will determine the collection method (since timed saliva flow is not 
appropriate with certain collection methods).  
 Temporal reliability 
Mean population values of salivary IgA are very stable over 3 months, but there is 
considerable intraindividual variability [358]. Estimates of test-retest correlation for 
concentration of salivary IgA range from (Pearson correlation coefficient) 0.43 over 
1-2 weeks [381], to 0.66 (after a two year interval, [401]). Test-retest correlation 
coefficients for secretory rate tend to be lower, ranging from 0.16 (over 4 weeks), 
[415] to 0.58 (over two years) [401].  
 Concurrent disease 
Gleeson (1995) observed elevations of salivary IgA in 90% of episodes of acute 
respiratory illness in children aged between 6 months and 5 years. Such elevations 
commenced, on average, two days after the appearance of symptoms (Day 2), reached 
a peak on Day 5 (range 2-6 days) then returned to pre-infection levels by Day 10 
[416].  
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 Season 
While Deinzer et al [417] raise the possibility that seasonal effects may have 
explained their findings in relation to the effects of academic stress on salivary IgA 
concentration, there are few studies that specifically address this question. Park and 
Tokura (1994) found that salivary IgA concentration was significantly higher in those 
wearing half-sleeve shirts and knee-length trousers than those in long sleeve shirts 
and full length trousers, presumably related to temperature effects (cited in [418]). In 
a small group of women, Li et al found a significant increase in IgA concentration 
from autumn to winter in those who wore knee length skirts, but not in those who 
wore trousers. It was postulated that this was an effect of SNS stimulation by colder 
temperatures [418]. The possibility of seasonal variation requires further 
investigation. 
 Diurnal rhythm 
Salivary IgA concentration peaks on awakening, falls steeply over the next four 
hours, then levels flatten out and remain relatively stable over the day [389]. This 
diurnal rhythm also applies to secretion rate of sIgA. The morning peak is dependent 
on waking, rather than time of day, while the rate of decline of sIgA after waking is 
positively correlated with the simultaneous rise in salivary cortisol [384, 389]. This 
diurnal pattern is present in 20-30 year olds, but absent in 60-80 year olds [384]. 
Collection of saliva should be standardised for time of day, or have time of collection 
included as a variable in the analysis [419]. 
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 Hydration 
Dehydration is associated with decreased saliva flow, and the mild dehydration 
commonly seen after exercise in non-elite athletes may explain the slightly increased 
levels of sIgA seen in this situation [379]. (Note that decreased saliva flow with no 
change in secretion of IgA will result in an increased concentration of sIgA.).  
3.12.4 Population distribution 
 Age 
Salivary IgA concentration tends to be lower in children less than 7 years of age than 
in older children or adults [411, 420], with a significant positive linear relationship 
between age and concentration of salivary IgA in children [420]. Healthy elderly 
persons (>70 years) have higher concentrations of salivary IgA compared to adults 
(25-50) years (median 205.4 mg/L vs. 113.4mg/L, p<0.001) [421], due to lower 
saliva flow rate but relative preservation of IgA secretion rate [384]. However, the 
absolute amount of IgA bathing mucosal surfaces may be decreased, with a resultant 
decrease in mucosal protection and increased susceptibility to disease. 
 Gender 
There is no apparent gender effect on salivary IgA levels [388, 396, 422]. 
3.12.5 Behavioural variation 
 Smoking 
Cigarette smokers have lower levels of salivary IgA [416].  
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 Physical activity  
Current research suggests that training at an intense level for many years may cause 
chronic suppression of salivary immunoglobulin levels [379, 419], and this may be 
linked to increased respiratory illness in these athletes [419]. Exercise in non-elite 
athletes is associated with no change or slightly increased concentration of salivary 
IgA and this is probably a result of mild dehydration during exercise, as already noted 
[419]. 
 Diet 
Vitamin A deficiency may be associated with a diminished salivary IgA response to 
infection, through impairment of the TH2 mediated immune response [423, 424] 
3.12.6 Psychosocial and SES variation 
The literature examining psychosocial and SES variation of salivary IgA is 
summarized in Table 3.7. These findings are covered in greater detail, in the context 
of my own findings, in the Discussion, Chapter 6. 
3.12.7 Conclusion 
Activation of the acute stress response and thus the sympathetic nervous system is 
associated with acute increases in both concentration and secretory rate of salivary 
IgA. However, the effects of chronic stress are less clear. There is considerable debate 
around the most appropriate collection method and whether to measure secretion rate 
or concentration and there are a number of issues in the collection and analysis of 
samples. 
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Table 3.7 Summary of SES and psychosocial variation in salivary IgA. 
 Direction of 
effect 
 References 
Adult SES Direct 
association 
With secretory rate, explained by smoking [425] 
Acute stress Direct 
association 
Inconsistent results depending on IgA 
parameter measured, but generally a direct 
association.  
[392-394], 
[426-428] 
Subacute 
stress 
Inverse 
association 
Examination stress; generally decrease in 
the lead up to exams. One study showed a 
direct association, one a null association. 
[429], [415], 
[409], [417], 
[430] 
Chronic 
stress 
Inverse 
association 
Daily hassles, life events, occupational 
strain, isolation, natural disasters. 
Generally consistent; one direct association 
but no control for personality, dose 
response relationship. Response may be 
modified by personality. 
[381, 431-
436] 
Relaxation, 
positive 
mood 
 Consistent increase in sIgA concentration 
and secretory rate with activities 
promoting relaxation. 
[437], [403, 
436, 438, 
439] 
Social 
support 
Direct 
association 
Higher sIgA in those with high social 
support in the pre-exam period. 
[415] 
 
There are limited data on the temporal reliability of salivary IgA concentration. Yet 
saliva provides a non-invasive method of examining the effects of stress on the 
humoral immune system. Despite limitations in our knowledge of the physiological 
effects of chronic stress on the mucosal immune system, salivary IgA is  
included as a biological marker in this study, both to complement the other, blood-
based markers, and as a measure of the humoral immune system. 
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The five biological markers, outlined above, have been selected to test the following 
hypothesized pathway from SES to ill health: 
 
SES → psychosocial stressors and psychosocial assets→ biological markers → 
disease 
 
The preceding discussion has presented evidence of the links between the 
physiological stress response, and the biological markers, as well as the evidence for 
links between the biological markers and disease.  
 
The Biomarkers Study collected data to examine the links between SES and 
psychosocial stressors and assets, as well as between SES and the biological markers. 
Statistical analysis of these data provides information on the mediating role of 
psychosocial stressors and assets in the relationship between SES and the biological 
markers. 
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Chapter 4.  
Methods 
4.1 Introduction 
The Biomarkers Study consists of two quite separate periods of data collection – a 
small pilot study in 2000 and the larger main study in 2001. In this chapter, I initially 
describe the two studies and then the general methodology that is common to both. 
 
This is a cross-sectional study using a sub-sample of the 40-44 year old cohort of the 
Personality and Total Health Study (PATH Study). Data collection included that 
obtained from questionnaires, body measurements and biological samples. (Copies of 
the questionnaire and a detailed description of the methods used in analysis of the 
biological markers not routinely measured are contained in Appendices B, C and D). 
 
I begin the chapter by describing the PATH study, and then discuss the sampling 
strategy for the pilot study and the 2001 study. I describe the mechanics of data 
collection and then summarize the psychosocial, socioeconomic, behavioural and 
health variables measured in the questionnaire, including details of the instrument 
used to measure each one and the rationale for this choice. I then build on the 
previous discussion of the biological markers, by describing sample collection and 
marker assay. Finally I discuss data management, issues of bias and representativenss 
and outline the analysis that was undertaken. 
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4.2 The Personality and Total Health Study (PATH study) 
The PATH Study is being conducted in Canberra, by the Centre for Mental Health 
Research at the Australian National University. It is a twenty-year prospective cohort 
study. In the initial wave, individuals were randomly selected from the Australian 
Electoral Roll to form three cohorts at different age groups - 20-24 years, 40-44 years 
and 60-64 years. In 1999, 2,500 individuals in the 20-24 year age group were 
interviewed and in 2000 and 2001 this was repeated for the 40-44 year age group and 
the 60-64 year age group respectively. 
 
The research aims to examine the mental and physical health of adults and to 
investigate how lifestyle, social and genetic factors might influence this. Each cohort 
is to be re-interviewed every four years. 
 
The Centre for Mental Health Research kindly allowed the Biomarkers Study to be 
added onto the PATH project for the 40-44 year age cohort of 2000. The questions 
asked of the participants in the PATH study allowed the selection of a sub-sample of 
healthy adults whose socioeconomic status as assessed by occupation and education 
was known. In the Biomarkers Study this sub-sample was studied in more detail with 
further questions on socioeconomic status and various psychosocial factors and with 
the collection of biological data from blood and saliva. 
4.3 Recruitment of participants 
At the end of each PATH study interview, participants were given an information 
sheet about the Biomarkers project. After reading this, each participant indicated 
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whether or not they were interested in being contacted regarding participation in this 
project and this was recorded.  
 
From the data obtained at the PATH study interview, occupational information was 
coded using the Australian Standard Classification of Occupations 2nd ed (ASCO 2nd 
ed). On the basis of these codes, occupational status codes were assigned using the 
ANU3_2 coding system and the participant ID numbers sorted by occupational status 
(details of the ASCO 2nd ed. Coding and the ANU3_2 occupational status scale are 
presented in section 4.6.1). Difficulties in assigning ASCO codes were resolved by 
the Australian Bureau of Statistics (ABS). 
4.3.1 Pilot study 
The occupations of the first 500 participants in the PATH study who had indicated 
that they might be willing to participate in the Biomarkers of Social Disadvantage 
Study were coded as outlined above. 
 
The PATH study measured self-rated health, limitation of daily activities due to 
health and participant status for a number of specific health problems, including 
hypertension, heart disease, asthma, cancer and diabetes. Only those PATH 
participants with self-rated health described as “good”, “very good” or “excellent”, 
who had no, or minimal limitation of activities due to health, and suffering from none 
of the specified diseases were included in the study population. Individuals who were 
no longer resident in the ACT were also ineligible for inclusion in the Biomarkers 
Study. 
 178
Within this study population, participants were ordered by occupational status and the 
pilot study sample was chosen to include the top 15 participants of each gender, and 
the bottom 15 of each gender. Different measures of SES, such as occupational level 
(ASCO coded), occupational status and education are highly correlated. To confirm 
that these two groups did indeed form two distinct SES groups, occupational level 
and education of the chosen study sample were examined, but final selection was on 
the basis of occupational status. In the lower SES group women had an occupational 
status <29 and men <34, while in the upper SES group, women had an occupational 
status of >65 and men >75.  
 
Figure 4.1 outlines the pilot study sample selection and data collection. 
 
These 60 people were contacted by mail to indicate that they had been chosen for this 
study and would be contacted by telephone soon. The questionnaire was included in 
this mail out and people were asked to fill this in and bring it to the interview. Once 
contacted by telephone, participants were asked if they were still willing to participate 
and if so, an interview time was arranged to be approximately two hours post-prandial 
(to allow saliva samples to be taken). Participants were requested to phone and 
change the appointment if they became unwell, e.g. upper respiratory infection, as 
this may alter the salivary IgA concentration. If this occurred the interview was 
rescheduled to be at least two weeks after the person was feeling well again. Any 
persons who were no longer willing to participate were dropped from the sample and 
the next eligible participant on the basis of status was contacted. 
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Figure 4.1 Pilot Study outline 
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At the interview, each participant signed a consent form and was invited to ask any 
questions relating to the study. The completed questionnaire was collected, or if not 
completed, a reply paid envelope was given to facilitate return of the questionnaire. 
The pilot study questionnaire requested information on personal income, household 
income, childhood socioeconomic status on the basis of education and occupation of 
parents at participant age 12, and indicators of household wealth, i.e. car and house 
ownership. It contained measures of self-esteem, coping style, social capital, 
economic strain, social support, and optimism. 
 
Height and weight, waist and hip circumference were measured and a saliva sample 
taken. A full explanation was given to each participant as to what we were looking for 
in the blood test and an explanation about why the sample was a fasting sample and  
what this involved. The form for the blood test was given to the participant, with a 
request to complete this at a Capital Pathology collecting centre, as soon as possible. 
Any problems with completing the blood test were discussed, e.g. inability to attend a 
collecting centre during the opening hours, and solutions sought. 
 
Participants elected on the questionnaire and were again asked at interview how they 
wanted the blood results dealt with, and were encouraged to be informed about the 
results. Results of blood tests were phoned through to participants and then a copy 
mailed to general practitioners (GPs) if this was requested. 
 
Ten weeks after the initial contact was made, the participants were contacted again to 
invite them to provide a further saliva sample and undergo another blood test. 
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Participants were encouraged to have the second blood test as close to three months 
from the original blood test as possible. Results of blood tests were reported back to 
participants, as above. 
4.3.2 2001 study 
Following completion of the PATH 40-44 years wave in early 2001, occupations of 
all participants were coded to occupation and then to occupational status (as above). 
All occupational codes were checked and rechecked to ensure they were consistent 
and accurately fitted the job title and description. 
 
Of the total PATH sample, those who did not want to participate were dropped. All 
those whose self-rated health on the PATH Study questionnaire was poor or fair were 
excluded as were all those who stated that they had diabetes, heart disease, 
hypertension or cancer, or stated on the SF-12 that they were limited a lot by their 
health. Only those who stated their race as “Caucasian” and who remained resident in 
the Canberra/Queanbeyan region were retained in the study population.   
 
The remaining possible participants were sorted by occupational status and gender, 
and then a histogram of occupational status was constructed for each gender. There 
was a fairly clear delineation into four groups for both men and women, with cut-offs 
at similar levels of occupational status for both genders.  
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Figure 4.2 Occupational status of 2001 study population
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The PATH Study identification (ID) numbers in each group were ordered from lowest 
to highest in an Excel spreadsheet, with no separation by gender. Using a list of 
random numbers, 100 possible participants were chosen from each group. The first 75 
in each group formed the participants of the 2001 study, while the remainder formed 
an ordered list of possible replacements for any of the first 75 who for any reason 
could no longer participate in the 2001 study.  
 
The four groups based on occupational status were deliberately not sorted by gender 
prior to random selection of participants, so that the selected individuals would reflect 
the gender makeup of the underlying population within the same range of 
occupational status. While the total sample is clearly not representative of the 
Male 
Female 
Approximate cut-off points for status groups 
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Canberra population (since it has been selected to give equal numbers across the SES 
spectrum), each status group should be representative of, and the results generalisable 
to, the corresponding population group. 
 
Because a significant period elapsed between the PATH study interview and the 2001 
study (up to about 20 months) it was necessary to update information on some of the 
variables that may have changed in the interim, e.g. life events. The 2001 study 
questionnaire thus contained these scales from the PATH study, the questions from 
the pilot questionnaire and additional items on social capital. However, the resultant 
questionnaire was quite large and it was thus split into two questionnaires. The first 
was similar to the pilot questionnaire, asking essential information on variables not 
covered in the PATH study and was sent out with the introductory letter in the same 
way as in the pilot study. A second questionnaire was then given out at interview, 
with the explanation that it was an update of some of the PATH questions, with a 
reply-paid envelope to encourage its return.  
 
Figure 4.3 outlines the 2001 study sample selection and data collection. 
 
Contact was made by mail out and then telephone call. During the telephone call the 
individual was first asked if they were still interested in participating. If this was 
affirmative, they were asked to indicate their self-rated health (poor, fair, good, very 
good or excellent) and then whether they had developed any of heart disease, cancer, 
diabetes, high blood pressure or other major illness. Provided self-rated health was 
good or better and the person was healthy and still resident in the study area, an 
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interview time was made. None of those contacted had poor or fair health, but a 
number had developed major illnesses and were excluded from the study. 
 
The interview took place in the same way as in the pilot study. Participants were 
interviewed two hours post-prandially, and a saliva sample and body measurements 
were taken. In this part of the study, a blood pressure reading was taken. The blood 
tests were explained and a blood form given to have fasting bloods collected at an 
ACT Pathology collecting centre. 
 
All participants were notified of their blood results by telephone and letter and were 
sent an additional copy of the blood results for their general practitioner.  
 
Each time a participant was found to be ineligible to participate, or unwilling to 
participate, the next ID number on the list of random ID numbers for the same SES 
group, was contacted to invite participation. 
 
At all times, the interviewer was blind to the SES group to which the participant 
belonged. The grouping was recorded only on an Excel spreadsheet where the PATH 
ID number identified possible participants. The ID numbers randomly chosen were 
given to the PATH study data manager, who then assigned a Biomarkers ID number 
and provided contact details. The group to which an individual belonged was only 
traced when a replacement needed to be made. 
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Figure 4.3 2001 study outline
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4.4 Ethics 
Prior to commencement of the Biomarkers Study in 2000, ethics approval was 
obtained from the Human Research Ethics Committee of the Australian National 
University. The research was carried out in accordance with the ethical guidelines set 
out by the National Health and Medical Research Council in the National Statement 
on Ethical Conduct in Research Involving Humans. 
 
The following sections detail the study measures used in the pilot and the 2001 
studies. 
4.5 Psychosocial factors 
Hemingway and Marmot define a psychosocial factor as “ a measurement that 
potentially relates psychological phenomena to the social environment and to 
pathophysiological changes” [116]. The following psychosocial factors were 
examined in this study. 
4.5.1 Social support 
No single measure is recognized as being the “gold standard” for the measurement of 
social support in health research. One can measure perceived social support of an 
instrumental (support with money, accommodation and other concrete items) and/or 
emotional type [440, 441], or actual number of individuals in the social network (that 
therefore should be available to provide support) [442]. Few measures incorporate the 
notion that social interactions can be negative and have detrimental health effects. 
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The PATH study uses the social support scale developed by Schuster et al [443] to 
measure both positive and negative aspects of social support. The authors postulate 
that social support derives from several different sources (spouse, relatives, and 
friends) and may entail both positive and negative interactions, which may moderate 
the health effects of stressor exposure.  
 
The scale measures positive and negative interactions separately for friends, family 
and partner. Schuster reports alpha reliabilities of greater than 0.6 and in the 2001 
study Cronbach’s alpha coefficients for these six subscales were between 0.68 
(negative interaction with friends) and 0.91 (positive interaction with partner). As per 
the original scale, all indices were scaled so that the theoretically lowest scores were 
coded to 0 and the theoretically highest scores were coded 1. 
 
This scale has been used to examine the effects of social support on mental health and 
well-being [443] and has clearly shown that negative social interactions (as measured 
by the scale) are associated with higher levels, and supportive interactions with lower 
levels, of psychological distress.  
 
In addition to the Schuster scale, an additional question asking about the number of 
close friends formed the final element of the assessment of social support/networks. 
4.5.2 Childhood adversity and parenting 
Questions on childhood adversity and parenting used in the PATH study were derived 
from the Parental Bonding instrument [444] and the National Comorbidity Survey 
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(NCS) [445]. Responses to these questions were taken from the data collected as part 
of the PATH study, i.e. they were not re-measured in the Biomarkers Study.  
 
The questions used in the PATH study represent two items from the Parental Bonding 
Instrument: “How affectionate was your mother (father) towards you?” and several 
questions that are a summary of questions from the NCS. The NCS contained twenty-
six childhood adversities consisting of: 
• Five interpersonal loss events – death of mother, death of father, parental 
separation or divorce, parental absence of 6 months or more other than due to 
separation or divorce, respondent absence of 6 months or longer. 
• Eight interpersonal traumas – maternal and paternal verbal aggression, 
isolated rape, repeated rape, sexual molestation, being mugged or held captive and 
being seriously physically attacked. 
• Eight measures of parental psychopathology – major depression in mother 
or father, generalized anxiety disorder, alcohol or drug abuse and antisocial 
personality disorder in either parent when the respondent was a child. 
• Five miscellaneous adversities – being in a life-threatening accident, being 
in a natural or man-made disaster, learning about a traumatic experience that occurred 
to a close loved one or witnessing a traumatic event.  
 
Of these, the PATH questions cover divorce or permanent separation of parents, 
parental psychopathology and drug abuse and sexual, verbal and physical abuse. 
There are also three items that rate respondent satisfaction with their childhood and 
upbringing. 
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Exposure to childhood adversity is commonly reported in those who suffer 
psychiatric disorders as adults [445] and there is mounting evidence that the 
childhood environment is important in setting the stage for later resilience or 
vulnerability to stressful life events [446]. 
4.5.3 Social capital 
In the pilot study, personal social capital was assessed by questions from the US 
General Social Surveys, looking at civic trust, (“Generally speaking would you say 
that most people can be trusted?” or “ You can’t be too careful in dealing with 
people.”) and perceptions of reciprocity, (“Would you say that most of the time 
people try to be helpful, or are they mostly looking out for themselves?”) [447]. A 
sense of belonging to the community was assessed by asking whether there was any 
membership of community groups and if so, how many. Using these very simple 
questions, Kawachi et al [447] have shown high correlation at a group level between 
low levels of social trust and fair or poor health. 
 
In the 2001 study, the social capital measure included the above measures as well as 
questions regarding the participant’s sense of belonging in the community and social 
trust. 
 
The belonging scale is part of Cohen’s Interpersonal Support Evaluation List (ISEL) 
that is widely used in health research to measure social support [448]. It consists of 
ten statements requiring a true/false response, such as “ No one I know would throw a 
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birthday party for me.” Half of the statements are positively worded, half negatively 
worded. Responses are scored out of a possible total of ten, with one point for each 
positively worded item marked as true and one for each negatively worded item 
marked as false. Cohen has demonstrated adequate test/retest reliability (0.82 over 
four weeks) and good internal reliability (alpha coefficient = 0.75-0.78) [448]. In the 
2001 study, the alpha coefficient for this scale was 0.81. 
 
The trust scale is a four-item scale derived from the Organizational Trust Inventory 
(OTI) developed by Cummings and Bromiley, 1996 [449]. Participants are asked to 
agree or disagree with statements such as, “Most people don’t mislead others”, on a 
seven point Likert scale from “definitely disagree” to “definitely agree”. Cronbach’s 
alpha in the 2001 study was 0.87. 
4.5.4 Optimism/Pessimism 
The Life Orientation Test (LOT) developed by Scheier (1985), is commonly used to 
evaluate an individual’s sense of optimism [450]. It indicates optimism/pessimism as 
a relatively pure trait, although there is some overlap with coping, self-esteem, self-
mastery and neuroticism. In 1994, Scheier and Carver revised the LOT to narrow the 
original instrument down to a more pure measure of the construct of optimism [451]. 
The revised LOT (LOT-R) is used in the Biomarkers Study. 
 
The LOT-R is a measure of dispositional rather than situational optimism. It is a ten-
item scale with four filler items, three positively worded items (“In uncertain times, I 
usually expect the best”) and three negatively worded items (“I hardly ever expect 
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things to go my way”). It is scored on a 5-point scale from “strongly agree” to 
“strongly disagree”. Negatively worded items can be reverse-coded and summed with 
the positively worded items, to give a single score, or the positively and negatively 
worded items can be scored separately. There is some evidence that the separately 
scored negatively worded items have a stronger relationship with SES and health 
outcomes [452]. 
 
Internal consistency is satisfactory, with a reported Cronbach’s alpha of 0.78 and test-
retest reliability of 0.79 after 28 months [451]; and Cronbach’s alpha for the 2001 
study of 0.83. 
4.5.5 Stressful Life Events 
The PATH study uses Brugha and Cragg’s List of Threatening Experiences (LTE) 
[453] to examine the number of recent stressful life events. This is a 12-item 
questionnaire, which asks whether or not a series of potentially stressful events have 
happened to the individual over the last six months. Items include: death of a close 
family friend or relative, a crisis or disappointment at work or the end of a steady 
relationship. In addition, two questions ask about stressful life events affecting the 
participant’s partner. 
 
Test-retest reliability has been demonstrated of >0.75 (Cohen’s kappa) and there is 
good correlation (Cohen’s kappa >0.63) between the LTE questionnaire and a 
contextually rated long-term threat rating, from interview [453]. Life events can be 
simply scored, i.e. there were 6 serious life events in the last six months, or a 
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weighting can be applied to the various items, i.e. death in the family is more stressful 
than loss of something valuable. In the Biomarkers Study the number of life events 
was summed without weighting. To adjust for the absence of a partner (and thus a 
lower possible total life events score) the total derived by summing, was divided by 
the number of items, to give each individual a score out of 1. 
4.5.6 Affect – PANAS scale 
Affect can be examined as a state (“how you are feeling now”) or as a trait (“how you 
usually feel”). For the purposes of this study, the latter is most important and is 
considered to be a stable personality characteristic. In the PATH study, the positive 
and negative affect scale (PANAS) [454] is used to measure affect, and this was 
repeated in the 2001 study. Positive and negative affect are not two ends of the same 
spectrum. The person high in PA (positive affect) is energetic, enthusiastic, alert and 
active, while the person low in PA is lethargic, bored and sad. The person high in 
negative affect (NA) is angry, hostile, fearful and contemptuous of others, while the 
person low in NA is calm and serene. In both the PATH and the 2001 studies the 
PANAS has added items to more fully assess trait hostility (from the PANAS-X 
scale, [455]). The scales of the PANAS have been demonstrated to have good 
test/retest reliability and high internal consistency. In the 2001 study, Cronbach’s 
alpha coefficients for each scale were: PA = 0.91; NA = 0.89; Hostility = 0.80. 
 
The scales consist of a number of words that describe different feelings or emotions. 
Respondents are asked to rate (on a scale of 1-5, where 1 = “very slightly or not at 
all” and 5 = “extremely”) to what extent they have been feeling this way over the last 
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month, e.g. disgusted, alert, proud. The version of the PANAS-X used has ten items 
to assess PA, ten to assess NA and six items to more fully assess hostility (four extra 
items and two items, hostile and irritable, that are part of both the NA scale and the 
hostility scale). For each subscale, the ratings are added to obtain a score for PA, NA 
and hostility. 
4.5.7 Affect - Behavioural inhibition/activation 
The behavioural inhibition system (BIS) is related strongly to negative affect as 
measured by the PANAS, while the behavioural activation system (BAS) relates 
strongly to positive affect. However, the BIS and BAS scales are thought to reflect 
the sensitivity of the individual to anxiety (BIS) or impulsivity (BAS) given a 
particular situation, whereas the PANAS measures emotions actually experienced. 
Thus a person may be vulnerable to anxiety in certain situations, but have learned 
behaviours to decrease that anxiety and thus experience less anxiety. The BIS and 
BAS scales are thought to tap more inherent elements of personality, whereas the 
PANAS looks at the net effect of this inherent personality plus some learned coping 
behaviours [456]. 
 
The BIS/BAS consists of a number of statements in which respondents rate the level 
of agreement with a statement, on a scale of 1 = “very false for me” to 4 = “very true 
for me”. The BIS/BAS scale is made up of four sub-scales: the BIS, the BAS Reward 
Responsiveness, the BAS drive and the BAS Fun Seeking. The BIS scale examines 
sensitivity to the anticipation of punishment, with such questions as “I worry about 
making mistakes”. The BAS Reward Responsiveness scale examines the extent of 
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positive reactions to the anticipation of a reward, e.g.” It would excite me to win a 
contest”. The BAS Drive scale looks at persistence in the pursuit of goals, with items 
such as “When I go after something I use a “no holds barred” approach”. The BAS 
Fun Seeking scale reflects the impulsive seeking of fun and excitement, e.g. “I crave 
excitement and new sensations”.  
 
Carver and White demonstrated reasonable test-retest correlations (0.66 for BIS, 0.66 
for Drive, 0.59 for Reward Responsiveness, and 0.69 for Fun Seeking) after 8 weeks 
[457]. Internal reliability is high, with reported Cronbach’s alpha of 0.74 BIS, 0.73 
Reward Responsiveness, 0.76 Drive and 0.66 Fun Seeking in the original study and 
the same or higher in Jorm’s application of the BIS/BAS to an Australian community 
sample [456]. In the 2001 study Cronbach’s alpha coefficients were high for all 
scales: BIS = 0.84; Drive = 0.82; Reward Responsiveness = 0.71; Fun Seeking = 
0.73. 
4.5.8 Neuroticism, Psychoticism, Extroversion 
These personality traits are measured in the PATH study and subsequently in the 
2001 study using the short version of the Eysenck Personality Questionnaire – 
Revised scale [458]. Requiring “Yes/No” answers, the EPQ-R contains simple 
questions such as, “ Are your feelings easily hurt?”, “Do you enjoy meeting new 
people?”, and “Do good manners and cleanliness matter much to you?” Groups of 
questions load onto each of the above facets of personality - neuroticism, extroversion 
and psychoticism.  
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There are 12 items for each of neuroticism, extraversion, and psychoticism, each 
scored 0 or 1. Items are then totalled out of a maximum of 12 for each subscale. 
Where there are missing values, within a subscale, provided there are ten or more 
non-missing values, the mean of these is taken and multiplied by twelve to obtain a 
final score. 
 
The reported alpha reliabilities for the extroversion and neuroticism scales are high 
(>0.8) while that of the psychoticism scale is not as high, but satisfactory (>0.6) Test-
retest reliability for the scale is >0.7 [458]. In the 2001 study, the alpha coefficients 
were similarly high for the extroversion and neuroticism scales (0.88 and 0.81 
respectively), but rather low for the psychoticism scale (0.46). 
4.5.9 Perceived Stress 
“Stress” is as difficult to measure as it is to define. An explicit definition makes 
measurement possible, but still reflects only one perception of stress. In the pilot 
study stress is measured by assessment of life events from the PATH study as well as 
questions on economic strain. Following suggestions by participants in the pilot 
study, some of the items measuring economic strain were dropped in favour of 
questions simply asking people how they assessed their stress levels and what the 
causes of this stress might be.  
 
In addition, a ten-item scale was introduced in the 2001 study to examine perceived 
stress more formally. The perceived stress scale (PSS) developed by Cohen et al 
examines the participant’s appraisal of how stressful particular situations have been, 
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over the last month [459]. It is a global measure of perceived stress, looking at 
difficulties in general, rather than specific events such as a life events scale examines.  
 
The PSS has been used in a number of studies examining links between stress and 
both physical and mental health [460-464]. 
 
Participants answer questions such as “In the last month, how often have you felt that 
things were going your way?” on a 5-point scale from 0 = “Never” to 4 = “very 
often”. A total score is achieved by reverse coding the positively worded items and 
then summing across all ten items, i.e. a maximum score of 40 indicating a high level 
of perceived stress. Cronbach’s alpha is reported as 0.87 for the 14-item version of 
the PSS [463] and 0.91 for the 10-item version [461]. In the 2001 study, Cronbach’s 
alpha for this scale was 0.86. 
4.5.10 Economic strain 
In the pilot study the economic strain variable had three components, based on 
Pearlin’s model of economic stress [465]. These were:  
• Economic strain, a 9-item scale asking questions about whether the 
participant felt he/she could afford to buy several essential and non-essential items. 
• Economic positive comparisons (EPC), a six-item scale that asks the 
participant to rate their economic circumstances against the perceived economic 
circumstances of others in the community. Thus a person, of any income, who feels 
that friends, relatives and neighbours are better off, is likely to feel some economic 
stress. 
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• Devaluation of the importance of money model (DIMM). This is a 3-item 
scale, which seeks to see how participants might reframe how unimportant money is 
to them, to cope with perceived lack compared to peers. 
 
Comments by participants in the pilot study suggested that the questionnaire was too 
heavily based on economic stress and several participants were unwilling to make 
comparisons of their economic circumstances with others (in the EPC) or had 
difficulties answering the questions on the DIMM. For the 2001 study, therefore, the 
latter two scales were dropped. The economic strain scale was retained (alpha 
coefficient in the 2001 study = 0.80) and a new three-item deprivation scale∗ was 
added – “Do you go to the dentist for routine dental checkups?”, “Does your partner 
go to the dentist for routine dental checkups?” and “Do you have household contents 
insurance?” 
4.5.11 Coping 
Coping strategies are assessed with the Brief COPE [466], an abbreviated version of 
Carver and Sheier’s COPE scale [466]. Both COPE scales have been widely used in 
health research. 
 
The original COPE scale consisted of 60 questions that loaded onto 15 coping 
strategies, e.g. active coping, mental disengagement, denial, substance use, use of 
emotional support, use of instrumental support, behavioural disengagement etc. The 
                                                 
∗ Contributed by Helen Berry, PhD scholar, Centre for Mental Health Research 
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Brief COPE is shortened to 28 questions loading onto 14 slightly different types of 
coping strategies.  
 
In the both the pilot and the 2001 studies, dispositional (rather than situational) 
coping is assessed by asking participants to “ think about what you usually do when 
you are under a lot of stress”, rather than asking how the person coped in response to 
a specific event or over a specific time period. 
 
The Brief COPE was used in both parts of the Biomarkers study to measure coping 
styles in a concise, but theoretically rigorous way that would not overload participants 
who also had to respond to a number of other questions. The scale consists of 28 
items asking the participant to rate, on a four point scale, how much they would use 
this action in response to a stressful event, from, “I don’t usually do this at all” (1), to 
“I usually do this a lot” (4). Each of the fourteen subscales consists of two items, to 
provide a total score out of eight for each coping strategy. The alpha coefficients in 
the 2001 study, for the subscales measuring use of humour, acceptance and self-
distraction were relatively low (<0.40); the subscales measuring denial, behavioural 
disengagement, and venting had modest alpha coefficients (0.51-0.65); the remaining 
subscales had high alpha coefficients (>0.74). 
4.5.12 Work Stress  
Occupational stress was assessed using Karasek’s job control/demand model [467] 
with the questionnaire used by Bosma et al [75] in the Whitehall studies. Of fifteen 
job control items, nine cover decision authority and six cover skill discretion. The 
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subscales are equally weighted and can be summed to give a job control scale which 
has been reported to have good internal consistency (Cronbach’s alpha = 0.84) [70]. 
In the 2001 study, Cronbach’s alpha for the skill discretion and decision authority 
subscales were high (0.79 and 0.84, respectively). Four items assess job demands. 
Cronbach’s alpha for this scale is reported as 0.67 [75] and in the 2001 study was 
0.69. 
 
Responses are required on a four point scale from, 1 = “Often”, to 4 = “Never”, to 
such questions as “I have a good deal of say in decisions about work”, and “Do you 
have to work very fast?” Twelve of the fifteen items in the job control scale are 
worded such that high control gives the lowest score – these are recoded and summed 
with the other three items to give a total score, where high score indicates high job 
control. In the job demand scale, three items are worded such that high job demand 
gives the lowest score. These are recoded and summed to the remaining questions, 
such that a high score indicates a high level of job demand. 
 
In addition, the PATH study (from which the pilot study derived data on job control 
and demands) and the 2001 study included two questions on job security, one 
question on perceived fairness of pay, conditions and benefits, one question on 
number of hours worked in a routine week and one question asking how many days 
off work the respondent had had in the past month. These were used individually in 
the analysis. 
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All responses are self-reported and no attempt was made to verify the respondents’ 
scores by independent assessment of the job control or demands. Bosma et al [75] 
found only a modest correlation between self-reported and independently assessed job 
control (Pearson correlation coefficient 0.41), but both showed a strong relationship 
to new reports of coronary disease. 
4.5.13 Hostility 
Trait hostility is assessed by four items in the PANAS-X scale, as outlined above. 
4.5.14 Self-esteem 
One of the most widely used measures of self-esteem for many different areas of 
research is Rosenberg’s Self Esteem scale, published in 1965 [468]. This is a ten-item 
scale in which participants are asked to agree on a scale of 1 to 4 (Strongly agree to 
Strongly Disagree) with a number of statements, such as “I certainly feel useless at 
times”. Positively and negatively worded questions are included. The scale can be 
recorded as a total score (after reverse coding negatively worded items) out of 40 or it 
can be categorised into positive and negative self-esteem. The scale has excellent test-
retest reliability and internal consistency [469]; in the 2001 study, the alpha 
coefficient was 0.85. 
4.5.15 Mastery 
Mastery, or a sense of personal control is measured in the PATH study and 
subsequently in the 2001 study using the Pearlin Personal Mastery Scale [470]. This 
is a 7-item scale requiring a response to a statement such as, “Sometimes I feel that 
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I’m being pushed around in life”, on a four point scale from 1 = “Strongly Agree” to 
4 = “Strongly Disagree”. Positively and negatively worded statements are included.  
 
After reverse coding of negatively worded statements and summing of the scores, a 
low score suggests a high level of control, while a high score suggests a low level of 
control. The scale has been widely used in health research [471] and has been shown 
to exhibit good construct validity and internal reliability [465]; in the 2001 study the 
alpha coefficient was 0.85. 
4.5.16 Ruminative Style 
Ruminative style is assessed by a 10-item scale, originally developed by Nolen-
Hoeksema et al [472] to study the effect of this style of thinking on depression and 
stress after the Loma Pieta earthquake.  
 
Participants respond to statements regarding their thoughts about themselves on a 
four-point scale, 1 = “Never”, to 4 = “Always”. Statements are of the form “I think 
about how alone I feel”, “I think about all my shortcomings, failings, faults and 
mistakes.” All items are worded such that a high score indicates a high degree of 
ruminative thinking. Scores are summed over all items. In the 2001 study, this scale 
had excellent internal consistency with a Cronbach’s alpha of 0.85. 
4.5.17 Household Responsibility 
Four questions were used in the PATH study and in the 2001 study to assess the level 
to which the participant assumed responsibility for different household tasks, such as 
childcare, financial management, housework and providing money for the household. 
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Participants answered questions such as, “To what extent are you responsible for 
childcare in your household?”, on a five point scale from “Fully responsible” to “Not 
at all responsible”. The responses were summed to give a total household 
responsibility score.  
4.6 Socioeconomic variables 
Socioeconomic status was assessed using a variety of measures, in an effort to see if 
these alternative indicators of SES performed differently in relation to the biological 
markers. 
4.6.1 Occupation  
Each participant’s occupation was assessed in the PATH study, with questions 
designed to allow coding to the Australian Standard Classification of Occupations, 2nd 
edition (ASCO, 2nd ed) [473]. Questions included, ‘job title’ and a description of the 
main duties and activities of that job. Basic information was sought on the nature of 
the employer (public service, own business, profit-making business, family business), 
the level of management responsibilities involved in the job and the size of the 
employing organisation. For those who were currently unemployed, the same 
information was sought on the last employment. Parents at home with children are 
assigned an ASCO code of 0999, i.e. they do not fit into the classification system, so 
that last employment was coded. 
 
In the 2001 study, similar information was sought on the participant’s partner to 
enable exploration of a household SES by occupation as well as personal SES by 
occupation. 
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All occupations were coded to the ASCO, 2nd ed. using the ASCO II coding CD-
ROM [474]. Any problems with coding were discussed with the ABS, for resolution. 
At the completion of coding, occupational data on a random sample of fifty 
participants was sent to the ABS for coding and checked against the coding for the 
2001 study. There was agreement on codes for 80% of the occupations, with the 
remaining differences in coding making only minor alterations to occupational level 
and occupational status.  
4.6.2 Occupational status   
Once occupations had been coded to the four-digit ASCO code, a corresponding 
occupational status score was assigned to each participant using the ANU3_2 
occupational status scale [475]. This converts each occupation (as coded to the ASCO 
II) to a scale from 1 to 100, which expresses the status of particular occupations as 
perceived by population samples. Examples of the extremes of the scale are medical 
specialists (occupational status 99.7), and domestic cleaners (occupational status 3.7). 
Incompletely described occupations, or non-paid occupations such as voluntary work 
cannot be assigned an ASCO code with the first figure between 1 and 9, or an 
occupational status. 
 
Two occupational status codes were assigned to each participant. The first 
represented their personal occupational status based on their own occupational level. 
The second represented the highest occupational status in the household (respondent’s 
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or partner’s occupation) and is subsequently termed “household occupational status” 
or “household status”. 
4.6.3 Education   
Education was assessed in the PATH study with questions designed to allow coding 
to the Australian Bureau of Statistics Classification of Qualifications (ABSCQ), 
which was developed by the ABS for the 1991 census. The Australian Standard 
Classification of Education (ASCED) has recently superseded this scale. 
 
The ABSCQ assesses the highest level of schooling completed and then the level of 
post-secondary or tertiary education completed, differentiating this into trade 
certificate, undergraduate diploma, bachelor’s degree, and higher degree. The 
ASCED codes levels of primary and secondary education more clearly than the 
ABSCQ, but the delineation of different certificates and diplomas as presented in the 
PATH questionnaire codes more clearly to the ABSCQ. Thus initial coding was to the 
ABSCQ, with subsequent conversion to the ASCED using published conversion 
sheets [476]. 
 
There are nine categories of educational attainment ranging from ‘1’ – higher degree, 
to ‘9’ – pre-primary education.   
4.6.4 Income   
Both personal and household income were measured in the Biomarkers Study. 
Categories for personal income are those used by the ABS in the 1996 Australian 
Census, except that a new highest income category was added, to spread those at the 
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top in relatively affluent Canberra. Similarly, the household income scale has 
additional high-income categories, to a maximum of $3,500 or more per week 
($182,000 per year). All income is gross income from all sources, i.e. tax is not 
deducted, and interest, rents received etc are included. Household income includes the 
income of all persons who are part of the household – the participant, their partner, 
children and others who share food and essentials for living in the dwelling. 
4.6.5 Number of cars  
The number of registered motor vehicles is used as a measure of wealth. There are 
clearly some difficulties in the interpretation of this as a measure of SES. The number 
of cars in a family is affected not just by SES, but also by the family composition. 
Thus a high SES family may have a car for each member of the family who can drive, 
which may be two for a family of four that consists of parents and two toddlers, or 
four if the family consists of parents and two teenage or adult offspring.  
 
In addition, while lack of any car may be an indicator of deprivation and hardship, it 
may also be an indicator of environmental awareness and a conscious decision not to 
be a vehicle-owner.  
4.6.6 Accommodation 
Type of accommodation provides another measure of wealth. In the 2001 study and 
the pilot study, participants were asked to indicate their current accommodation type, 
from a given list ranging from home ownership to rental housing to government 
housing to caravans etc. 
 206
4.6.7 Perceived place in the community and in Australia 
In the 2001 study, a measure of where people see themselves in relation to others was 
included. This consisted of a picture of a ladder. Participants were asked to place 
themselves on the rung that depicted where they thought they stood at this time in 
their lives. In two separate questions, participants ranked themselves compared to 
their own community and to the Australian community as a whole. This format has 
been used to examine subjective social status [477], but specifies “standing” in the 
community, rather than SES. It is assumed, for the purposes of this thesis, that this is 
largely a self-rated measure of SES, although factors such as the importance of 
money, individual self-esteem etc may play a part in where people rank themselves 
on the ladders. 
4.6.8 Childhood socioeconomic status 
Childhood socioeconomic status was measured in both parts of the Biomarkers study 
by questions about parents’ occupation and education when the participant was aged 
12. 
Education. Parents’ education was assessed separately on a simple scale asking about 
the highest educational achievement, ranging from “no schooling” through “some 
primary schooling” to “completed high school”, “trade certificate” and “ university 
degree”. 
Occupation. Parents’ occupations were assessed by asking the job title and the job 
description for each parent, when the participant was aged 12. This occupational data 
was then coded to the ASCO 2nd edition, using the ASCO coder (as above), and an 
occupational status assigned in the same way as for “Occupational status” above. 
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(Note this may not provide an accurate assessment of the status of occupations thirty 
years ago).  
 
Participants experienced some difficulty with the question regarding parent’s 
occupation. A few people read it as “ the occupation of the parents when they 
themselves were 12” – usually answered as “they didn’t work when they were 12”; 
while others answered that their fathers were computer technicians or consultants – 
hardly likely thirty odd years ago!   
4.7 Health variables 
4.7.1 Physical 
Self-rated health was assessed in the PATH study and in the 2001 study using the SF-
12, which gives two global summary measures – physical health and mental health 
[478]. There is some disagreement as to whether the SF-12 adequately measures 
general physical and mental health in Australian populations, however it has recently 
been validated for use in Australia [479-481]. Taking any mediations was recorded as  
Yes/No, and details of exact medication were listed. 
4.7.2 Psychological  
The SF-12 provides a general measure of mental health, including questions such as, 
“How much of the time during the past 4 weeks have you felt down?” 
 
In addition, Goldberg’s scale provides a global measure of anxiety and depression 
[482]. The scale was adapted from a standardised psychiatric research interview and 
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designed to be used by non-psychiatrically trained personnel to detect psychiatric 
illness. It is an 18-item questionnaire requiring “Yes/No” responses to questions 
asking how the participant has been feeling in the past month, e.g. “Have you felt 
keyed up or on edge?” 
4.8 Behavioural variables 
4.8.1 Physical activity 
Both frequency of physical activity (from “Never” to “3 times a week or more”) and 
total number of hours per week were measured in the PATH study and the 2001 
study. Each of these required separate responses for mildly energetic, moderately 
energetic and vigorous activity. 
 
From these responses, number of hours of exercise per week was converted to a 
weighted summary measure of physical activity using the working metabolic rate for 
each level of activity, to create a common metric [483]. Number of hours of mild 
activity is multiplied by 4, moderate activity by 6 and vigorous activity by 10 
(representing metabolic equivalents, (METs)). 
 
Mild activities, with an energy expenditure of 3-5 METs include brisk walking, 
golfing; moderate activities, with an energy expenditure of 5-7 METs include cross-
country skiing, swimming and dancing with sufficient intensity to cause sweating and 
breathlessness; heavy exercise, with an energy expenditure of 7 or more METs 
includes jogging at a sufficient intensity to cause profound sweating and/or 
breathlessness.  
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The frequency of mild, moderate and vigorous activity were retained as separate 
variables. 
4.8.2 Smoking 
Smoking status was assessed with two questions, “Do you currently smoke?” and 
“How many cigarettes do you usually smoke in one week?”. Of those who did not 
currently smoke (87% of the sample), 39% had smoked in the past, but no further 
detail was elicited.  
4.8.3 Alcohol intake 
A single question from the PATH study was used to assess frequency of alcohol 
intake, from “not in the last year” to “four or more times per week”. 
4.9 Biological variables 
Blood was collected by Capital Pathology in the pilot study and by ACT Pathology in 
the 2001 study. All samples were taken fasting, and the majority were thus early 
morning samples. 
4.9.1 Fibrinogen 
Blood was collected in a citrated tube, then centrifuged to separate the plasma. 
Specimens were stored at 4º C and tested within 2 hours of collection. Estimation of 
the fibrinogen level uses the thrombin method, which relies on the principle that the 
thrombin clotting time of dilute plasma is inversely proportional to the fibrinogen 
concentration of the plasma. Thrombin clotting time is the rate of the reaction in 
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which soluble plasma fibrinogen is converted by the enzyme, thrombin, into insoluble 
fibrin. At high thrombin concentrations and low fibrinogen concentrations (as it is 
diluted in the test system), the reaction rate becomes a function of the fibrinogen 
concentration. 
4.9.2 Serum lipids 
The 2001 study and the pilot study measured total serum cholesterol, high-density 
lipoproteins (HDL), low-density lipoproteins (LDL) and triglycerides. Fibrinogen is 
associated with low levels of HDL and high levels of triglycerides, and these in turn 
may vary by SES and different health states. HDL and triglycerides are thus possible 
confounders of the relationship between fibrinogen and SES and fibrinogen and 
health. 
 
In addition, total cholesterol and LDL are measured as a part of this battery of tests 
and provide useful information to feed back to participants. 
 
Cholesterol measurement is performed using the Ortho Clinical Diagnostics dry slide 
technology Cholesterol slide. 
4.9.3 Glycated haemoglobin 
Glycated haemoglobin is measured by high performance liquid chromatography, from 
whole blood collected into an EDTA tube. The sample can be kept at 4º C for up to 7 
days.  Fasting serum glucose was measured to check for hyperglycaemia and to 
provide information on this possible confounder. 
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4.9.4 Serum neopterin 
ACT Pathology performed the serum neopterin assay, using a commercial ELISA kit 
supplied by Brahms Diagnostica.  
 
Serum for neopterin assay was collected by venipuncture in the standard way, into a 
light-protected tube (wrapped in aluminium foil), and refrigerated. The serum was 
separated and frozen at –20ºC until assay, within six months. Due to a communication 
failure, the first specimens in the pilot study were not light protected, and other odd 
samples during the pilot study were not light protected for a variety of reasons. Lack 
of light protection was noted on the result form. 
4.9.5 Salivary IgA 
Saliva was collected by gentle suction using a suction pump (supplied by the 
Canberra Centre for Mucosal Immunology) and a disposable plastic catheter with a 
mucous trap. This ensured that no saliva contaminated the pump. (Details of saliva 
collection and analysis are contained in Appendix C) 
 
Saliva was collected in the mucous trap, sealed and placed on ice for transportation. It 
was then frozen at –20ºC within one hour and subsequently transferred to –80ºC. 
Each saliva tube was labelled with the ID number, date and time of collection with an 
indelible marker. All samples were collected approximately two hours post-
prandially, and participants had been asked not to eat or drink between the meal and 
the saliva collection. No stimulation was used to increase saliva flow. 
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Salivary IgA is detected by use of an antibody-sandwich ELISA technique. In 
essence, the wells of the ELISA plate are coated with unconjugated anti-IgA and 
allowed to incubate. This allows the anti-IgA to attach to the base and sides of the 
well. Excess anti-IgA is washed off and saliva (or standard) is then added to the well. 
The anti-IgA binds to the IgA in the saliva while it incubates. Excess saliva is washed 
off. Then a conjugated anti-IgA is added to the wells, which will in turn bind to the 
IgA that has already been bound to the unconjugated anti-IgA and therefore the well 
itself. The conjugated anti-IgA has an enzyme attached to it, which causes a colour 
change when certain chemicals are added to the mixture. After the conjugated anti-
IgA has been allowed to incubate, excess is washed off and the appropriate chemical 
added. A colour change occurs that is proportional in optical density to the amount of 
enzyme (and thus conjugated anti-IgA bound to IgA) in the solution. This is 
compared to standards that have known levels of IgA and have been tested on the 
same plate, to give the IgA level. 
 
A qualified technician at the laboratories of the Canberra Centre for Mucosal 
Immunology (CCMI), University of Canberra carried out all salivary IgA analyses. 
4.9.6 Waist-hip ratio 
Waist measurement. Participants were measured in light street clothing, without 
jumpers, coats or belts. They were requested to stand upright, feet together, stomach 
relaxed and hands at their sides. The waist measurement was then made at the end of 
normal expiration, at the narrowest point between the ribs and the hips as viewed 
from the front. The tape measure was adjusted several times to ensure a consistent 
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measure of the narrowest point was made. This is in keeping with the method of 
Boyle et al [301], chosen as a simple method that takes account of differing body 
shapes. 
 
Hip measurement. As above, measurements were made over light street clothing 
with participants standing upright, feet together and hands at their sides. The hip 
measurement was measured at the point of maximal extension of the buttocks, when 
viewed from the side. Again several measurements were taken to ensure this was the 
maximum hip circumference and that the measurement was accurate. All 
measurements were recorded to the nearest half centimetre.  
 
All measurements were taken along a horizontal plane with a plastic tape measure. 
The flexibility of the plastic tape measure was preferred over a metal tape measure, 
but the accuracy of the plastic measure was checked following every ten participants. 
4.9.7 Body mass index 
Height. Height was measured with the participant without shoes, standing with heels 
against the wall and using a stadiometer to ensure the correct angle of measurement at 
the top of the head. A metal tape measure was then used to measure from the floor to 
the bar of the stadiometer. There was modest variation in the surface that participants 
stood on, so that height was measured only to the nearest centimetre. 
Weight.  Participants were weighed on electronic scales in light street clothing 
without shoes, with weights recorded to the nearest 0.5 kg. 
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All height, weight, waist and hip measurements were taken by the same person to 
ensure consistency in measurement technique. 
4.9.8 Blood pressure 
Blood pressure (BP) was measured in the PATH study using an automatic blood 
pressure device. Because the participants in the pilot study had only recently 
participated in the PATH study, blood pressure was not re-checked and the reading 
from the PATH study was used in the analysis. 
 
In the 2001 study, blood pressure was measured using a Speidel and Keller Iso-Stabil 
5 anaeroid sphygmomanometer, with a standard and large cuff, and a Hewlett 
Packard stethoscope. Blood pressure was measured in the left upper arm, with the 
participant seated. A standard BP cuff was used unless this covered less than two-
thirds of the distance from the elbow to the shoulder. A small cuff can lead to a 
spuriously high blood pressure measurement [484]. The systolic pressure was taken at 
the first phase of the Korotkoff’s sounds. The diastolic pressure was recorded as 
phase 5 of the Korotkoff’s sounds (when the sound disappears) except for the 
occasional person where the sounds continued down to zero. In this instance, the 
muffling of the sounds (phase 4) was taken as the recorded diastolic pressure. The 
sphygmomanometer gauge had 2mm Hg gradations, so that BP is recorded to the 
nearest 2mm Hg. 
 
In the event that the blood pressure was elevated, (systolic greater than 150mmHg, 
diastolic greater than 95mm Hg) the participant rested (and usually did the saliva 
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sample) and a repeat blood pressure was taken 5-10 minutes later. The lower of these 
two blood pressure measurements was taken as the recorded blood pressure. 
4.10 Data management 
Separate Access databases for the pilot study and the 2001 study were maintained to 
record contact information, interview details, address changes etc as well as to record 
date of blood collection and date of saliva collection, date of final correspondence, 
and date of data entry. Data on all potential study participants were retained to aid in 
analysis of representativeness of the sample. All databases were password protected. 
 
Data from the questionnaires, body and biological measurements were entered into 
Access databases using forms to minimize data entry errors. Limits were placed on 
acceptable values and acceptable data types (numeric, string, date etc). On completion 
of data entry, all data were transferred to Stata 7 files using Stat Transfer 6. Double 
data entry was performed for the pilot study to check on accuracy of data entry. 
4.11 Data checking 
Using Stata 7, data were checked initially by simple tabulation looking for unlikely 
values. These had been largely screened out by the use of limits on entered values in 
the Access database. Missing values were checked back against the original data. 
Further checks were carried out using cross-tabulation searching for impossible 
values, e.g. participants recorded as being non-smokers, who were recorded as 
smoking a certain number of cigarettes per day. 
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Categorical variables with categories containing only a few observations were 
collapsed. All missing values had been entered in Access as “99” and these were 
recoded to “.”, the missing variable code in Stata 7.  
 
All variable scores were calculated in accordance with the original formulation of the 
scales. For those psychosocial scales in which the score was a sum of the individual 
items (after reverse coding when necessary), a single missing value was imputed as 
an average of the other items in the scale, i.e. a total for the scale was calculated, 
using the sum of the remaining items in the variable, divided by the number of 
remaining items and then multiplied by the total number of items in the scale to 
achieve a summary score. 
 
For the assessment of the temporal stability of the markers, only the data from the 
pilot study were analysed, as this included, for each participant, measures of each 
marker taken on two occasions, three months apart. However, for the analysis of the 
performance of the markers and their relationship to psychosocial factors, the pilot 
data were aggregated with the data from the 2001 study to increase the sample size. 
The variables measured in the pilot study and in the 2001 study were similar, 
although some questions in the pilot study were omitted from the 2001 study and thus 
were not included in the subsequent statistical analysis.  
 
In aggregating the data, PATH study data on the pilot subjects were used. Participants 
in the pilot study had been interviewed for the PATH study within the previous six 
months (in 2000). Comparison of scores on identical variables measured in the PATH 
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study and again in the 2001 study indicated that most variables had high test-retest 
reliability (intraclass correlations generally greater than 0.45) over twelve to eighteen 
months, suggesting that the use of PATH study data for the pilot participants was 
valid. (Details of this analysis are reported in Appendix E). 
4.12 Data manipulation 
For the purpose of this thesis, and the examination of the relationships between a 
number of psychosocial factors and several biological variables, the data were 
reduced using principal components analysis. In this way, factors representing groups 
of variables could be included in the analysis. The single factor with the largest 
eigenvalue was retained (unrotated), unless a second eigenvalue was of a similar 
magnitude. When more than one factor was retained, a varimax rotation was applied. 
Following principal components analysis, the weighting of each element of the 
retained factor(s) was examined to ensure that these retained some meaning, eg two 
coping factors were retained – one with the highest loadings from positive, problem-
focused coping, the other with the highest loadings from negative coping strategies. 
This is in line with the coping literature. Specific details of factors retained are 
outlined in the following sections.  
4.12.1 Social support 
The original social support scale separates positive and negative interactions with 
family, partner and friends. This was collapsed to create two new variables 
encompassing total positive support and total negative interaction [485]. Principal 
components analysis, retaining separate single factors for positive and negative 
interaction confirmed that support from family, friends and partner loaded 
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approximately equally onto the single factors. Number of friends was retained as a 
separate variable. 
4.12.2 Childhood adversity and parenting 
Two summary measures of childhood adversity were derived. The first summed the 
number of defined adverse childhood events (verbal abuse, sexual abuse etc). 
Notably, only 5 participants out of 339 had a score greater than zero, so this variable 
was dropped from further analysis. The second summary score was created by 
summing responses relating to a more general assessment of the emotional milieu of 
participants’ childhoods, e.g. the presence of parental affection, conflict and drug use 
in the household.  
4.12.3 Social capital 
Social capital was measured with two questions in both studies, but sense of trust and 
belonging were measured in more detail only in the main study. For the purposes of 
the current analysis, the original two questions were retained as separate variables. A 
summary measure of trust and belonging was derived from principal component 
analysis of the trust and belonging items, with one factor retained. 
4.12.4 Personality variables  
Principal components analysis of the personality variables (extroversion, 
psychoticism, neuroticism, personal mastery, self-esteem, optimism, hostility, affect, 
ruminative style, behavioural inhibition and activation) resulted in the retention of 
two personality factors. In the first factor there is strong positive loading from self-
esteem, sense of optimism, positive affect and locus of control with moderate positive 
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loading from extroversion. In addition there is strong negative loading from negative 
affect, hostility, neuroticism, ruminative style and behavioural inhibition. The second 
personality factor has a strong positive loading from responsiveness to rewards, fun-
seeking, drive and extroversion with a moderate positive loading from hostility, 
negative affect and ruminative style. The first factor thus has high loadings from 
“positive” personality variables while the second contains more elements of typically 
“negative” personality, including some aspects of Type A personality type. 
4.12.5 Perceived stress scale 
This scale was included only in the main study and analysis is thus restricted to these 
participants. 
4.12.6 Coping 
The original Brief Cope Scale results were reduced to two factors using principal 
components analysis with varimax rotation. In the first of these the main loadings 
were from positive reframing, planning, active coping and use of emotional and 
instrumental support. This factor thus represents active, positive coping skills. The 
second factor was composed largely of disengagement, venting, denial and self-
blaming, i.e. largely negative coping skills. These two factors were used in the 
analysis. 
4.12.7 Work strain 
Work strain variables include those assessing decision authority and skill discretion, 
which together constitute ‘job control’, and those assessing job demands. Each of job 
control and demand were split at the median to create four categories of job strain 
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(according to the Karasek model): high control with low demands, low control with 
high demands, low control and low demands, and high control with high demands. 
These were entered into the analysis as three separate dummy variables. 
4.12.8 Household responsibility 
Four questions assess the level of household responsibility assumed by the 
participant. One of these measures responsibility for childcare and thus is limited to 
those with children. An “average household responsibility” variable was obtained by 
summing scores across all variables and dividing by the number of variables 
included, to create comparable scores for those with and without children. A second 
variable was created to represent a total of the four household responsibility variables, 
assigning a value of 5 (0% responsible) to those with no children. This was then 
recoded so that a high score reflected a high level of responsibility in several different 
spheres of life, i.e. fully responsible for household tasks, childcare, financial 
management and providing money for the household. 
4.12.9 Economic strain 
The data from the pilot study were slightly different from those collected for the 2001 
study as noted above. To maximize the use of the data and avoid large numbers of 
missing values, the extra questions from the 2001 study were summed and averaged 
as a separate variable, with a range of 1-4, where a high value denotes a high level of 
economic strain. Principal components analysis was used to create a single factor 
from the nine items common to both studies, with approximately equal loading from 
each item.  
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4.12.10 Occupation  
All occupational variables were classified to the Australian Standard Classification of 
Occupation 2nd ed. as already outlined. Occupational variables included: subject’s 
occupation; partner’s occupation; mother’s occupation; father’s occupation. While 
occupations were coded to the four-figure or six-figure code (when there was 
sufficient information) this was used only to assign an occupational status value. In 
the statistical analysis only the first level occupational code was used, corresponding 
to the nine basic occupational groups. 
 
Occupational status was assigned according to the ANU3_2 Occupational Status 
Scale, based on the four-figure ASCO code and retained as a continuous variable. 
4.12.11 Education  
Australian Standard Classification of Education coded educational codes were 
collapsed to single figure codes for use in the analysis. Parent’s educational 
achievement was measured on an ordinal scale from “no schooling” to “university 
degree” in seven categories. 
4.12.12 Accommodation 
Accommodation was measured as a categorical variable in the original data on an 8-
point scale. In the analysis, the ordering of the variable was altered to make it ordinal, 
based on the expected association with socioeconomic status, i.e. own house/flat, 
rented house/flat, ACT Housing Trust/flat, living with relatives + other. Of only six 
participants in the last category, four were living with relatives, one was house-sitting 
and one was living in a workshop owned by the participant.  
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4.12.13 Equivalent income 
Adjusted household income (equivalent income) was calculated based on gross 
weekly personal and household income, spouse’s occupation, number of children and 
their ages, and whether children lived at home part-time, full-time or not at all. Full 
details of the method are outlined in Appendix F. 
4.12.14 Composite SES 
A composite SES factor was derived from principal components analysis of measures 
of participants’ current SES. There was a strong loading on this factor from ‘personal 
income’ (0.32), ‘household income’ (0.35), ‘occupational status’ (0.41), ‘highest 
occupational status in the household’ (0.39), ‘educational level’ (0.31), ‘occupation’ 
(0.39) and ‘self-rated position in Australia’ (0.34). ‘Type of accommodation’ and 
‘self-rated position in the community’ had weaker loadings (0.21 and 0.18 
respectively), while the loading for ‘number of cars in the household’ was very low 
(0.02). 
4.13 Missing values 
There were few missing values, with good completion of the questionnaires and a 
good response rate to blood sampling. Comparison of those who completed the 
questionnaires with those who did not, revealed no statistically significant differences 
in biological measures or available SES measures. Comparison of those who had 
blood tests with those who did not revealed no significant differences between the 
groups (including on SES measures), except that those who did not complete the 
blood test had a significantly higher waist measurement and waist-hip ratio, and 
significantly lower total physical activity score, i.e. tended to be less healthy. These 
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people may have contributed significantly to abnormalities in biological measures. 
The restriction of the sample with complete data to a more healthy subset of the study 
sample may decrease the variance in the biological measurements and thus decrease 
the likelihood of finding significant results. These are just the people that we may be 
most likely to see relationships in, so that their loss is unfortunate, with a likely bias 
towards the null. Analyses were performed only on those with complete data for each 
part of the analysis. 
4.14 Statistical analysis 
In general, bivariate correlation tests were conducted to analyse the relationship 
between the marker and different measures of socioeconomic status, as well as 
between each psychosocial, behavioural, biological and health variable and SES. 
Mediation analysis was then used to examine the mediating effect of the behavioural, 
psychosocial, health and biological variables on the association between each marker 
and each measure of SES. This was followed by the construction of multiple linear 
regression models for the marker and SES, psychosocial, behavioural, health and 
biological factors. Month of blood or saliva collection was controlled for in all 
multivariate analyses. Age was not included in the models as the study sample was 
restricted to a narrow age range (40-44 years). 
 
In some situations, summary variables, eg job strain, were included in the analysis in 
addition to the individual variables from which they were derived, eg job control, job 
demands. In this situation multiple collinearity is a problem, however both types of 
variables were initially included in the models and then repeated models examined 
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with and without each individual or summary variable to find the best model. In some 
situations, a model was obtained that included both individual and summary 
variables, with opposite signs for the coefficient. In such situations, the variables 
essentially cancel each other out and the model fit was not significantly different 
when both sets of variables were dropped.  
4.14.1 Mediation analysis 
My first two hypotheses are that the biomarkers vary with some measure of 
socioeconomic status and there is also variation in the psychosocial factors, with 
socioeconomic status. Having established this, the third hypothesis states that at least 
some of this co-variation can be ‘explained’ by the measured psychosocial factors. A 
number of statistical methods have been used to test the importance of variables that 
have associations to both the independent and the dependent variable and ‘mediate’ 
the relationship between them, i.e. X→I→Y, where X is the independent variable, I is 
the intervening or mediating variable and Y is the outcome or dependent variable 
[486]. 
 
Mediation is distinct from effect modification in which the relationship between the 
dependent and the independent variables is different at different levels of a third 
variable. In mediation, an intervening variable is related to both the dependent and the 
independent variable and when this relationship is modeled, the direct relationship 
between the dependent and independent variables is weakened. The association 
between the X and Y variables may be completely or partially mediated by an 
intervening variable. 
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Note that mediation implies a causal hypothesis – an independent variable affects a 
mediator, which in turn influences a dependent variable. However, causality cannot 
be demonstrated from the analysis alone.  
Figure 4.1. Mediation model 
 
 
 
 
 
 
The indirect effect is given by τ and is the (unstandardised) coefficient of the 
regression equation containing only the dependent variable and the independent 
variable, 
 Y = intercept1 + τX + ε1           (Equation 1) 
 
(ε1 represents unexplained variability). 
 
The direct effect is given by τ', which is the regression coefficient of the independent 
variable, in the full model containing the dependent variable, the independent variable 
and the mediator(s),  
 Y = intercept2 + τ'X +βM+ ε2   (Equation 2) 
 
β 
Independent 
variable
Dependent 
variable
Mediator
α 
τ' 
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The mediated effect is then τ- τ'. This is mathematically identical to the product of the 
two regression parameters α and β, where α is the regression coefficient of the 
equation containing the mediating variable regressed on the independent variable,  
 
 M = intercept3 + αX + ε3            (Equation 3) 
 
and β is the regression coefficient of the mediating variable in the full model, 
(Equation 2). Thus the mediation depends on the extent to which the independent 
variable changes the mediator and the mediator changes the dependent variable. 
 
In psychology, path analysis represents a type of mediation analysis, and mediation 
analysis was indeed derived from path analysis. Less formal/quantitative mediation 
analysis can be performed by examining the change in the regression coefficient 
before and after adjustment for a third variable in a regression model. Difficulties 
arise in the presence of time-varying covariates such as smoking, diet, exercise etc, 
where the time-dependent covariate may both affect and be affected by, the study 
exposure [130]. In the current study, the exposure of interest is socioeconomic status, 
the outcome a biological measure. It seems unlikely that smoking, diet, exercise etc 
would affect SES – rather any association of these covariates, with the study exposure 
and outcome would logically be as intermediate or confounding variables. McKinnon 
notes that mediation and confounding are identical statistically [487]. The distinction 
must be made on conceptual grounds. 
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Mediation analysis also allows the consideration of multiple intervening variables, 
and the contribution of each intervening variable to the total effect can be calculated 
as: 
 αn βn   
                  τ 
 
Figure 4.2 Multiple mediator model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
However, two problems may arise using this method to calculate the proportion of the 
total effect mediated by any intervening variable: 
1. If τ is very small, the proportion of the total effect mediated can be greater than 1. 
β6
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2. When the signs of α, β, and τ are different, the proportion mediated may have a 
negative sign, which is difficult to interpret.  
 
An alternative is to use significance testing to identify statistically significant 
mediating effects and this method was used in the Biomarkers Study. 
 
A commonly used (but conservative) method to identify significant mediating effects 
is based on the testing of three hypotheses based on the regression equations. Firstly, 
there must be a significant direct effect of the independent variable on the dependent 
variable. Secondly, there must be a significant effect of the independent variable on 
the mediating variable and thirdly, the mediator must have a significant relationship 
with the dependent variable, when both the independent variable and the mediator are 
included in the regression equation (cited in [488]). 
 
However, MacKinnon notes “ it is possible for there to be mediation even when the 
program effect is insignificant. If some mediators reduce the problem behaviour 
(dependent variable) and others increase the problem behaviour (a suppressor effect), 
there may be a nonsignificant overall program effect when mediation actually exists” 
[489]. (Mediation analysis has been mainly used in the evaluation of preventive 
programs, e.g. for smoking cessation, to assess elements that mediate the program’s 
success or failure. Hence the term program refers to the independent or X variable). 
 
Several authors have developed other methods to test the significance of the 
intervening variable effect, i.e. tests of the hypothesis that τ – τ’ = 0 or α*β = 0 using 
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a variety of assumptions [488]. In the subsequent analysis, I have used the method of 
Sobel [490] to produce a z statistic, which is then compared to the standard normal 
distribution. 
2222
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4.15 Sources of error 
4.15.1 Confounding 
Possible cofounders, including exercise levels, gender, serum lipids, fasting serum 
glucose and smoking status were measured and tested in the regression model. 
4.15.2 Selection bias 
Participants were selected randomly within each SES group to minimise selection 
bias. The use of biological markers as outcome variables means that participants 
could not have been selectively recruited to achieve particular outcome variables. 
There were strict selection criteria to form the base SES groups, from which the study 
groups were then chosen randomly to provide samples representative of each 
occupational status grouping. 
4.15.3 Measurement bias 
All blood and saliva measurements were collected at a distance from the analysing 
laboratories and were carried out using study ID numbers as identification, i.e. the 
laboratory had no knowledge of the study hypotheses or of the identity of the 
participants. All body measurements, including diastolic and systolic blood pressure 
were carried out by the same person in an effort to decrease measurement error. 
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Although there was access to the SES of the interviewed participants, once the study 
groups had been defined, no record was kept of the SES group status on the contact 
list and no attempt was made to ascertain the SES group status during the contact and 
interviewing phases of the study. However, many participants were visited in their 
homes and to some extent SES was obvious from the living circumstances of the 
participant. All measurements were objective, requiring no interpretation and 
following a strict methodological protocol, to minimise bias and error. The pilot study 
blood pressures were measured by a number of different observers in the process of 
interviewing for the PATH study, but comparison of the PATH blood pressures for 
main study participants with those taken as part of the 2001 study suggested that these 
were comparable, with a reasonable correlation (intraclass correlation (ICC) = 0.67 
(95% CI 0.61-0.73) for systolic blood pressure; ICC = 0.58 (0.50-0.65) for diastolic 
blood pressure). 
 
Interviewing was carried out on an area basis, starting in the outer north and moving 
to the centre of Canberra, then starting in the outer south and moving to the centre. 
This was done for convenience since a single interviewer was seeing all participants. 
To a certain extent there is a greater proportion of higher SES people in the inner 
suburbs and that may have meant that these people were seen in a different month 
than those in other suburbs, thus potentially biasing results for those markers that vary 
by season or month of collection. However, participants did not undertake the blood 
tests immediately they were seen and there was a large degree of crossover in the 
months in which people from the same suburb were seen and when the blood test was 
done. Measurement bias would have been present if certain SES groups were over 
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represented in any month of blood collection. However, analysis of SES for month of 
blood collection reveals that there is no statistically significant difference in SES 
group status (based on occupational status) or household income in participants 
having blood taken in different months. 
4.15.4 Self-report bias 
Self-report was used for all measures of the SES variables and the psychosocial 
variables. Self-report is always subject to bias and error.  
Exposure: SES was determined by a number of different variables, which were highly 
correlated. Occupation was coded on the basis of detailed job characteristics, 
allowing little opportunity for non-deliberate error. Educational attainment is 
generally completed in early adulthood and there is little reason to expect differential 
recall across the study sample. Income could be subject to exaggeration or 
minimization, however the high correlation with the other SES measures suggests this 
has not occurred to any great extent (see Results).  
 
Covariates: Self-report psychological scales were chosen that had proven temporal 
reliability. Smoking status is subject to inaccurate self-report, particularly in ex-
smokers [491] and may be a source of misclassification. Self-rated stress levels, 
number of friends, measures of social capital may be influenced by current or recent 
events and thus be unreliable indicators of the usual situation. There seems no reason 
to suspect that this misclassification would be differential. 
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4.16 Sample size considerations 
The sample size of 60 per group (five groups) was chosen to deliver 90% power to 
detect a slope of 0.08 mmol/l fibrinogen per step of a 5-point socioeconomic scale, 
using a two-sided significance test at the 5% level. This value is derived from 
Markowe (1985) who reported an average difference of 0.34mmol/l between three 
groups based on job stress [78]. This gives a total sample size of 300. In the 2001 
study, four groups of 75 persons were actually delineated, as occupational status 
separated more clearly into four, rather than five groups. 
4.17 Representativeness of the PATH sample 
Age-specific data from the 2001 Australian Census were used to compare the PATH 
and 2001 study populations to the general population of the Canberra/Queanbeyan 
region with respect to marital status, occupation, and employment status. 
 
Registered marital status: 
For the purposes of the comparison, those who stated in the PATH study that they 
were in a ‘de facto’ relationship were combined with the ‘never married’. The census 
data do not have a ‘de facto’ relationship category. For this age group it is likely that 
in the census those who describe a de facto relationship in the PATH study could 
describe themselves as “married”, “separated”, “divorced”, “widowed” or “never 
married”.  
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Table 4.1 Marital status – percentage of population in each group 
PATH-total: refers to the total PATH 40-44 years sample 
PATH-yes: refers to those in the PATH 40-44 years sample who expressed interest in 
participating in the Biomarkers Study 
 
 
Participants in the PATH study and the 2001 study are slightly more likely to be 
married than the general population of this region. There is a somewhat lower 
proportion of divorced people in both the PATH study and the 2001 study. If de facto 
relationships are included in the “never married” category, the proportions of never 
married are similar in the 2001 study, PATH study and Census data. 
 
Current occupation: 
 
The proportion of the population in each occupational group are very similar for the 
PATH study and the 2001 Census, but for males there is a much higher proportion of 
the population in the “Managers and Administrators” group in the PATH study, and 
slightly less in the “Intermediate Production and Transport workers” group. 
 Male Female 
 Census PATH - 
total 
PATH
-yes 
2001 
study 
Census PATH 
- total 
PATH 
- yes 
2001 
study 
Married 67.6 74.2 75.6 76.5 65.6 68.8 68.3 72.7 
Married 
+de facto 
 81.6 83.1 84.7  77.5 77.1 83.3 
Separated 4.9 3.5 3.7 7.1 5.9 5.8 6.3 4.5 
Divorced 9.6 5.5 4.9 3.5 14.0 9.0 8.8 7.5 
Widowed 0.3 0.5 0.5  1.1 0.3 1.0  
Never 
married 
17.5 8.9 7.8 4.7 13.4 6.7 6.7 4.5 
Never 
married + 
defacto 
 16.4 15.3 12.9  15.5 15.5 15.2 
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Table  4.2  Percentage in each occupational group  
 Male Female 
 
Census -
2001 
PATH -
total 
PATH -
yes 
Census 
- 2001
PATH - 
total 
PATH - 
yes 
Managers and Administrators 19.2 30.3 30.4 11.8 12.7 13.6 
Professionals 29.0 27.3 29.1 29.7 31.8 31.2 
Associate Professionals 16.1 18.3 19.1 14.4 17.4 17.3 
Tradespersons and Related 
Workers 12.6 10.2 9.2 1.5 1.1 0.9 
Advanced Clerical and Service 
Workers 0.6 0.7 0.5 6.0 5.8 5.7 
Intermediate Clerical, Sales and 
Service Workers 9.4 4.2 4.0 25.0 21.1 21.0 
Intermediate Production and 
Transport Workers 6.1 4.2 3.5 0.9 0.6 0.6 
Elementary Clerical, Sales and 
Service Workers 3.5 2.6 2.3 7.5 7.2 7.2 
Labourers and Related Workers 3.6 2.2 1.7 3.2 2.3 1.9 
Inadequately described 1.5 0.2 0.2 1.3 0.2 0.3 
Not stated 0.4 0.2 0 0.5 0.3 0 
 
PATH-total: refers to the total PATH 40-44 years sample 
PATH-yes: refers to those in the PATH 40-44 years sample who expressed interest in 
participating in the Biomarkers Study 
 
Current employment status: 
The 2001 census age group is 35-44 years and is compared to the PATH study 40-44 
years. 
Table 4.3  Percentage of sample by employment status 
 Male Female 
 Census 
- 2001 
PATH - 
total 
PATH-
yes 
Census - 
2001 
PATH - 
total 
PATH-
yes 
Employed full-
time 
73.7 89.0 91.2 41.5 52.3 53.8 
Employed part-
time 
11.3 5.6 4.6 32.2 32.6 32.6 
Unemployed 3.4 2.0 1.9 2.6 2.6 2.5 
Not in the labour 
force 
6.9 2.3 2.3 20.7 11.6 11.1 
 
PATH-total: refers to the total PATH 40-44 years sample 
PATH-yes: refers to those in the PATH 40-44 years sample who expressed interest in 
participating in the Biomarkers Study 
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More of the PATH participants are engaged in full-time work than in the Census data, 
for both males and females. Fewer males are engaged in part-time work, are 
‘unemployed’ or ‘not in the labour force’ in the PATH sample compared to the 
Census data. Fewer females are ‘not in the labour force’. Part-time workers and 
unemployed females are equally represented in the PATH sample and in the Census 
data. 
 
The PATH sample is reasonably representative of the Canberra-Queanbeyan 
population, although participants are more likely to be in the labour force, employed 
full time, be married and be managers or administrators. Similarly, the PATH-yes 
group is similar to the total PATH study sample on these parameters. The 2001 study 
sample is not designed to be representative of the Canberra Queanbeyan population – 
rather it is deliberately engineered to create equal numbers of participants in groups 
defined by SES. However, since within the cutoffs of occupational status chosen to 
delineate the SES groups in the 2001 study, the sample was randomly chosen, the 
participants should be representative of their SES group, at least as defined by 
occupational status. 
4.18 Response rates 
In the PATH study, 64.6% of eligible people agreed to participate and were 
interviewed (n = 2530). Of these, 2042 expressed interest in participating in the 
Biomarkers study. However, 794 people were ineligible for participation in the 
Biomarkers study due to poor health or changed residence status (moved out of area). 
This left a total study population of 1248 people. 
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In the pilot study, of 64 people contacted, 60 people agreed to participate – a response 
rate of 94%. Of these, 100% returned the questionnaire and had a saliva sample taken 
on two occasions. 100% had the first blood test and 59 out of 60 had two blood tests, 
three months apart (98%). One participant was found to have diabetes on blood 
testing and was subsequently excluded from the analysis. 
 
In the 2001 study a total of 349 possible participants were contacted but 24 of these 
were no longer eligible to participate, either because they had now moved out of area, 
or because they had now developed a major illness. Of the 325 who were eligible to 
participate, 302 were interviewed, a response rate of 93%. 
  
Of the 23 people who were eligible to participate in the 2001 study but who 
subsequently declined participation, 35% were in the lowest SES group, 35% in the 
next, 26% in the next and 4.3% in the highest SES group. While there is clearly a 
higher rate of failure to participate in lower SES groups, the total number declining to 
participate was small. In addition, randomly selected individuals from the same SES 
group replaced those declining participation, so that each SES group was equally 
represented in the final study sample. It is possible that those declining to participate 
were systematically different from those participating, but the numbers are low and 
this is unlikely to bias the results.   
 
Of those who consented to participate in the 2001 study, 96% completed and returned 
the first questionnaire, 94% completed and returned the second questionnaire, 95% of 
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participants completed the blood sampling and saliva samples were obtained from 
100% of participants. However, two saliva samples were unable to be analyzed as the 
tubes broke during storage (99.3% of samples available for analysis). 
 
 
The preceding sections have outlined in detail the recruitment process and the 
collection, management and manipulation of the data in preparation for specific 
analyses to test the study hypotheses. The following chapter outlines and presents the 
results of that analysis. 
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Chapter 5. 
Results 
5.1 Introduction 
In this chapter, I firstly examine (in section 5.2) the various measures of 
socioeconomic status and the associations between them. The detail of the actual and 
derived measurements is outlined in Chapter 4. Previous studies have noted the high 
correlation between various measures of SES, but this is not absolute, and different 
measures may provide information on different aspects of the concept of SES. Thus, 
education is usually gained as a young person and may partly reflect childhood and 
early adulthood SES more than income and occupation which may be more purely a 
measure of current SES. Accommodation and cars are used as measures of wealth – 
cumulative, rather than current, SES, while subjective measures of SES are relatively 
new, based on the theory of the importance of relative, rather than absolute SES in the 
determination of health. 
 
My first hypothesis states that psychosocial factors vary by socioeconomic status. The 
psychosocial hypothesis suggests that such variation is at least partially causative of 
the socioeconomic variation in ill-health. Yet few studies have specifically 
investigated whether such a co-variation occurs in the general population. A wide 
range of social and psychological factors was measured in this study, and their 
variation by SES is outlined. There is ample evidence that various behavioural 
practices differ by SES. For example, smoking and low levels of physical activity are 
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more common in lower SES groups. Such associations are also examined in this study 
population. 
 
Kelly et al suggest that one necessary requirement of a biological marker of the 
association between SES and health is that it should be stable over time [154]. That 
is, a single measurement reflects the usual level of the marker; the level of the marker 
is not highly variable so that any single measurement is not subject to wide day-to-
day fluctuations. In section 5.4 this is specifically examined using the results from the 
pilot study, where blood and saliva samples were collected on two occasions, three 
months apart. 
 
Biological systems are interconnected and the psychosocial hypothesis as well as the 
wide range of health conditions that have an SES gradient, suggest that 
socioeconomic status may somehow cause a general susceptibility to ill-health. 
Previous research suggests that stressor exposure may have effects on the immune 
[461, 462], endocrine [158], and metabolic systems [265], so that parallel variations 
in markers of several different body systems might be expected. Bivariate correlations 
between the measured markers are explored in section 5.5. 
 
In section 5.6, I examine each marker in turn, to look at the variation of the measured 
biological markers with the various measures of socioeconomic status (SES). The 
literature shows that mortality and morbidity vary by SES for most measures of both. 
This thesis investigates the period before morbidity might occur – the participants in 
this study were all healthy, with self-rated health “good”, “very good” or “excellent". 
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My second hypothesis is that there is a socioeconomic gradient of increasingly 
adverse biological profile (as indicated by these biological markers) in healthy adults. 
The bivariate associations between each marker and the measured behavioural and 
psychosocial variables are also explored to provide background for the subsequent 
mediation and multiple regression analysis.  
 
My third hypothesis states that the socioeconomic variations in the biological 
variables are mediated by psychosocial factors. The mediating role of both 
behavioural and psychosocial variables on the association between each marker and 
each measure of SES is thus explored using mediation analysis. Finally, multiple 
regression models are constructed to examine the concurrent effects of 
socioeconomic, behavioural and psychosocial variables. Although this is a cross-
sectional study and no causal inferences can be drawn, the models examine the 
relative (independent) contributions of various factors to the variation in each 
biomarker. 
 
Table 5.1 presents a brief outline of some of the socioeconomic characteristics of the 
study participants (total of pilot and 2001 study). 
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Table 5.1. Socioeconomic characteristics of study participants. 
 Male N (%) Female N (%) All N (%) 
Personal income ($ per 
week) 
 
<500 17      (8.9) 56    (36.4) 73    (21.2) 
500-999 55      (28.9) 42    (27.3) 97    (28.2) 
1000-1499 66      (34.7) 36    (23.4) 102  (29.7) 
1500-1999 29      (15.3) 14    (9.1) 43    (12.5) 
≥ 2000 23      (12.1) 6      (3.9) 29    (8.4) 
Total 190    154 344 
Household income ($ per 
week) 
   
<1000 35    (18.6) 27     (17.2) 62     (18.0) 
1000-1999 76    (40.4) 71     (45.2) 147   (42.6) 
2000-2999 56    (29.8) 39     (24.8) 95     (27.5) 
≥3000 21   (11.2) 20    (12.7) 41    (11.9) 
Total 188 157 345 
Occupational status    
<24 56   (28.0) 36   (22.4) 92  (25.5) 
≥24and <50 42   (21.0) 48   (29.8) 90  (24.9) 
≥51and <70 41   (20.5) 40   (24.8) 81  (22.4) 
≥70 61   (30.5) 37   (23.0) 98  (27.2) 
Total 200 161 361 
5.2 Correlation of socioeconomic variables 
Table 5.2 presents the Pearson and Spearman correlation coefficients for different 
measures of current and childhood socioeconomic status. Pearson correlation 
coefficients are given for continuous variables, while Spearman’s rho is calculated for 
ordinal categorical variables.  
 
Most measures of SES in this study are highly inter-correlated. The correlation of 
equivalent income and household income, and of occupational status and occupation 
are clearly the result of one being derived from the other. There is, however, a strong 
correlation between occupational and income variables, between education and 
income variables and between occupation and education variables. Interestingly, the 
correlation between current income and occupational variables is generally higher 
 243
than between either of these and education. Education, in turn, correlates more highly 
with elements of childhood SES (parental occupation and education) than do 
measures of current personal SES (occupation and income). This supports the notion 
that education carries an element of childhood and early adult SES since most 
education is obtained in these periods of life. 
 
Accommodation type has a relatively low, but statistically significant correlation with 
income and occupational variables, and only a marginally statistically significant 
association with education. Notably 85.4% of participants owned their own 
accommodation (compared to 66.0% in the Census 2001 for this region) with 9.7% in 
rental accommodation (21.5% in the Census) and 3.1% in government housing (8.0% 
in Census 2001). The remaining 1.7% were in some other type of accommodation 
(living with relatives, house-sitting etc). Accommodation type thus provides little 
variation compared to other measures of SES. 
 
The number of cars in the household is poorly correlated with most other measures of 
SES. As noted in Chapter 4, number of cars in the household may be more related to 
household composition than SES in this study sample. In fact, the number of cars may 
represent a reverse measure of SES, since those who married younger and had larger 
families would now (in their forties) have teenage families. Those who married later 
or delayed childbearing (more common in higher SES groups) may now have only 
young children and no more than two cars. In addition, not having a car may not be a 
measure of low SES and hardship – rather it may be a lifestyle decision, by educated  
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Table 5.2 Correlation between socioeconomic variables  - Female below diagonal; male above diagonal 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1. Equivalent income  1.000 0.57* 0.65* 0.16 0.49* 0.38# 0.41* 0.47* 0.44* -0.09 0.11 0.09 0.06 0.20 0.68* 
2. Personal income 0.62* 1.000 0.78* 0.15 0.64* 0.52# 0.47* 0.55* 0.47* 0.05 0.22# 0.22# 0.20# 0.26 0.74* 
3. Household income 0.68* 0.54* 1.000 0.27 0.68* 0.40# 0.48* 0.53* 0.56* 0.20# 0.29# 0.10 0.13 0.27 0.76* 
4. Perceived position in 
community 
0.17  0.03 0.17† 1.000 0.47* 0.12 0.23 0.24 0.27 0.03 0.06 0.11 0.13 0.14 0.26 
5. Perceived position in 
Australia 
0.45* 0.44* 0.49* 0.47* 1.000 0.41# 0.50* 0.54* 0.50* 0.08 0.26# 0.19 0.23# 0.22 0.67* 
6. Education level 0.40# 0.49# 0.34# 0.32# 0.42# 1.000 0.58# 0.64# 0.62# 0.10 0.11 0.28# 0.34# 0.42# 0.73# 
7. Occupational code 0.52* 0.54* 0.50* 0.21 0.35† 0.59# 1.000 0.85* 0.78* 0.16 0.25# 0.12 0.20# 0.30† 0.85* 
8. Occupational status 0.50* 0.56* 0.50* 0.21 0.45* 0.64# 0.89* 1.000 0.91* -0.11 0.20# 0.19# 0.28# 0.33† 0.91* 
9. Household 
occupational status 
0.46* 0.47* 0.62* 0.25 0.44* 0.56# 0.72* 0.81* 1.000 -0.07 0.21# 0.18 0.26# 0.32† 0.89* 
10. Number of cars 0.03 0.05 0.27# 0.09 0.06 0.06 0.03 0.04 -0.02 1.000 0.03 -0.05 -0.07 -0.06 -0.07 
11. Accommodation type 0.36# 0.25# 0.41# 0.11 0.30# 0.19 0.28# 0.30# 0.35# 0.18 1.000 -0.10 0.00 0.10 0.24# 
12. Mother’s education 0.13 0.04 0.10 0.13 0.11 0.20 0.17 0.17 0.12 -0.15 -0.11 1.000 0.54# 0.31# 0.19# 
13. Father’s education 0.18 0.08 0.20 0.08 0.14 0.15 0.16 0.18 0.15 -0.09 0.01 0.47# 1.000 0.47# 0.26# 
14. Father’s occupational 
status 
0.16 0.22 0.24 0.10 0.16 0.33# 0.32# 0.33* 0.35* -0.06 0.11 0.35# 0.44# 1.000 0.37* 
15. Composite SES 0.73* 0.74* 0.74* 0.25 0.56* 0.72# 0.87* 0.90* 0.85* -0.01 0.39# 0.17 0.18 0.36† 1.000 
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inner city couples who have little need for a car (close proximity to work and shopping 
and no children) and are conscious of the environmental effects of cars (lack of physical 
exercise, air and noise pollution).  
 
Such an interpretation is given added weight by inspection of the correlation matrix. 
Number of cars has a weak (non-significant) positive correlation with increasing SES for 
most measures. However there is a negative correlation with education, occupation and 
occupational status. In addition, although there is a weak positive correlation with 
personal income and particularly household income, when household income is adjusted 
for number of people in the household, the correlation becomes negative, i.e. those with 
higher equivalent income have fewer cars. The stronger correlation between household 
income and number of cars may reflect a larger household, rather than higher SES. 
 
Perceived position in the community also correlates poorly with the more objective 
measures of SES (income, occupation, education). Possibly participants interpreted this 
“position” as something other than an SES position, e.g. general status, being well-
thought of, or participating in the community.  
 
By contrast, perceived position in Australia has a much higher correlation with education, 
occupational and income variables. This is perhaps a reflection of the perception that 
Canberrans are well-off compared to the rest of Australia - even those who do not 
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consider themselves particularly well-off within their own Canberra community, perceive 
that, compared to the rest of Australia, they are higher up the SES ladder. 
 
Measures of parental socioeconomic status have a high intercorrelation, but a weaker 
correlation with measures of current SES. There is a modest correlation between father’s 
occupational status and the participant’s household income and occupational status. 
Parents’ educational achievement has a statistically significant correlation with 
participant’s education and current occupational level. 
5.3 Socioeconomic variation of psychosocial, behavioural, 
biological and health factors 
5.3.1 Psychosocial factors 
In correlation analyses, the composite SES factor showed a strong negative correlation 
with a sense of economic strain (r = -0.44, p<0.001), and a high positive correlation with 
job demands (r = 0.45, p<0.001) and job control (skill discretion r = 0.50, p<0.001; 
decision authority r = 0.37, p<0.001).  
 
Weaker, but statistically significant (at p<0.05), correlations existed with positive, active 
coping style (r = 0.28), sense of optimism (r = 0.24), social capital (r = 0.26), job security 
(r = 0.17), job marketability (r = 0.16), number of hours worked per week (r = 0.35), 
sense of belonging (r = 0.22), total number of adverse life events (r = -0.13), and positive 
interaction with friends and family (r = 0.20).  
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Thus, with higher SES there is a greater sense of the ease with which participants could 
get a job at the same pay level and hours as their current job. Higher SES is also 
associated with greater number of hours worked per week as well as increased job 
demands, job control and job security. Lower SES persons in this sample are less 
optimistic, use less positive and active coping styles, have a weaker sense of belonging to 
their community and had more major life events. 
 
Anxiety, depression and personality variables such as neuroticism, psychoticism, 
hostility, extroversion, locus of control and ruminative style did not have a statistically 
significant correlation with SES in this study sample. In addition there was no statistically 
significant correlation between SES (as measured by this composite factor) and negative 
interaction with family and friends, self-esteem, perceived stress or mental health as 
assessed by the SF-12.  
 
Separate analyses by gender indicated that the magnitude and direction of effect was 
similar for men and women (see Table 5.3). 
5.3.2 Biological and health variables 
Using the composite SES factor, there was a weak but statistically significant correlation 
between lower SES and poorer self-rated health (Spearman’s rho = 0.13), and physical 
health as assessed by the SF-12 (r = 0.11). This pattern is stronger in males than females. 
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Table 5.3 Socioeconomic variation of psychosocial factors  
Variable  Male Female Overall 
Economic strain  r = -0.50  r = -0.40 r = -0.44;     p <0.001  
Job demands r = 0.43 r = 0.45 r = 0.45;      p <0.001  
Job control r = 0.24 r = 0.28 r = 0.26;      p <0.001 
Skill discretion r = 0.39 r = 0.60 r = 0.50;      p <0.001  
Decision Authority r = 0.26 r = 0.46 r = 0.37;      p <0.001  
Active coping r = 0.35 r = 0.25 r = 0.28;      p <0.001 
Passive coping  r = -0.21   r = 0.004 r = -0.13;     p = 0.02 
Sense of optimism r = 0.20 r = 0.28 r = 0.24;      p <0.001 
Social capital* r = 0.23  r = -0.29 r = 0.26;      p <0.001 
Job security* r = 0.15 r = 0.20 r = 0.17;      p =0.002 
Job marketability*  r = -0.20  r = -0.10 r = -0.16;     p =0.005 
Work hours/week r = 0.23 r = 0.47 r = 0.35;      p <0.001 
Sense of belonging r = 0.19 r = 0.26 r = 0.22;      p <0.001 
Life events  r = -0.21  r = -0.04 r = -0.13;     p =0.01 
Positive interaction r = 0.16 r = 0.25 r = 0.20;      p <0.001 
BAS reward r = 0.07 r = 0.12 r = 0.08;      p = 0.19 
BAS drive r = 0.09 r = 0.16 r = 0.14;      p = 0.02 
BAS fun  r = -0.03 r = 0.09 r = 0.04;      p = 0.47 
Anxiety r = 0.06 r = 0.01 r = 0.03;      p = 0.55 
Depression  r = -0.07   r = -0.03 r = -0.06;      p = 0.25 
Neuroticism r = 0.02  r = -0.09 r = -0.04;     p = 0.50 
Psychoticism  r = -0.08 r = 0.06 r = 0.01;      p = 0.81 
Hostility  r = -0.08   r = -0.18 r = -0.12;     p = 0.05 
Extroversion    r = -0.004 r = 0.15 r = 0.06;      p = 0.33 
Ruminative style  r = -0.09 r = 0.02 r = -0.05;       p = 0.38 
Negative interaction r = 0.03 r = 0.01 r = 0.02;       p = 0.69 
Self esteem r = 0.08 r = 0.04 r = 0.07;       p = 0.25 
Perceived stress  r = -0.03  r = -0.03 r = -0.04;      p = 0.53 
Mental health  r = -0.06    r = -0.002 r = -0.03;     p = 0.56 
* Spearman’s rho 
 
 
There was no correlation between weight and SES in men, but a weak correlation in 
women (r =-0.17). Of the biological measures, there was no statistically significant 
correlation between SES and diastolic blood pressure (r = -0.03) or systolic blood 
pressure (r = -0.03) in either sex. In men there was a weak SES correlation with serum 
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cholesterol (r = -0.16), but there was no significant SES correlation in either sex with 
serum triglycerides (r = -0.03), serum HDL cholesterol (r = -0.01), serum LDL 
cholesterol (r = -0.07). These findings are summarized in Table 5.4. 
Table 5.4 Socioeconomic variation of biological and health variables 
 Male Female Overall 
Physical health  r = 0.20 r = 0.01 r = 0.11;       p = 0.05
Self rated health* r = 0.14 r = 0.14 r = 0.13;       p = 0.02
Diastolic BP r = -0.02 r = -0.12 r = -0.03;     p = 0.60 
Systolic BP r = -0.06 r = -0.09 r = -0.03;     p = 0.52 
Cholesterol r = -0.16 r = -0.05 r = -0.09;     p = 0.11 
Triglycerides r = -0.14 r = -0.03 r = -0.03;     p = 0.65 
HDL cholesterol r = -0.06 r = 0.14 r = -0.01;     p = 0.80 
LDL cholesterol r = -0.08 r = -0.14 r = -0.07;     p = 0.20 
BMI r = 0.00 r = -0.24 r = -0.10;      p = 0.07 
Weight r = 0.02 r = -0.17 r =0.009;     p = 0.87 
 * Spearman’s rho 
5.3.3 Behavioural measures  
The association between SES and mild or moderate physical activity was not statistically 
significant, but there was a statistically significant positive correlation in men with the 
frequency of vigorous physical activity (r = 0.21, p = 0.004). Alcohol consumption was 
significantly correlated with SES in men and women (r = 0.30, p<0.001). Note that the 
item measuring frequency of consuming alcohol measured the range from “Not in the last 
year”, to “four or more times a week”; higher SES is associated with a level of alcohol 
intake that most people would consider healthy (less than a glass of wine with dinner 
each night) rather than excessive. In addition there was a statistically significant negative 
correlation with current smoking status in men (r = -0.34, p<0.001). These findings are 
summarized in Table 5.5. 
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Table 5.5 Socioeconomic variation of behavioural variables  
 Male Female Overall 
Physical activity r = -0.21 r = -0.21 r = -0.19;   p < 0.001 
Freq mild phys. activity* r = 0.04 r = -0.01 r = 0.02;     p = 0.68 
Freq mod phys. activity * r = 0.14 r = 0.05 r = -0.05;    p = 0.33 
Freq vig phys. activity * r = 0.21 r = -0.09 r = -0.16;    p = 0.002 
Alcohol intake* r = 0.25 r = 0.35 r = 0.30;     p < 0.001 
Smoking status* r = -0.34 r = -0.14 r = -0.25;    p < 0.001 
(*Spearman’s rho) 
5.4  Temporal stability of biomarkers (pilot study) 
Intraclass correlation was performed for biological measures sampled on two occasions, 
three months apart (n = 59): 
Table 5.6. Intraclass correlations for biological measures. 
 Intraclass correlation 95% Confidence interval 
Fibrinogen 0.32 0.09-0.55 
HbA1c 0.86 0.79-0.92 
Salivary IgA 0.35 0.13-0.58 
Neopterin 0.41 0.20-0.62 
Cholesterol 0.82 0.74-0.90 
Triglycerides 0.84 0.77-0.92 
Fasting glucose 0.86 0.80-0.93 
HDL cholesterol 0.90 0.85-0.95 
LDL cholesterol 0.79 0.69-0.88 
5.4.1 Fibrinogen 
The intraclass correlation (ICC) for plasma fibrinogen measured at two time points three 
months apart was low at 0.32 (95% CI 0.09-0.55). Further investigation was undertaken 
to examine whether this low ICC was due to blood collections being taken at different 
times of the year, for different participants. Previous research has suggested that 
fibrinogen levels tend to be higher in blood collected in late winter/early spring [213]. 
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The first blood samples were collected from participants in the pilot study from July to 
October (winter to spring), with second collections from November to January (summer). 
Figure 5.1a suggests lower fibrinogen levels at the second collection than the first, with 
the low ICC relating to the increase in fibrinogen from first collection to second 
collection for a few participants, while for most participants, fibrinogen decreased 
between the first and second collections. 
Figure 5.1a Fibrinogen level by collection time. 
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In a regression model with “change in fibrinogen”, (fibrinogen (time1) – fibrinogen 
(time2), since plasma fibrinogen is generally higher at time1 than time2) as the dependent 
variable and the month of the first blood collection as the explanatory variable there was 
a significant difference in “change in fibrinogen” according to the month of first blood 
collection, with blood first collected in July and August showing a higher mean change 
than that first collected in September and October (July 0.48, August 0.52, September 
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0.11, October 0.07). Inclusion of month of second collection and number of months 
between collections did not improve the model. Thus, blood collected in July and August 
tends to have higher levels of plasma fibrinogen than that collected in other months and 
the difference in month of first blood collection may account for part of the poor 
temporal stability. 
 
Standardization of fibrinogen levels to the mean (by subtracting the mean for each month 
from each sample taken in that month) for each collection month resulted in a small 
improvement of the ICC to 0.41 (95% CI 0.19-0.62). Figure 5.1b presents standardised 
plasma fibrinogen at each time point. 
Figure 5.1b Standardised fibrinogen by collection time 
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When plasma fibrinogen levels for the 2001 study were analysed by month of blood 
collection, there was an apparent pattern over one year: 
Figure 5.2. Mean and 95% confidence intervals of log plasma fibrinogen by month of blood 
collection (2001, using a cubic spline smoother).  
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In the 2001 study data, there appears to be a winter peak in values and perhaps a smaller 
mid-summer peak, with lowest levels in spring. Summary statistics for plasma fibrinogen 
by month are presented in Table 5.7.  
 
  254
Table 5.7. Plasma fibrinogen by month of blood collection (2001 study and pilot study) 
 2001 study Pilot study 
 Male Female Male Female 
 n Median 
(range) 
n Median 
(range) 
n Median 
(range) 
n Median 
(range) 
Jan 11 2.4 
(2.0-2.8) 
6 2.35 
(1.5-3.5) 
2 2.3 
(2.2-2.4) 
3 4.3 
(2.8-4.8) 
Feb 9 2.3 
(1.6-2.6) 
5 2.7 
(2.3-3.0) 
3 3.0 
(2.6-3.5) 
3 3.1 
(2.3-4.1) 
Mar 1 1.8 2 2.0 
(1.8-2.2) 
1 2.5 1 2.6 
Apr 2 2.0 
(1.7-2.3) 
2 2.6 
(2.3-2.9) 
    
May 1 2.8 3 2.2 
(2.1-2.3) 
    
Jun 12 2.3 
(1.9-3.9) 
8 2.15 
(1.9-2.6) 
    
Jul 6 2.5 
(2.0-2.9) 
3 2.5 
(2.1-2.8) 
6 3.5   
(3.4-3.9) 
3 3.8 
(3.3-3.9) 
Aug 22 2.55 
(1.7-4.7) 
15 2.1 
(1.1-4.1) 
17 3.5 
(2.5-5.5) 
16 3.6 
(2.6-5.4) 
Sep 12 2.3 
(1.8-2.6) 
13 2.4 
(1.7-3.9) 
7 2.9 
(2.5-4.2) 
8 3.0 
(2.6-3.6) 
Oct 24 2.2 
(1.3-3.3) 
31 2.4 
(1.2-4.2) 
5 3.0 
(2.7-3.2) 
4 2.9 
(2.8-3.5) 
Nov 36 2.1 
(1.7-4.0) 
23 2.4 
(1.6-3.1) 
11 3.0 
(2.7-3.7) 
16 3.3 
(2.3-4.0) 
Dec 18 2.3 
(1.9-3.2) 
14 2.55 
(1.2-3.9) 
10 2.75 
(2.3-4.3) 
6 3.4 
(2.8-4.0) 
 
Plasma fibrinogen varied significantly according to the month in which blood was 
collected with no significant difference in this variation between males and females. 
Month of blood collection was retained in subsequent analyses to adjust for this effect. 
 
In addition, plasma fibrinogen differed by which laboratory analysed the blood sample, 
with those in the pilot study having statistically significantly higher fibrinogen levels for 
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each month, in each gender. For this reason, the remainder of the analysis for plasma 
fibrinogen was carried out separately for the pilot study and the 2001 study. 
5.4.2 Glycated Haemoglobin 
The intraclass correlation for glycated haemoglobin values collected on two occasions 
three months apart was high at 0.86 (95% CI 0.79-0.92). Despite this, there was a 
significant variation in levels of glycated haemoglobin depending on the month of blood 
collection, with a peak in May/June and lowest levels in February/March. This has been 
previously noted by Schuck who observed a peak in the northern hemisphere in February 
and a nadir in August [244]. 
Figure 5.3.  Variation in blood glycated haemoglobin by month of blood collection (mean ± 
SE mean, cubic spline smoothing curve) 
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In addition, there was a statistically significant difference between measured levels of 
glycated haemoglobin in the pilot study and in the 2001 study. The two sets of samples 
were collected and analysed by two different pathology providers and those in the pilot 
study were significantly higher than those in the 2001 study (pilot: median = 5.8; range = 
5.05-6.8; 2001 study: median = 4.6; range = 3.6-5.9). Indeed the quoted normal range is 
wider from the initial pathology provider (4.3-6.4% compared to (2001 study) 4.5-6.0%). 
Variability between laboratories is a recognised problem with measurement of glycated 
haemoglobin [242]. The difference between the two samples could not be accounted for 
by month of blood collection, or any systematic difference in the participants in the two 
samples. The remainder of the analysis is undertaken only on the 2001 study sample in 
view of the small sample size of the pilot study. 
5.4.3 Waist-hip ratio 
WHR was considered to be a stable measure and was not measured on two occasions in 
the pilot study. A substantial change in WHR over a three-month period is unlikely. 
5.4.4 Neopterin 
The intraclass correlation for neopterin samples collected three months apart was rather 
low at 0.41 (95% CI 0.20-0.62). Neopterin is degraded by exposure to natural light and 
specimens must be collected and stored in light protected tubes. At the commencement of 
the pilot study, this was overlooked and several specimens were collected without light 
protection. However, it is natural, rather than artificial light that has been shown to break 
down neopterin and all samples were collected indoors in a blood-collecting centre. 
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Immediately after collection the samples were refrigerated and then stored in a -20º C 
freezer, both of which are darkened. 
 
If lack of light protection had indeed caused a breakdown of neopterin, the non-light 
protected specimens would be expected to have a lower level of neopterin than the light 
protected specimens. In particular, it seems likely that in comparison with their pair (from 
the same participant) we would expect the neopterin levels of all the non-light protected 
samples to be lower than their pairs. However, this was not the case. Figure 5.4 shows 
that the difference in neopterin levels between specimens from two different collection 
times, where one specimen was not light protected, was relatively evenly distributed 
around zero. This lack of a consistent direction to the difference between the samples of a 
pair suggests that the lack of light protection has made little difference to the neopterin 
levels of the specimens.  
 
In addition, two samples were recorded by the laboratory as being haemolysed. In these 
two samples, there was a consistent positive difference between the haemolysed sample 
and the non-haemolysed sample. This may indicate release of cellular neopterin to the 
serum and these results were dropped from further analysis. 
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Figure 5.4. Difference in serum neopterin between pairs where one is not light protected. 
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Note: The x-axis is the difference in the serum neopterin level between the light protected sample 
and the non-light protected sample. 
 
The intraclass correlation, excluding these two haemolysed samples (but including the 
non-light protected samples) was 0.39 (95% CI 0.17-0.6).  
 
The neopterin results included in the main part of the analysis are the averaged neopterin 
level in each pair, except those in which one sample was haemolysed. For these 
participants, only the value of the non-haemolysed sample was used. 
 
There is no significant variation in the difference between neopterin levels in the two 
samples, depending on the month of blood collection in the pilot study. However, there is 
statistically significant variation in serum neopterin levels by month of blood collection 
Fraction 
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in the 2001 study, with lowest levels in late winter. Month of blood collection is included 
in subsequent models. 
Figure 5.5  Serum neopterin by month of blood collection. (Bars are mean ±SE mean 
connected by a cubic spline smoother, calculated for the transformed, normalized variable, then 
converted to neopterin values)  
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5.4.5 Salivary IgA 
The intraclass correlation for salivary IgA measured at two time points, three months 
apart is low, at 0.35 (95% CI 0.13-0.58). Salivary IgA samples are sensitive to repeated 
thawing and refreezing as saliva contains proteolytic enzymes that destroy the antibody. 
In the early stages of the analysis of the samples, seventeen samples (out of a total of 
420) were subjected to thawing during sample preparation and dilution. Note was taken 
of these specimen numbers. 
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Examination was made of the difference in salivary IgA levels between samples, where 
one sample of a pair (from the same person at different times) had been thawed. If 
thawing and subsequent proteolysis had occurred, the thawed specimen would be 
expected to have a lower IgA concentration than the undamaged specimen. If thawing 
had no effect, we might expect some specimens to have lower IgA levels than their pairs 
and some to have higher (note: it was not always the first or the second sample which had 
been thawed, rather it was random). 
 
In all of the samples in which one of the pair had been repeatedly thawed, the thawed 
sample had a lower IgA value than the non-thawed pair. The differences ranged from 
41.1mg/ml to 1058.6 mg/ml. This suggests that the thawing process had indeed damaged 
these samples and the measured level was probably not accurate. When these pairs were 
omitted from the analysis, the ICC improved to 0.64 (95% CI 0.41-0.86).  
 
The concentration of salivary IgA showed no seasonal variation in this study population 
and there is no difference in the change in IgA concentration depending on the month of 
initial or final saliva collection. Research indicates that salivary IgA concentration peaks 
on awakening, falls steeply over the next four hours, and then levels flatten out and 
remain relatively stable over the day [389]. Efforts were made to avoid this diurnal 
rhythm by not collecting samples early in the morning and recording the time of sample 
collection. In addition, all samples were collected two hours post-prandially to 
standardise collection in relation to food intake. In this study sample, there was no 
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significant variation in salivary IgA concentration related to time of collection of the 
sample, and no significant difference in concentration between samples collected before 
10am and those collected after 10am. 
 
For those participants from the pilot study where there were two valid IgA measurements, 
these are averaged and included in the main analysis. For those pilot participants where 
one specimen had been repeatedly thawed, only the IgA concentration of the unaffected 
specimen was included. In addition, there were five participants for whom both saliva 
specimens had undergone repeated thawing – these results were dropped from the IgA 
analysis.  
 
The normal range for salivary IgA in non-fasting adults is 10-105 mg/L; fasting adults 
20-500 mg/L, although this range was established using a slightly different ELISA 
technique. Several of the results in this study were much higher than these normal ranges, 
e.g. 2000 mg/L. It is possible that these participants were developing upper respiratory 
infections with consequent elevation of salivary IgA levels. Subsequent analyses were 
repeated after dropping extreme values (greater than two standard deviations from the 
mean) but with no alteration of the results. 
5.5 Correlation between the biomarkers. 
It might be expected that there would be a high correlation between these markers, all of 
which were chosen on the basis of their probable association with activation of the 
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neuroendocrine stress response. However, they are representatives of different body 
systems and it is clear that despite biological connections between such systems, 
covariation is not absolute. 
 
A correlation matrix using Pearson correlation and transformed markers (Table 5.8, 
presented here by the marker name) indicates the markers are generally not significantly 
correlated.  
Table 5.8. Correlation matrix for biomarkers – male in lower half; female in upper half 
(italics). 
 
 Fibrinogen Waist-hip 
ratio 
Salivary IgA Neopterin Glycated 
haemoglobin 
Fibrinogen 
 
1.000 0.39 
p = 0.0001 
0.046 
p = 1.000 
0.17 
p = 1.000 
0.29 
p = 0.01 
Waist-hip 
ratio 
0.13 
p = 1.000 
1.000 -0.02 
p = 1.000 
0.04 
p = 1.000 
0.27 
p = 0.02 
Salivary IgA 0.02 
p = 1.000 
0.15 
p = 0.34 1.000 
0.12 
p = 1.000 
-0.09 
p = 1.000 
Neopterin 
 
0.05 
p = 1.000 
0.03 
p = 1.000 
0.07 
p = 1.000 1.000 
-0.014 
p = 1.000 
Glycated 
haemoglobin 
0.23 
p = 0.04 
-0.08 
p = 1.000 
0.12 
p = 1.000 
0.02 
p = 1.000 
1.000 
 
Bonferroni correction applied 
5.6 Variation of biological markers 
The remainder of this chapter focuses on the analysis of the variation in each biological 
marker. Bivariate analysis of each marker and the range of socioeconomic, behavioural, 
psychosocial, work and health variables is considered. The various measures of SES were 
grouped according to different facets of socioeconomic status. Thus measures of income 
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included personal income, total household income and calculated (adjusted for number of 
individuals in the household) equivalent income. Occupational measures included 
personal occupational level (derived from the ASCO II coding system) and derived 
personal occupational status and the highest occupational status of any individual in the 
household (household occupational status). A single variable measured the highest 
educational achievement attained by the participant (coded to the ASCED). The type of 
current accommodation and the total number of cars in the household were used as 
measures of wealth. Perceived SES consisted of perceived position in the community and 
perceived position in Australia. Composite SES refers to the variable derived from 
principal components analysis of all of the SES measures. 
 
There are significant correlations between different SES measures, but each marker was 
tested separately against each facet of SES to examine the particular association of each 
to marker variability. 
 
Following bivariate analysis of associations with SES, each marker was considered in 
relation to each of the psychosocial, behavioural, biological and health variables, grouped 
in the following way: 
• Behavioural variables included alcohol intake, several measures of physical activity, 
smoking status and number of cigarettes smoked per week. 
• Strain variables included measures of economic strain or financial hardship, perceived 
stress (two measures), household responsibility, and total number of recent life events. 
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• Psychosocial variables included measures of social capital, friendship and pet 
ownership, as well as the two summary personality variables (see Methods, section 4.12), 
two summary coping factors and measures of depression and anxiety. 
• Childhood circumstances were measured by using a number of measures of parental 
SES when the participant was aged 12 years (education, occupation and occupational 
status), as well as the summary measure of childhood adversity.  
• Biological variables included serum cholesterol, serum HDL cholesterol, serum LDL 
cholesterol, serum triglycerides, and serum fasting glucose. Health variables included 
self-rated health, weight and body mass index and status with respect to medications 
taken. 
• Work variables included measures of job demands and control, as well as the individual 
elements of job control, skill discretion and decision authority, and a summary job strain 
variable (based on the Karasek model [467]). The statistical analysis also examined 
associations with the number of hours worked per week, amount of time off work in the 
last month, and employment status, as well as measures examining the level of job 
security, likelihood of being able to obtain similar level work if this job was lost and the 
extent to which the participant felt that the rewards associated with the job were fair. 
 
Although the problem of multiple comparisons is recognised when such a large number 
of bivariate analyses are conducted, no Bonferroni correction was applied. This means 
that some of the apparently statistically significant results may be spurious and simply 
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due to chance. However, these analyses were performed only to guide the model building 
process and to explore possible associations within the data. 
 
Following the bivariate analyses, mediation analysis was used to examine the third 
hypothesis, i.e. psychosocial factors mediate the association between measures of SES 
and the biological markers. This analysis was carried out on variables grouped as above – 
behavioural and psychosocial variables, childhood circumstances, health/biological 
variables, and work variables, to examine which of the elements within these groups had 
the most important mediating role in the relationship between measures of SES and the 
markers. While it is recognized that several of the markers had no statistically significant 
association with several of the SES measures, it is possible to have positive and negative 
mediating effects from intermediate variables, that ‘cancel each other out’ so that the net 
effect is non-significant, even though significant mediation is occurring [489]. In view of 
the problems outlined in section 4.14.1, I have presented significant mediating effects 
rather than the proportion of total effect mediated. 
 
Finally multiple regression models were constructed to examine both the interplay of 
socioeconomic measures with behavioural, psychosocial, work and health measures and 
the relative strength of the independent associations of each of these variables, with each 
marker (by comparing standardised beta coefficients as variables are measured in a range 
of different units). 
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This was undertaken in several steps. First a model was created using the marker as the 
dependent variable and measures of socioeconomic status as the explanatory variables. 
Since the determinants of the markers seemed to be quite different for men and women, 
the analyses were conducted separately by gender. All indices of SES were entered in the 
model, and then removed in order of the highest on ‘p’ values, checking after each 
removal with likelihood ratios as to whether the removal caused a significant change in 
the model. Once the final model of the marker and measures of SES was developed, the 
remaining explanatory variables were entered in groups – behavioural variables, 
psychosocial variables, biological measures, work variables etc. With each group of 
explanatory variables, those with p values of greater than 0.2 were removed from the 
model, using likelihood ratios to ensure the model suffered no significant loss of 
explanatory power. When all variables had been entered into the model, a final model 
was developed which explained the maximum variance using the least number of 
explanatory variables. Following this, variables identified by literature review as being 
important to include in the model were re-entered and the model fit re-examined 
repeatedly. The SES variables from the original model were retained in order to examine 
the strength of their independent effects, as were possible confounders identified from the 
literature or suggested by the bivariate analyses. 
5.6.1 Fibrinogen 
Fibrinogen is measured in grams/litre with a normal range of 1.5-4.0 g/L. The median 
(range) in the 2001 sample was 2.3 (1.1-4.7) g/L. 
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Log transformation was used to normalize the skewed distribution of values of plasma 
fibrinogen, (skewness = 1.10, transformed skewness = 0.18). 
Figure 5.6.  Transformation of plasma fibrinogen 
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 Variation with SES 
There were statistically significant correlations only between log plasma fibrinogen and 
number of cars in the household for males, and occupational SES measures for females. 
However, at least in women, there appears to be a trend to a negative association between 
SES and plasma fibrinogen for almost all SES variables, i.e. plasma fibrinogen tends to 
be lower in those with higher SES. Childhood SES, as measured by father’s occupational 
status and the composite SES measure also show statistically significant associations with 
plasma fibrinogen level of female participants. 
 
These bivariate analyses indicate likely gender differences in the socioeconomic 
determinants of plasma fibrinogen in this sample, so that the remainder of the analysis 
was performed with groups separated by gender. Similar trends were seen between SES 
variables and plasma fibrinogen levels in the pilot data, but these were not significant. 
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Due to the small sample size of the pilot study, no further analyses were performed on 
those data. 
Table 5.9. Correlation of log fibrinogen with different measures of socioeconomic status 
 Males Females 
 r p r p 
Personal income 
 
-0.01 0.87 -0.07 0.47 
Household income 
 
-0.08 0.32 -0.15 0.09 
Equivalent household income 
 
0.03 0.69 -0.17 0.05 
Occupational level 
 
0.05 0.56 -0.18 0.04 
Personal occupational status 
 
0.04 0.64 -0.23 0.009 
Household occupational status 
 
-0.01 0.90 -0.22 0.02 
Educational attainment 
 
-0.01 0.90 -0.09 0.31 
Accommodation type 
 
-0.06 0.48 -0.08 0.36 
Number of cars in household 
 
-0.26 0.001 -0.02 0.84 
Perceived position in 
community 
 
-0.02 0.76 -0.003 0.97 
Perceived position in Australia 
 
-0.03 0.75 -0.07 0.41 
Mother’s educational level 
 
-0.10 0.21 -0.05 0.60 
Father’s educational level 
 
0.008 0.92 -0.18 0.05 
Father’s occupational level 
 
-0.06 0.44 -0.12 0.18 
Father’s occupational status 
 
-0.04 0.65 -0.21 0.009 
Childhood household 
occupational status 
-0.08 0.32 -0.27 0.004 
Composite SES -0.08 0.30 -0.26 0.002 
 
Note: all SES measures have been recoded so that higher values denote higher SES. 
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 Variation with other measures 
Behavioural risk factors: Increasing frequency of alcohol intake had a statistically 
significant association with decreasing levels of plasma fibrinogen in men and women (p 
= 0.03, p = 0.005 respectively). Number of cigarettes per week had a weakly statistically 
significant positive association with plasma fibrinogen in men (p = 0.04). While there 
was no statistically significant association between any level of physical activity and 
plasma fibrinogen in this sample, the negative association with vigorous activity was of 
borderline significance in males (p = 0.05). 
 
Strain variables: Economic strain, particularly in females, was positively associated 
with plasma fibrinogen (p = 0.04, p = 0.02 for two different economic strain measures). 
However, there was no statistically significant association between plasma fibrinogen and 
any measure of perceived stress, life events or household responsibility in either gender. 
 
Psychosocial variables: There was a negative, statistically significant association 
between negative coping and plasma fibrinogen in women (r = -0.22, p = 0.01), but no 
other statistically significant associations with any personality measure, social capital, 
social support, depression or anxiety. 
 
Biological and health variables: Weight and body mass index in women had positive 
and statistically significant associations with plasma fibrinogen (p = <0.0001 in both 
cases). In men, increased body mass index and lower levels of HDL cholesterol were 
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associated with higher levels of plasma fibrinogen (p = -0.02, p = 0.004 respectively). 
There were no statistically significant associations between plasma fibrinogen and other 
biological measures or self-rated health, and the positive association between diastolic 
blood pressure and plasma fibrinogen just failed to reach statistical significance (p = 
0.05). 
 
Work factors: In men there was a positive, statistically significant association between 
plasma fibrinogen and skill discretion (p <0.001), but no statistically significant 
association between other measures of job control, work demands or job strain and 
plasma fibrinogen in either sex. Sense of job fairness had a statistically significant 
positive association with plasma fibrinogen in women.  
 
In bivariate analysis, the correlates of plasma fibrinogen levels in this study appear 
similar to those described elsewhere (see section 3.8). Smoking, lack of exercise, elevated 
diastolic blood pressure, decreased serum HDL cholesterol and increased body mass 
index and weight are common risk factors associated with both elevated levels of 
fibrinogen and cardiovascular disease. Other associations, such as those with measures of 
work conditions have been found by others [78] and implicated causally with increased 
risk of cardiovascular disease. The positive association between levels of plasma 
fibrinogen and measures of perceived economic strain has not been reported elsewhere to 
my knowledge.  
  271
 Mediation analysis 
Tables 5.10 to 5.19 summarise the results of mediation analysis examining the 
association between plasma fibrinogen levels and elements of SES. Although each 
measure of SES was analysed separately, and there were non-significant bivariate 
correlations with most SES measures, the mediators of different elements of SES are very 
similar. Thus job control, number of hours worked per week, perceived economic strain, 
smoking, physical activity, alcohol intake, use of active coping styles and perceived 
stress are common threads throughout this analysis. In addition father’s occupational 
status contributes significantly to the association between plasma fibrinogen and SES. 
Income: 
 
Table 5.10. Statistically significant mediators of the association between plasma fibrinogen 
levels and personal income. 
 
 Males Females 
Current smoking p<0.001 ns 
Moderate physical activity ns p = 0.03 
Frequency of alcohol intake ns p = 0.01 
Economic strain p<0.001 ns 
Household responsibility p = 0.022 ns 
Perceived stress p = 0.018 ns 
Active coping p = 0.008 ns 
Father’s occupational status p = 0.024 ns 
Job control p <0.001 ns 
Hours worked per week p <0.001 p <0.001 
Skill discretion ns p = 0.001 
Decision authority p = 0.005 ns 
Positive interaction with friends and 
family 
ns p = 0.024 
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Household income:  
 
Table 5.11. Statistically significant mediators of the association between plasma fibrinogen 
levels and household income. 
 
 Males Females 
Current smoking  p<0.001 ns 
Frequency of alcohol intake p = 0.01 p<0.001 
Economic strain  p<0.001 p = 0.002 
Active coping  p = 0.010 ns 
Sense of belonging and trust in others  p = 0.009 ns 
Father’s occupational status p = 0.033 ns 
Job control  p <0.001 p = 0.010 
Hours worked per week  p = 0.004 p = 0.012 
Decision authority  p = 0.002 ns 
High job control, high work demands  p<0.001 p = 0.032 
Positive interaction with friends and 
family 
 p = 0.023 ns 
 
 
 
Equivalent income:  
 
Table 5.12. Statistically significant mediators of the association between plasma fibrinogen 
levels and household equivalent income. 
 
 Males Females 
Frequency of alcohol intake p = 0.014 p = 0.014 
Economic strain p<0.001 p = 0.005 
Household responsibility ns p = 0.005 
Perceived stress p = 0.040 ns 
Decision authority ns p = 0.018 
Job control p = 0.013 p<0.001 
Sense of job fairness ns p = 0.007 
Number of hours worked per week p<0.001 p<0.001 
High job control, high work demands p = 0.027 p = 0.044 
Glycated haemoglobin ns p = 0.029 
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Occupational level:  
 
Table 5.13. Statistically significant mediators of the association between plasma fibrinogen 
levels and personal occupational level. 
 
 Males Females 
Current smoking p = 0.003 ns 
Frequency of alcohol intake ns p = 0.043 
Economic strain p<0.001 p = 0.015 
Active coping p = 0.004 ns 
Social capital 1 ns p = 0.045 
Highest parental occupational 
status 
p = 0.004 p = 0.019 
Skill discretion p<0.001 ns 
Job control p <0.001 p = 0.002 
Number of hours worked per 
week 
ns p = 0.026 
High job control, high work 
demands 
p = 0.048 p = 0.012 
Fasting glucose ns p = 0.035 
Glycated haemoglobin ns p = 0.012 
 
 
 
Occupational status:  
 
Table 5.14. Statistically significant mediators of the association between plasma fibrinogen 
levels and personal occupational status. 
 
 Males Females 
Current smoking p<0.001 ns 
Economic strain p<0.001 p = 0.010 
Active coping p = 0.004 ns 
Sense of belonging and trust in others ns p = 0.026 
Highest parental occupational status p = 0.002 p = 0.020 
Father’s education p = 0.010 ns 
Mother’s education ns p = 0.028 
Work demands ns p = 0.011 
Job control p <0.001 ns 
Number of hours worked per week ns p = 0.027 
High job control, high work demands p = 0.048 p = 0.003 
Fasting glucose ns p = 0.009 
Glycated haemoglobin ns p = 0.021 
Body mass index ns p = 0.006 
Waist-hip ratio p = 0.010 ns 
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Household occupational status:  
 
Table 5.15. Statistically significant mediators of the association between plasma fibrinogen 
levels and household occupational status. 
 
 Males Females 
Current smoking p<0.001 ns 
Economic strain p<0.001 p = 0.003 
Active coping p = 0.016 ns 
Sense of belonging and trust in others ns p = 0.026 
Father’s occupational status p = 0.004 p = 0.014 
Father’s education p = 0.012 ns 
Mother’s education ns p = 0.021 
Work demands ns p<0.001 
Job control p = 0.003 p = 0.005 
Skill discretion P<0.001 ns 
High job control, high work demands ns p = 0.001 
Positive interaction with friends and 
family 
p = 0.023 ns 
Body mass index ns p = 0.005 
Waist-hip ratio p = 0.037 ns 
 
 
Educational level:  
 
Table 5.16. Statistically significant mediators of the association between plasma fibrinogen 
levels and highest attained education of participant. 
 
 Males Females 
Highest parental occupational status p = 0.037 ns 
Father’s occupational status p = 0.030 ns 
Time set aside for relaxation ns p = 0.025 
 
 
Accommodation type: None of the measured variables provided significant mediation of 
the association between accommodation type and plasma fibrinogen. 
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Number of cars in the household: Only economic strain had a significant mediating 
effect in the association between plasma fibrinogen and number of cars in the household, 
and only in women. 
Community ladder:  
Table 5.17. Statistically significant mediators of the association between plasma fibrinogen 
levels and perceived position in the community. 
 
 
 
Perceived position in Australia:  
Table 5.18. Statistically significant mediators of the association between plasma fibrinogen 
levels and perceived position in Australia. 
 
 Males Females 
Current smoking status p = 0.009 ns 
Economic strain p<0.001 p = 0.002 
Active coping p = 0.001 ns 
Social capital - trust ns p = 0.008 
Sense of belonging and trust in others p = 0.025 p = 0.011 
Depression p = 0.016 ns 
Positive interaction with family and friends p = 0.059 p = 0.017 
Decision authority p = 0.001 ns 
Number of hours worked per week p = 0.001  
Job control p <0.001 p<0.001 
Combination of high job control and high work 
demands 
p = 0.026 p = 0.002 
Fasting serum glucose ns p = 0.030 
 Males Females 
Economic strain p = 0.021 p = 0.033 
Total serious life events p = 0.002 ns 
Active coping p = 0.005 ns 
Sense of belonging and trust in others p = 0.008 p = 0.046 
Depression p = 0.020 ns 
Anxiety p = 0.009 ns 
Positive personality (high self-esteem, 
optimism etc) 
p = 0.001 ns 
Positive interaction with family and 
friends 
ns p = 0.044 
Decision authority p = 0.007 ns 
Job control p = 0.001 p = 0.006 
Table 5.19a Summary of significant mediation between SES and plasma fibrinogen (X p<0.001) 
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Mediating variables 
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Current smoking X X X  X  X  X 
Moderate phys. 
activity 
         
Freq alcohol intake     X X    
Economic strain X X X  X X X X X 
Household 
responsibility 
X         
Perceived stress X     X    
Life events        X  
Depression        X X 
Anxiety        X  
Positive personality        X  
Active coping X X X  X X  X X 
Positive interaction      X  X   
Belonging     X   X X 
Social capital          
Work demands          
Job control X X X  X X X X X 
Hours worked per 
week 
X    X X   X 
Skill discretion  X     X   
Decision authority X    X X  X X 
High control, high 
demands 
 X X  X X   X 
Job fairness          
Relaxation time          
Parental occ. Status  X X X      
Father's occ. status  X   X X  X   
Father's education   X    X   
Mother's education          
Glycated haemoglobin          
Fasting glucose          
BMI          
Waist-hip ratio   X    X   
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Table 5.19b Summary of significant mediation between SES and plasma fibrinogen 
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Mediating variables 
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Current smoking          
Moderate phys. 
activity 
X         
Freq alcohol intake X X   X X    
Economic strain  X X  X X X X X 
Household 
responsibility 
     X    
Perceived stress          
Life events          
Depression          
Anxiety          
Positive personality          
Active coping          
Positive interaction  X       X X 
Belonging   X    X X X 
Social capital  X       X 
Work demands   X    X   
Job control  X X  X X X X X 
Hours worked per 
week 
X X X  X X    
Skill discretion X         
Decision authority      X    
High control, high 
demands 
 X X  X X X  X 
Job fairness      X    
Relaxation time    X      
Parental occ. Status  X X       
Father's occ. status        X   
Father's education          
Mother's education   X    X   
Glycated haemoglobin  X X   X    
Fasting glucose  X X      X 
BMI   X    X   
Waist-hip ratio          
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Tables 5.19a and b suggest that mediation by psychosocial factors is more important for 
men than women. Smoking, economic strain and work factors are most important in men, 
and work factors in women. In men, mediation occurs for both individual and household 
measures of SES, while for women the few significant mediation effects occur 
principally in household measures of SES. 
Multiple regression analysis  
In males, the simple model using only SES variables consisted only of the dependent 
variable, log fibrinogen, and number of cars in the household as the explanatory variable. 
The full model also contained active coping style, frequency of physical activity, 
smoking status, work demands, skill discretion, number of hours worked per week, sense 
of job fairness, diastolic blood pressure and HDL cholesterol. This model explained 36% 
of the variation in log fibrinogen (p<0.0001). The largest standardised beta coefficient 
was for having any cars, compared to no car (one car, beta = -0.70, two cars, beta = -
0.86). However, only two male participants had no car, so this result may be misleading. 
Vigorous physical activity (beta = -0.40), skill discretion (beta = 0.36), depression (beta = 
0.30), anxiety (beta = -0.29), diastolic blood pressure (beta = 0.27), HDL cholesterol 
(beta = -0.25) and being a smoker (beta = -0.20), also had important independent effects 
on plasma fibrinogen levels in men. Note that although there was no statistically 
significant association between plasma fibrinogen and depression or anxiety in univariate 
analysis, these variables have strong effects in the regression model, but in opposite 
directions. Although depression and anxiety should be distinct, the Goldberg scale may 
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not be distinguishing clearly between them and the equal magnitude but opposite sign 
suggests that in this analysis, they are collinear. 
 
In females, the simple model included log fibrinogen as the dependent variable and 
income, household status and equivalent income as the SES explanatory variables. The 
full model included frequency of alcohol intake, job security, father’s occupational level, 
ownership of a pet, body mass index, serum cholesterol, HDL cholesterol, serum 
triglycerides, LDL cholesterol and marital status (specifically never having been married, 
compared to currently being married). This model accounted for 43.8% of the variation in 
plasma fibrinogen (p<0.0001). The strongest independent associations with plasma 
fibrinogen were for total cholesterol (beta = -4.25), LDL cholesterol (beta = 3.48), HDL 
cholesterol (beta = -1.63), triglycerides (beta = 1.45), and BMI (beta = -0.75). Of the SES 
variables, household status (beta = -0.29) had the strongest association with plasma 
fibrinogen, but this was relatively weak compared to the association with serum lipids 
and body mass index. 
5.6.2 Glycated haemoglobin  
Glycated haemoglobin (HbA1c) is measured as a percent of haemoglobin that is glycated, 
with a normal range of 4.5-6.0 %. The median (range) in the 2001 study sample was 
4.6% (3.6% - 5.9 %). In the 2001 study population there was a non-normal distribution 
(skewness = 0.26). Transformation by taking the natural log resulted in a relatively 
normal distribution (skewness = -0.03). 
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Figure  5.7 Transformation of glycated haemoglobin 
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 Variation with SES 
Table 5.20. Variation of glycated haemoglobin with measures of SES 
 Males Females 
 r p r p 
Personal income -0.05 0.55 -0.10 0.27 
Household income -0.11 0.18 -0.15 0.09 
Equivalent household income 0.03 0.75 -0.22 0.01 
Occupational level -0.09 0.27 -0.24 0.008 
Personal occupational status -0.09 0.25 -0.24 0.008 
Household occupational status -0.14 0.09 -0.14 0.12 
Educational attainment -0.12 0.13 -0.19 0.03 
Accommodation type -0.07 0.42 -0.03 0.74 
Number of cars in household -0.14 0.09 0.02 0.86 
Perceived position in community -0.07 0.38 0.01 0.89 
Perceived position in Australia -0.18 0.03 -0.04 0.68 
Mother’s educational level -0.13 0.12 -0.05 0.61 
Father’s educational level -0.03 0.69 -0.02 0.82 
Father’s occupational level 0.07 0.41 -0.06 0.50 
Father’s occupational status -0.13 0.11 -0.13 0.15 
Childhood household occupational status -0.16 0.06 -0.12 0.20 
Composite SES -0.11 0.17 -0.23 0.01 
 
 
For men, the only statistically significant association between levels of glycated 
haemoglobin and any measure of SES, was with perceived position in Australia, although 
the general trend was to a negative association (lower levels of glycated haemoglobin 
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with higher SES). Due to the number of comparisons this single significant association 
may be due to chance rather than a genuine association. 
 
In women, there were statistically significant associations with equivalent household 
income, personal occupational measures and education. Most SES measures showed a 
negative association with glycated haemoglobin. Elevated levels of glycated haemoglobin 
are a reflection of past elevations of serum glucose and lack of control of blood glucose 
levels. While none of the current participants had abnormal levels of glycated 
haemoglobin, lower SES tends to be associated with less favourable levels of glycated 
haemoglobin. 
 Variation with other measures 
Behavioural variables: There were no statistically significant associations between 
glycated haemoglobin levels and alcohol intake, or mild, moderate or vigorous physical 
activity. For males only, current smokers had significantly higher levels of glycated 
haemoglobin than did non-smokers (p = 0.01) and there was a positive and significant 
association with the number of cigarettes smoked per week (p = 0.007). 
 
Strain variables: Economic strain in males and financial hardship in females were 
associated with higher levels of glycated haemoglobin (p = 0.03, p = 0.03 respectively). 
However, there was no statistically significant association of glycated haemoglobin levels 
with any measure of self-rated stress, household responsibility or number of serious 
recent life events.  
  282
 
Psychosocial variables: In males, active coping showed a statistically significant 
negative association with levels of glycated haemoglobin in males (p = 0.0002) while 
depression and anxiety were both positively associated with levels of glycated 
haemoglobin in women (p = 0.04, p = 0.02 respectively). There was no association with 
measures of personality, or any measures of social capital or number of friends. Positive 
interaction with family and friends was associated with decreasing levels of glycated 
haemoglobin and negative interaction with increasing glycated haemoglobin in males (p 
= 0.02, p = 0.03 respectively). 
 
Biological variables: As expected in view of its close association with serum glucose 
levels, there was a statistically significant positive association between levels of glycated 
haemoglobin and fasting serum glucose in males and females (p = 0.01, p = <0.0001 
respectively). For women, but not men, there was a statistically significant positive 
association between glycated haemoglobin levels and weight (p = 0.02) and body mass 
index (p = 0.03). Serum lipids (total cholesterol, triglycerides, HDL and LDL cholesterol) 
were not statistically significantly associated with glycated haemoglobin in this study 
sample. 
  
Work variables: Within the variables examining working conditions only measures of 
job control (skill discretion: males r = -0.24, p = 0.004, females r = -0.23, p = 0.01) and 
number of hours worked per week (r = -0.19, p = 0.02, males only) were significantly 
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associated with blood levels of glycated haemoglobin. In particular, the association with 
work demands and the summary measures of job strain were not statistically significant.  
 Mediation analysis 
Tables 5.21 and 5.22 summarize the results of the mediation analysis for glycated 
haemoglobin. 
Table 5.21. Mediating variables in the association of glycated haemoglobin and SES. 
 
 Males Females 
 Mediating variable p Mediating variable p 
Personal income Active coping 0.01 None  
Household income Active coping 0.01 None  
Equivalent household 
income 
Number of hours 
worked per week 
0.047 None  
Occupational level Active coping 0.01 None  
Personal occupational 
status 
Active coping 0.02 Fasting blood glucose 0.036 
Household occupational 
status 
Active coping 0.02 None   
Educational attainment None  None  
Accommodation type None  None  
Number of cars in 
household 
None  None  
Perceived position in 
community 
Active coping 0.005 None  
Perceived position in 
Australia 
Active coping 
Job control 
0.007 
0.036 
Fasting blood glucose 0.046 
 
 
None of the measured psychosocial or behavioural variables provided statistically 
significant mediation of the association between glycated haemoglobin and any measure 
of SES in females. For males, work variables, but particularly having an active coping 
style, provided important mediation in this association.  
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Table 5.22. Summary of the significant mediation in the association between measures of 
SES and glycated haemoglobin 
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Active coping X X X  X  X X X 
          
Job control         X 
Hours worked per 
week 
     X    
fasting glucose          
          
Female          
Active coping          
          
Job control          
Hours worked per 
week 
         
Fasting glucose   X      X 
 
 Multiple regression analysis 
The multiple regression model of SES and glycated haemoglobin for males, contained 
only perceived position in Australia (p = 0.01, Adj R2 = 0.03). The full model contained 
mother’s education, child adversity, positive personality, financial problems, self-rated 
health, skill discretion, job security, number of hours worked per week, positive 
interaction with family or friends, salivary IgA, fasting glucose, weight and body mass 
index. This model accounted for 28% of the variation in glycated haemoglobin (p = 
0.0001). The strongest associations with glycated haemoglobin in this model are with 
body mass index (beta = -0.57), weight (beta = 0.47), fasting blood glucose (beta = 0.26), 
positive social support (beta = -0.24), salivary IgA (beta = 0.22) and job security (beta = -
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0.33 for “extremely secure” compared to “not at all secure”). In this model, perceived 
position in Australia had a non-significant association with glycated haemoglobin (beta = 
0.08, p = 0.43). (Body mass index and weight are collinear, but the model explains 
significantly less of the variation in log glycated haemoglobin if either is excluded). 
 
In women, the simple model included only occupational level. While bivariate 
correlations suggested that equivalent income, education and occupational status had a 
statistically significant association with glycated haemoglobin levels, a model containing 
only occupation provided the best fit (p = 0.008, Adj R2 = 0.05). A full model, testing all 
biological, psychosocial and behavioural variables contained diastolic blood pressure, 
waist-hip ratio, fasting glucose, negative coping style, anxiety and number of friends. 
This model explained 27% of the variation in log HbA1c (p<0.0001). Anxiety (beta = 
0.34), fasting glucose (beta = 0.23), and WHR (beta = 0.20) showed the strongest 
independent associations, but the association with occupational level remained 
statistically significant (beta = 0.18, p = 0.04).  
5.6.3 Waist-hip ratio  
Waist-hip ratio (WHR) had an approximately normal distribution, and was therefore not 
transformed. The “normal” range varies by age and sex, but in an Australian study of 40-
44 year old adults, the mean and standard deviation were: men 0.89 (SD 0.05); women 
0.76 (SD 0.05). In the Biomarkers Study, the mean WHR in men was 0.90 (SD 0.06, 
range 0.77-1.08) and in women 0.76 (SD 0.05, range 0.66-0.88). 
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 Variation with SES 
Table 5.23. Correlation of waist-hip ratio with measures of SES. 
 
 
The associations between waist-hip ratio and socioeconomic status (Table 5.23) were 
stronger for males than females in this study sample. There were particularly strong 
associations with measures of occupational level and educational attainment and with 
measures of childhood socioeconomic status. The apparent association of WHR with 
perceived socioeconomic position could be influenced by reverse causation – those with 
high waist-hip ratio could view themselves less favourably because of their body shape 
and thus score themselves poorly on this measure. In general the trend is to higher waist-
hip ratio with lower SES, on almost all measures of current and childhood SES. 
 Males Females 
 r p r p 
Personal income -0.12 0.13 -0.11 0.22 
Household income -0.16 0.045 -0.03 0.73 
Equivalent household income -0.11 0.15 -0.12 0.18 
Occupational level -0.26 0.0008 -0.19 0.03 
Personal occupational status -0.26 0.0006 -0.22 0.01 
Household occupational status -0.22 0.004 -0.12 0.17 
Educational attainment -0.24 0.002 -0.20 0.02 
Accommodation type -0.03 0.66 0.07 0.41 
Number of cars in household 0.04 0.58 0.04 0.65 
Perceived position in 
community 
-0.14 0.08 -0.02 0.80 
Perceived position in Australia -0.19 0.02 0.07 0.44 
Mother’s educational level -0.14 0.09 -0.18 0.047 
Father’s educational level -0.18 0.02 -0.15 0.09 
Father’s occupational level -0.15 0.06 -0.23 0.01 
Father’s occupational status -0.22 0.004 -0.12 0.17 
Childhood household 
occupational status 
-0.26 0.001 -0.28 0.002 
Composite SES -0.27 0.0007 -0.19 0.03 
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 Variation with other measures 
Behavioural variables: Waist-hip ratio showed no statistically significant association 
with frequency of alcohol intake, smoking status, number of cigarettes per week or mild 
physical activity in men or women. However, moderate and vigorous physical activity 
were associated with decreased waist-hip ratio in men but not in women (p = 0.006, p = 
0.001 for moderate and vigorous activity, respectively).  
 
Strain measures: There were no statistically significant associations between any 
measure of economic strain, perceived stress or number of life events and waist-hip ratio. 
 
Psychosocial factors: WHR was not statistically significantly associated with any 
personality variables, coping factors, depression, anxiety, social capital or social support. 
 
Childhood circumstances: There was a weakly significant positive association between 
WHR and childhood adversity in women (p = 0.04). 
 
Biological and health variables: WHR had negative, statistically significant associations 
with self-rated health (p<0.0001), and physical health (as assessed in the SF-12, p = 
0.006), and positive, statistically significant associations with fasting glucose (p<0.0001) 
and systolic blood pressure (p = 0.0003) in men only. In addition, there were statistically 
significant positive associations between WHR and diastolic blood pressure (men: p = 
0.0001, women: p = 0.006), serum cholesterol (men: p = 0.02, women: p = 0.0015), body 
mass index (men: p<0.0001, women: p<0.0001) and weight (p<0.0001, p<0.0001) in men 
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and women. There was a negative, statistically significant association with HDL 
cholesterol (men: p<0.0001, women: p<0.0001). LDL cholesterol showed a statistically 
significant positive association with WHR in women only (p = 0.0001).  
 
Work-related variables: There was no statistically significant association with 
employment status, job demands, decision authority, job security, job marketability, job 
fairness, total number of hours worked per week, the amount of relaxation time available 
or the summary variable of job control. However, the association between WHR and skill 
discretion was statistically significant for men (r = -0.21, p = 0.004) and women (r = -
0.26, p = 0.002) as was the combination of low job control and high job demands in men 
(p = 0.01; higher WHR compared to those with high control/high demand jobs). 
 Mediation analysis 
Tables 5.24 and 5.25 summarize the results of the mediation analysis for WHR and SES. 
 
Table 5.24  Mediating variables in the association between WHR and SES. 
 Males Females 
 Mediating 
variable 
p Mediating 
variable 
p 
Personal income None  Skill discretion 0.071 
Household income None  Skill discretion 0.075 
Equivalent household income None  Skill discretion 0.058 
Occupational level None  None  
Personal occupational status None  Body mass index 0.027 
Household occupational status Job marketability 0.064 Body mass index 
Skill discretion 
0.038 
0.066 
Educational attainment None  None  
Accommodation type None  None  
Number of cars in household None  None  
Perceived position in 
community 
Depression 
Anxiety 
0.022 
0.042 
None   
Perceived position in Australia Depression 
Active coping 
style 
0.02 
0.07 
Social capital  0.062 
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Although there appears to be a strong negative association between WHR and SES, there 
was little evidence of significant mediation by any of the measured behavioural or 
psychosocial variables. WHR and BMI are strongly correlated (r = 0.46, p<0.0001) and 
may be subject to similar causal influences, rather than BMI being on the causal pathway 
between WHR and SES. BMI is a measure of body fatness, whereas WHR is a measure 
of fat distribution. Other influences may operate to control the site of deposition of 
increasing body mass, producing variations in WHR. However, although the review of 
physiology suggests that psychosocial influences may guide the site of fat deposition, 
there is no suggestion of important mediation by these factors in this study. There is no 
evidence of mediation by any psychosocial variable in the association between BMI and 
WHR. 
Table 5.25. Summary of significant mediation between SES and WHR 
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Depression        X X 
Anxiety        X  
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Females          
Depression          
Anxiety          
          
BMI   X    X   
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 Multiple regression analysis 
Males: in the simple model, only personal occupational status remained in the model (p = 
0.0001, Adj R2 = 0.07). The full model, including the SES term consisted of body mass 
index, self rated health (good compared to excellent), job marketability (with a trend 
from not at all difficult to extremely difficult), active coping, diastolic blood pressure and 
job strain (high control, low demands) (p<0.0001, Adj R2 = 0.57). The strongest 
associations were with BMI (beta = 0.51), personal occupational status (beta = -0.29), 
self rated health (beta = 0.25, for good compared to excellent health), diastolic blood 
pressure (beta = 0.18), and active coping (beta = -0.11). Those in high control/low 
demand work had significantly lower WHR (beta = -0.17) than any other combination of 
demands and control (and there were no significant differences between the other 
combinations). BMI alone explained much of the variation in WHR (p<0.0001, Adj R2 = 
0.397 in the model containing only WHR and BMI). 
 
Females: In the simple model, only occupational level was explanatory for the variation 
in WHR (p = 0.012, Adj R2 = 0.032). The full model included BMI, serum cholesterol, 
and serum HDL cholesterol in addition to occupational level (p<0.0001, Adj R2 0.38). On 
its own, BMI accounted for 24% of the variation in WHR. In the final model BMI had 
the strongest association with WHR (beta = 0.42), while total cholesterol (beta = 0.25) 
and HDL cholesterol (beta = -0.22) had associations of similar strength, but opposite 
direction.  
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5.6.4 Neopterin 
The normal reference range for serum neopterin is adults is 5.4 ± 2.3 nmol/L. The median 
(range) for serum neopterin in this study sample was 5.5 (2.9-15.4) nmol/L. 9.7% of 
values were greater than the 10nmol/L, which is similar to that found by Maes in a 
population sample of normal volunteers [357].  
 
Neopterin had a non-normal distribution (skewness = 2.78), which was transformed to a 
near-normal distribution using the reciprocal of the square root of neopterin (skewness = 
-0.84). 
 
Figure 5.8 Transformation of serum neopterin 
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 Variation with SES 
There was a general trend towards lower serum neopterin with higher SES. Effects 
appear to be stronger in women than in men, with the strongest associations for measures 
of current occupational status. Childhood socioeconomic situation and current income 
measures correlate poorly with neopterin levels in males and females.  
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Table 5.26. Correlation between serum neopterin and socioeconomic status. 
 
 Males Females 
 r p r p 
Personal income -0.05 0.49 -0.10 0.24
Household income -0.06 0.40 -0.09 0.24
Equivalent household income -0.05 0.47 -0.12 0.14
Occupational level -0.14 0.07 -0.12 0.12
Personal occupational status -0.02 0.82 -0.26 0.001
Household occupational status 0.008 0.92 -0.24 0.003
Educational attainment -0.04 0.57 -0.005 0.95
Accommodation type -0.04 0.60 0.08 0.35
Number of cars in household 0.10 0.16 -0.04 0.61
Perceived position in 
community 
0.04 0.59 -0.17 0.06 
Perceived position in Australia -0.05 0.57 -0.14 0.13 
Mother’s educational level 0.07 0.33 -0.06 0.46 
Father’s educational level 0.03 0.77 -0.13 0.12 
Father’s occupational level -0.06 0.47 -0.09 0.31 
Father’s occupational status 0.01 0.88 -0.11 0.18 
Childhood household 
occupational status 
0.02 0.80 -0.07 0.39 
Composite SES -0.04 0.56 -0.21 0.009 
 
 Variation with other measures 
Behavioural variables: No behavioural variables showed a statistically significant 
association with serum neopterin. 
 
Strain measures: There were marginally significant positive associations with economic 
strain in females (p = 0.03, p = 0.06) for two different measures of strain (increasing 
strain associated with increasing serum neopterin). However, serum neopterin levels were 
not statistically significantly associated with any measure of perceived stress, household 
responsibility or recent life events in this study sample. 
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Psychosocial variables: Serum neopterin had a negative, statistically significant 
association with levels of trust and a sense of belonging (r = 0.22, p = 0.006) in men, but 
was not statistically significantly associated with depression, anxiety, social support, 
marital status, number of friends or personality style, in this study sample.  
 
Biological variables: None of the measured biological variables had a statistically 
significant association with serum neopterin levels in males, apart from a negative 
association with HDL cholesterol (r = 0.16, p = 0.03). For women, serum neopterin had a 
negative and weakly statistically significant association with HDL cholesterol (r = 0.16, p 
= 0.04), but a stronger positive association with weight (r = 0.23, p = 0.004) and body 
mass index (r = 0.26, p = 0.003). 
 
Work-related variables: There were no statistically significant associations with any 
work variable for men or women, apart from a positive association with job strain (low 
control/high demands, p = 0.002; low control/low demands, p = 0.03 compared to high 
control/high demands) for women only. 
 Mediation analysis 
Even though the associations between SES and neopterin levels in bivariate analysis were 
weak, in mediation analysis there was a consistent pattern in which economic strain and 
number of cigarettes smoked per week were statistically significant mediators of the 
association between serum neopterin and SES in men. Economic strain was a positive 
mediator of this association, while the number of cigarettes smoked per week was a 
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negative mediator. Positive mediators are the route through which the explanatory 
variable has its effect on the dependent variable. On the other hand, negative mediators 
undermine this effect, so that increased cigarette smoking lessens the impact of SES on 
serum neopterin. Tables 5.27 and 5.28 summarize the results of the mediation analysis for 
serum neopterin. 
Table 5.27. Mediating variables in the association between serum neopterin and SES. 
 Males Females 
 Mediating variable p Mediating variable p 
Personal income Economic strain 
Low control, low 
demand work 
0.018 
0.045 
Number of hours 
worked per week 
0.010 
Household income Economic strain 0.019 Number of hours 
worked per week 
0.054 
Equivalent 
household income 
Economic strain 0.012 Number of hours 
worked per week 
0.045 
Occupational level Economic strain 
Cigarettes smoked per 
week 
0.011 
0.046 
Number of hours 
worked per week 
0.036 
Personal 
occupational status 
Economic strain 
Cigarettes smoked per 
week 
0.011 
0.055 
Number of hours 
worked per week 
0.047 
Household 
occupational status 
Economic strain 
Cigarettes smoked per 
week 
0.011 
0.050 
Low control, low 
demand work 
0.04 
Educational 
attainment 
None  None  
Accommodation 
type 
None  None  
Number of cars in 
household 
None  None  
Perceived position in 
community 
Economic strain 
Social capital 
0.038 
0.039 
None  
Perceived position in 
Australia 
Economic strain 
Job control 
Cigarettes smoked per 
week 
0.006 
0.028 
0.053 
Number of hours 
worked per week 
0.067 
 
Studies examining the effects of smoking on neopterin levels have shown contradictory 
results (see Section 3.11.6) and there was no significant bivariate correlation between 
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neopterin and smoking status in this sample. Some studies have however reported 
depression of neopterin levels in smokers – this would fit with a negative mediating 
effect of smoking on the inverse association between SES and neopterin levels. 
 
For women, only the number of hours worked per week provided significant mediation, 
particularly for the association between serum neopterin levels and income and 
occupational measures of SES. 
Table 5.28. Summary of significant mediation between SES and serum neopterin 
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Cigarettes per week  X X    X   
Economic strain          
Social capital        X  
Economic strain X X X  X X X X X 
Hours worked per week          
Job control         X 
Low control, low demands X         
          
Females          
Cigarettes per week  X        
Economic strain          
Social capital          
Economic strain          
Hours worked per week X  X  X X    
Job control          
Low control, low demands       X   
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 Multiple regression analysis 
Males: there was no statistically significant association of any SES variable or 
combination of SES variables with neopterin levels in this sample. A model constructed 
using the behavioural, psychosocial and biological variables contained only decision 
authority, weight, job security, time taken to relax in the last month and sense of job 
fairness (p = 0.005, Adj R2 = 0.09). Of these variables, the strongest association was for 
any level of job security (compared to “not at all secure”, beta = 0.38), and any level of 
relaxation time (compared to none, beta = 0.22). 
 
Females: The simple model, including only SES, terms included only personal 
occupational status and education (p = 0.0008, Adj R2 = 0.10). Higher levels of neopterin 
were associated with lower personal occupational status and lower SES as measured by 
educational level. The full model consisted of job strain (low control/high demands), 
BMI and vigorous physical activity (p<0.0001, Adj R2 = 0.23). Lower frequency of 
vigorous activity (beta = 0.32) and higher BMI (beta = -0.28) were associated with higher 
levels of neopterin (note that the signs refer to the association with the transformed 
variable and thus are in the opposite direction to the association with the non-transformed 
variable). Having low job control and high demands was associated with a higher level of 
neopterin than any other combination of job demands and control (beta = -0.22). 
Occupational status had a strong (negative) independent association with neopterin (beta 
= 0.32), as did having a postgraduate degree (lower neopterin), compared to having only 
a secondary education (beta = 0.44). 
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5.6.5 Salivary IgA  
The normal range for salivary IgA concentration in adults (fasting, non-stimulated) is 20-
500 mg/L. In this study the median (range) was 301.9 (33.4-2000) mg/L. 30.4% of 
samples fell outside the normal range. (Although this represents a high proportion of 
results outside the normal range, results were double-checked and are correct). 
The distribution of values of salivary IgA concentration was positively skewed (skewness 
= 1.76), but was normalized with a log transformation (skewness = -0.017). 
Figure 5.9 Transformation of salivary IgA 
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 Variation with SES 
The correlations of salivary IgA with measures of current SES were weak and 
inconsistent in direction, for both genders.  
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Table 5.29  Correlation between salivary IgA and SES 
 
  Males Females 
 r p r p 
Personal income -0.05 0.49 -0.14 0.10 
Household income -0.03 0.72 0.006 0.94 
Equivalent household income -0.02 0.80 0.03 0.74 
Occupational level 0.01 0.85 -0.03 0.72 
Personal occupational status 0.03 0.71 -0.06 0.49 
Household occupational status 0.01 0.88 -0.11 0.19 
Educational attainment -0.03 0.64 -0.19 0.02 
Accommodation type 0.0009 0.99 -0.07 0.41 
Number of cars in household -0.14 0.06 -0.08 0.32 
Perceived position in community 0.18 0.03 -0.14 0.11 
Perceived position in Australia 0.02 0.75 -0.20 0.03 
Mother’s educational level -0.10 0.17 0.11 0.19 
Father’s educational level -0.15 0.04 0.06 0.48 
Father’s occupational level -0.08 0.28 0.03 0.69 
Father’s occupational status -0.14 0.07 0.01 0.87 
Childhood household occupational 
status 
-0.13 0.09 0.06 0.45 
Composite SES 0.004 0.97 -0.07 0.38 
 
For males, the strongest associations were with measures of childhood SES with higher 
SES associated with lower levels of salivary IgA. A similar pattern was not seen in 
women. The only statistically significant association for women was with educational 
attainment (increasing education associated with decreasing sIgA concentration) – this is 
also a measure of child and early adult SES, rather than current SES. 
 Variation with other measures 
Behavioural variables: Salivary IgA concentration showed no statistically significant 
association with measures of alcohol intake, physical activity or smoking status. There 
was however, a statistically significant negative association with number of cigarettes 
smoked per week, for women only (r=-0.22, p = 0.006). 
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Strain measures: There were no statistically significant associations between salivary 
IgA concentration and any measure of economic strain, perceived stress, or total recent 
life events. 
 
Psychosocial variables: There were no statistically significant associations between 
salivary IgA concentration and any measures of personality, coping style, social capital or 
social support. 
 
Biological and health variables: No biological variables showed a significant 
association with salivary IgA levels in men in this sample. In women, salivary IgA 
concentration was positively and statistically significantly associated with diastolic blood 
pressure (r = 0.16, p = 0.04) and had a negative, statistically significant association with 
serum cholesterol (r = -0.17, p = 0.04), HDL cholesterol (r = -0.18, p = 0.03) and LDL 
cholesterol (r = -0.18, p = 0.03).  
 
Work-related variables: There was a positive, statistically significant association 
between salivary IgA concentration and job strain (low control, high demands compared 
to high control, high demand work) in men (p = 0.03) but not in women. Work variables 
had otherwise no statistically significant association with IgA concentration, as measured 
in the current study. 
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 Mediation analysis 
Tables 5.30 and 5.31 present the results of mediation analysis of the association between 
salivary IgA concentration and measures of socioeconomic status.  
 
In males, elements of the work environment provide significant mediation of the 
SES/biomarker association, despite the lack of a significant association between IgA 
concentration and SES in bivariate analysis. 
 
In females, only cigarette smoking provides any important mediating effect, but this 
generally fails to reach statistical significance. 
Table 5.30 Mediators of the association between salivary IgA and SES. 
 Males Females 
 Mediating variable p Mediating variable p 
Personal income High job control, 
high demands 
0.027 
None 
 
Household income High job control, 
high demands 
0.028 None  
Equivalent household income High job control, 
high demands 
Fasting glucose 
0.033 
 
0.058 
  
Occupational level High job control, 
high demands 
Job control  
Waist-hip ratio 
0.040 
 
0.066 
0.066 
Number of 
cigarettes per week 
0.077 
Personal occupational status High job control, 
high demands 
Job control 
0.037 
 
0.049 
Number of 
cigarettes per week 
0.079 
Household occupational 
status 
High job control, 
high demands 
Job control 
0.038 
 
0.036 
Number of 
cigarettes per week 
0.042 
Educational attainment None  None  
Accommodation type None  None  
Number of cars in household None  None  
Perceived position in 
community 
Vigorous physical 
activity 
0.051 None  
Perceived position in Australia None  None  
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Table 5.31. Summary of significant mediation between SES and salivary IgA 
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Vigorous activity          
High control, high 
demands 
X X X  X X X   
Job control   X    X   
Fasting glucose          
Waist hip ratio          
Cigarettes per week          
          
Females          
Vigorous activity          
High control, high 
demands 
         
Job control          
Fasting glucose          
Waist hip ratio          
Cigarettes per week       X   
 Multiple regression analysis 
Males: There was no statistically significant association with any SES variable or any 
combination of variables, for salivary IgA concentration. 
 
Females: The simple model for SES terms in women included income, household 
income, occupational level, highest occupational status in the household and number of 
cars in the household (p = 0.004, Adj R2 = 0.10). Notably, income, occupational level and 
household status have negative coefficients (increasing SES associated with decreasing 
IgA concentration) while household income has a positive coefficient (increasing SES 
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associated with increasing IgA concentration). Having one car compared to having no car 
is associated with a higher concentration of salivary IgA, but having two or more cars is 
associated with a lower IgA concentration. Income and household income are likely to be 
strongly collinear and perhaps the opposite signs reflect one making up for the inclusion 
of the other, but the model is significantly worse if neither is included, or if either one is 
excluded. Perhaps for women, having a low personal income is associated with a high 
concentration of salivary IgA, but the combination of low personal income in a home 
with high household income is particularly adverse to IgA levels.  
 
The full model included the SES measures already described as well as sense of job 
fairness (how fair the pay benefits and conditions are for the work done), number of 
cigarettes per week and systolic blood pressure. The final model was statistically 
significant (p<0.0001, Adj R2 = 0.23). Household occupational status had the strongest 
association with salivary IgA (beta = -0.42), while household income (beta = 0.26), 
income (beta = -0.19), occupational level (beta = 0.29), number of cigarettes per week 
(beta = -0.16) and systolic blood pressure (beta = 0.16) also showed statistically 
significant independent associations. 
5.7 Conclusion 
This chapter has presented the results of the Biomarkers Study and the analysis required 
to test the study hypotheses. It has explored some characteristics of the markers 
themselves to determine their suitability for use under Kelly et al’s criteria: their validity 
as stable markers of the physiological status of various body systems; their associations 
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with behavioural, psychosocial and other biological measures and their variation with 
SES. 
 
In this study sample there was indeed socioeconomic variation in some, but not all, 
psychosocial measures, in particular increasing SES was associated with decreasing sense 
of economic strain, increasing job control and increasing work demands. Weaker, but 
statistically significant associations were found between increasing SES and more active 
coping style, stronger sense of optimism, fewer major life events, more job security, 
stronger sense of belonging and civic trust, higher levels of social capital and social 
support, longer job hours and decreasing difficulty of getting another job if the current 
job was lost. Notably, there was no significant socioeconomic variation in a measure of 
perceived stress, sense of control, hostility, mental health or neuroticism. 
 
Examination of the variation in the biological measures indicated that all measures except 
salivary IgA concentration showed trends in the expected direction, i.e. plasma 
fibrinogen, glycated haemoglobin, serum neopterin levels and waist-hip ratio decreased 
with increasing SES. Salivary IgA showed a weak and inconsistent direction of variation 
with SES. For each of those four markers that did show a consistent trend with 
socioeconomic status, this trend was in a direction of increasing favourability with 
increasing SES. Notably the strength of the association with each SES measure varied by 
gender: plasma fibrinogen and glycated haemoglobin were most strongly associated with 
SES in females and for measures of occupation and income; waist-hip ratio was most 
strongly associated with SES in males and for measures of occupation, education and 
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childhood SES; and serum neopterin was most strongly associated with SES in women 
and for occupational measures. 
 
In bivariate analysis there were few associations between the biological markers and the 
psychosocial factors. Plasma fibrinogen was negatively associated with negative coping 
style in women only and with skill discretion in men. Glycated haemoglobin was 
negatively associated with active coping style and social support in men and positively 
with depression and anxiety in women. There were no associations between WHR and 
any psychosocial factor. Serum neopterin was negatively associated with trust and 
belonging in men and positively with job strain in women. Salivary IgA was positively 
associated with job strain in men only. In this healthy, middle-aged population there 
seems to be little evidence of the measured psychosocial factors affecting body systems 
represented by the chosen markers. 
 
Mediation analysis suggested that the mediators of the association between the markers 
and SES, were relatively consistent for different measures of SES for any particular 
marker, but were markedly different from marker to marker. Thus the most important 
mediators of the association between plasma fibrinogen and SES were measures of job 
control, sense of economic strain, smoking status, active coping style and positive 
interaction with friends and family, in males. In women, frequency of alcohol intake, job 
control, economic strain, number of hours worked per week and sense of job fairness 
were the most important mediating variables. For glycated haemoglobin, only active 
coping style in men was important in mediating the association between glycated 
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haemoglobin and SES, and there were no statistically significant mediating variables in 
women. Although there were strong associations between waist-hip ratio and SES, none 
of the measured variables provided statistically significant mediation of this association. 
In the association between serum neopterin and SES, significant mediating variables were 
economic strain and number of cigarettes smoked per week in males and number of hours 
worked per week in females. For salivary IgA, only work demands provided significant 
mediation of the association with measures of SES in males, while number of cigarettes 
smoked per week was the most important mediating variable in females. 
 
In general, SES explained only a small proportion of the variation in the biological 
markers. While the inclusion of behavioural, psychosocial and other biological measures 
in multiple regression models accounted for a large proportion of the variation in some of 
the markers, few of these other variables were significant mediators of the SES variation 
in marker levels. To some extent this was because those variables retained in the multiple 
regression models did not themselves show any SES variation. However, even in those 
models, e.g. WHR in males, that did contain variables that were themselves associated 
with SES in correlation analysis, there was no significant mediation of the SES 
association with the marker. 
 
Work variables and active coping style seemed to be of particular general importance in 
mediating the association between these biological markers and a variety of measures of 
SES. 
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Chapter 6. 
Discussion 
6.1 Introduction 
The Biomarkers study tested three hypotheses relating to the theory that psychosocial 
factors contribute to the socioeconomic gradient in health. Rather than using a measure of 
ill health as an outcome, I measured five biological parameters that have a plausible 
association with the likelihood of future disease. This allowed the study to be conducted 
in healthy individuals, thus avoiding any possibility of reverse causality in which 
reporting of psychosocial or SES factors were altered by disease status. 
 
In addition, the five biological markers represented different body systems that may be 
affected by activation of the physiological stress response. If psychological stressor 
perception activates the stress response, then it is likely that these markers would also be 
altered as part of that response. Because this is a cross-sectional study, I cannot infer 
causation between the outcome and explanatory variables, but mediation analysis 
provides an indication of possible causal pathways. Longitudinal studies would be 
required to confirm these. 
 
To my knowledge, no researcher has previously used physiological variables in healthy 
individuals as markers, in this manner. In Chapter 3, Part 2 I outlined the literature that 
examines each of these biological parameters against Kelly et al’s criteria for population 
markers of the SES-stress-disease connection [154]. I begin this chapter by discussing the 
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results from the Biomarkers Study that test these criteria. I then examine the results in 
regard to each of the three study hypotheses, with reference to pertinent literature, and 
conclude with a more general discussion of how this research complements other 
research in the health inequalities field. 
6.2 Testing the markers 
Kelly et al suggest that criteria for ideal markers to investigate the SES-stress-health 
pathway include:  
1. It must be affected/caused/created by stress; 
2. It should have a long half-life (months to years). It should not require repeat 
measurements; 
3. It should be independent of demographic factors (e.g. sex or age) or else have a 
well-defined demographic distribution; 
4. It must be relatively easy and cheap to measure (preferably with an easily 
reproducible, automated method); 
5. It should require no special sample preparation; and 
6. It should have readily available reference standards. 
6.2.1 Plasma fibrinogen 
The review of fibrinogen (section 3.8) confirmed that plasma fibrinogen, as part of the 
acute phase response, is likely to be elevated in response to activation of the 
neuroendocrine and immune response to stressor exposure and perception, via the 
sympathetic nervous system, glucocorticoids and IL-6. Fibrinogen has a well-defined 
demographic distribution, requires no special sample preparation and measurement, 
  309
though not routine, is common, relatively cheap and automated, with readily available 
reference standards. 
 
However, fibrinogen has a relatively short half-life and substantial evidence points to 
wide intraindividual and seasonal variation in serum levels, suggesting that there may be 
problems in regard to the second criterion, for this biomarker. The Biomarkers Study also 
found substantial intraindividual variation and a seasonal pattern, with higher fibrinogen 
levels in winter months. Furthermore, this study suggests probable systematic differences 
in fibrinogen levels, dependent on which laboratory performed the sample analysis. 
 
Plasma fibrinogen has a plausible association with activation of the body’s stress 
response, and is commonly and easily measured. However, wide intraindividual, 
interlaboratory and seasonal variation, meaning that a single measurement may not 
accurately reflect the steady state, limits its use as a marker of chronic activation of the 
stress response. 
6.2.2 Glycated haemoglobin 
Glycated haemoglobin is plausibly increased under conditions of repeated activation of 
the stress response, has a long half-life and the Biomarkers Study confirms that there is 
little intraindividual variation. There is, however, a seasonal pattern with a peak in late 
autumn and a trough in late spring. Glycated haemoglobin has a well-defined 
demographic distribution and is relatively cheap and easy to measure. However, 
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measurements vary depending on the laboratory in which the samples are analysed, thus 
some caution is required in its use in population studies.  
 
The stability over time, ease of collection and measurement of samples, and its plausible 
association with repeated or chronic activation of the stress response makes glycated 
haemoglobin a good potential marker for this type of investigation. 
6.2.3 Waist-hip ratio 
Although the evidence and hypotheses reviewed in section 3.10 indicated that increased 
waist-hip ratio may be caused by chronic stress, the Biomarkers study found few 
associations between WHR and measures of psychosocial stress. WHR has a well-
defined demographic distribution, is stable over time and easily measured on a population 
basis, although care must be taken to ensure standardised measurements. Different 
populations may have a different distribution of WHR due to genetic factors [301, 492], 
so that its chief use is probably in comparative studies of different population subgroups, 
rather than as a measure of abnormality per se. 
6.2.4 Serum neopterin 
Physiological pathways exist whereby neopterin levels could be depressed as a result of 
the acute stress response, but the effect of chronic stress is less clear. The one study that 
has examined intraindividual variability of neopterin levels indicated that population 
levels were quite stable over time, but there was marked intraindividual variability. In the 
Biomarkers Study, the intraclass correlation for neopterin in two samples taken three 
months apart was only modest. Single measurements may not reflect long-term levels of 
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neopterin, on an individual basis, and it would be preferable to have samples taken on 
more than one occasion. There is a well-defined demographic distribution and sample 
collection, preparation and analysis is relatively easy, inexpensive and can be automated.  
 
It is likely to be difficult to find accurate markers of the effects of chronic stress on the 
immune system, which by its nature is designed to respond to acute threats, whether 
physical or psychological. Neopterin is a general marker of activation of the cellular 
immune system that, unlike many of the cytokines, is produced in measurable amounts in 
serum. It is moderately stable over time in individuals and in population groups, and may 
represent the most appropriate marker of the cellular immune system currently available 
for population studies. 
6.2.5 Salivary IgA 
Theoretically, humoral immunity may be depressed by repeated activation of the stress 
response and there are known effects on the secretion of both saliva and salivary IgA, by 
stress hormones. Salivary IgA has a well-defined demographic distribution and samples 
are easily collected, stored and analyzed. However, there are several different collection 
techniques, resulting in lack of standardization of the results from different research 
groups. Salivary IgA concentration is affected by recent food intake, impending upper 
respiratory tract infections, acute stress, time since rising, smoking habits and perhaps 
physical activity. Results from the Biomarkers Study support previous findings of only 
modest intraindividual stability over time in the measures, so a single measurement may 
not be ideal as a reflection of the steady state in an individual. 
  312
 
In the pilot study, some wildly high IgA concentrations were recorded (compared to the 
available reference range), which were likely to be associated with infection, despite 
participants being instructed to defer the sample collection if they felt unwell. Such 
samples may have been collected in the preclinical period of an upper respiratory tract 
infection, and be unrelated to activation of the acute or chronic stress response. 
 
Difficulties in ensuring that collection takes place during an infection-free time, with 
standardization to time since waking, food intake, physical activity and level of hydration 
are serious problems in the use of salivary IgA in population studies to examine 
associations with chronic stress and as a marker of chronic stress. 
6.3 Stress, SES and Disease 
The theory that psychosocial factors cause at least part of the SES gradient in health 
implies that psychosocial stress (e.g. job strain), or psychosocial assets (e.g. social 
support), are differentially distributed, by SES. Psychosocial stress could be causative of 
ill health either directly by affecting body systems via the stress response and promoting 
a general susceptibility to disease, or indirectly via health damaging behaviours, adverse 
material circumstances or poorer access to preventive services. Psychosocial assets would 
moderate stressor exposure, or the perception of stress, to decrease the deleterious effects 
of the stress response, on body systems. Either or both of these mechanisms could 
contribute to the SES-health gradient. 
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This study explicitly sought to measure the presence of a gradient in psychosocial factors 
and psychosocial assets. As the results indicate, there was indeed a socioeconomic 
gradient in some measures of stressor exposure, e.g. economic strain, and number of life 
events, with lower SES associated with increased levels of stressor exposure. In addition 
there was a gradient in psychosocial assets, e.g. optimism, sense of belonging and 
positive support from family and friends, with a gradient of increasing psychosocial 
assets with increasing SES. Thus psychosocial forces are acting at two points to 
maximize the experience of stress in lower SES groups.  
 
In this section I discuss the results of the Biomarkers Study in the context of relevant 
research linking stressor exposure and experience, to SES and to disease to examine steps 
of the hypothesized pathway: 
SES → Stress → Disease 
Few other investigators have specifically examined the associations between 
psychosocial factors and SES, apart from perhaps SES variation in work characteristics. 
In general there is a variation of psychosocial job attributes with socio-economic status, 
with more adverse conditions (more demands, less control, more insecurity, less 
opportunity for monetary and esteem rewards) in lower socio-economic groups, whether 
self-reported or based on imputed job characteristics [493-495]. In the Whitehall II study, 
Marmot found that fewer of those men and women in lower status jobs reported control 
over their working lives, or satisfaction with their work situation [74]. As in the 
Biomarkers study, more of those in higher status jobs reported having to work at a fast 
pace.  
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However, Davey-Smith et al have raised the question of collinearity in the measurement 
of job control and SES, suggesting that job control may be a proxy for SES [496]. The 
Biomarkers Study does not support this possibility, with subgroup analysis revealing that 
even in the lowest quartile of occupational status, the full range of job control scores is 
represented. In addition, within this lower SES group there is an almost significant 
(p=0.06) difference in plasma fibrinogen levels between those in different job strain 
categories. High levels of job control are correlated with higher levels of SES, but the 
association with markers of ill health is present at each level of the socioeconomic 
hierarchy. 
 
Not all studies have found links between SES and job stress. Using a composite job strain 
index that included measures of work social support, work overload, identity destructive 
character of work and security decreasing character of work, Matthews et al found no 
correlation between occupational prestige and work strain in healthy middle-aged men 
and women [123]. However, the elements of the work strain index were not examined 
separately and on the basis of other studies, including the Biomarkers Study, work 
overload might be expected to vary in the opposite direction to the other measures of job 
strain, thus creating a null correlation of the overall index, with SES.  
 
Among women, Wamala noted that lower occupational class was consistently associated 
with lower job control, but an association of increasing work demands with increasing 
SES was apparent only for women with coronary heart disease [497]. A number of 
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studies have found a positive association of work demands with SES [498, 499], while 
several studies have found that there is an interaction between SES and workplace 
characteristics, so that the combination of low SES and adverse work conditions is 
particularly potent in explaining the increased adverse health events seen in lower SES 
groups [495, 500]. 
 
Job strain is associated with adverse health outcomes, but there is little consistency in 
which elements of job strain are associated with ill health. Ischaemic heart disease and 
myocardial infarction have been associated with job demands only [131], job control only 
[501] and with the composite measure, job strain [502]. A few studies have shown no 
relationship between measures of ill health and job control/demand/strain [503] while 
others show an inverse association between incident coronary heart disease and job strain 
[504]. Job strain has been associated with increased diastolic blood pressure [505], 
decreased testosterone [506], elevated ambulatory blood pressure [500], elevated 
glycated haemoglobin [507] and elevated early morning cortisol [508]. Low job control 
has been associated with high plasma fibrinogen [509], especially in women. Adverse 
work conditions have been associated with immunosuppression and increased incidence 
of upper respiratory infections [510]. 
 
Longitudinal studies have suggested a causal relationship between various aspects of 
adverse psychosocial work conditions and ill health (measured in a number of different 
ways) [511-513]. Some studies have indicated that the effects of job strain are 
particularly potent in particular segments of the population – men less than 50 (compared 
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to older men) [131]; lower income groups [495]; and manual workers [514]. Morrison et 
al point out that control is likely to be most important if it is over those particular 
demands that are seen as demanding: “When people perceive their jobs to be demanding 
they will tend to be less satisfied unless they also see their jobs to be giving them the 
control and support necessary to successfully deal with the demands” [515].  
 
Not surprisingly higher SES men and women in the Biomarkers Study perceived their 
jobs as more secure and themselves as more marketable should they lose their job, than 
those in lower SES groups. Traditionally, the unskilled and least educated are most 
vulnerable to layoffs, but with restructuring of employment to create smaller permanent 
workforces there has been an increase in casual employment and contract work. Such 
work by its nature has uncertain prospects of continuity [516], perhaps increasing the 
experience of job insecurity across all occupational groups. In a Canadian survey, one 
third of employed persons believed that they could lose their job in the next two years, 
and over one third were not confident that they would be able to find an equivalent job 
within six months if job loss did occur (cited in [517]). In Kornhauser’s (1965) study, 
concern about job security is “expressed by equal proportion of men at all skill levels” 
(cited in [518]). There appear to be few empirical data specifically examining the 
association between job insecurity and socioeconomic position. McDonough 
demonstrated a negative correlation with income (-0.19, p<0.01) and a positive 
correlation with education (in years) (0.03, p<0.01) using a dichotomized measure of job 
security where 1 = high insecurity and 0 = low insecurity [517].  
 
  317
Perceived job insecurity and lack of marketability are associated with psychological 
distress [519], depression [518] and effects on physical health with significant increases 
in blood pressure among workers in lower occupational classes faced with possible job 
loss [520] and poorer self-rated health [517] in cross-sectional studies. In longitudinal 
studies, job insecurity was associated with increased hospital admissions [521], and the 
development of increased risk factors for cardiovascular disease [516, 522, 523]. Heany 
showed that chronic job insecurity was associated with increased physical symptoms 
compared to job insecurity measured at a single point in time [524] but this was not 
confirmed in the Whitehall II studies [523]. Personality modifies the impact of job 
insecurity, with positive personality disposition (congruent to optimism) lessening, and 
negative personality disposition (negative affect) worsening, the impact of job insecurity 
on psychological distress [525].  
 
It seems hardly surprising that economic strain is associated with lower SES, and might 
even be considered a proxy for SES. Economic strain is a subjective measure of the 
impact of low SES on the individual. Indeed the variable has a higher correlation with 
subjective social status (perceived position in Australia) than with any other measure of 
childhood or adult SES in this study, except household income. However, a correlation 
coefficient of  –0.39 (between composite SES and the economic strain variable available 
for the combined studies) suggests that SES and economic strain are not automatic 
partners. 
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Ullah postulates that perceived financial hardship may be more important than objective 
measures of income in determining health outcomes [526]. Power found that the adjusted 
odds ratio for experiencing financial hardship in social classes IV and V (lowest) 
compared to social classes I and II was 2.02 (p<0.05). Financial hardship was, in turn, 
associated with increased psychological distress, particularly in women [527]. Economic 
strain is a critical mediator of the path from job loss to poor physical and psychological 
health [528, 529] and the combined experience of being in a lower SES group and having 
a severe impairment due to illness increased the odds ratio for experiencing financial 
hardship (compared to a higher SES group) from 2.3 to 8.0 [530]. In a cross-sectional 
study of unemployed men and women, financial hardship was positively associated with 
both emotion-focused coping and emotional distress, but all were less frequent among 
those who had been unemployed for more than three years [531]. Longitudinal studies are 
required to clarify the importance of coping style in the route between objective and 
subjective financial hardship.  
 
In the Biomarkers Study active coping style was positively correlated with 
socioeconomic status. There is evidence of modest genetic influences on coping style and 
gene-environment interactions are likely [532]. Adverse coping styles, including self-
distraction, thought suppression and suppression of feelings, were negatively correlated 
with income and education in survivors of Hurricane Andrew [533] and problem focused 
coping was less frequent among subjects with low education and perceived financial 
hardship [531]. While several studies have examined the impact of different coping styles 
on psychological and physical ill-health [534-536], the association with SES in these 
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studies is not documented. In general passive, avoidant coping styles are associated with 
poorer health outcomes [534], while active, problem focused coping is associated with 
fewer hospital admissions [535], longer survival after melanoma diagnosis [536] and 
improved immune status [537]. 
 
Sense of optimism increased with increasing SES in this study sample. Several studies 
have found a stronger association between SES and the negatively worded items on the 
LOT compared to the positively worded items, i.e. the variation in SES is a variation in 
the expectation that fewer negative events will occur, rather than the expectation that 
more positive events will occur [452, 538, 539]. This finding is not confirmed in the 
Biomarkers study, with positive and negatively worded items having a similar correlation 
with SES. 
 
Increased optimism has been associated with decreased susceptibility to colon cancer 
[538, 540], faster recovery following a heart transplant [541], and more favourable 
adjustment to important life transitions [542]. In the Kaunas-Rotterdam study, Lithuanian 
men were much less optimistic than men in Rotterdam, and this factor statistically 
explained 30% of the excess in all-cause mortality seen in men in Kaunas (cited in [119]). 
Pessimism is associated with several negative health outcomes (for review see [452]), but 
there is some inconsistency in the association of optimism and pessimism with positive 
and negative health outcomes, including the effect of optimism/pessimism on 
immunocompetence in response to stress [452]. Furthermore at least part of the effect of 
optimism on health is through a close connection with an active coping style [451]. 
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Social capital was assessed in the Biomarkers study using two questions, one relating to 
trust, and the other to how helpful other people were. SES was most strongly correlated 
with trust. Lochner stresses that social capital is exclusively a community level measure; 
aggregated individual responses are used as an explanatory factor for the ecological 
association of income inequality to poor health [543]. However, Berry et al develop the 
notion of personal social capital to examine the connection of individuals to their 
communities [544]. In the current study, social capital is measured as an attribute of an 
individual, recognizing that at this level there is a strong association with optimism and 
positive social support. Studies of community level social capital show clear associations 
between increased social capital and health of communities [447, 545], while initial 
studies using the concept of personal social capital show a protective effect for general 
psychological health [544]. Sense of belonging in the community (measuring the 
perceived availability of people one can do things with) was significantly stronger in 
higher socioeconomic status individuals. 
 
Social support was tested with two items: positive interaction with family and friends, 
and negative interaction with family and friends [443]. Only the positive interaction 
elements showed a significant socioeconomic variation with higher support correlated 
with higher SES. This is a measure of the functional rather than structural components of 
social support and particularly examines emotional support. 
 
  321
Several other studies have shown a positive correlation between social support and SES 
[124, 546, 547], although differences by social class are generally modest. Notably, in the 
Whitehall studies there were SES gradients for both positive and negative social support, 
operating in opposite directions. 
 
A large body of literature supports the association of lower levels of psychological 
distress with higher levels of emotional support [513, 546]. Much of the early work 
examining links between social support and physical health used measures of 
instrumental support and showed links between social isolation and increased mortality 
[37, 548, 549]. Higher levels of emotional social support are associated with improved 
survival after a myocardial infarct in the elderly [550], and post-stroke prognosis [551]. 
However, there is a paucity of research examining social support and disease incidence. 
In a recent cross-sectional study, Sorkin noted that lack of emotional and structural social 
support was associated with a greater prevalence of coronary heart disease in the elderly 
[552] and there is some support for deleterious effects of low social support on 
physiological outcomes, e.g. cardiovascular reactivity [553], CD4 counts in men with 
HIV [554], and HPA and SNS reactivity to stress [554]. 
 
In the Biomarkers Study, there is a negative correlation between the number of recent life 
events suffered by the participant or his/her partner, and socioeconomic status. Several 
studies have found a similar association in youth [555, 556], pregnant women [557], and 
community samples [558, 559].  
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Stressful life events have been causally implicated in the development of appendicitis 
[560], exacerbations of multiple sclerosis [561], onset of breast cancer [562], progression 
of AIDS [563] and myocardial infarction [559]. There is substantial literature on the 
association of recent life events with subsequent depression, with Brown and Harris 
calculating a population attributable risk of 73.1% for the relationship of severe life 
events and major difficulties, to the onset of cases of depression [560]. 
 
More recently, the effect of negative life events on physiological parameters has been 
studied. Stressful events in healthy subjects resulted in alterations in levels of TNF-α 
[564], and observation of new brain lesions on magnetic resonance imaging in patients 
with multiple sclerosis [565]. There have been conflicting results from studies 
investigating the association of life events with risk factors for cardiovascular diseases, 
with some studies finding positive correlation with systolic and diastolic blood pressure 
and serum lipid levels, but others finding negative or null results [566]. Consistent 
associations have been observed between life events and smoking, alcohol consumption 
and lack of leisure physical activity [566]. In addition, interactive deleterious effects on 
health of the combination of low SES and negative life events have been noted [567, 
568]. 
 
The reward scale of the BAS examines the extent of positive feelings in the anticipation 
of a reward. In the Biomarkers Study there was a positive association with SES while 
there was no statistically significant association with other elements of scales measuring 
affect. Reward responsiveness predicts happiness and is moderately correlated with 
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extraversion, positive affectivity and positive temperament, but not optimism [457]. 
Several studies have noted a negative correlation between SES and aspects of negative 
affect [569, 570] but few studies seem to have explored the socioeconomic variation of 
positive affect. Similarly links between health and affect have largely explored 
associations between negative affect and health [571] rather than the possibly protective 
effects of positive affect. 
6.4 Biological Markers and SES 
Kelly et al state that initial conditions for markers of the SES-stress-health pathway are 
that they should be: 
• sensitive to systematic, long term differences in socioeconomic status and living 
conditions 
• they must be feasible to measure in large scale population surveys. 
This section explicitly examines the first condition, i.e. that the markers vary by 
socioeconomic status.  
 
I found significant SES variation in four of the markers in the expected direction, i.e. 
increasing SES is associated with more favorable levels of the biological markers. This is 
remarkable in a population of healthy, middle-aged men and women, living in a small 
city with good access to medical care, most owning their own homes and at least one car. 
It is a relatively affluent group, in a relatively affluent city, and yet these biological 
factors vary significantly with SES. 
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Substantial and somewhat consistent evidence exists of an inverse relationship between 
socioeconomic status and plasma fibrinogen, using a number of different indicators of 
SES, although in some studies major cardiovascular risk factors and health-related 
behaviours accounted for part of this social gradient in fibrinogen [182]. In the Whitehall 
II study of men and women aged 45-55 years, several measures of childhood SES (adult 
height, father’s social class and participant’s education) were inversely associated with 
adult plasma fibrinogen [196, 199]. In addition, adult SES (indicated by employment 
grade) was inversely associated with plasma fibrinogen in men (difference between high 
SES and low SES of 0.22g/L (95% CI 0.13-0.31)) and women (0.37g/L (CI 0.18-0.56)). 
In the Kuopio Ischaemic Heart Disease Risk Factor Study, there was an age-adjusted 
inverse association between levels of plasma fibrinogen and four of five indices of SES: 
current income, education, lifetime occupational status and current material possessions. 
After adjustment for covariates (alcohol consumption, BMI, physical fitness, smoking, 
coffee consumption, HDL, LDL, blood leukocyte count and prevalent disease) the 
association persisted for education, current income and lifetime occupation. Analysis of 
the joint effect of childhood and adult SES indicated that those who were economically 
disadvantaged at both times had the highest fibrinogen levels but the fibrinogen levels of 
those who were not poor as adults showed no variation by childhood SES, in men and 
women [218].  
 
In separate studies, Myllykangas and Woodward demonstrated an inverse association 
between SES and plasma fibrinogen, but this association disappeared after adjustment for 
smoking in men, but not in women [200, 226]. Wilson found that the SES variation in 
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fibrinogen was strongest for income, followed by education and then occupation [218], 
while Brunner showed that fibrinogen concentrations were lower in owner-occupiers than 
in those in rented accommodation [196]. The educational variation in plasma fibrinogen 
in women less than 65 years old was markedly weakened by adjustment for psychosocial 
stress and lifestyle patterns [228].  
 
There is little direct research on the association of levels of glycated haemoglobin with 
socioeconomic status. Daniel et al [251] examined levels of HbA1c in indigenous 
populations in Australia and Canada and compared these to non-indigenous populations 
in Melbourne. Mean HbA1c concentration was 18.2% higher for indigenous people, but 
this figure was largely influenced by much higher levels of HbA1c among indigenous 
diabetics. While blood glucose and 2-hour post-load glucose concentrations were 
controlled for, it is likely that indigenous populations would experience poorer diabetic 
control (reflected in higher HbA1c) that may not be reflected in a single fasting glucose or 
glucose tolerance test at a clinic. In addition, the indigenous populations were from 
remote rural areas, whilst the non-indigenous populations were urban-dwellers. While 
some of the variation in HbA1c concentration may have been due to differences in 
socioeconomic status, it is difficult to apportion the variation between the various other 
differences between these groups. 
 
In a survey of Jamaican school children, glycated haemoglobin was directly related to 
shortness at birth as well as fatness in childhood, but there was no independent 
association between socioeconomic status and HbA1c [572]. 
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A number of studies undertaken to examine diabetic control have measured 
socioeconomic status and HbA1c simultaneously, using HbA1c as a monitor of diabetic 
control over time. While Frindik [252] and Larsson [250] showed lower levels of 
glycated haemoglobin in diabetics of higher socioeconomic status, probably reflecting 
higher education levels contributing to improved control, Baumer found no effect of 
social disadvantage on either diabetes prevalence or outcome, in childhood. Diabetes has 
such an overwhelming effect on HbA1c that results from the diabetic population are not 
transferable to the non-diabetic population [573]. 
 
In the Biomarkers Study, there were strong, consistent negative associations between 
WHR and SES, particularly in men and for occupational measures and education, as well 
as measures of childhood SES, e.g. parental occupational status. 
 
Previous research has shown that in women, central fat deposition and BMI have a 
reliable negative association with both socioeconomic status of childhood as well as 
current socioeconomic status, measured in a variety of ways [286, 306-308]. Thus high 
WHR is linked to lower social class [265], lower educational level [265, 301], poorer 
income [226], partner’s occupational level [311] and personal occupation [265, 301]. 
Several studies indicate that the association is strongest with education level [301, 311] 
and that this is a graded relationship [311], although Adler suggests that subjective social 
status may have a stronger association with body fat distribution than objective indicators 
[314]. Lapidus demonstrated that low status employed women were 1.4 times as likely to 
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be overweight as high status employed women [312] and women working outside the 
home had significantly lower WHR than housewives [297]. 
 
Around 30% of studies in men report a direct (rather than an inverse) relationship [308] 
between measures of SES and WHR. However, most studies report an inverse 
relationship with SES, as measured by personal income [226] or education [256]. Marmot 
reported that father’s educational level, but not mother’s, was inversely associated with 
WHR in men; but parents’ education was not associated with WHR in women [310].  
 
Some studies suggest that there is no association between WHR and employment status 
[312], but others have found that unemployed individuals had higher WHR than 
employed individuals [290, 304]. There are inconsistent results for an association 
between WHR and housing type in men and women [297]. 
 
The majority of studies have been carried out in developed Caucasian countries (USA, 
UK, Australia etc) and these results may not be generalisable to other cultures or races. 
For example, Martikainen showed that in Japan, both BMI and WHR are positively 
associated with SES (by employment grade) and there is no significant association with 
education [313]. 
 
In Australian adults (20-69 years) there is regional variation in mean WHR, with the 
lowest average WHR for men in Melbourne and Canberra and for women in Darwin and 
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North Sydney. The highest average WHR for men was in Brisbane and Darwin and for 
women, Melbourne and South Sydney [301].  
 
The association between central obesity and SES is susceptible to reverse causality, 
where obese individuals become part of lower SES groups, because of decreased 
employment opportunities, ill-health etc. However, a limited number of longitudinal 
studies indicate that low SES predicts weight gain and risk of obesity [312]. In addition, 
the strong, graded relationship of WHR with education (often taken as a measure of early 
SES) provides some evidence against reverse causation. SES gradients in central obesity 
are present in children (after controlling for perinatal health), with some studies 
suggesting that rather than low SES children being overweight, upper SES children are 
lean [308]. Upward mobility does not necessarily mitigate or reverse the adverse effects 
of low childhood SES on adult health, i.e. adults who grew up in lower SES households 
had higher WHR as adults, even after adjustment for adult SES [309]. However, women 
with only secondary schooling who moved up the social scale had consistently lower 
WHR than women who married down [281]. 
 
Brunner et al demonstrated a monotonic trend in the odds ratio of having an elevated 
WHR by employment grade in the Whitehall studies [287] and there was a clustering of 
risk factors for the metabolic syndrome in the lower grades of the civil service for both 
men (OR=2.2) and women (OR=2.8). Despite health promotion campaigns the SES 
gradient in WHR does not appear to be decreasing [306], and health related behaviours 
  329
such as smoking, alcohol consumption and exercise level make only a small contribution 
to this inverse association [287]. 
 
To my knowledge, the Biomarkers study is the first to examine the socioeconomic 
distribution of serum neopterin. While there was no statistically significant association 
with SES in men, a socioeconomic gradient was evident in women, particularly for 
occupational measures. 
 
No studies have noted the presence of variation in salivary IgA concentration with 
socioeconomic status. Evans et al [425] showed that lower social class (as measured by 
the occupational social class of the head of the household) was associated with lower 
salivary IgA secretory rate. However, much of this social class difference could be 
explained by differences in smoking rates between the classes [425].  
6.5 Variation of markers with psychosocial factors 
The five biological markers were chosen because they could theoretically be affected by 
the physiological stress response. However, for at least some of these markers, substantial 
research has been conducted on actual associations with stressor exposure and the effects 
of psychosocial assets. My research has also examined these links. 
 
In the Biomarkers Study, plasma fibrinogen levels were higher in women reporting 
economic strain and in men reporting increased skill discretion. Other researchers have 
noted consistent positive associations between acute psychological stress and plasma 
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fibrinogen [182, 229, 230], but less consistent associations with measures of chronic 
stress. Raikkonen found a decrease in fibrinogen with long-term mental stress [229], 
while others found no change or an increase [182]. A review of 18 studies examining 
associations between chronic psychological stress (as measured by job strain) and 
haemostatic variables found that, compared with controls, chronic stressor exposure was 
associated with an average increase in plasma fibrinogen of 8% (range 4%-30%) [182]. 
 
Several other studies have found that measures of job stress, particularly low control, 
monotony and under-utilization of skills, are associated with increased fibrinogen 
concentrations in both sexes [78, 196, 198]. In the Whitehall II study, men in the top 
tertile of both self-rated and externally assessed control over work had lower fibrinogen 
levels than those in the bottom tertile of both measures (-0.16 g/L, 95% CI (-0.07, -0.26), 
p<0.001) [199]. Similar results are found in studies using the Siegrist effort-reward 
imbalance model of job stress [231]. The current study found no association between 
measures of job strain and plasma fibrinogen in women, and the association with skill 
discretion is in the opposite direction in men, with those with increased utilization of 
skills having increased fibrinogen levels. 
 
I found no statistically significant association between fibrinogen levels and any measure 
of social support. Helminen showed a negative association between measures of social 
participation and plasma fibrinogen that persisted after adjustment for covariates 
including age, smoking, educational level, WHR and cardiovascular health [227]. The 
social participation measure used largely tapped involvement in sports clubs and sporting 
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activities, and was also associated with higher levels of cardio respiratory fitness. When 
the association between social participation and plasma fibrinogen was adjusted for 
cardio-respiratory fitness, it was no longer significant, suggesting that there was no 
independent social effect. Men with high scores on overall social support had 0.20g/L 
higher plasma fibrinogen level compared to men with low scores, and this difference 
persisted after age, cardiovascular health status, education level, WHR, HDL cholesterol 
and cardio-respiratory fitness were taken into account. This somewhat counterintuitive 
difference was (statistically) explained by a smaller number of smokers among men with 
low overall support, compared to those with high support. 
 
The Biomarkers Study demonstrated a statistically significant negative association 
between glycated haemoglobin and elements of job control and a statistically significant 
positive association with economic strain and number of hours worked per week. Few 
other studies have specifically examined associations between glycated haemoglobin and 
measures of chronic stress. Daniel et al postulate that the small but significant increase 
seen in HbA1c in normoglycemic indigenous people in Canada and Australia, compared 
to normoglycemic non-indigenous people was caused by the stresses of social change, 
low control and poorer living conditions associated with Westernisation [251]. Cesana 
evaluated levels of glycated haemoglobin in relation to stressful working conditions and 
found that printing workers exposed to noise, shift work and long job hours had HbA1c 
levels that were 8.64% higher than male clerical workers [574]. After controlling for 
smoking and alcohol intake, Kawakami found a significant positive association between a 
measure of job dissatisfaction and levels of glycated haemoglobin in male employees of 
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an electric corporation [575] and between job strain (using the Karasek demand/control 
model) and glycated haemoglobin in male Japanese employees in a manufacturing firm 
[507]. In a therapeutic trial of a psychosocial activation program in elderly people, Arnetz 
noted an improvement in HbA1c levels in the stimulated group over six months [576]. 
 
Schuck investigated the use of glycated haemoglobin as a stress marker in a small group 
of non-diabetic medical students undergoing academic examinations [244]. He measured 
a large number of psychosocial variables including extroversion, neuroticism, internality, 
self-efficacy, anger, anxiety, social support, social constraint, coping style, as well as 
deriving a daily hassles and uplifts score and a global stress rating. Although there was an 
increase in HbA1c during the exam condition compared to controls, there were generally 
low correlations between the psychosocial variables and levels of HbA1c. In males, active 
coping style was negatively associated with glycated haemoglobin in the Biomarkers 
Study, but there was only a low correlation between problem focused coping and HbA1c 
in Schuck’s study. 
 
Increased anxiety and depression were positively associated with increased levels of 
glycated haemoglobin in women in the Biomarkers Study. This finding has some support 
in the literature, with Theorell reporting a similar association with anxiety in a 
longitudinal study of relatives of cancer patients. He found that a high level of anxiety 
was associated with rising levels of HbA1c during monthly assessments [247].  
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Positive interaction with family and friends was associated with lower glycated 
haemoglobin, and negative interaction with family and friends higher glycated 
haemoglobin, in males only, in the Biomarkers Study. Few studies have examined the 
influence of social support on levels of glycated haemoglobin in non-diabetic individuals. 
Schuck reported a low inverse correlation between HbA1c and levels of social support (r 
= -0.10) in his study of academic stress in medical students [244]. Improved glycaemic 
control in diabetics may be associated with a perception of stronger family support, 
however, such studies may not be generalisable to the non-diabetic population [577]. 
 
Previous research has documented associations between elevated WHR and cynical 
distrust in men and women [578], depression [254, 578, 579], hostility [274, 287], 
economic strain [580], Type A behaviour [274], anger [274], vital exhaustion [274], 
lower self esteem [254], and extraversion [263, 297]. Women with low BMI and high 
WHR had the most negative profile – greater pessimism, negative affect, and avoidant 
coping [254].  
 
Women with high WHR found laboratory stressors more challenging and stressful than 
those with low WHR (across a range of BMIs), secreted significantly more cortisol in 
relation to stressor exposure and the cortisol response failed to habituate to stressor 
exposure [254, 315]. Men had a higher desire for control and greater cortisol reactivity 
when faced with uncontrollable stress than either high or low WHR women and this was 
most marked in men with central obesity [271].  
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However, in the Biomarkers Study, I found no association of WHR with any measure of 
psychosocial stress except for skill discretion at work, which was statistically significant 
in men and women, and the combination of low job control and high job demands at 
work, in men. In addition, there was no association with social support, belonging or 
social capital. Few studies have examined the association between WHR and measures of 
job strain. Van Amelsvoort et al observed increased WHR and BMI in association with 
the number of years in shift work, which persisted after adjustment for age, physical 
activity and smoking status [581], while Georges reported a significant association 
between job control and abdominal obesity, which became non-significant after 
adjustment for education (cited in [582]). Steptoe et al found job control did not differ in 
groups of teachers defined by high or low WHR status, but men with high WHR and low 
job control exhibited heightened stress-induced physiological activation with increased 
heart rate and ambulatory blood pressure [582]. 
 
Lack of social support and social isolation have been associated with increased risk for 
the metabolic syndrome in men and women [317], and longitudinal studies suggest that 
lack of perceived social support precedes an increase in central body fat [317]. In the 
Whitehall II studies, strain in social relationships was associated with higher WHR, as 
was perceived inequality, in women [310]. 
 
In the Biomarkers Study, serum neopterin had a statistically significant positive 
association with job strain (low control/low demands and low control/high demands) and 
economic strain in women. Increased levels of trust and belonging were associated with 
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decreased neopterin levels. These results, as well as the SES variation in neopterin levels, 
suggest that increased strain is associated with increased levels of neopterin, rather than 
the decrease predicted (and observed) in acute stress. 
 
Elevated neopterin levels have been noted in anorexia nervosa [304], depression [357, 
374-377], and seasonal affective disorder [374], with conflicting results for schizophrenia 
[360, 377, 378]. In contrast, depressed neopterin levels were found in post-traumatic 
stress disorder [368], and following acute stressor exposure [318, 367, 583]. Dunbar 
noted that the lowest neopterin levels coincided with the period of maximum self-
perceived stress, and there was a slow return to baseline levels (>six weeks) [367].  
 
De Gucht examined groups defined by self-perceived high and low levels of chronic 
occupational stress and found no significant differences in neopterin levels until the 
groups were separated into those with low, and those with high, psychopathology 
(anxiety, depression). There was a marked and significant elevation of serum neopterin in 
those with high stress and low psychopathology [373]. Interestingly, changes in other 
measures of immune function, e.g. CD8+CD11b+, were more marked in the group with 
high stress/high psychopathology, leading the authors to conclude that in the presence of 
chronic stress, different psychological outcomes are associated with specific immune 
function changes [373].  
 
Only one study has investigated the effect of social support on neopterin levels, and 
found no association [329]. 
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The association of stressor exposure with either concentration or secretory rate of salivary 
IgA has been extensively studied using acute (arithmetic tasks, cold pressor tests etc), 
subacute (academic examination) and chronic stressors (occupational stress, chronic 
caregiving). In general, salivary IgA is increased during and directly following acute 
stressor exposure [392-394], although there are some studies reporting decreases in 
salivary IgA measures [426, 427, 433]. Following sub-acute stressor exposure, most 
studies report decreased levels of salivary IgA, with concentration showing stronger 
associations than secretory rate [412, 415, 417, 430, 584]. However, increases in salivary 
IgA concentration with examinations [429] as well as minimal change in IgA levels [409] 
have been reported. Exposure to chronic stressors has been associated with depression of 
salivary IgA concentration, [434, 435], with some inconsistent results showing increases 
in salivary IgA concentration and secretory rate [432] or no difference [431]. 
 
Both concentration and secretory rate of salivary IgA are consistently increased following 
activities promoting relaxation and induction of a positive mood [403, 436-439]. 
Techniques include Reiki touch healing [437], relaxation techniques [436, 438], a nursing 
back rub [439] and mood manipulation using mental recall or music [403, 585]. 
 
Although I was unable to demonstrate any significant association of any personality 
factor with salivary IgA concentration in the Biomarkers Study, inverse associations have 
been noted, under conditions of high stress, with internal locus of control [431, 436], and 
passive coping [381]. While at first glance these findings may appear inconsistent, 
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persons with a high locus of control and with passive coping skills may feel similarly 
more threatened under conditions of high stress, with resultant depression of humoral 
immunity. 
 
Pleasurable social events and increased social support (during stressor exposure) have 
been associated with an increase in salivary IgA concentration and secretory rate [384, 
415]. 
6.6 SES, psychosocial factors and biology. 
The third hypothesis to be tested in this thesis states that the measured psychosocial 
factors mediate the association between SES and each biological marker. To test this 
hypothesis, I used mediation analysis. This form of statistical analysis is more commonly 
used to analyze prevention programs and the factors that mediate their success or failure. 
As noted in Methods 4.13.1, both positive and negative mediation are possible, the latter 
resulting from a difference in sign between the coefficients of the regression equations 
involved (equivalently, if τ’ is increased relative to τ, rather than decreased). However, 
negative mediation has little intuitive meaning. Particular problems also arise if there is 
collinearity between variables in the full regression model, having opposite signs due to 
their inclusion in the same model. The proportion of the total mediation that is 
contributed by each variable may be opposite in sign to collinear others, e.g. in the 
association of serum neopterin with current educational level, mother’s education and 
father’s education are highly correlated and result in opposite directions of mediation  (-
2% for mother’s education; 31% for father’s education).  
  338
 
While MacKinnon recommends the use of absolute values to calculate the proportion of 
effect mediated [486], there is no rationale for doing this. This is unfortunate, as it would 
be advantageous to assess the relative contributions of various factors to the total 
mediation. The calculation of statistical significance involves squared terms, so that the 
sign of the coefficients is not a problem. The results presented and the following 
discussion is thus based on statistical significance of the mediating effect, rather than 
proportion of the total mediation.  
 
Psychosocial factors did provide significant mediation of the association between each 
biomarker and measures of SES, but which particular factors were important mediators 
differed by gender and for different markers. 
 
The association between plasma fibrinogen and SES was largely mediated by work 
variables, behavioural factors, such as smoking and alcohol intake, and the use of an 
active coping style. Although there was no independent association between plasma 
fibrinogen and perceived stress, the latter did mediate the association between fibrinogen 
and several measures of SES. Several authors have recommended the use of different 
measures of SES in research, as each measures something slightly different [90, 586]. 
However, the mediators of the SES-marker association are surprisingly consistent over 
different SES measures, for any particular marker. 
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Although the strength of the mediation varied by gender for different SES measures, 
overall the actual mediators for a particular biomarker were similar for males and 
females. Thus, the association with income, household income and subjective social 
status showed particularly strong mediation from psychosocial factors for plasma 
fibrinogen in males, while the same is true for equivalent income in women, with 
occupational level and occupational status showing similar associations in men and 
women. Perhaps signs of status, such as income, household income and occupational 
measures have more effect on male physiology. Equivalent income is a measure of 
household income adjusted for family size and as such is a closer measure of income 
actually available to the family unit. Women are more affected by their ability to 
purchase family goods and the affordability of resources for children, than men who may 
be more distant from this need. 
 
Mediation by psychosocial factors involves a mix of psychosocial variables – it is not just 
stressors but psychosocial assets that are important in the SES association with 
fibrinogen. Thus economic strain, perceived strain, job control, and number of hours 
worked per week are statistically significant mediators, as are positive interaction with 
family and friends and use of an active coping style. In addition, sense of belonging, and 
trust in others in the community mediates the association between fibrinogen and some 
measures of SES, in men and in women.  
 
Few factors mediated the association between SES and glycated haemoglobin. Indeed, 
none of the measured psychosocial or behavioural factors mediated this association in 
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women, despite the bivariate correlation between glycated haemoglobin and SES being 
stronger for women than men. As for the mediation analysis for fibrinogen, the factors 
providing mediation were rather consistent, over a range of measures of SES. In men, 
only active coping style provides statistical mediation of the association between glycated 
haemoglobin and SES.  
 
Despite a strong association between WHR and SES in males, none of the measured 
factors provide significant mediation of the association with the traditional measures of 
SES. Depression is a significant mediator of the association of WHR with the subjective 
measures of SES, but not of more objective measures of SES. Depression may alter the 
reporting of perceived SES, although Singh-Manoux found that subjective social status, 
using the same measure as that used in the Biomarkers Study, was free from 
psychological biases [477]. There are clearly interconnecting pathways between 
subjective SES, depression and WHR, but the direction of these pathways cannot be 
determined in this cross-sectional study. 
 
In women, consistent, statistically significant mediation for the association of WHR with 
SES is provided only by body mass index, although skill discretion is almost significant 
for some measures of SES, particularly occupational and income variables.  
 
Economic strain in males and the number of hours worked per week in females are the 
most statistically important mediators of the association between SES and serum 
neopterin. This is a consistent effect across most measures of SES. Lower SES is 
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associated with higher levels of serum neopterin, and although this association is not 
statistically significant in males for any measure of SES, it is mediated mainly by 
economic strain and the number of cigarettes smoked per week. In the mediation 
analysis, these two variables have opposite signs, essentially canceling out the effect of 
each other, possibly causing the overall association between neopterin and SES to be 
non-significant. This highlights the importance of examining mediators, even when the 
overall association between two variables is non-significant. In traditional regression 
analyses, we may adjust for possible “confounders” such as smoking (e.g. of the 
association between fibrinogen and SES) and report that the association is no longer 
significant after adjustment. Such analysis misses the important mediating effect of 
smoking on the association between plasma fibrinogen and SES – rather than reporting 
that there is no independent SES association with plasma fibrinogen, it is valuable to note 
that smoking mediates this socioeconomic variation. 
 
For salivary IgA, there are no significant mediating variables for the association between 
IgA concentration and SES in women, while in males, the most statistically important 
factors are work related, particularly job control and demands. Previous studies 
examining the association between salivary IgA and stress have generally used acute 
laboratory, or subacute examination, stress in a small sample of volunteers. Chronic 
stressors in population studies have included work stress [432], low SES [587], exposure 
to natural disasters [434] and over-wintering in Antarctica [435]. In Zeier’s study of air 
traffic controllers, increased work stress was associated with increased salivary IgA 
concentration, but there was no correlation with cortisol levels and the authors postulated 
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that the changes in IgA concentration were associated with positive emotional 
engagement, rather than stressor perception [432]. 
 
I noted particular problems with the measurement of salivary IgA concentration. Given a 
normal range of 20-500 mg/L [405] (assuming that 2-hour post-prandial collection is 
‘fasting’), 30.4% of participants in the Biomarkers Study had salivary IgA concentrations 
higher than the upper limit of the reference range, with marked interindividual variability. 
In a longitudinal study examining the effects of exercise and competition stress in elite 
swimmers, participants were used as their own controls, because of a similar wide range 
of interindividual variability [588]. 
 
Gender differences in the strength and character of the mediating variables are marked. I 
propose three possible explanations for this: 
 
1. Different stressors are perceived and thus impact, differently on the stress 
response and the subsequent pathways, 
2. The stress response pathways are different in males and females, so that different 
biological parameters are altered by different stressors, 
3. The differences are artefactual. 
 
The first two explanations are not mutually exclusive, and some evidence exists to 
support each one. A great deal of research indicates gender differences in stressor 
perception and response. In addition, Taylor postulates that there is an evolutionary 
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difference in the female stress response, which is more species preservative than the more 
self-preservative response that was required for male survival [161]. Social programming 
over the life-course will serve to modulate (and possibly amplify) any inherited gender 
differences in the biological stress response. In addition to innate variations in the stress 
response, there is compelling evidence that the first six years of life, and particularly the 
first three, are of critical importance in setting basic coping skills, emotional control and 
habitual ways of responding to events in the environment [589]. 
 
It is possible that the biological markers shown are inadequate measures of the stress 
response, that the questionnaires used to measure life stressors and psychosocial assets 
are inadequate, and that gender differences are artefactual. However, the questions used 
to evaluate psychosocial factors were from standard scales, with proven reliability and 
validity. The data provide evidence of differential distribution of these perceived (self-
reported) psychosocial factors by both SES and gender. There is good physiological and 
empirical support for the status of these biological factors as markers of the stress 
response. This does not rule out artefactual explanations, but requires that serious 
consideration be taken of the non-artefactual possible explanations. 
 
If gender-specific stress responses do exist, can different psychosocial factors activate 
alternative parts of the stress response and their subsequent pathways? Why should 
fibrinogen be particularly sensitive to the effects of work? Why should glycated 
haemoglobin be particularly sensitive to the effects of coping style? Is salivary IgA more 
  344
sensitive to acute stress and positive mood than to chronic stress, or is it just not a good 
reflection of chronic stress? These are questions that this thesis can raise, but not answer. 
 
This study had two main purposes: to evaluate these five biological parameters as 
markers of a chronic stress response for use in research on the socioeconomic 
determinants of health, and to investigate the psychosocial theory of health inequalities. 
 
For the first purpose, fibrinogen, glycated haemoglobin, WHR and serum neopterin 
appear to have some utility, although the association with self-reported stress as 
measured in these questionnaires is poor, perhaps because the questionnaires fail to 
capture those psychosocial factors most likely to trigger the physiological stress response. 
 
For the second purpose, the Biomarkers Study supports a hypothesis that psychosocial 
factors, both stressors and assets, mediate the association between SES and these 
biological markers. However, there are puzzling gender differences and a lack of 
consistency in which particular stressors and assets are important, suggesting that 
assumptions whereby a universal neuroendocrine response to stress causes alteration in 
these markers (and possibly later disease) is too simplistic. Any particular stressor does 
not produce a generalized susceptibility to disease via alterations of the endocrine, 
haemostatic and immune systems; rather stressors may be more specific – work related 
stressors may be particularly related to coronary heart disease, at least partly through 
elevation of plasma fibrinogen, WHR or through an abnormal immune response. 
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Disordered glucose metabolism may be particularly affected not just by stressor 
exposure, but by how people cope with such exposure.  
 
This is the first study to use mediation analysis to examine possible routes from SES to 
health. Sacker et al used path analysis (which has similarities to mediation analysis) to 
show that different dimensions of social position correlate with distinct pathways to ill-
health. In a study of women, aged 20-59 years, Sacker et al hypothesized that alternative 
measures of SES would work through different pathways to affect self-rated health: 
“lifestyle” social status (as measured by the Cambridge Scale) would affect self-rated 
health via behavioural factors such as diet, physical activity, smoking, and alcohol intake, 
and social support; occupation-based social status would work through job strain; and 
measures of material wealth or deprivation would alter diet, social and sport participation, 
as well as lifestyle behaviours. The final model supported this hypothesis, but accounted 
for only 25% of the variance in general self-assessed health. Furthermore, of the social 
status measures, material deprivation had the greatest effect on health, mediated by 
smoking, alcohol intake, social support, physical activity and diet [590].  
 
Mediation analysis does not investigate more upstream determinants of health. Smoking 
is an important mediator of the association between SES and plasma fibrinogen. But what 
are the important mediators of the smoking – SES association? This may be another route 
by which psychosocial factors may affect the biological markers but is not explored in 
this study. Only the immediate effects of psychosocial factors on the SES-marker 
association are explored. More detailed multi-level analysis would be required to 
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examine other pathways between SES and the markers, that may work indirectly through 
behaviour. 
 
Results from the Biomarkers Study suggest that specific types of health outcomes may be 
mediated by particular intermediate factors and have varying associations with different 
measures of SES. The results do not support the concept of a stress-induced increased 
generalized susceptibility to disease; rather particular types of stressors may work 
through alternative stress pathways and be more commonly associated with particular 
classes of disease. During the last century, socioeconomic gradients in ill-health have 
persisted, despite marked changes in the main disease outcomes involved. This has been 
interpreted as evidence of a generalized susceptibility to disease being associated with 
lower SES; but perhaps there has been a change in the nature of stressors experienced by 
lower SES groups. At the beginning of the twentieth century disease gradients existed for 
infectious diseases. Stressors experienced by lower SES groups may have affected the 
immune system, increasing the risk of disease. With the advent of changes in the work 
and living environment, stressors began to work through the haemostatic system to cause 
socioeconomic gradients in coronary heart disease. And we have yet to see how stressors 
of the future may impact on human physiology. 
 
The Biomarkers study sample was relatively small, with an engineered distribution of 
SES. The sample was not representative of the Canberra population, but each SES group 
was randomly selected from the study population (of similar SES) and should be 
reasonably representative of the SES group from which it derives. All participants were 
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Caucasian, living in a high quality social and physical environment with probably under-
representation from the lowest SES groups [91]. All participants rated their own health 
good or better and gave no history of ongoing disease. The study results cannot be 
generalized to the general Australian population of this age group. However, the SES and 
psychosocial variation between the participants is likely to be less than that existing in the 
greater Australian population of this age, so these results may underestimate both the 
variability in the measures and the associations between them. 
6.7 Conclusion 
In this study, I found demonstrable socioeconomic gradients in the levels of several 
biological factors that are plausible markers of the physiological stress response. In 
addition, the data indicated socioeconomic gradients in a number of psychosocial factors, 
including both stressors and psychosocial assets, such as active coping skills and social 
support. However there were few associations between the measured psychosocial factors 
and any of the biological markers. The mediation analysis provides some support for a 
role of both psychosocial stressors and assets in mediating the association between 
socioeconomic status and ill health.  
 
The lack of association between the biological markers and the psychosocial factors is 
surprising in view of previous work and understanding of the neuroendocrine stress 
response. The reasons for this are most likely to be found in the relatively small sample 
size, the good health of the participants and their relatively high socioeconomic status, 
with limited SES variability. 
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Several questions are raised about the pathways from stressor exposure to physiological 
change, in particular to explain gender differences in perception or response as well as 
differential physiological effects for different psychosocial exposures.  
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Chapter 7. 
Conclusion 
Health inequalities in general, and socioeconomic health inequalities in particular, have 
received much research interest at individual, community, state and country levels in the 
last three decades. At the ecological level, it is clear that the association between 
socioeconomic status and health is not straightforward, with some countries and states 
defying the usual trend, both in the direction of better health outcomes despite generally 
lower international SES (GDP per capita) e.g. Costa Rica, and to poorer overall health 
despite higher SES, e.g. the United States. The level of income inequality within 
countries may be important, or may be a sign of government policies that allow both 
income inequality and low public investment in education, health and community-level 
social functioning.  
 
It seems likely that the poorer health associated with lower SES has multiple causes, with 
both group and individual influences. The current study concerns individual attributes 
and health, and aims to further knowledge of effects operating at the individual level. 
Previous research has suggested that there are four major routes to unequal health 
outcomes, each of which act at all stages of the life-course: behavioural influences, 
health-related selection, issues of access (to health care, adequate diet, appropriate 
housing etc), and psychosocial influences. These four routes do not form separate and 
competing pathways (although analytically they may be separated to assess their relative 
significance); rather they interlink and together determine health outcomes. This thesis 
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has focused on an hypothesis that suggests that psychosocial factors have direct, proximal 
(via the neuroendocrine stress response) effects on health, as well as more distal 
influences on the other three routes: health behaviours, health selection and the 
determinants of access.  
 
The Biomarkers Study supports the psychosocial theory. Both psychosocial stressors 
(more prevalent in lower SES groups) and psychosocial assets (more prevalent with 
higher SES) mediate the socioeconomic variation in biological markers, alterations of 
which may predate disease onset. Particular psychosocial factors appear to be linked to 
specific biological measures, suggesting that there may be some variation in the pathways 
by which different stressors or resilience factors have a physiological affect.  
 
John Donne wrote “no man is an island, entire of itself: every man is a piece of the 
continent, a part of the main”[591]. Humans do not exist somehow independent of the 
social, economic and political circumstances in which they live. Yet, as McMichael 
points out, epidemiologists have, in general, become “prisoners of the proximate”, 
focused on the most proximal risk factors for disease [592]. He urges that the marriage of 
epidemiology with the biomedical model of health requires broader reconsideration, with 
a stronger focus on the ecological framework in which communities and populations 
exist.  
 
Nevertheless, the current study does focus on the individual, but with full recognition of 
the part that the larger environment plays in determining health, both directly and 
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indirectly through health behaviours, acquisition of health knowledge, access and use of 
health services and interaction with others. Somehow, the social environment “gets into” 
the biology of a person, affecting the health of individuals and the collective health of 
populations. We need to improve our understanding of each level of influence if we are to 
maximize the health potential of the population. 
 
Notably, it is SES that is associated with health; that is, it is not only poverty that is 
linked to poor health, but there is variation in health status across the full range of SES. 
Certainly, those lowest on the SES ladder have the worst health as a group. But those in 
the middle class, though higher on the SES/health curve, are the most numerous, so the 
majority of those suffering sub-optimal health are not the poverty-stricken, but are from 
the middle class. Rose suggests that this is “one of the most fundamental axioms in 
preventive medicine: a large number of people exposed to a small risk may generate 
many more cases than a small number exposed to a high risk” [593].  
 
Socioeconomic health inequality is a multi-level problem, requiring multi-level research 
(both at multiple different levels and integrated over multiple levels), and action at 
multiple levels. Dahlgren’s model of the causes of health inequalities (Figure 1.1) is 
superficially like the layers of an onion. In reality, the layers are not distinct, but are 
blurred by the interaction between both adjacent and distant, layers. As scientists most of 
us have become locked in our spheres of interest, each discipline studying one layer of 
the onion. Yet such study is of limited relevance – we could become experts in our 
particular layer and remain ignorant of the important influences of the other layers and 
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the interactions between them, by failing to recognize the value of multidisciplinary 
teams of study. 
 
Although the Biomarkers Study was individual-based, it drew from the disciplines of 
psychology, sociology, endocrinology, physiology and immunology. Aspects of several 
different layers of Dahlgren’s schema were included: different elements of 
socioeconomic status, work factors, social conditions, lifestyle factors, gender and some 
constitutional factors. Psychosocial factors are not specifically mentioned in this schema, 
but probably act at several different levels. However, the final pathways of effect from all 
factors are at the level of individual body physiology. The Biomarkers Study used a 
cross-disciplinary approach to examine the factors that lie at levels between 
socioeconomic status and this final pathway of effect. 
 
The future research agenda is large, but much work has already been done, albeit not 
explicitly within the health inequalities framework. For example, if we are to understand 
socioeconomic influences on health behaviours, then we need to include socioeconomic 
terms in the investigation of health behaviours: why do people smoke and what enables 
some of them to stop smoking? What are the determinants of physical activity? Of 
education? Of access to preventive care? If one were to draw in all the intertwining 
threads between the layers of the onion, we would see that many of these pathways have 
already been studied, but in fields distant from health. Figure 7.1 suggests some of the 
interacting pathways to health. 
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Woodward and Kawachi have asked, “Why reduce health inequalities?” [594]. They 
suggest four answers to this simple question: 
1. Inequalities are unfair. Perhaps one of the most important evolutionary 
developments of Homo sapiens is that of a large and complex brain, giving the human 
advantage of abstract thinking, forward planning, language and a social conscience [4]. 
While, given apparent equal opportunity, individuals may be thought responsible for their 
own actions in regard to health, in reality the social, political and economic environment 
throughout the life-course shapes health-affecting decisions. Such real inequality of 
opportunity offends our sense of justice (but perhaps appeals to the sense of selfishness of 
some higher on the SES ladder). 
2. Inequalities affect everyone. The work of Wilkinson, Kawachi and others 
suggests that marked income inequality is associated with loss of social cohesion and 
increased violence and crime as well as poorer overall population health (see Chapter 2). 
Even though the lowest SES groups suffer the worst health, the whole population fails to 
achieve optimal health outcomes. Woodward et al note the spill-over effects of diseases 
that arise under conditions of poverty and go on to affect whole populations, e.g. AIDS, 
cholera and tuberculosis [594]. 
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 Figure 7.1 Interacting pathways to health across multiple levels of influence 
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3. Inequalities are largely avoidable. By the shape of the income/health curve, it 
should be possible to reduce health inequalities without diminishing the health of the 
population overall. The promotion of economic growth does not mean an automatic 
increase in economic or health inequality, provided there is social and political will to 
retain public funding for education and health as well as safety-nets for the disadvantaged 
or those in need in times of crisis, e.g. unemployment.  
4. Cost effective interventions exist. Substantial gains in population health are likely 
to follow from interventions that reduce health inequalities, improving the health of 
whole populations towards that currently enjoyed only by those of higher SES. The 
Independent Inquiry into Inequalities in Health (UK) showed that for men aged 20-64 
years, if all social groups had the same mortality rates as the top two social classes, there 
would have been approximately 17,000 fewer deaths each year from 1991 to 1993 [63]. 
However, there is little empirical evidence of either effectiveness or cost-effectiveness 
from trialled interventions. Further research will be necessary to decide whether 
interventions to improve population health by decreasing socioeconomic health 
inequalities can be cost-effective (although a saving of 17,000 lives over three years in a 
prime working age group should justify considerable cost!). 
 
There are two requirements for interventions to improve health inequalities: the first is a 
government interested in long-term gain for substantial current investment, and the 
second is a greater understanding of what type of intervention might work. Rose 
proposed “the prevention paradox” in which “ a preventive measure that brings large 
benefits to the community offers little to each participating individual” [593]. It may be 
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difficult to justify (to the public) programs that appear to provide little gain to 
individuals, despite considerable community and population-level health gain. 
 
Universal rather than targeted programs may be more effective (though perhaps less 
appreciated as such by individuals) in reducing socioeconomic health inequalities, as well 
as avoiding the “blame the victim” problem. Targeted interventions risk stigmatisation of 
lower SES people and fail to recognize that while there is a higher level of potential 
health loss among the poorest groups in society, in absolute terms the greatest health loss 
is in the middle classes (who have higher numbers but lower per person health loss). 
Interventions must recognize the societal influences on the “victim” and even the 
community level “victim”. It may not be possible to alter individual behaviour or 
community level attributes such as social capital without an understanding of the 
upstream factors that have determined the individual behaviours or the loss of social 
capital within that community.  
 
Prevention, as well as intervention, at many different levels will be the key to alleviating 
socioeconomic health disparities. The recent Early Years Report from Ontario, Canada, 
recommends universal interventions across the life-course: (universal) programs to 
improve parenting skills to optimize neural sculpting of infants and young children, to 
improve maternal and infant nutrition, and to ensure that the education system teaches 
life skills as well as academics [589]. But, simultaneous with these interventions, the 
wider community must recognize the importance of improving parenting skills, support 
changes in the workplace to allow such skills development, and vote for governments that 
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provide education initiatives and adequate welfare support, to allow universal access to 
adequate nutrition, education and health care. 
 
This thesis has described the Biomarkers of Social Disadvantage Study. In a relatively 
small sample of healthy middle-aged adults in an affluent, small, planned, Australian city, 
with universal access to high-quality health care there are demonstrable socioeconomic 
gradients in psychosocial stressors and assets and in biological parameters that may be 
antecedent to ill-health. The results presented suggest complex pathways between facets 
of socioeconomic status, psychosocial factors and physiological changes, but particularly 
highlight the pervasive and fine-grained nature of socioeconomic health gradients that are 
present even in a group of healthy, mainly middle class, adults 
. 
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Appendix A 
The stress response and its effect on body systems 
The neuroendocrine response to stress primarily involves two major body systems, the 
autonomic nervous system (particularly the sympathetic branch) and the hypothalamic 
pituitary axis. 
A.1 Physiological stress pathways 
A.1.1  The Autonomic Nervous System 
The autonomic nervous system (ANS) consists of two limbs, the sympathetic nervous 
system (SNS) and the parasympathetic nervous system (PNS). The SNS is primarily 
associated with conferring an adaptive advantage during stressful situations, mobilizing 
energy, heightening awareness and preparing for action. The PNS primarily opposes the 
actions of the SNS allowing tight control of body systems innervated by both.  
 
The sympatho-adrenal medullary system (SAM) consists of the sympathetic nerves and 
the adrenal medulla. Its actions are mediated by noradrenaline and adrenaline, the latter 
being released from the adrenal medulla on stimulation by sympathetic nerves. 
Adrenaline is the circulating hormone of the SAM, while noradrenaline is the 
neurotransmitter of the postganglionic sympathetic nerve endings [235]. The effects of 
the SNS are induced promptly but dissipate rapidly. 
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A.1.2  The Hypothalamic Pituitary Adrenal Axis 
The hypothalamus secretes a number of neuropeptides that act on the anterior pituitary 
gland to stimulate the release of pituitary hormones. Thus, corticotrophin releasing 
hormone (CRH) stimulates the release of adrenocorticotrophin hormone (ACTH), growth 
hormone releasing hormone (GHRH) stimulates the release of growth hormone (GH), 
thyrotrophin releasing hormone (TRH) stimulates the release of thyroid stimulating 
hormone (TSH) and gonadotrophin releasing hormone (GnRH) stimulates the release of 
luteinizing hormone (LH) and follicle stimulating hormone (FSH). In addition, dopamine 
inhibits the release of prolactin from the anterior pituitary, and arginine vasopressin 
(AVP) and oxytocin are produced in neurons of the hypothalamus and stored in the 
posterior pituitary. Each of these hormones has specific effects on target tissues in the 
periphery. Of particular interest in the stress response, ACTH stimulates the release of 
glucocorticoids, principally cortisol, from the adrenal cortex. Cortisol has wide ranging 
effects on metabolism, the immune system and the brain. These are dealt with in greater 
detail later in this section. 
A.2 The neuroendocrine response to stress  
The response to a stressor has both central and peripheral elements. The central 
components are located in the hypothalamus and brainstem and include: 
1. The parvocellular neurons in the paraventricular nuclei of the hypothalamus, 
producing CRH; 
2. Noradrenergic cell groups in the medulla and pons, including the locus coerulus (LC-
NE); 
3. The arginine vasopressin neurons of the paraventricular nuclei of the hypothalamus; 
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4. The CRH-producing neurons of the paragigantocellular and parabranchial nuclei of 
the medulla and the locus coerulus. 
 
Peripheral components include 
1. The peripheral limbs of the HPA axis, 
2. The efferent SAM, 
3. Components of the PNS, 
4. The immune system and the system of cytokines that provide the interface between the 
nervous, neuroendocrine and immune systems [595]. 
 
The central and peripheral components of the neuroendocrine stress response are shown 
diagrammatically in Figure A.1. 
 
Central components: 
The early signs of activation of the stress response are of activation of the sympathetic 
nervous system, controlled by the LC-NE, in turn stimulated by CRH released from 
various sites. Importantly, the LC-NE also contains CRH-producing neurons, allowing 
communication between the immediate neural response and the slower endocrine 
response. Indeed, the central CRH and LC-NE/autonomic systems function as 
components in a positive, reverberatory, feedback loop, in which activation of one system 
appears to activate the other [162]. 
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Figure A.1:  The Neuroendocrine stress response  Adapted from [158] 
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The LC-NE produces most of the noradrenaline in the brain and this serves as the alarm 
system for the brain, activating the amygdala, which is the principal brain locus for fear-
related behaviours. In addition, noradrenaline promotes the long-term storage of 
aversively charged memories in the hippocampus [158]. 
 
CRH is released from a number of brain sites including the paraventricular nucleus of the 
hypothalamus and the amygdala. AVP, released from the posterior pituitary, is 
synergistic with CRH for the release of ACTH from the anterior pituitary. In addition, 
CRH and AVP have a reciprocal positive interaction, with each stimulating secretion of 
the other. This means that CRH and AVP continuously upregulate their secretion, 
allowing large amounts of ACTH to be produced. ACTH shares a common precursor 
(pro-opiomelanocortin, POMC) with α-melanocyte-stimulating hormone and β-
endorphin, so that during the acute stress response there may be increased secretion of β- 
endorphin, which may, in turn stimulate the adrenal medulla to produce adrenaline. In 
association with increased release of CRH from the hypothalamus there is decreased 
release of GnRH (and thus decreased release of pituitary gonadotrophins) and decreased 
production of neuropeptide Y (NPY, important in stimulating appetite). ACTH acts on 
the adrenal gland to produce glucocorticoids (from the zona fasciculata) and adrenal 
androgens (from the zona reticularis). 
 
There is a tight linkage between the immune systems and the HPA axis and immune 
mediators such as interleukins 1 and 6 (IL-1, Il-6) are also potent stimulators of ACTH 
secretion.  
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There are multiple inhibitory and excitatory connections within the brain stem and the 
cortex. The mesocorticolimbic system is activated by the stress system and has direct 
connections to the LC-NE and via the amygdala to the hypothalamus. The mesocortical 
component is involved in anticipatory phenomena and cognitive functions, while the 
mesolimbic component plays a principal role in motivational/reinforcement/reward 
phenomena. The hippocampus exerts an inhibitory influence on the activity of the LC-
NE, the amygdala and the paraventricular nucleus of the hypothalamus. The amygdala-
hippocampus complex is activated during stress by ascending neurons of the SNS, by 
glucocorticoids (GCs) and by inner emotional stressors such as fear [159]. Activation of 
the amygdala is important for retrieval and emotional analysis of relevant information for 
any given stressor. In response to emotional stressors, the amygdala can stimulate the 
hypothalamus, the SAM and the mesocorticolimbic system. The hippocampus exerts 
tonic and inhibitory effects on the activity of the amygdala and the HPA [171]. It has 
important functions in the memory of context, particularly where events have a strong 
emotional bias and allows retrieval and emotional analysis of memories associated with 
the stressor [172]. 
 
The stress response, in turn, facilitates the memory of events associated with strong 
emotions, mediated by adrenaline and GCs [157]. However, there may be stress-induced 
hippocampal dysfunction and memory impairment. Increased glucocorticoid secretion in 
the acute stress response suppresses the mechanisms in the hippocampus and temporal 
lobe that subserve short-term memory [165]. These effects are reversible and relatively 
short-lived. However, repeated stressor exposure may cause the atrophy of hippocampal 
neurons through a mechanism involving both cortisol and various neurotransmitters 
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released during and after stress. While this atrophy is reversible if the stress is short lived, 
stress lasting many months or years can kill hippocampal neurons with consequent 
memory impairment [157, 596]. 
 
Several other brain stem nuclei (Barrington nucleus, nucleus tractus solitarus, dorsal 
motor vagal nucleus) act via the PNS to mediate the gut responses to stress [158]. 
 
The central components act both to activate the peripheral elements of the stress response 
and to facilitate the neural pathways that result in enhanced arousal, alertness, vigilance, 
cognition, focused attention and appropriate aggression [171]. 
 
Peripheral components: 
Activation of the LC-NE and of the SNS causes release of adrenaline from the adrenal 
medulla and stimulation of sympathetic effects on target tissues. Peripheral changes 
include increased cardiovascular tone (with consequent increases in blood pressure and 
heart rate), increased thermogenesis, increased respiratory rate and dilatation of the 
pupils. These effects occur within seconds and are the basis of the fight/flight stress 
response. 
 
Cortisol is released over minutes to hours and exerts its effect through widely distributed 
intracellular receptors. It has a permissive effect on secretion of adrenaline. It causes an 
increase in blood glucose by acting as an insulin antagonist, as well as by stimulating 
gluconeogenesis, to ensure the maximum availability of essential nutrients (e.g. oxygen 
and glucose) to the central nervous system and body sites such as muscles that may be 
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required to deal with a threat. There is an increase in protein breakdown, and lipolysis. 
Glucocorticoids cause an elevation of circulating polymorphonuclear leucocytes by 
increasing the release of mature cells from the bone marrow and inhibiting their loss 
through the capillaries as part of the acute inflammatory process. There is depletion of 
circulating eosinophils and T cells by redistribution from the circulation into other 
compartments. Cortisol inhibits several transcription factors (e.g. NF-κβ), which are 
involved in the transcription of several genes controlling the function and growth of 
nonimmune and immune cells. There appears to be an inverted U-shaped response of 
neuronal function to cortisol levels, with low concentrations maintaining, moderate 
concentrations promoting and high concentrations impairing function [596]. 
 
The stress response is tightly controlled by negative feedback loops. Cortisol produced by 
the adrenal cortex inhibits the secretion of ACTH and CRH, as well as acting on the 
hippocampus and the frontal cortex. While much is known about the stress response, the 
exact mechanism by which the response is turned on and off is still unclear. 
A.3 Effects on target systems 
The stress response results in release of adrenaline and cortisol from the adrenal gland, 
increased activity of the SNS and inhibition of the release of a number of hormones 
controlling vegetative functions, e.g. growth hormone and the sex steroids. These 
neurohumoral products of the stress response have wide ranging effects on all body 
systems. Some of these effects are briefly reviewed below, as an introduction to the wide-
ranging effects of stressor exposure on the body. 
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A.3.1  Gastrointestinal tract 
Inhibition of the PNS as well as release of CRH from stress responsive enteric neurons 
may be responsible for the effects of stressors on the gastrointestinal system. Such effects 
range from diarrhea (acute stress) to gastric mucosal disruption and bleeding (stress 
ulcer). 
A.3.2  Reproductive system 
The reproductive system is inhibited at all levels by various components of the HPA axis. 
Both CRH and glucocorticoids suppress GnRH, inhibiting the release of LH and FSH 
from the anterior pituitary. GCs act on target tissues of sex steroids making them resistant 
to these hormones. Suppression of gonadal function is a common feature of those under 
severe physical stress, such as ballet dancers, gymnasts and highly trained runners [158]. 
A.3.3  Growth 
GHRH is suppressed by CRH, leading to suppression of GH secretion from the anterior 
pituitary. In addition, GCs inhibit the effects of other growth factors (including insulin 
like growth factor 1, IGF-1) on their target tissues [158]. Prolonged activation of the 
stress response is associated with inhibition of growth, such as that seen in psychosocial 
short stature in children and adolescents with severe emotional deprivation and/or 
physical or psychological abuse [159]. 
A.3.4  Metabolic system  
The metabolic system is primarily concerned with the maintenance of body tissues and 
energy balance in the body – the availability of energy as required (in the form of 
glucose), the storage of excess energy (as fat and glycogen) and the maintenance of tissue 
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protein. The liver is a particularly important organ for the maintenance of metabolic 
homeostasis. Figure A.2 outlines stress effects on the metabolic system. 
 Carbohydrate metabolism 
Maintenance of blood sugar within relatively narrow limits is achieved by a combination 
of glycogenesis (formation of glycogen), glycogenolysis (glycogen breakdown), 
glycolysis (the breakdown of glucose) and gluconeogenesis (the formation of glucose) in 
the liver. These actions are under the control of a number of hormones, including: 
 
1. Insulin: released from the pancreas in response to elevations of blood glucose, it 
increases glucose uptake by tissues, slows glycogenolysis and inhibits 
gluconeogenesis.  
2. Glucagon: also released from the pancreas, it is antagonistic to the actions of insulin. 
It stimulates glycogenolysis and gluconeogenesis and the release of glucose back 
into the circulation. 
3. Growth hormone: stimulates the growth of bones and cartilage via insulin-like growth 
factor (IGF-1) that is produced in the liver under GH stimulation, as well as 
facilitating the release of insulin. IGF-1 has some insulin like action. GH may also 
have a direct effect as an insulin antagonist, opposing the effects of insulin on 
glucose uptake and fatty acid release.  
4. Adrenaline: increases the rate of glycogenolysis in the liver and skeletal muscles and 
the release of glucose into the blood.  
5. Cortisol: stimulates gluconeogenesis from proteins and fat to increase blood sugar. 
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Figure A2: Carbohydrate and Fat Metabolism 
 
  436
Activation of both the SAM and the HPA axis results in acute increases in blood glucose, 
providing energy, while inhibiting vegetative functions such as muscle and bone anabolism, 
lipogenesis and reproduction. 
 Fat metabolism 
Fat forms the body’s store of energy. Fat deposition is a balance between lipogenesis (fat 
formation) and lipolysis (fat breakdown). It is a complex process controlled by 
neuropeptide Y, leptin, the SAM pathways and the HPA axis. Leptin (secreted by 
adipocytes under the control of TNF-α, and IL-6 [257]) and neuropeptide Y have opposite 
effects on the hypothalamus inducing satiation or appetite respectively [163, 597, 598]. In 
addition, leptin stimulates the LC-NE system and inhibits hypothalamic CRH production, 
while NPY inhibits the LC-NE system and stimulates hypothalamic CRH production. 
Insulin promotes lipogenesis, while growth hormone and the sex hormones stimulate 
lipolysis. Adrenaline and noradrenaline stimulate lipolysis by stimulating hormone 
sensitive lipase (HSL), while cortisol inhibits the effects of insulin on skeletal muscle but 
potentiates its effects on adipose tissue, enhancing lipogenesis [599]. TNF-α, IL-1 and IL-6 
inhibit lipogenesis and stimulate lipolysis, while IFN-γ enhances hepatic fatty acid 
synthesis [600]. 
A.3.5  Immune system 
The human immune system is responsible for the surveillance and management of breaches 
of the physical protective barriers of the body, the skin and mucous membranes. The cells 
and molecules of the immune system combine to attack and destroy potentially invasive 
microbes. 
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Stress has long been thought to weaken the immune system, enhancing susceptibility to 
infectious disease. It has proven more difficult to demonstrate this conclusively humans. 
The difficulty lies in the choice of immune marker, the measurement of stressor exposure 
and the confounding effect of psychosocial factors. 
 
That there is communication between the HPA axis, the SMA system and the immune 
system is clear. The communication is bi-directional, mediated by cytokines, 
glucocorticoids and other hormones. 
 
Each immune response generally has two fundamentally different elements (outlined in 
Figure A.3), working together: 
• a primitive innate non-specific response based on phagocytic cells, complement, 
cytokines and natural killer cells that occurs in the same way no matter how many times the 
pathogen is encountered 
• an adaptive or acquired specific response based on immunological memory via T cells 
and B cells, that responds with increasing efficiency with each repeated exposure to the 
pathogen. 
 
In the acute inflammatory response to an invading pathogen, complement is activated 
through the classic, alternative or lectin pathways. The ensuing cascade results in the 
release of various elements of complement. These enhance the attraction of phagocytic 
cells to the site, as well as stimulating phagocytosis of the pathogen and the release of 
inflammatory mediators such as histamine, which in turn cause increases in local vascular 
permeability and further attraction of neutrophils. This is the primitive innate immune 
response. 
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The acquired immune response is based on lymphocytes and comprises antigen-specific B 
and T cells and antigen-presenting cells. Both T cells and B cells derive from pluripotent 
stem cells present in the bone marrow and fetal liver. Potential T cells migrate to the 
thymus and undergo maturation and differentiation there. Potential B cells develop in the 
bone marrow and become concentrated in lymph nodes and the spleen as well as circulating 
in blood and lymph. In response to antigens, naive lymphocytes may develop into T or B 
memory cells, cytotoxic T cells, Helper T cells (TH cells) or antibody secreting plasma 
cells.  
 
T cells can be characterized by the presence of different cell surface molecules each of 
which has been assigned a “cluster of differentiation” or CD, number on the cell surface. 
Thus there are CD1, CD2, CD3 molecules, but T cells bearing the CD4 and CD8 molecules 
appear to be of particular importance. CD8 T cells are usually cytotoxic and kill infected 
cells, as well as producing cytokines such as tumour necrosis factor alpha (TNF-α) and 
interferon gamma (IFN-γ). CD4 cells usually act as helper T cells and the CD4 population 
can be divided into TH1 (Type 1 helper) cells and TH2 (Type 2 helper) cells. TH2 helper 
cells secrete a variety of cytokines (including interleukins (IL) 4, 5, 6 and 10) that help B 
cells secrete protective antibodies. Most antigens are unable to  
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Figure A.3 The immune system (from [337]) 
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stimulate B cells without help from CD4 T helper cells. TH1 helper cells produce other 
cytokines, including IFN-γ and IL-2 that are involved in the activation of macrophages and 
cytotoxic T cells. B cells and macrophages produce IL-12, which is involved in the 
proliferation of natural killer cells, IFN-γ production and promotion of cell-mediated 
immune functions. 
 
During the stress response, the activated SNS exerts systemic effects on immune organs by 
inducing the secretion of IL-6 in the systemic circulation. IL-6, in turn, stimulates GC 
secretion. Catecholamines inhibit IL-12 secretion from B cells and stimulate IL-10 
secretion from TH2 helper T cells via β-adrenergic receptors. The net result of the combined 
effects of GCs and catecholeamines is the suppression of innate and cellular immunity and 
stimulation of humoral immunity. Thus stress related immunosuppression involves mainly 
the innate and cellular immune responses, facilitating diseases related to deficiency of this 
type immune response, such as the common cold, tuberculosis and certain tumours. 
A.3.6  Haemostatic system 
The acute stress response, as well as the coagulation cascade and the acute phase response, 
form a tightly interwoven matrix for the reaction, protection and restoration to health of the 
challenged individual. While the acute stress response is initiated by a perceived threat to 
homeostasis, the coagulation cascade is initiated within seconds by trauma or disease that 
disrupts the vascular endothelial lining and the acute phase response is initiated by 
activation of tissue macrophages and monocytes by bacterial by-products or mediators  
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released from aggregation-induced platelet activation in the course of the coagulation 
cascade. The matrix is designed to protect an individual from typical evolutionary 
challenges – primarily physical. If an injury is sustained, the coagulation cascade and the 
acute phase response immediately act to diminish the extent of damage and ultimately to 
restore homeostasis. 
 The coagulation cascade [186] 
Disruption of the vascular endothelium results in exposure of subendothelial connective 
tissue. Platelets adhere to this tissue and undergo release of preformed granules, producing 
ADP, Factor Va, platelet-derived growth factor (PDGF), fibronectin, thromoxane A2 and 
heparinase. Released ADP initiates changes in the conformation of platelet membrane 
glycoproteins, such that they bind circulating fibrinogen. In this way, the initially adherent 
platelets bind fibrinogen, which in turn binds further platelets to form the initial 
haemostatic platelet plug. This process takes only seconds. Released PDGF stimulates the 
growth and migration of fibroblasts and smooth muscle cells within the vessel wall to begin 
the definitive repair of the blood vessel. Simultaneous with the formation of the primary 
platelet plug, a secondary haemostatic system is initiated, resulting over several minutes in 
the formation of a firmer, definitive clot. The coagulation cascade involves the conversion 
of small amounts of a series of inactive coagulation factors to active factors with the 
formation of a succession of surface-bound complexes. The penultimate step is the 
conversion of prothrombin to thrombin in the presence of activated factor V (Factor Va), 
calcium and phospholipid on the surface of the activated platelets. Thrombin converts a 
small portion of circulating fibrinogen to fibrin, by lysis of A and B fibrinopeptides from 
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the alpha and beta chains of fibrinogen. The resulting fibrin monomer undergoes structural 
change to become cross-linked fibrin, the basis of the definitive clot. 
 
As well as providing haemostasis, the clot forms a basis on which fibroblasts and epithelial 
cells can adhere and promote wound healing [601]. Formation of fibrin, in turn, enhances 
the rate of activation of plasminogen by plasminogen activators (tissue-type plasminogen 
activator (tPA) and urokinase-type plasminogen activator (u-PA)) resulting in the formation 
of plasmin, which acts to breakdown fibrin into fibrin degradation products (FDPs) [184]. 
Thus, as soon as a thrombus is formed, the fibrinolytic system is activated to control the 
extent of clot formation. The formation of fibrin from fibrinogen and its breakdown by 
plasmin is a dynamic process designed to provide the essential “plug” in a disrupted vessel 
(and subsequent tissue repair processes) while ensuring that the clot remains localized to 
the site of injury. 
 
While the coagulation cascade is narrowly focused on restoring vascular integrity, the acute 
phase response has a wider role in restoring stability following a challenge – to prevent 
ongoing tissue damage, isolate and destroy infective organisms and activate repair 
processes. The acute phase response involves the immune system, the haemostatic system 
and the systems involved in the stress response (HPA, SAM) to provide a coordinated 
response. 
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 The acute phase response [181] 
Mast cell degranulation and aggregation-induced platelet activation result in the release of 
mediators that are chemotactic for tissue macrophages and blood monocytes. Activated 
macrophages and monocytes release a number of cytokines, particularly IL-1 and TNF-α, 
which, in turn act on stromal cells (including fibroblasts and endothelial cells) to cause the 
release of a secondary wave of cytokines including IL-8 (chemotactic for neutrophils), 
monocyte chemoattractant protein (MCP, chemotactic for monocytes), intercellular 
adhesion molecule (ICAM, promotes transendothelial migration of leukocytes) and 
interleukin-6 (IL-6). While many of the cytokines released (including those above) are 
involved in the attraction of leukocytes to the site of injury, and their migration through the 
vessel wall, IL-6 is a potent stimulator of the HPA axis and acts on hepatocytes to increase 
the production of most of the acute phase proteins (APPs). It is a primary activator of type 2 
APPs – fibrinogen, haptoglobin and α1-antitrypsin. Production of other acute phase 
proteins, such as C-reactive protein, complement component C3, and α1-acid glycoprotein 
is primarily mediated by IL-1 type cytokines. Fibrinogen and the other acute phase proteins 
have important roles in enhancing the inflammatory and immune responses to challenge.  
 
Glucocorticoids enhance the effect of IL-1 and IL-6 on acute phase protein production, but 
inhibit the production of IL-6. The acute phase response is also regulated by naturally 
occurring antagonists such as IL-1 receptor antagonist (IL-1RA) and soluble TNF receptor 
and other cytokines including IL-4 and IL-10. Once activated, the acute phase response  
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subsides over 24-48 hours as a result of inhibition of release of IL-1 and IL-6 by cortisol 
and antagonistic cytokines. 
 
The acute stress response is activated in a similar way whether the stressor be physical or 
psychological, but the coagulation cascade is not activated unless there is a breach of the 
vascular endothelium. However, the acute phase response may be activated in both physical 
and psychological stress under the effect of IL-6 and GCs. Acute psychological stress 
appears to increase levels of IL-6 and TNF-α and cortisol enhances the effects of IL-1 and 
IL-6 type cytokines on the hepatic synthesis of acute phase proteins, as well as inhibiting 
release of IL-6 in a negative feedback control loop.  
 
The physiological result of the acute phase response is four-fold: 
 
1. release of mediators that cause leukocytes to be drawn to the site of injury; 
2. altered vessel permeability allowing the escape into tissues of plasma constituents; 
3. release of pain mediators such as bradykinin at the site of injury; 
4. release of acute phase proteins, fibrinogen, haptoglobin, C-reactive protein etc.  
 
While these outcomes are protective following a physical threat and subsequent injury, 
such a response to psychological stress is inappropriate. Elevated levels of IL-6, IL-1, TNF-
α as well as fibrinogen and C-reactive protein are not required for the individual to recover 
from psychological stress and may be disease-inducing. 
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Table A.1 Physiologic/somatic consequences of chronic stress system activation/target tissue 
effects [583] 
HPA axis cortisol Locus coerulus/noradrenaline 
catecholeamines, IL-6 
CNS effects  
+ Hippocampal negative feedback impairment  
+ Potentiation of amygdala actions/fear + (Catecholeamines) 
+ Mesocorticolimbic dopaminergic system 
dysfunction 
 
- Leptin actions  
- GH/IGF-1  
-LH/T/E2  
- TSH/T3 - (IL-6) 
Increased blood pressure  
+ Vasoconstrictor systems  
   Catecholeamines/angiotensin 2 + (Catecholeamines) 
   Arginine-vasopressin/endothelin  
-  Vasodilatory systems  
   Kallikrein/prostacyclin  
   Nitric oxide synthase/inflammatory cytokines  
+ Salt retention  
- Renin substrate + Renin (catecholeamines) 
Visceral fat syndrome  
Insulin resistance  
+ Gluconeogenesis + (Catecholeamines) 
-  Peripheral glucose disposal  
+ Insulin concentrations  
+ Visceral fat cell growth/function  
+ Carbohydrate intolerance  
+  Cholesterol, LDL, small dense LDL, FFA, 
triglycerides 
 
-  HDL  
+ Coagulation processes + (IL-6) 
-  Thrombolytic processes  
-  Insulin-induced vasodilation causing hypertension  
+ Impaired insulin secretion  
Atherosclerosis/cardiovascular diseases + (IL-6 proinflammatory activity) 
Low bone mineral density/osteoporosis  
-  Osteoblastic activity + Osteoclastic activity (IL-6) 
Immune dysfunction  
-  IL-12, TH1 + IL-4, IL-10, IL-13, TH2 
+, stimulation; -, inhibition; CNS, central nervous system; HPA axis, hypothalamic-pituitary-
adrenal axis; GH/IGF-1, Growth hormone/IGF-1; LH/T/E2, luteinizing 
hormone/testosterone/oestradiol; TSH/T3, thyroid stimulating hormone/triiodothyronine; LDL, low 
density lipoprotein; FFA, free fatty acid; HDL, high density lipoprotein; IL, interleukin; TH1, T 
helper 1; TH2, T helper 2. 
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Table A.1 presents a summary of the effects of chronic activation of the stress response, on 
body systems.  
 
This overview of bodily systems involved in the acute stress response forms a background 
to the choice of biological markers, outlined in Chapter 3, part two. 
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Appendix B 
 
Study Questionnaires 
 
 
 
 
 
THE  AUSTRALIAN  NATIONAL  UNIVERSITY 
 
National Centre for Epidemiology and Population Health 
& The Centre for Mental Health Research  
 
Biomarkers of Stress Study 
 
 
Confidentiality 
The information provided by you in this questionnaire will be treated in the 
strictest confidence.  Information will be stored by ID number only.  Names 
are stored separately from all other information that has been provided. 
 
Completing the questionnaire 
Please complete all questions.  Work quickly, not spending too much time on 
any one item.   
Don’t worry about being “consistent” in your answers.  Respond to each 
question as if it was the only one. 
 
When completed please seal the questionnaire in the envelope provided.  I 
will collect this questionnaire at the time of the interview. 
 
Thank you for taking part in this project. 
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Question 1 
 
What is the gross income (including pensions and allowances) that you usually receive each 
week from all sources?  
If this has recently changed please mark the typical weekly income over the last year or so.
  
 
Mark one box only for personal income and one box for total household income. 
 
Count all income including:  family payment 
                                                  Additional family payment 
                                                  Rental assistance 
     Pensions 
     Unemployment benefits 
     Student allowance 
     Maintenance (child support) 
     Worker’s compensation 
     Superannuation 
     Wages 
     Salary 
     Overtime 
     Commissions and bonuses 
     Interest received 
     Dividends 
     Rents received  
      (less expenses of operation) 
     Business or farm income  
      (less expenses of operation) 
Do not deduct:   tax 
 Superannuation 
 Health insurance 
 
 
Please note: 
For total household income please include the income of all persons who you feel are part of your 
household –yourself, your partner, children, others who share food and essentials for living in your 
dwelling. 
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Personal income 
 
 $2000 or more per week                                                                   
      ($104,000 or more per year) 
 
 $1500 - $1999 per week 
      ($78,000 - $103,948 per year) 
  
 $1000 - $1499 per week 
      ($52,000 - $77,999 per year) 
 
 $800 - $999 per week 
      ($41,600-$51,999 per year) 
 
 $700 - $799 per week 
      ($36,400 - $41,599 per year) 
 
 $600 - $699 per week 
       ($31,200 - $36,399 per year) 
 
 $500 - $599 per week 
      ($26,000 - $31,199 per year) 
 
 $400 - $499 per week 
      ($20,800 - $25,999 per year) 
 
 $300 - $399 per week 
       ($15,600 - $20,799 per year) 
 
 $200 - $299 per week 
       ($10,400 - $15,599 per year) 
 
 $160 – $199 per week 
       ($8,320 - $10,399 per year) 
 
 $120 - $159 per week 
      ($6,240 - $8,319 per year) 
 
 $80 - $119 per week 
      ($4,160 - $6,239 per year) 
 
 $40 - $79 per week 
       ($2,080 - $4,159 per year) 
 
 $1 - $39 per week 
       ($1 - $2,079 per year) 
 
 Nil income 
 
 Negative income 
 
 
 
 
 
 
 
 
Total Household income (including your own 
income) 
 
 $3500 or more per week 
       ($182,000 per year) 
 
 $3000 - $3499  per week 
       ($156,000 - $181,948 per year) 
 
 $2500 - $2999 per week 
       ($130,000 - $155,948 per year) 
 
 $2000 -$2499 per week 
       ($104,000 -$129,948 per year) 
 
 $1750 - $1999 per week 
       ($91,000 - $103,948 per year) 
 
 $1500 - $1749 per week 
       ($78,000 - $90,948 per year) 
 
 $1250 - $1499 per week 
       ($65,000 - $77,948 per year) 
 $1000 - $1249 per week 
       ($52,000 - $64,948 per year) 
 
 $900 - $999 per week 
       ($46,800 - $51,948 per year) 
 
 $800 - $899 per week 
       ($41,600 - 46,748 per year) 
 
 $700 - $799 per week 
       ($36,400 - $41,599 per year) 
 
 $600 - $699 per week 
       ($31,200 - $36,399 per year) 
 
 $500 - $599 per week 
       ($26,000 - $31,199 per year) 
 
 $400 - $499 per week 
       ($20,800 - $25,999 per year) 
 
 $300 - $399 per week 
       ($15,600 - $20,799 per year) 
 
 $200 - $299 per week 
       ($10,400 - $15,599 per year) 
 
 $100 - $199 per week 
        ($5,200 - $10,348) 
 
 Less than $100 per week 
       ($5,200 per year) 
 
 Nil income / negative income
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2.  What is your current relationship  
     status?   
1.  Married 
2.  De facto 
3. Separated 
4.  Divorced 
5.  Widowed 
6.  Never married 
3.  How long is it since your last marriage or  
     de facto relationship ended? 
 
           _____ years      _____months        
4. Have you changed jobs in the last six 
       months? 
 
         Yes           No (go to Q7) 
 
5. Would you say you have more or less  
       control of your work in the new job?     
    
        More            Less         Same 
 
6. Would you say there are more or less  
      demands on you in the new job? 
 
       More              Less        Same 
 
7. Are you taking any medications  
(including oral contraceptives, over the counter 
preparations, prescription medications,  
herbal remedies, homeopathic remedies etc). 
              Yes           No  
     If ‘Yes” please list medication and what you 
     use this medication for :  
 
     Medication                           Used for: 
___________________________________ 
___________________________________ 
___________________________________ 
___________________________________ 
___________________________________  
8.  Do you currently smoke?  
                     
                     Yes           No 
 
9. How many cigarettes do you usually smoke in  
      one week?        ________ 
 
10.  Have any of the following things happened 
to you during the last six months? 
 
a) You yourself suffered a serious illness, injury 
or an assault.  
                              Yes         No 
 
b) A serious illness, injury or assault happened 
to a close relative. 
                               Yes         No 
  
c) Your parent, child or partner died. 
 
                               Yes         No 
          
d) A close family friend or another relative         
      (aunt, cousin, grandparent) died. 
 
                               Yes         No 
 
e) You broke off a steady relationship. 
 
                                Yes         No 
  
f) You had a serious problem with a close friend,  {
      neighbour or relative. 
 
                                Yes         No 
 
g) You had a crisis or serious disappointment in 
your work or career. 
 
                                Yes         No 
 
h) You thought you would soon lose your job.  
 
                                Yes         No 
 
i) You became unemployed or you were seeking work  
      unsuccessfully for more than one month. 
 
                                Yes         No 
 
j) You were sacked from your job. 
 
                               Yes         No 
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k) You had a major financial crisis. 
 
              Yes         No 
    
l) You had problems with the police and a court 
appearance. 
 
              Yes         No 
    
m) Something you valued was lost or stolen.  
 
              Yes         No 
 
11. What do you consider to be the major  
     stresses in your life in the last six months? 
   _____________________________ 
   _____________________________ 
12. How would you rate your average stress  
      level over the last six months? 
 
        High        Medium      Low 
 
By partner we mean spouse or de facto  
partner.  
 
13. What is your partner’s job title? If more than 
     one job, record title of    main job. 
     (Please include level/rank)                    
   _________________________________ 
   ___________________________________ 
14. What are his/her main duties or activities? 
   __________________________________ 
   __________________________________ 
   ___________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15.  Is he/she   
 
                       Employed by a government agency  
 
                       Employed by a profit-making  
                           organization 
 
                        Self-employed .Please state number of 
employees________ 
 
                       Other 
 
16.  Which of the following best describes the position  
       he/she holds within the business or organisation? 
 
                         Managerial position         
                         Supervisory position 
                         Non-management position 
 
17.  Have any of the following happened in the last  
        six months? 
 
a)  Your partner thought he/she would soon lose  
        his/her job? 
                         Yes         No 
b) Your partner had a crisis or serious disappointment  
       in his/her work or career. 
                         Yes         No 
18. About how many close friends and close  
        relatives do you have (people you feel at ease  
        with and can talk to about what is on your mind)? 
                          
     Write in the number of close friends and close  
      relatives.  
                        __________  
                       
19. How many registered motor vehicles are owned  
        and/or used by members of this household that  
        are usually garaged or parked near your dwelling? 
        (Exclude motor bikes, motor scooters, and  
        tractors. Include company vehicles kept at home) 
 
  0  None 
                 1  One motor vehicle 
                 2  Two motor vehicles 
                 3  Three motor vehicles 
                 4  Four or more motor vehicles 
                 5  Not Applicable  (e.g. no driver’s 
licence) 
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Now I want to ask you some questions about  
your childhood. 
 
When you were age 12, what was the highest 
educational achievement of: 
20. Your mother 
 
1  No schooling                                                               
2  Some primary schooling,  
        but did not complete 
3  Completed primary school 
4  Left school before age 15,  
       no qualifications later 
5  Completed high school,  
        no qualifications later 
6  Trade certificate, diploma or equivalent 
7  University degree 
 
21. Your father 
 
1  No schooling                                                               
2  Some primary schooling,  
        but did not complete 
3  Completed primary school 
4  Left school before age 15,  
       no qualifications later 
5  Completed high school,  
        no qualifications later 
6  Trade certificate, diploma or equivalent 
7  University degree 
 
At age 12, what were your parents’ occupations?  
(Title and brief description of job) 
 
22. Mother:    
      Job Title (include rank/level) 
__________________________________ 
 
     Job description:  
___________________________________ 
 
23.  Father:   
      Job Title (include rank/level):  
___________________________________ 
 
     Job description:  
___________________________________ 
 
This is the end of the section about your  
childhood. 
 
 
 
24.  How would you describe your accommodation? 
       (Please mark ONE circle only) 
 
1    Rented house 
2    Rented flat/unit/apartment/townhouse 
3    Own house 
4    Own flat/unit/apartment/townhouse 
5    ACT Housing Trust house 
6    ACT Housing Trust flat/unit/semi-detached house 
7    Living with relatives who are the primary occupants  
of a dwelling 
8    Other eg caravan park, mobile, please specify  
_____________________________________ 
 
25. These questions ask what you think about the way  
       most people behave nowadays.  Please mark the  
       circle below each statement that is closest to  
       your opinion. 
 
a) Most people tell the truth when they’re sorting out a                   
problem. 
              1      Definitely disagree 
              2      Disagree 
              3      Disagree a bit 
              4      Neither agree nor disagree 
              5      Agree a bit 
              6      Agree 
              7      Definitely agree  
                          
b) Most people make agreements honestly. 
             1      Definitely disagree 
             2      Disagree 
             3      Disagree a bit 
             4      Neither agree nor disagree 
             5      Agree a bit 
             6      Agree 
      7       Definitely agree  
 
c) Most people don’t mislead others. 
             1      Definitely disagree 
             2      Disagree 
             3      Disagree a bit 
             4      Neither agree nor disagree 
             5      Agree a bit 
             6      Agree 
             7      Definitely agree 
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d) Most people decide what they expect from  
      each other fairly. 
1      Definitely disagree 
2      Disagree 
3      Disagree a bit 
4      Neither agree nor disagree 
5      Agree a bit 
6      Agree 
7      Definitely agree  
 
Now I would like to ask some questions about  
how you feel about your neighbourhood. 
 
26. Generally speaking, would you say that: 
a). Most people can be trusted or that you can't  
      be too careful in dealing with people? 
 
              1        Most people can be trusted 
              2        Can't be too careful  
 
b). Most of the time people try to be helpful or  
     are they mostly looking out for themselves? 
 
   1       People try to be helpful 
   2       People are mostly looking out for  
                themselves 
 
27. The following statements are about how  
much support you have in your community.  
Please read each one quickly and mark True  
if the statement is probably  true for you, and  
False if it is probably false. If a statement  
seems neither clearly true nor clearly false, try  
to decide quickly which is more likely. 
      
a) No-one I know would throw a birthday party  
    for me. 
                  True          False 
 
c) When I feel lonely there are several people  
       I could call and talk to. 
                 True          False 
 
c) If I decide one afternoon that I would like to 
   go to a movie that evening I could find  
   someone to go with me.       
                 True          False 
 
d) I don’t often get invited to do things  
    with others. 
                 True          False 
 
 
 
e) If I wanted to go out of town (eg to the coast) 
    for  the day, I would have a hard time finding       
someone to go with me. 
                                True          False 
f) If I wanted to have lunch with someone I could  
      easily find someone to join me. 
                                 True          False 
g) I feel that I’m on the fringe in my circle of friends. 
                                 True          False 
h) There are several different people with whom I 
      enjoy spending time. 
                                 True          False 
i) Most people I know don’t enjoy the same things  
      that I do. 
                                 True          False 
j) I regularly meet or talk with members of my family  
      or friends. 
                                 True          False
28. These questions ask about how often you join 
in things in your community.  Please use the 
answer code to circle the number that is closest to 
what you do for each statement below. 
a) I eat my main meal with members of my immediate  
      family.   
                               1   Never          
                               2   Almost never         
                               3   Sometimes         
                               4   Fairly often       
                               5   Very Often   
b)   I do unpaid voluntary work or helping out for free              
(eg, school P&C, fund-raising walks, meals-on-
wheels, cooking sausages at a fete, selling raffle 
tickets).        
                              1   Never          
                              2   Almost never         
                              3   Sometimes         
                              4   Fairly often       
                              5   Very Often   
c)   I pay membership fees to a group that organises  
      activities in my community (eg, sports club, choir,  
      reading circle.) 
                                    1   Never          
                                    2   Almost never         
                                    3   Sometimes         
                                    4   Fairly often       
                                    5   Very Often   
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d) I go to courses on subjects that interest me. 
                        1   Never          
                        2   Almost never         
                        3   Sometimes         
                        4   Fairly often       
                        5   Very Often   
k) I talk to my neighbours “over the fence”         
or in “in the  stairwell”.    
                          1   Never          
                          2   Almost never         
                          3   Sometimes         
                          4   Fairly often       
                          5   Very Often   
l) I take an active part in at least one group      
that organises activities in my community (eg, 
sports club, choir, reading circle.) 
       1   Never          
                           2   Almost never         
                           3   Sometimes         
                           4   Fairly often       
                           5   Very Often   
m) I make time to attend services at a place of  
worship.      
      1   Never          
                         2   Almost never         
                         3   Sometimes         
                         4   Fairly often       
                         5   Very Often   
h)My friends come over to my place or I go  
      to theirs.  
     1   Never          
                         2   Almost never         
                         3   Sometimes         
                         4   Fairly often       
                         5   Very Often   
i)When I do unpaid voluntary work or helping out 
for free, I take on jobs like secretary or treasurer. 
     1   Never          
                         2   Almost never         
                         3   Sometimes         
                         4   Fairly often       
                         5   Very Often   
j)I make time to keep in touch with my friends.          
                          1   Never          
                          2   Almost never         
                          3   Sometimes         
                          4   Fairly often       
                          5   Very Often   
k)   I give money to charity if I’m asked. 
            1   Never          
                                2   Almost never         
                                3   Sometimes         
                                4   Fairly often       
                                5   Very Often   
l) I talk about current affairs with my friends or 
family. 
            1   Never          
                                2   Almost never         
                                3   Sometimes         
                                4   Fairly often       
                                5   Very Often   
29. Think of this ladder as representing where 
people  stand in their communities. 
 
People define community in different ways;  
please define it in whatever way is most meaningful 
to you. At the top of the ladder are the people who 
have the highest standing in their community.  
At the bottom are the people who have the lowest 
standing in their community. 
 
Where would you place yourself on this ladder? 
Please place a large “X” on the rung where you think  
you stand at this time in your life, relative to other  
people in your community. 
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The next questions are about how you feel 
about yourself. 
 
30. How strongly do you agree or disagree 
with these statements? Please use the answer 
code to circle the number that is closest to 
how you feel about each statement. 
 
Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
1 2 3 4 
 
1 I feel that I’m a person of worth, at 
least on an equal with others. 
        1         2         3         4   
 
2. I feel that I have a number of good 
qualities. 
        1         2         3         4   
3. All in all, I am inclined to feel that 
I’m a failure. 
        1         2         3         4   
4. I am able to do things as well as 
most other people. 
        1         2         3         4   
5. I feel I do not have much to be 
proud of. 
        1         2         3         4   
6. I take a positive attitude toward 
myself. 
        1         2         3         4   
7. On the whole, I am satisfied with 
myself. 
        1         2         3         4   
8. I certainly feel useless at times. 
        1         2         3         4   
9. I wish I could have more respect for 
myself. 
        1         2         3         4   
10. At times I think I am no good at ll. 
        1         2         3         4   
 
 
The following questions try to look at how 
you see life. 
 
31. How strongly do you agree or disagree 
with    these statements?  Please use the 
answer code to circle the number that is 
closest to how you feel about each 
statement. Please note that this is a 
different code to the previous question. 
 
Strongly 
Agree 
Agree Neutral Disagree Strongly 
Disagree 
1 2 3 4 5 
 
1. In uncertain times, I usually expect the 
best. 
                   1        2        3        4        5 
2. It’s easy for me to relax.  
                   1        2        3        4        5 
3. If something can go wrong for me, it will.  
                   1        2        3        4        5 
4. I’m always optimistic about my future. 
                   1        2        3        4        5 
5. I enjoy my friends a lot.  
                   1        2        3        4        5 
6. It’s important for me to keep busy.  
                   1        2        3        4        5 
7. I hardly ever expect things to go my way.  
                   1        2        3        4        5 
8. I don’t get upset too easily.  
                   1        2        3        4        5 
9. I rarely count on good things happening 
to me.  
                   1        2        3        4        5 
10. Overall, I expect more good things to 
happen to me than bad. 
                   1        2        3        4        5 
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32. The following questions ask you about  
your feelings and thoughts during the last month.  
In each case, please indicate how often you felt  
or thought a certain way. 
(a) In the last month, how often have you been 
upset because of something that happened       
unexpectedly?       1   Never          
                                    2   Almost never         
                                    3   Sometimes         
                                    4   Fairly often       
                                    5   Very Often   
(b) In the last month, how often have you felt  
      that you were unable to control the important      
things in   your life?         
                                    1   Never          
                                    2   Almost never         
                                    3   Sometimes         
                                    4   Fairly often       
                                    5   Very Often   
(c) In the last month, how often have you felt  
      nervous and “stressed”? 
                                    1   Never          
                                    2   Almost never         
                                    3   Sometimes         
                                    4   Fairly often       
                                    5   Very Often   
(d) In the last month, how often have you felt 
confident about your ability to handle your 
personal problems?  
                                    1   Never          
                                    2   Almost never         
                                    3   Sometimes         
                                    4   Fairly often       
                                    5   Very Often   
(e) In the last month, how often have you felt  
      that things were going your way? 
                                    1   Never          
                                    2   Almost never         
                                    3   Sometimes         
                                    4   Fairly often       
                                    5   Very Often   
(f) In the last month, how often have you found 
that you could not cope with all the things that 
you had to do? 
                                    1   Never          
                                    2   Almost never         
                                    3   Sometimes         
                                    4   Fairly often       
                                    5   Very Often   
g) In the last month, how often have you been 
able to control irritations in your life? 
                                    1   Never          
                                    2   Almost never         
                                    3   Sometimes         
                                    4   Fairly often       
                                    5   Very Often   
h) In the last month, how often have your felt 
that you were on top of things? 
                                    1   Never          
                                    2   Almost never         
                                    3   Sometimes         
                                    4   Fairly often       
                                    5   Very Often   
i) In the last month, how often have you been 
angered because of things that were outside 
of your control? 
                                    1   Never          
                                    2   Almost never         
                                    3   Sometimes         
                                    4   Fairly often       
                                    5   Very Often   
j) In the last month, how often have you felt 
difficulties were piling up so high that you 
could not overcome them? 
                                    1   Never          
                                    2   Almost never         
                                    3   Sometimes         
                                    4   Fairly often       
                                    5   Very Often   
33. At the present time: 
 
a) Are you able to afford a home suitable for 
(yourself/your family)?    
                                    1    Yes       
                                    2    No 
b)   Are you able to afford furniture or 
household equipment that needs to be 
replaced?                   
                                    1    Yes       
                                    2    No 
c)   Are you able to afford the kind of car you 
need?                                          
                                    1    Yes       
                                    2    No 
d)   Do you have enough money for the kind 
of food (you/your family) should have?        
                                    1    Yes       
                                    2    No 
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e)   Do you have enough money for the 
kind of medical care (you/your family) 
should have?  
                             1      Yes       
                             2      No 
f)   Do you have enough money for the 
kind of clothing (you/your family) should 
have?    
                              1      Yes       
                              2      No 
g)   Do you have enough money for the 
leisure activities (you/your family) 
want(s)?  
                              1      Yes       
                              2      No 
h)   Do you have any difficulty in paying 
your bills?  
1  A great deal of 
difficulty 
2  Some difficulty 
3  A little difficulty 
4  No difficulty         
i)   At the end of the month/fortnight do 
you end up with: 
     1      some money left over,  
     2      just enough to make ends meet,  
     3      not enough money to make ends 
meet. 
j)   Do you go to the dentist for routine 
dental check-ups? 
      1      Yes, about once a year 
      2      Yes, but less than once a year 
      3      Yes, but it’s a rare event 
      4      No, never 
k)   Does your partner go to the dentist for 
routine dental check-ups? 
      1      Yes, about once a year 
      2      Yes, but less than once a year 
      3      Yes, but it’s a rare event 
      4      No, never 
l)  Do you have household contents/ 
household effects insurance? 
     1       Yes, comprehensive and to full 
replacement value, including 
all items of value. 
     2      Yes, comprehensive but not                                 
quite to full replacement value 
of all items.  
     3      Yes, partial cover 
     4      No,  none 
34.  We are interested in how people respond 
when they confront difficult or stressful 
events in their lives. There are lots of ways to 
try to deal with stress. This part of the 
questionnaire asks you to indicate what you 
generally do and feel, when you experience 
stressful events. Obviously, different events 
bring out somewhat different responses, but 
think about what you usually do when you 
are under a lot of stress. You should treat 
each item separately from every other item. 
There are no right or wrong answers.   
Please circle one number for each question. 
I usually 
don’t do 
this at all 
I usually 
do this a 
little bit 
I usually do 
this a 
medium 
amount 
I 
usually 
do this 
a lot 
1 2 3 4 
  
In response to a stressful event: 
 
1)  I turn to work or other activities to take 
my mind off things.  
1           2          3          4    
2)  I concentrate my efforts on doing 
something   about the situation I’m in. 
1           2          3          4    
3) I say to myself  “this isn’t real” 
1           2          3          4    
4) I use alcohol or other drugs to make 
myself feel better.  
1           2          3          4 
5) I get emotional support from others. 
                               1           2          3          4 
6) I give up trying to deal with it. 
                               1           2          3          4 
7) I take action to try to make the situation 
better. 
                               1           2          3          4 
8) I refuse to believe that it has happened. 
                               1           2          3          4 
9) I say things to let my unpleasant feelings 
escape. 
                               1           2          3          4
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I usually 
don’t do 
this at all 
I usually 
do this a 
little bit 
I usually do 
this a 
medium 
amount 
I 
usually 
do this 
a lot 
1 2 3 4 
 
10)  I get help and advice from other people. 
                1           2          3          4 
 
11)  I use alcohol or other drugs to help me get 
through it. 
                1           2          3          4 
 
12) I try to see it in a different light, to 
make it seem more positive. 
                1           2          3          4 
 
13)  I criticize myself. 
                1           2          3          4 
 
14)  I try to come up with a strategy about 
what to do.    
                1           2          3          4 
 
15)  I get comfort and understanding from 
someone. 
                1           2          3          4 
 
16)  I give up the attempt to cope.  
                1           2          3          4 
 
17)  I look for something good in what is 
happening. 
                1           2          3          4 
 
18)  I make jokes about it.  
               1           2          3          4 
 
19)  I do something to think about it less, 
such as going to movies, watching 
TV, reading, daydreaming, sleeping, 
or shopping. 
               1           2          3          4 
 
20)  I accept the reality of the fact that it 
has happened. 
               1           2          3          4 
 
21)  I express my negative feelings. 
               1           2          3          4 
 
 
 
22)  I try to find comfort in my religion or spiritual 
beliefs. 
                    1           2          3          4 
23)  I try to get advice or help from other people 
about what to do. 
                    1           2          3          4 
24)  I learn to live with it. 
                    1           2          3          4 
25)  I think hard about what steps to take. 
                    1           2          3          4 
26)  I blame myself for things that happened. 
                    1           2          3          4 
27)  I pray or meditate. 
                    1           2          3          4 
28)  I make fun of the situation. 
                    1           2          3          4 
The next few questions ask about your situation at 
work. If you are not in the workforce, please go to 
Q 59. 
35. Do you have a choice in deciding how you do 
your job? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
36.  Do you have a choice in deciding what you do 
at work? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
37.  Others take decisions concerning my work. 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
38.  I have a good deal to say in decisions about 
work. 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
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39.  I have a say in my own work speed. 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
40.  My working time can be flexible. 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
41.  I can decide when to take a break. 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
42.  I have a say in choosing with whom I 
work. 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
43.  I have a great deal of say in planning 
my work environment.   
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
44.  Do you have to do the same thing over 
and over again? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
45.  Does your job provide you with a 
variety of interesting things? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
46.  Is your job boring? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
 
 
47.  Do you have the possibility of learning 
new things through your work? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
48.  Does your work demand a high level of 
skill or expertise? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
49.  Does your job require you to take 
initiative? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
50.  Do you have to work very fast? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
51.  Do you have to work very intensively? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
52.  Do you have enough time to do 
everything? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
53.  Do different groups at work demand 
things from you that you think are hard to 
combine? 
                   1    Often           
                   2    Sometimes               
                   3    Rarely            
                   4    Never 
54.  How secure do you feel about your job or 
career future in your current workplace? 
                   1     Not at all secure 
                   2     Moderately secure 
                   3     Secure 
                   4     Extremely secure 
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55.  If you lost your present job, how 
difficult do you think it would be to get 
another job (with the same pay and same 
hours)? 
                   1     Not at all difficult 
                   2    Moderately difficult 
                   3    Difficult 
                   4    Extremely difficult 
56.  For the work you do in your main job, 
how fair is the pay, benefits and conditions 
you receive? 
                    1    Completely unfair       
                    2    Somewhat unfair      
                    3    Somewhat fair      
                    4    Completely fair 
57.  How many hours do you work in a 
routine week (including unpaid overtime, 
work taken home, etc)? 
                       _______  hours/week   
                                  
58.  How many working days in the last 
four weeks have you stayed away from 
your work (or school, or place of study)? 
                              _________days 
                                   
59.  During the past MONTH how often 
have you set aside time just to relax? 
 
1  Not at all 
 
2  Some or a little of the time 
(about once a  month or more) 
 
3  Occasionally or a moderate 
amount of the time (about once a week or 
more) 
 
4  Often or a lot of the time (about 
once a day) 
 
5  Frequently (more than once a 
day) 
 
60. To what extent are you responsible for 
household tasks? (these include such 
activities as preparing meals, shopping, 
cleaning, washing clothes and gardening). 
1    Fully responsible (100%) 
2    75% responsible 
3    50% responsible 
4    25% responsible 
5    Not at all responsible (0%) 
If you have no children go to Q 62. 
 
61.  To what extent are you responsible for 
childcare in your household? (Children’s care 
includes activities such as making meals, 
organising activities, supervising homework, 
discipline). 
1    Fully responsible (100%) 
2    75% responsible 
3    50% responsible 
4    25% responsible 
5    Not at all responsible (0%) 
62.  To what extent are you responsible for 
financial management in your household? 
(Financial management includes paying bills, 
saving, planning investments or priorities in 
money use). 
1    Fully responsible (100%) 
2    75% responsible 
3    50% responsible 
4    25% responsible 
5    Not at all responsible (0%) 
63.  To what extent are you responsible for 
providing the money for your household? 
1    Fully responsible (100%) 
2    75% responsible 
3    50% responsible 
4    25% responsible 
5    Not at all responsible (0%) 
64.  How would you describe your current 
employment status? 
1    Employed full time 
             2    Employed part-time, looking for full-        
time work 
3    Employed part-time 
4    Unemployed, looking for work 
5    Not in the workforce 
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65. Think of this ladder as representing where people ‘stand’ in Australia. 
 
At the top of the ladder are the people who are the best off – those who have the most money, the most 
education and the most respected jobs.  At the bottom are the people who are the worst off – who have 
the least money, least education, and the least respected jobs or no job.  The higher up you are on this 
ladder, the closer you are to the people at the very top; the lower you are, the closer you are to the people 
at the very bottom. 
 
Where would you place yourself on this ladder? 
 
Please place a large “X” on the rung where you think you stand at this time in your life, relative to other 
people in Australia. 
                
 
 
Thank you for completing this part of the study. 
Do you have any comments you would like to make about the questionnaire or the study in general? 
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Biomarkers of Stress Study 
 
  Part 2 
 
Update of PATH interview 
 
Please complete all questions, seal in the envelope provided and post to: 
 
Dr R Lucas 
NCEPH 
ANU 
Canberra 0200 
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The following questions ask for your 
views about your health, how you feel 
and how well you are able to do your 
usual activities on a typical day.  If you 
are unsure about how to answer a 
question, please give the best answer 
you can. 
 
1. Does you health now limit you in 
moderate activities, such as moving a 
table, pushing a vacuum cleaner, 
bowling or playing golf? 
1       Yes – limited a lot 
2       Yes – limited a little 
3       No –  not at all 
 
2.Does you health now limit you in 
climbing  several flights of stairs? 
1       Yes – limited a lot 
2       Yes – limited a little 
3       No –  not at all 
 
During the past 4 weeks, have you had 
any of the following problems with 
your work or other regular daily 
activities as a result of your physical 
health? 
 
3. Have you accomplished less than 
you would like as a result of your 
physical health? 
        Yes            No 
4. Were you limited in the kind of 
work or other activities as a result of 
your physical health?            
         Yes             No 
 
During the past 4 weeks, have you had 
any of the following problems with 
your work or other regular daily 
activities as a result of any emotional 
problems (such as feeling depressed or 
anxious)? 
 
5.Have you accomplished less than you 
would like as a result of any emotional 
problems? 
 
        Yes             No 
6. Did you not do work or other 
activities as  carefully as usual as a 
result of any emotional problems?  
        Yes             No 
During the past 4 weeks, how much did pain interfere 
with your normal work (including both work outside the 
home and housework)? 
 
  1   Not at all 
  2   A little bit 
  3   Moderately 
  4   Quite a bit 
  5   Extremely 
  
The next few questions are about how you feel and 
how things have been with you during the past four 
weeks.  For each question, please give the one answer 
that comes closest to the way you have been feeling. 
 
8.  How much of the time during the past 4 weeks 
have you felt calm and peaceful? 
                           1    All of the time 
                           2    Most of the time 
                           3    A good bit of the time 
                           4    Some of the time 
                           5    A little of the time 
                           6    None of the time 
 
9.  How much of the time during the past 4 weeks did 
you have a lot of energy? 
 
                           1    All of the time 
                           2    Most of the time 
                           3    A good bit of the time 
                           4    Some of the time 
                           5    A little of the time 
                           6    None of the time 
 
10.  How much of the time during the past 4 weeks  
have you felt down? 
 
                           1    All of the time 
                           2    Most of the time 
                           3    A good bit of the time 
                           4    Some of the time 
                           5    A little of the time 
                           6    None of the time 
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11. How much of the time during the 
past 4 weeks has your physical health 
or emotional problems interfered with 
your social activities (like visiting with 
friends, relatives, etc)? 
 
       1     All of the time 
       2    Most of the time 
       3    A good bit of the time 
       4    Some of the time 
       5    A little of the time 
       6    None of the time 
 
The next group of questions are about 
your relationships with other people. 
 
12.  How often do friends make you 
feel cared for? 
1    Often          
2    Sometimes               
3    Rarely             
4    Never 
 
13.  How often do they express interest 
in how you are doing? 
1    Often          
2    Sometimes               
3    Rarely             
4    Never 
14.  How often do friends make too 
many demands on you? 
1    Often          
2    Sometimes               
3    Rarely             
4    Never 
15.  How often do they criticise you? 
1    Often          
2    Sometimes               
3    Rarely             
4    Never 
16.  How often do friends create 
tensions or arguments with you? 
1    Often          
2    Sometimes               
3    Rarely             
4    Never 
 
 
 
 
 
 
 
17.  How often do family members make you feel 
cared for? 
                           1    Often          
                           2    Sometimes               
                           3    Rarely             
                           4    Never 
18.  How often do family members express 
interest in how you are doing? 
                           1    Often          
                           2    Sometimes               
                           3    Rarely             
                           4    Never 
19.  How often do they make too many 
demands on you? 
                           1    Often          
                           2    Sometimes               
                           3    Rarely             
                           4    Never 
20.  How often do family members criticise you? 
                           1    Often          
                           2    Sometimes               
                           3    Rarely             
                           4    Never 
21.  How often do they create tensions or 
arguments with you? 
                           1    Often          
                           2    Sometimes               
                           3    Rarely             
                           4    Never 
If you don’t have a current partner, go to Q 32 
22.  How much does your partner understand 
the way you feel about things? 
                           1    A lot       
                           2    Some  
                           3    A little         
                           4    Not at all 
23.  How much can you depend on your 
partner to be there when you really need 
him/her?     1    A lot       
                           2    Some  
                           3    A little         
                           4    Not at all 
24.  How much does your partner show 
concern for your feelings and problems? 
                           1    A lot       
                           2    Some  
                           3    A little         
                           4    Not at all 
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25.  How much can your trust 
your partner to keep 
promises to you? 
1     A lot          
2     Some              
3     A little              
4     Not at all 
26.  How much can you open up to 
your partner about things that are 
really important to you? 
1     A lot          
2     Some              
3     A little              
 4     Not at all  
 
27. How much tension is there between 
you and your partner? 
1     A lot          
2     Some              
3     A little              
4     Not at all 
 
28. How often do you have an 
unpleasant disagreement with 
your partner? 
1     A lot          
2     Some              
3     A little              
4     Not at all 
 
29. How often do things become tense 
when the two of you disagree? 
1     A lot          
2     Some              
3     A little              
4     Not at all 
 
30.  How often does your partner say 
cruel or angry things during a 
disagreement? 
1     A lot          
2     Some              
3     A little              
4     Not at all 
 
31. How often do the two of you both 
refuse to compromise during 
disagreements? 
1     A lot          
2     Some              
3     A little              
4     Not at all 
32.  The following scale consists of a 
number of words that describe 
different feelings or emotions.  Please 
read each item and indicate to what 
extent you have been feeling this way 
in the past month. 
Disgusted        1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
 Attentive         1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
Strong             1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
Scornful         1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
Irritable          1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
Inspired         1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
Afraid             1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
Alert              1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
Upset           1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
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Angry    
  1  Very slightly or not at all 
  2  A little     
  3  Moderately     
  4  Quite a bit     
5  Extremely 
Active                
1  Very slightly or not at all 
2  A little     
3  Moderately     
  4  Quite a bit     
  5  Extremely 
Guilty                
1  Very slightly or not at all 
  2  A little     
  3  Moderately     
  4  Quite a bit     
  5  Extremely 
Nervous            
1  Very slightly or not at all 
  2  A little     
  3  Moderately     
  4  Quite a bit     
  5  Extremely 
Excited 
1  Very slightly or not at all 
  2  A little     
  3  Moderately     
  4  Quite a bit     
  5  Extremely 
Hostile 
1  Very slightly or not at all 
  2  A little     
  3  Moderately     
  4  Quite a bit     
5  Extremely 
Proud  1  Very slightly or not at all 
  2  A little     
  3  Moderately     
  4  Quite a bit     
  5  Extremely 
Jittery 
 1  Very slightly or not at all 
  2  A little     
  3  Moderately     
  4  Quite a bit     
  5  Extremely 
Ashamed 
 1  Very slightly or not at all 
  2  A little     
  3  Moderately     
  4  Quite a bit     
 5  Extremely 
Scared              1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
 
Enthusiastic     1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
Distressed       1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
Determined     1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
Interested        1   Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
Loathing         1  Very slightly or not at all 
                     2  A little     
                          3  Moderately     
                          4  Quite a bit     
                          5  Extremely 
 
Next are some specific questions about your health 
and how you have been feeling in the past month. 
 
In the past month: 
33.  Have you felt keyed up or on edge? 
             Yes                  No 
34.  Have you been worrying a lot?  
                         Yes                  No 
35.  Have you been irritable?   
                         Yes                 No 
36.  Have you had difficulty relaxing?  
           Yes                 No 
37.   Have you been sleeping poorly. 
                        Yes                  No 
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38.  Have you had headaches or 
neckaches? 
               Yes                  No 
In the past month: 
39.  Have you had any of the 
following: trembling, tingling, 
dizzy spells, sweating, diarrhoea, 
or needing to pass water more 
often than usual? 
 Yes                  No 
 40. Have you been worried about your 
health?  
               Yes                  No 
41. Have you had difficulty falling asleep?
   
  Yes                  No 
42.   Have you been lacking energy? 
               Yes                  No 
43.  Have you lost interest in things? 
              Yes                  No 
44.  Have you lost confidence in yourself?
   
              Yes                  No 
45.  Have you felt hopeless?  
             Yes                  No 
46.  Have you had difficulty 
concentrating?   
             Yes                  No 
47.  Have you lost weight (due to poor 
appetite)?  
           Yes                  No 
48.  Have you been waking early?
  Yes                  No 
49.  Have you felt slowed up? 
   Yes                  No 
50.  Have you tended to feel worse in 
the mornings? 
               Yes                 No 
 
 
How strongly do you agree or disagree with 
the following statements? 
 
51.  There is really no way I can solve some of the 
problems I have. 
1    Strongly agree     
             2    Agree          
3    Disagree         
4    Strongly disagree 
52.  Sometimes I feel that I’m being pushed around in 
life. 
1    Strongly agree     
             2    Agree          
3    Disagree         
4    Strongly disagree 
53.  I have little control over the things that happen to 
me. 
1    Strongly agree     
             2    Agree          
3    Disagree         
4    Strongly disagree 
54.  I can do just about anything I really set my mind 
to do. 
1    Strongly agree     
             2    Agree          
3    Disagree         
4    Strongly disagree 
55.  I often feel helpless in dealing with the problems 
of life. 
1    Strongly agree     
             2    Agree          
3    Disagree         
4    Strongly disagree 
56.  What happens to me in the future mostly depends 
on me. 
1    Strongly agree     
             2    Agree          
3    Disagree         
4    Strongly disagree 
57.  There is little I can do to change many of the 
important things in my life. 
1    Strongly agree     
            2    Agree          
3    Disagree         
4    Strongly disagree 
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People think and do many different 
things when they feel sad, blue or 
depressed.  Please read each of the 
items below and indicate whether you 
never, sometimes, often or always 
think or do each one when you feel 
sad, down or depressed. Please indicate 
what you generally do, not what you 
think you should do. 
 
58.   I think about how alone I feel.  
1    Never      
2    Sometimes      
3    Often       
4    Always 
59.  I think about my feelings of 
fatigue and achiness. 
1    Never      
2    Sometimes      
3    Often       
4    Always 
60.  I think about how hard it is to 
concentrate. 
1    Never      
2    Sometimes      
3    Often       
4    Always 
61.  I think about how passive and 
unmotivated I  feel. 
1    Never      
2    Sometimes      
3    Often       
4    Always 
62.  I think,  “Why can’t I get going?” 
1    Never      
2    Sometimes      
3    Often       
4    Always 
63. I think about a recent situation, 
wishing it had gone better. 
1    Never      
2    Sometimes      
3    Often       
4    Always 
64.  I think about how sad I feel.  
1    Never      
2    Sometimes      
3    Often       
4    Always 
 
 
 
 
65.   I think about all my shortcomings, 
failings, faults and mistakes. 
                              1    Never      
                              2    Sometimes      
                              3    Often       
                              4    Always 
66. I think about how I don’t feel up to doing 
anything. 
                              1    Never      
                              2    Sometimes      
                              3    Often       
                              4    Always 
67.  I think, “Why can’t I do things better?” 
                              1    Never      
                              2    Sometimes      
                              3    Often       
                              4    Always 
 
The following questions concern the way you 
behave, feel and act. Decide for each 
question whether “YES” or “NO” represents 
your usual way of acting or feeling. Work 
quickly, and don’t spend too much time over 
any question. 
68.  Does your mood often go up and down? 
                 Yes             No 
69.  Do you take much notice of what people think?
                  Yes             No 
70. Are you a talkative person?   
    Yes             No 
71. Do you ever feel “just miserable” for no reason?
   
                              Yes             No 
72. Would being in debt worry you?  
    Yes             No 
73. Are you rather lively?   
     Yes             No 
74. Are you an irritable person?   
    Yes             No 
75. Would you take drugs which may have strange or 
dangerous effects?  
                              Yes             No 
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76. Do you enjoy meeting new people?
   Yes             No 
77. Are your feelings easily hurt?
   Yes             No 
78. Do you prefer to go your own 
way rather than act by the rules? 
  
   Yes             No                      
79. Can you usually let yourself go and 
enjoy yourself at a lively party?  
   Yes             No 
80. Do you often feel ‘fed-up’? 
  Yes             No 
81. Do good manners and cleanliness 
matter much to you?  
  Yes             No 
82. Do you usually take the initiative in 
making new friends?  
  Yes             No 
83. Would you call yourself a nervous 
person?    Yes             No 
84. Do you think marriage is old-
fashioned and should be done away 
with? 
    Yes             No 
85. Can you easily get some life into a 
rather dull party?   
              Yes             No 
86. Are you a worrier?  
   Yes             No 
87. Do you enjoy co-operating with 
others?   
  Yes             No 
88. Do you tend to keep in the 
background on social occasions? 
              Yes             No 
89.  Does it worry you if you know 
there are mistakes in your work? 
              Yes             No 
90. Would you call yourself tense or ‘highly-strung’?
   
                                    Yes             No 
91. Do you think people spend too much time  
safeguarding their future with savings and insurance? 
                                    Yes             No 
92. Do you like mixing with people?  
      Yes             No 
93. Do you worry too long after an embarrassing 
experience? 
                                   Yes             No 
94. Do you try not to be rude to people?  
          Yes             No 
95. Do you like plenty of bustle and excitement around 
you?  
                                       Yes             No 
96. Do you suffer from “nerves”?  
               Yes             No 
97. Would you like other people to be afraid of you?
   
                                      Yes             No 
98. Are you mostly quiet when you are with other 
people?  
                                      Yes             No 
99. Do you often feel lonely?   
             Yes             No 
100. Is it better to follow society’s rules than go your 
own way?  
                                     Yes             No 
101. Do other people think of you as being very lively?
   
                                    Yes             No 
102. Are you often troubled about feelings of guilt?
            Yes             No 
103. Can you get a party going?   
            Yes             No 
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Each of the following is a statement 
that a person may either agree or 
disagree with. Indicate how much you 
agree or disagree with each statement. 
 
Please be as accurate and as honest as 
you can be.  Respond to each item as if 
it were the only item.  That is, don’t 
worry about being ‘consistent’ in your 
responses. 
 
104. A person’s family is the most 
important thing in life. 
         1   Very false for me     
         2   Somewhat false for me 
         3   Somewhat true for me 
         4   Very true for me                                     
105. Even if something bad is about 
to happen to me, I rarely experience 
fear or  nervousness. 
         1   Very false for me     
         2   Somewhat false for me 
         3   Somewhat true for me 
         4   Very true for me                                    
106. I go out of my way to get things 
I want. 
         1   Very false for me     
         2   Somewhat false for me 
         3   Somewhat true for me 
         4   Very true for me                                    
107. When I’m doing well at 
something, I love to keep at it. 
         1   Very false for me     
         2   Somewhat false for me 
         3   Somewhat true for me 
         4   Very true for me                                    
108. I’m always willing to try  
something new if I think it will be 
fun. 
         1   Very false for me     
         2   Somewhat false for me 
         3   Somewhat true for me 
         4   Very true for me                                    
109. How I dress is important to me. 
         1   Very false for me     
         2   Somewhat false for me 
         3   Somewhat true for me 
         4   Very true for me                                                                       
 
 
110. When I get something I want, I feel excited and 
energised.         1   Very false for me     
                                  2   Somewhat false for me 
                                  3   Somewhat true for me 
                                  4   Very true for me                                     
111. Criticism or scolding hurts me quite a bit. 
                                  1   Very false for me     
                                  2   Somewhat false for me 
                                  3   Somewhat true for me 
                                  4   Very true for me                                     
112. When I want something I usually go all-out to 
get it. 
                                  1   Very false for me     
                                  2   Somewhat false for me 
                                  3   Somewhat true for me 
                                  4   Very true for me                                     
113. I will often do things for no other reason than 
that they might be fun. 
                                  1   Very false for me     
                                  2   Somewhat false for me 
                                  3   Somewhat true for me 
                                  4   Very true for me                                     
114. It’s hard for me to find the time to do things 
such as get a hair cut. 
                                  1   Very false for me     
                                  2   Somewhat false for me 
                                  3   Somewhat true for me 
                                  4   Very true for me                                     
115. If I see a chance to get something I want I move 
on it right away. 
                                  1   Very false for me     
                                  2   Somewhat false for me 
                                  3   Somewhat true for me 
                                  4   Very true for me                                     
116. I feel pretty worried or upset when I think or 
know somebody is angry at me. 
                                  1   Very false for me     
                                  2   Somewhat false for me 
                                  3   Somewhat true for me 
                                  4   Very true for me                                     
117. When I see an opportunity for something I like 
I get excited right away. 
                                  1   Very false for me     
                                  2   Somewhat false for me 
                                  3   Somewhat true for me 
                                  4   Very true for me                                     
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118.  I often act on the spur of the 
moment. 
          1   Very false for me     
          2   Somewhat false for me 
          3   Somewhat true for me 
          4    Very true for me                                     
119. If I think something unpleasant 
is going to happen I usually get 
pretty ‘worked-up’. 
          1   Very false for me     
          2   Somewhat false for me 
          3   Somewhat true for me 
          4    Very true for me                                  
120.  I often wonder why people act 
the way they do. 
          1   Very false for me     
          2   Somewhat false for me 
          3   Somewhat true for me 
          4    Very true for me                                    
121.  When good things happen to 
me, it affects me strongly. 
          1   Very false for me     
          2   Somewhat false for me 
          3   Somewhat true for me 
          4    Very true for me                                    
122.  I feel worried when I think I 
have done poorly at something 
important. 
          1   Very false for me     
          2   Somewhat false for me 
          3   Somewhat true for me 
          4    Very true for me                                    
123.  I crave excitement and new 
sensations. 
          1   Very false for me     
          2   Somewhat false for me 
          3   Somewhat true for me 
          4    Very true for me                                    
124.  When I go after something, I 
use a ‘no-holds-barred’ approach. 
          1   Very false for me     
          2   Somewhat false for me 
          3   Somewhat true for me 
          4    Very true for me                                     
 
 
 
 
 
125.  I have very few fears compared to my friends. 
                                  1   Very false for me     
                                  2   Somewhat false for me 
                                  3   Somewhat true for me 
                                  4   Very true for me                                     
126. It would excite me to win a contest. 
                                  1   Very false for me     
                                  2   Somewhat false for me 
                                  3   Somewhat true for me 
                                  4   Very true for me                                     
127.  I worry about making mistakes. 
                         1   Very false for me     
                                  2   Somewhat false for me 
                                  3   Somewhat true for me 
                                  4   Very true for me                                     
128. How often do you take part in sports or activities 
that are mildly energetic, moderately energetic or 
vigorous? 
Mildly energetic (eg. walking, woodwork, weeding, 
hoeing, bicycle repair, playing pool, general 
housework). 
                          1      3 times a week or more       
                          2      Once or twice a week 
                          3     About 1-3 times a month 
                          4     Never/hardly ever  
Moderately energetic (eg. scrubbing, polishing car, 
dancing, golf, cycling, decorating, lawn mowing, 
leisurely swimming). 
                          1      3 times a week or more       
                          2     Once or twice a week 
                          3     About 1-3 times a month 
               4     Never/hardly ever  
Vigorous (eg running, hard swimming, tennis, 
squash, digging, cycle racing). 
                          1      3 times a week or more       
                          2      Once or twice a week 
                          3     About 1-3 times a month 
                          4     Never/hardly ever  
Please give the average number of hours per week 
you spend in such sports or activities. 
 
Mildly energetic (eg walking, weeding)               
__________Hours  __________minutes  
Moderately energetic (eg dancing, cycling)                         
__________Hours  __________minutes 
Vigorous (eg running, squash)    
__________Hours  __________minutes
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Congratulations, you have completed Part 2 of the Questionnaire.  Thank you very much for 
your time and patience. 
 
Please seal in the reply paid envelope and post to: 
 
Dr R Lucas 
NCEPH 
ANU  
Canberra 0200 
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Appendix C 
Protocol for the collection and determination of IgA in saliva by enzyme 
linked immunosorbent assay. 
C.1  Specimen Details 
C.1.1  Specimen Collection 
Saliva is collected by gentle suction using a paediatric suction set directly into a 
paediatric collection tube. 
The saliva is immediately placed on ice and frozen at –20oC within one hour of 
collection. 
Contamination with food or coloured substances is to be avoided.  
Saliva is collected 2 hours post-prandially with no stimulation. 
C.1.2  Specimen Preparation 
Remove the saliva from the collection tube and store in a Nunc cryotube    at –70oC. 
Microfuge the sample for 5 minutes on speed 2 or centrifuge at 3000rpm for 10 
minutes. The supernatant is aspirated and used directly in the assay. 
C.1.3  Specimen Stability 
The saliva sample can be kept for 2 years if stored at –20oC and 10 years at –70oC 
If the sample is kept at 4oC it will be stable for 1 hour.  When assaying it is important to 
keep the sample at 4oC and return to the freezer as soon as possible. 
Repeated freeze/thawing must be avoided as there is a 1-2% loss of stability each time. 
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C.2 Assay Method 
C.2.1  Principle of Assay 
Immunoglobulin class specific goat anti-human antibody adsorbed to the surface of an 
immunoplate acts as antigen to salivary antibody. The complex formed when standard 
or sample is added to the immunoplate is then bound to horseradish peroxidase- 
conjugated goat anti-human antibody. Tetramethylbenzidine is added to the plate as the 
substrate for a colour reaction. The reaction is stopped with 0.5M H2SO4   after 
incubation and the absorbance read at 450nm. A quantifiable correlation exists between 
the intensity of colour development and the concentration of antibody in the sample. 
C.2.2  Materials 
Sodium chloride 
Sodium carbonate Na2CO3 
Sodium bicarbonate  NaHCO3 
Citric acid 
Sodium hydrogen phosphate, anhydrous Na2HPO4  
Skim Milk Powder (Diploma) 
Unconjugated goat anti human IgA 
HRP-conjugated anti-human IgA 
Standard human IgA 
Hydrogen peroxide – 30%w/v 
3’,3’,5’,5’,5’-tetramethylbenzidine (TMB) 
Dimethyl sulfoxide (DMSO) 
Tween 20 (Amresco 00777) 
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C.2.3  Equipment 
Finn pipetting system – 0.5-10µl, 5-40µl, 40-200µl, 200-1000µl, 1-5ml, 1-10ml. 
Pipette tips 
Magnetic stirrer 
Nunc Maxisorb 96 well immunoplates 
Multichannel pipettes  - 5-50µl, 50-300µl 
Microfuge tubes 
4L container for Wash Solution 
Weighing trays 
Measuring cylinders – 100ml, 200ml, 2L 
Molecular Devices Thermomax Microplate Reader 
IBM Personal Computer 
Printer 
Power Supply 
Magnetic stirring fleas 
Absorbent wash cloths 
Nunc cryotubes 
Paediatric suction collection sets 
Suction pump 
pH meter 
1 litre glass bottles (6) 
C.2.4  Reagents 
Carbonate buffer, pH 9.6, 0.1M 
Sodium carbonate 
Sodium bicarbonate 
  478
PBS Tween 20, 0.05%, pH 7.2 
5% skim milk in PBS 
ELISA diluent; 0.1% skim milk in PBS-Tween 20. 
TMB substrate buffer 
Citric acid 
Trisodium citrate 
0.5M H2SO4 
Unconjugated anti-IgA diluted 1:2000 in carbonate buffer 
Conjugated anti-IgA diluted 1:2000 in 0.1% skim milk PBS-Tween 20, 0.05% 
10 dilutions of standard human IgA in 0.1% skim milk PBS-Tween 20, 0.05% 
10X PBS 
C.2.5 Reagent Preparation 
Preparation prior to day of assay 
Carbonate/bicarbonate  buffer – pH 9.6   
• Weigh out     1.59g Na2CO3   (Proanlys SL 969) 
                                                   2.93g NaHCO3 (Proanlys SL 900) 
• Dissolve in 800ml nanopure water 
• Adjust pH to 9.6 and make up to a total volume of 1 litre with 
nanopure water 
• Store in a glass bottle at 4oC for 1 week 
 
Phosphate buffered saline (10 x PBS) pH 6.6 
1.38 M NaCl  (Mwt 58.44) 162g 
28mM Na2HPO4.12H2O (Mwt 358.15) 20.04g 
11mM NaH2PO4.2H2O (Mwt 156.01) 3.3g 
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• Weigh out the above chemicals in a 2 litre beaker and dissolve in 1.91 nanopure 
water 
• Adjust pH to 6.6 with 1M HCl 
• Make up volume to 2 L with nanopure water 
 
TMB substrate buffer 
            0.5M Citric Acid (anyhdrous)  Mwt 192.1 1.01g 
            100mM Na2HPO4.12H20  Mwt 358.15 3.58g 
 
• Weigh out the above chemicals in a 100ml beaker  
• Dissolve in 90mls nanopure H2O 
• Adjust pH to 5.0 and make up to a total volume of 100mls with 
nanopure water 
• Store at 4oC indefinitely 
 
TMB in DMSO 
• Dissolve 0.1g  3’,3’,5’,5’,5’ – tetramethylbenzidine (TMB) in 10 
mls Dimethyl sulfoxide (DMSO). 
• Store at in fume cupboard at room temperature indefinitely. 
Preparation on Day of Assay 
Wash solution (PBS-Tween 20 – 0.05%) 
• Add 200 ml 10x PBS to 1800 ml nanopure water. (to make 1x 
PBS) 
• Add 1ml Tween 20 
• Cover with parafilm and invert gently to mix 
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Blocking buffer – 5% skim milk 
• Weigh 1g milk powder (non fat skim milk) 
• Dissolve in 100ml PBS/Tween 
• Allow 30 ml/plate 
               
Spit Diluent (0.1% skim milk in Wash Solution) 
• To prepare 50ml spit diluent, add 1ml blocking buffer to 49ml 
wash solution. 
• Allow 350 ml for 3 plates. 
 
TMB working solution 
• Mix    10ml TMB substrate buffer 
                  100µl TMB in DMSO 
                  2.25µl H2O2 (added just before use ) 30%w/v 
• Need 15ml per plate 
• Prepare on day of assay 
• Use within 30 minutes ( immediately once H2O2 added) 
 
Standard/Antibodies 
• Standard – Human IgA Sigma T1010 1mg/ml 
• α Human IgA / 7S Nordic SK 2917/02 
• α Human IgA (α chain) PO- conjugate Sigma 
 
  481
C.3 Method Protocol 
C.3.1  Test Procedure 
DAY 1 
• Make up 10mls of α-human IgA/7S at dilution of 1 in 800 with coating buffer. 
Pipette 50μL into all wells except blank wells. 
•  
Volume required 
for 2 plates 
Required dilution Volume of α-
human IgA/7S 
Volume of coating 
buffer 
10mls 1:800 12.5μL 9987.5μL 
 
DAY 2 
• Wash all plates 5x in PBS/Tween 20 solution 
• Block all wells with 100μL of 5% skim milk powder/PBS/Tween solution 
• Incubate for 60 mins at 37ºC 
 
• Make up Standard Dilutions as follows: 
Standard Final conc. 
Standard (μg/ml) 
Volume standard Volume of 5% skim 
milk/PBS/Tween 
S0 25.0 25μL of 1mg/ml 975μL 
S1 0.25 20μL of S0 1980 μL 
S2 0.13 1000 μL of S1 1000 μL 
S3 0.06 1000μL of S2 1000μL 
S4 0.03 1000μL of S3 1000 μL 
S5 0.015 1000μL of S4 1000 μL 
S6 0.008 1000μL of S5 1000 μL 
S7 0.004 1000μL of S6 1000 μL 
 
• Make up unknown samples as follows: 
  They are usually diluted 1:100, 1:1000, 1:10000 
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Dilution Volume unknown sample Volume 5% skim 
milk/PBS/Tween 
1:100 6μL 594μL 
1:1000 30μL of 1:100 270 μL 
1:10000 30μL of 1:1000 270 μL 
 
• Wash all plates as before 5x 
• Add 50μL of Sample to sample wells 
  50μL of Standard to appropriate to standard wells 
  50 μL of positive and negative Control to appropriate wells 
  50 μL of skim milk powder to blank wells 
  (Negative control diluted 1:100, Positive control diluted 1:400) 
  After loading, plates are incubated at 37ºC for 60 mins 
Wash plates 5x as before 
Add 50 μL conjugate to all wells 
Dilution Volume for: Volume of IgA PO 
conjugate 
Volume of 1% 
milk/PBS/Tween 
1:1600 10mls – 2 plates 6.3 μL 10mls 
1:1600 20mls – 4 plates 12.5 μL 20mls 
 
Incubate plates for 60 mins at 37ºC. 
Wash plates 5X as before 
Add 50 μL of TMB working solution to all wells 
 
Reagent Volume required  
TMB substrate 10mls-2 plates 20mls – 4 plates 
TMB in DMSO 100 μL 200 μL 
H2O2 1.5 μL 3.0 μL 
 
Stop reaction after 10 mins by adding 50 μL of 0.5M H2SO4 to all wells. 
Read plates on plate reader at 450nm 
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C.3.2  Calculations and Computations. 
The computer software will calculate the values of the unknown by 
constructing a standard curve using the 4 parameter equation 
                                Y=(A-D)/1+(x/C)^B)+D 
The standard curve is acceptable when: 
• The correlation coefficient is higher than 0.980 for IgA 
• The calculated values for standards in the linear portion of the 
curve are in good agreement with the real values.  One outlying 
value can be omitted from triplicates if the other two values are in 
good agreement. 
• Values calculated for controls are in agreement with the range set 
by previous analyses or with the stated value in the case where 
there is a known value. 
Unknowns are acceptable when: 
• The optical density (OD) falls in the portion of the graph that is 
linear.  If the OD is higher than the standard which is at the 
highest spot of the linear segment, the specimen should be diluted 
by a further factor of 2 and re-run.  If the OD falls below the 
standard at the lowest point of the linear section of the standard 
curve, the results should be reported as being a “NIL 
DETECTED” result or recorded as being < (STD value) if it is 
considered to be a very small but measureable amount or return at 
a lower dilution to confirm “NIL DETECTED”. 
• The triplicates are in good agreement with one another. One 
triplicate can be omitted and the result calculated from the 
remaining duplicates if that triplicate is clearly an outlying result. 
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Appendix D 
Protocol for the analysis of serum for Neopterin by enzyme 
linked immunosorbent assay. 
D.1 Specimen Details 
 D.1.1 Specimen Collection 
Serum should be collected by venepuncture in the standard way.   
Neopterin is sensitive to light. Patient samples should therefore be protected from 
light by wrapping the collection tube in foil. 
The sample is immediately centrifuged to separate out the serum and frozen at –
20oC 
 D.1.2 Specimen Stability 
1.2.1  Neopterin is stable at 4-8oC for 3 days, and at –20oC for six months. 
1.2.2    Repeated thawing and refreezing should be avoided. 
 D.1.3 Specimen Preparation 
1.3.1    All samples should be free from microbial contamination. Before storage at 
–  20oC serum or plasma should be separated from blood clots. 
1.3.2 Insoluble material should be removed from the samples by centrifugation 
prior to the test. 
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D.2. Method  
D.2.1 Principle of the Assay 
The ELItest Neopterin assay is a competitive enzyme immunoassay using coated 
microtitre plates. The wells of the microtitre plate are coated with anti-neopterin 
antibodies (sheep, polyclonal). After addition of the enzyme conjugate 
(neopterin/alkaline phosphatase conjugate) to standard and control sera and to 
patient samples the neopterin of the patient samples competes with the 
neopterin/enzyme conjugate for the binding sites of the coating antibodies to form 
an immune complex bound to the solid phase (anti-neopterin antibody/neopterin 
or anti-neopterin antibody/neopterin enzyme conjugate complexes). 
Subsequent intensive washing ensures the complete removal of all unbound 
components. The addition of 4-nitrophenyl phosphate as a substrate solution starts 
the enzyme reaction in which the alkaline phosphatase contained in the 
neopterin/enzyme conjugate catalyses the cleavage of the phosphate of 4-
nitrophenyl phosphate, thus forming the yellow 4-nitrophenol. The enzymatic 
reaction is stopped by alkalinisation with sodium hydroxide. The intensity of the 
colour (measured in optical density OD) depends on the quantity of enzyme bound 
for a constant reaction time and consequently is inversely proportional to the 
neopterin concentration in the patient sample. Thus high neopterin values 
correspond to a low optical density. 
 
The optical density is measured by means of a microtitre plate reader at an 
absorption maximum of 405nm. The results are calculated by plotting a standard 
curve (optical density versus concentrations of neopterin standard), from which 
the neopterin concentrations  in the patient samples can be read off directly. 
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D.2.2 Materials and Reagents 
ELItest Neopterin   Brahms Diagnostica 
1 plate, coated with anti-neopterin antibodies (polyclonal, sheep) 
1 plate, uncoated 
1 vial, enzyme conjugate (neopterin/alkaline phosphatase conjugate),     lypophilized. 
1 vial (16ml)  enzyme conjugate buffer 
2 tablets 4-nitorphenyl phosphate 
1 vial substrate buffer 
1 vial 2N sodium hydroxide (stop solution) 
Washing solution concentrate 
Neopterin standards, human serum (6 vials) 
 Control sera (2 vials) 
 D.2.3 Equipment 
1 black cover sheet 
Finn pipetting system – 1-10ml, 40-200µl, 200-1000µl 
Multichannel pipettes – 50µl, 100µl 
1 litre container for washing solution 
Molecular Devices Thermomax Microplate Reader 
IBM Personal Computer 
Printer 
Power Supply 
Absorbent wash cloths 
Pipette tips 
Measuring cylinders – 500ml, 20ml, 10ml 
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 D.2.4  Stability and Storage of kit 
Store all reagents and the coated microtitre plate (A) at 4-8oC in their original 
shipping  containers until immediately prior to use. Uncoated microtitre plates (A2) 
can be stored at room temperature. 
Adjust the kit components to room temperature before use (about 30 minutes 
beforehand) and store cool again after use. If a fraction of the standard, the controls, 
the enzyme conjugate buffer, the substrate buffer, the concentrated washing solution 
and the stop solution is removed aseptically, the unused quantity of the reagents is 
stable at 4-8oC in the original containers until the expiry date indicated. 
 D.2.5 Reagent preparation on day of Assay 
Adjust the reagents to room temperature before undertaking the test and ensure the 
homogeneity of the solution. 
Add buffer ( C)  to the enzyme conjugate (B) to prepare the ready to use form.  
Stable for at least 4 weeks when kept at 4oC 
Prepare washing solution: dilute 11 ml concentrate with distilled water to yield 
550ml.  Diluted washing solution may be used for up to 4 weeks if stored at 4-8oC.  
Contaminated washing solution must not be used.  This is the case if the liquid is 
clouded or the pH value is <6. 
Ensure the substrate tablets (D) are completely dissolved in substrate buffer (E). 
This ready to use substrate solution (D+E) is stable for 3 days at 4oC.  
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D.3  Method Protocol 
D.3.1 Test Procedure 
Do not interrupt the individual stages in the procedure. Keep the order and the 
incubation times constant for all samples. The wells in the plate should always be 
filled in the same order. 
Incubation must be carried out in the dark because of the sensitivity of neopterin 
to light (black cover sheet); the substrate/enzyme reaction can also be carried out 
in normal daylight. 
A standard series and negative and positive controls must be carried out for each 
microtitre plate. 
It is recommended that a blank be determined, for which a corresponding well 
should be left free. (pipette 100µl of the substrate and add 100µl of the stop 
solution coincident with adding substrate and stop solution to the rest of the plate). 
Duplicates are recommended. 
 
Pipette 50µl of the standards (in increasing concentrations), 50µl of the controls and 
50µl of the serum samples each with 150µl of the enzyme conjugate into the 
uncoated microtitre plate (A2). 
Mix thoroughly by shaking briefly or aspirating and ejecting twice. 
Transfer an aliquot of 150µl of this mixture into the neopterin-antibody coated 
microtitre plate (A) using a multichannel pipette. The transfer time should not 
exceed 5 minutes. 
Incubate the microtitre plate for 2 hours at room temperature in the dark (using the 
black cover sheet). 
Aspirate or decant the incubation volume. 
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Wash all the wells with 350µl of washing solution W. 
Aspirate or decant the wells again completely. 
Repeat the last two steps 3 times to ensure a total of 4 washing steps. 
After the last washing step, remove any remaining droplets by tapping the plate 
sharply on blotting paper, taking care to ensure no droplets remain in the wells. 
Pipette 100µl of the dissolved substrate (4-nitrophenyl phosphate) into all wells – 
including that of the blank. 
Incubate the microtitre plate (A) again for 30± 5 minutes at room temperature.  This 
reaction can be performed in normal daylight. 
Because of the temperature dependency of the enzyme activity, it is recommended the 
incubation of the enzyme/substrate reaction should be as follows: 
 
Room Temperature range  
           (oC) 
Duration of 
enzyme/substrate 
interaction (minutes) 
17.0-20.4 
20.5-24.9 
>25.0 
35 
30 
25 
  
Pipette 100µl of stop solution F into all wells to stop the enzyme reaction and the 
formation of colour. Sodium hydroxide must be added in the same order as for the 
substrate.  
Ensure the contents of the wells are thoroughly mixed by shaking the microtitre 
plate (A) briefly before measuring the optical density. 
The optical density (OD) is measured in a photometer at a wavelength of 405nm.  
Optionally the measured blank is subtracted from the optical density results 
obtained. 
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D.3.2 Calculations and Computations 
All commercially available photometer-computer combinations allowing an 
analysis by spline function or point to point are suitable for the computer-assisted 
evaluation of the ELItest neopterin. 
Alternatively, the results can also be calculated using semilogarithmic graph 
paper. In this case the standards (x-axis, logarithmic) are plotted against the mean 
values of the optical density of the standards (y-axis, linear), thus creating a 
standard curve with the 6 points obtained. The optical density of the samples can 
now be used to read off the corresponding neopterin concentrations directly in 
nmol/l. 
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Appendix E 
 
Table E.1 Intraclass correlation between variables measured in the PATH study and the 
same variables measured over a year later in the 2001 study. 
 Intraclass correlation 
coefficient  
(95% CI) 
p 
SF-12 mental health 0.45 (0.35-0.54) <0.001 
Anxiety (Goldberg) 0.52 (0.44-0.60) <0.001 
Depression (Goldberg) 0.47 (0.38-0.56) <0.001 
Mastery 0.63 (0.56-0.70) <0.001 
Ruminative style 0.62 (0.55-0.69) <0.001 
Systolic blood pressure 0.67 (0.61-0.73) <0.001 
Diastolic blood pressure 0.58 (0.50-0.65) <0.001 
Positive interaction with 
friends 
0.54 (0.45-0.62) <0.001 
Negative interaction with 
friends 
0.59 (0.51-0.66) <0.001 
Positive interaction with 
family 
0.48 (0.39-0.57) <0.001 
Negative interaction with 
family 
0.48 (0.39-0.57) <0.001 
Positive interaction with 
partner 
0.63 (0.55-0.70) <0.001 
Negative interaction with 
partner 
0.68 (0.61-0.75) <0.001 
Negative affect 0.47 (0.38-0.56) <0.001 
Positive affect 0.63 (0.56-0.70) <0.001 
Hostility 0.33 (0.23-0.44) <0.001 
Drive 0.72 (0.67-0.78) <0.001 
Fun-seeking 0.70 (0.64-0.76) <0.001 
Reward responsiveness 0.63 (0.56-0.70) <0.001 
Behavioural inhibition 0.74 (0.69-0.79) <0.001 
Neuroticism 0.77 (0.73-0.82) <0.001 
Extroversion 0.83 (0.80-0.87) <0.001 
Psychoticism 0.66 (0.60-0.73) <0.001 
Marital status 0.95 (0.94-0.96) <0.001 
Employment status 0.87 (0.84-0.90) <0.001 
Self rated health 0.55 (0.47-0.63) <0.001 
Decision authority 0.76 (0.71-0.81) <0.001 
Skill discretion 0.18 (0.07-0.30) 0.001 
Job demands 0.63 (0.56-0.70) <0.001 
SF 12 physical health 0.35 (0.25-0.45) <0.001 
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Appendix F 
 
Calculation of equivalent income. 
Data collected included gross weekly personal and household income, spouse’s 
occupation, number of children, ages of children and whether they lived at home part-
time, full-time or not at all. Personal income was set at the mean of the range of income 
indicated for both personal and household income Spouse gross income was calculated 
by subtracting personal income from household income. The resulting figure was 
checked against spouse’s occupation and marital status, i.e. if personal income was 
identical to household income, checks were made that there was either no spouse, or 
that the spouse was not working. Annual gross personal and spouse income were 
calculated (by multiplying weekly income by 52). 
 
Disposable personal and spouse income were calculated by reference to Tax Pack 2001 
[602]. Only personal income tax was taken into account in calculating approximate 
disposable income. Disposable household income was then calculated as the sum of the 
personal and spouse disposable income. 
 
Points were assigned to a household depending on household characteristics as outlined 
for the simplified Henderson equivalence scale (as modified by NATSEM [603]. This 
scale uses the labour force status of parents as well as age and dependency status of 
children to calculate points. A dependent child was defined according to the definition 
used by the Australian Bureau of Statistics [604] as: 
• All persons less than 15 years of age 
• Persons aged 15-24 years who are full-time students, live with a parent, guardian 
or other relative and do not have a spouse or offspring of their own living with 
them  
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There were no available data on the labour force status of children; so that persons aged 
15-24 were considered to be dependent if they lived with parents more than half time. In 
those situations where parents were living in separate accommodation and children 
spent time in both places, children accrued half of the points of a fully dependent child 
(clearly this misses the determination of which parent has financial responsibility for 
non-custodial children). 
 
Table F.1 “Individual points’ for the simplified Henderson equivalence scale (as 
modified by NATSEM) 
Reference person, working 20.00 
Reference person, not in the labour 
force or part time 
13.00 
Partner, working 18.50 
Partner, not in the labour force or part 
time 
9.50 
Dependent child, 0-5 years 5.080 
Dependent child, 6-14 years 8.355 
Dependent child, 15-24 years 12.025 
 
    Table F.2 “Household points” for the simplified Henderson equivalence scale 
Household size Housing Fuel/power Total 
1 12.1 4.9 17.0 
2 13.3 6.7 20.0 
3 14.5 8.0 22.5 
4 15.7 9.3 25.0 
5 16.9 10.6 27.5 
6 18.2 11.8 30.0 
7 19.4 12.6 32.0 
8 20.0 14.0 34.0 
9 21.2 14.8 36.0 
10 21.8 16.2 38.0 
11 22.4 17.6 40.0 
12+ 24.2 19.8 44.0 
 
The total points for the household (individual and household) are summed. The 
equivalence ratio was then calculated by comparison to the standard income unit 
comprising a full time worker, a partner not working full time and two dependent 
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children (67.94). Disposable household income was then divided by the adjusted points 
to give the equivalent household income.  
 
i.e. S = P/PS 
where S = equivalence ratio 
          P = the total points for the income unit 
          PS = the points for a standard income unit (67.94) 
The equivalence ratio is then used to adjust the household disposable income to give 
an estimate of the equivalent income, 
 
Ie = I/S 
Where  Ie = the equivalent income (adjusted for household circumstances) 
              I = disposable household income 
              S = the equivalence ratio 
